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Phosphorus in the form of inorganic phosphate, PO4
3-, is necessary for all living beings. As such, it is 
incorporated in diverse structural organic and inorganic components that make up cells, organisms 
and entire life-forms. Adult human beings contain on average 700 g of phosphorus of which 90% is 
present in bones and teeth as apatite. The rest is located in tissues and extracellular fluids.[1] 
Transformations that rely on the formation or cleavage of a P-O bond are omnipresent in nature.[2-3] 
The phosphate fraction that is not bound in bone and teeth plays a role in major biological systems 
and functions: DNA and RNA that contain genetic information are both phosphate esters, ATP is an 
important energy carrier, phosphoenolpyruvate (PEP) is a metabolic intermediate involved in 
glycolysis, inositol phosphates are responsible for cellular signaling, etc.[4-7] 
Phosphonates are analogous to phosphates but one P-O single bond has been substituted by a P-C 
single bond. Contrary to phosphates, phosphonates are much less ubiquitous in living organisms. 
Nevertheless, a number of naturally occurring phosphonates have been identified and some display 
exquisite biological properties. Ciliatine 1 was the first phosphonate isolated from living beings: it 
was discovered in 1959 during an investigation on the aminoacid composition of rumen protozoa 
(Figure 1).[8] Later in the 20th century, fosfomycin 2 was discovered in Streptomyces sp. and is 
nowadays used as a broad-spectrum antibiotic in urinary tract infections.[9-10] Fosmidomycin 3, a 
phosphonate with antimalarial activity, was also isolated from Steptomyces microorganisms.[11]  
 
Figure 1. Naturally occurring phosphonates. 
The presence of a P-C single bond in phosphonates has a dramatic influence on their reactivity. 
Where phosphates are prone to hydrolysis, phosphonate hydrolysis would require the breaking of a 
P-C bond and concomitant expulsion of a carbanion. Needless to state that this is not a favored 
process so as a consequence, phosphonates are more stable towards hydrolysis than phosphates.[12-
13]  
The large structural resemblance of phosphonates to phosphates is responsible for their biological 
activity.[14] Accordingly, nucleoside phosphonates have found application as antiviral drugs,[15] e.g. 
cidofovir 4, a compound that inhibits viral DNA polymerase (Figure 2).[16-17] 
I. Introduction and Goals 
3 
 
Phosphonomethylphenylalanine 5 (pmp) is the phosphonate analog of phosphotyrosine, an 
important intermediate in signal transduction and regulation of enzymatic activity. Its non-
hydrolyzable nature however is responsible for the inhibition of protein tyrosine phosphatases 
(PTPases).[18-19] 
 
Figure 2. Cidofovir and pmp. 
Bisphosphonates are of importance in the treatment of osteoporosis, Paget’s disease and tumor 
bone disease (Figure 3). These compounds are analogs of pyrophosphate 8 and hence, inhibit 
enzymes that employ pyrophosphate. In contrast to pyrophosphate, the P-C-P bond in 
bisphosphonates is hydrolytically stable. Due to their double negative charge at physiological pH, 
bisphosphonates display a strong affinity for Ca2+ ions. Thus, they accumulate in bone tissue where 
they can exert their activity.[20-21] 
 
Figure 3. Bisphosphonate drugs tiludronic acid and zoledronic acid, and pyrophosphoric acid. 
Furthermore, phosphonates are known as bioisosteres of carboxylic acid derivatives. Indeed, they 
are different in shape (tetrahedral vs. planar), acidity (phosphoric acid is more acidic) and steric bulk 
(difference in atomic radii). Nevertheless, aminophosphonates 11 (X = O) are structural mimics of the 
transition state of amino acids during hydrolysis (Scheme 1).[18] 
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Scheme 1. Regular and enzymatic hydrolysis of a peptide, along with phosphonate-based transition state 
analogs. 
The formation of a high-energy transition state 10 is usually followed by cleavage of a peptide bond. 
However, upon addition of phosphonates that resemble this transition state the active site of the 
enzyme is blocked and inhibition prevails. This approach has been most successful in the case of 
metalloproteases as the presence of a coordinating phosphonate moiety in the active site of the 
enzyme induces strong complexation with active site metals. In this light, serine proteases can 
become covalently phosphonylated due to attack of a serine residue onto a diphenylphosphonate 
and concomitant expulsion of phenol.[18, 22]  
For instance, aptly substituted phosphonates inhibit HIV protease (Figure 4, 12),[23-24] renin (13),[25] 
PTPases[26-27] and can be used in molecular imprinting.[28] Moreover, alafosfalin 14 is an antibacterial 
compound that contains two stereogenic centers and is easily taken up in the cell. In the cytoplasm, 
hydrolysis takes place and the resulting phosphonoalanine inhibits alanine racemase, an enzyme that 
is required for bacterial cell wall synthesis. Only one stereoisomer of alafosfalin is active.[29-30] A well-
known biologically active phosphonate is glyphosate 15, better known as Roundup. It was brought on 
the market by Monsanto in 1970 and is a post-emergence broad-spectrum herbicide that inhibits 5-
enolpyruvoylshikimate 3-phosphate synthase, an enzyme that is responsible for the synthesis of 
aromatic amino acids.[13, 31] Recently, glyphosate has been reported to cause non-Hodgkin lymphoma 
and was classified as “probably carcinogenic to humans” (2A).[32] 
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Figure 4. Inhibitors of HIV-protease and renin, alafosfalin and glyphosate. 
Glutamate 16 is the main neurotransmitter in the central nervous system and operates through two 
main classes of receptors: ionotropic and metabotropic Glu receptors (iGluRs and mGluRs, 
respectively). Phosphonate analogs of glutamate are of interest for the characterization of different 
Glu receptor subtypes and for the treatment of central nervous system diseases such as epilepsy, 
Huntington’s disease, Parkinson’s disease, etc. (Figure 5). (S)-AP4 17 is a group III mGluR agonist 
which is some tenfold more potent than Glu 16 itself. (R)-AP5 18 is a potent and selective iGluR 
antagonist.[33-36] The cyclic (R)-CPP 19 is a selective and competitive N-methyl ᴅ-aspartate receptor 
(NMDA, iGluR) antagonist.[37]  
 
Figure 5. Glutamate and biologically active phosphonate analogs. 
Cyclic aminophosphonates are conformationally restricted and as a result they have a well-defined 
spatial arrangement. This has for instance been exploited in the design of herbicides and endothelin 
converting enzyme (ECE) inhibitors (Figure 6).[38-39] 
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Figure 6. Biologically relevant cyclic aminophosphonates. 
At the SynBioC Research Group of the Department of Sustainable Organic Chemistry and Technology, 
Faculty of Bioscience Engineering at Ghent University, the interest in azaheterocyclic phosphonates 
has resulted in an array of novel phosphonylated compounds, for instance aziridines,[40-41] 
pyrrolidines,[42] 2-phosphonopyrroles,[43-44] benzazepines,[45] benzazocines,[46] tricyclic 
aminophosphonates,[47] oxazolidinones and imidazolidinones,[48] β-lactams,[49-51] γ-lactams,[52] 
benzocarbacephems,[53] tetrahydroquinolines[54] and isoindoles.[55] 
Furthermore, the Heteroatom Transfer Radical Cyclization (HATRC) methodology has been applied on 
several occasions for the construction of pyrrolidinones,[56] pyrrolinones[57] and spiro-indoles.[58-59] In 
this approach, trichloroacetamides 22 with a pending alkene undergo a radical ring closure in the 
presence of Cu(I)Cl via abstraction of a Cl radical and recombination (Scheme 2).[60] 
 
Scheme 2. Principle of Cu(I)-catalyzed HATRC. 
In this light the HATRC-mediated synthesis of 3-phosphonylated pyrroles was envisioned. This class of 
compounds has been prepared on several occasions in literature but never using the HATRC 
strategy.[61-65] Instead of trichloroacetamides 22, N-allyl α,α-dichloroimines 25 would undergo a 
radical ring closure and yield 1-pyrrolines 26 (Scheme 3). Upon treatment with base, a 1,4-
dehydrochlorination would take place with formation of 3H-pyrrole 27 which would readily isomerize 
and furnish the corresponding 1H-pyrrole 28.[41, 66] The substrate for the ring closure could be 
accessed from 29 via imination and α,α-dichlorination using N-chlorosuccinimide (NCS). 
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Scheme 3. Retrosynthetic approach to phosphonylated pyrroles using HATRC. 
The influence of the steric and electronic nature of R1 on the HATRC and the dehydrohalogenation 
will be investigated. Several bases will be evaluated for the elimination reaction to ensure optimal 
conditions. In this approach phosphonylated precursors will be cyclized and further derivatized in 
order to obtain phosphonylated azaheterocycles. 
A second part of this work will focus on the addition of phosphorus nucleophiles to imine Michael 
acceptors. This methodology has been elaborated at the department over the past 10 years. It has 
been shown that α,β-unsaturated imines 30 react with dialkyl trimethylsilyl phosphites and trialkyl 
phosphites in a tandem fashion: a double 1,4-1,2-addition takes place with formation of 3-
phosphonylated 1-aminoalkylphosphonates 31 (PAPs, Scheme 4). This method has been applied to 
imines,[67-68] hydrazones,[69] quinolines[54] and phenanthrolines.[70] 
 
Scheme 4. Tandem 1,4-1,2-addition to α,β-unsaturated imines. 
The current goal is to extend this methodology to α,β,γ,δ-diunsaturated imines 32 to try and obtain a 
triple 1,6-1,4-1,2-addition. This would give rise to 3,5-diphosphonylated 1-aminoalkylphosphonates 
33 (DPAPs, Scheme 5). The effect of the steric and electronic nature of R1 and R2 will be evaluated by 
generating a library of these compounds. Furthermore, both silylated dialkyl phosphites as well as 
trialkyl phosphites will be assessed as nucleophiles. 
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Scheme 5. Envisioned triple addition of phosphorus nucleophiles to α,β,γ,δ-diunsaturated imines. 
Once these compounds have been produced, they could be converted into their corresponding 
phosphonylated β-lactams.[49-50] N-Acylation using chloroacetyl chloride followed by deprotonation 
between the amine and phosphonate functional groups could result in substitution and concomitant 
ring closure. These β-lactams are of interest as potential antibiotics.[71] 
In a third part of this thesis the Au-catalyzed preparation of benzo[c]thiophenes will be evaluated. 
This project has its roots in the serendipitous preparation of phosphonylated isoindoles 40, earlier at 
the department. In the course of previous research on enyne metathesis the synthesis of 
phosphonylated benzazepines was envisaged. However, no enyne metathesis of 34 took place but 
after a prolonged period at reflux temperature, a trace amount of phosphonylated isoindole 40 was 
formed. Optimization and mechanistic investigations revealed that a 5-exo-dig cyclization to 35 had 
taken place and was followed by immediate proton transfer and a fragmentative allyl shift at high 
temperature (Scheme 6).[55] 
 
Scheme 6. Thermally induced 5-exo-dig cyclization and formal [1,3]-alkyl shift. 
Next, it was discovered that this transformation proceeds smoothly at room temperature under 
AuCl3-catalysis. In this case however no fragmentation takes place. Instead, a Claisen rearrangement 
is responsible for the molecular reorganization. This approach was further extended to 
cyanoisoindoles and dihydrothiazoles.[72-73] Based on this research, a Au-catalyzed preparation of 
benzo[c]thiophenes 42 is proposed (Scheme 7). Initial 5-exo-dig ring closure, catalyzed by AuCl3, 
would be followed by Claisen rearrangement and aromatization. The combination of Au-catalysis 
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with S-nucleophiles is not very common, as witnessed by the literature overview of this work (vide 
infra). 
 
Scheme 7. Proposed Au-catalyzed route to benzo[c]thiophenes. 
These compounds are of interest mainly due to their physical properties: they could be used in 
organic photovoltaic systems (OPV).[74] 
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Homogeneous Au-catalyzed  
cyclization reactions of alkynes  
with N- and S-nucleophiles 
As outlined in the Introduction and Goals, this work is a hybrid between phosphonate chemistry and 
heterocyclic frameworks. However, one common trait is the intention to construct cyclic molecules. 
Therefore, this literature overview will focus on a specific cyclization method: homogeneous Au-
catalyzed cyclizations with N- and S-nucleophiles on alkynes.  
1. Homogeneous Au-catalyzed intramolecular attack of N-
nucleophiles on alkynes  
1.1 Formation of 5-membered rings 
1.1.1 5-endo-dig cyclization 
1.1.1.1 Pyrroles 
In 2005 Toste and co-workers discovered an intramolecular Au(I)-catalyzed acetylenic Schmidt 
reaction with formation of pyrroles 44 (Scheme 8). Initial alkyne activation by the catalyst results in 
formation of a five-membered ring after attack of the proximal N-atom of the azide. Back-bonding 
from the metal into the electron-deficient intermediate 46 expels nitrogen gas and yields a cationic 
intermediate 47, which is stabilized by electron donation from gold. The catalyst is regenerated by a 
formal 1,2-H-shift with concomitant release of a 2H-pyrrole, which is swiftly transformed into the 
desired pyrrole 44a. Replacement of the migrating H-atom by another migrating group allowed for 
the synthesis of annulated pyrroles from cyclobutylmethyl azides. Heteroatoms could also act as 
migrating group, e.g. silyl ethers.[75-76] Xia and Huang performed a DFT study to investigate the 
operative mechanism in detail. They concluded that intermolecular proton transfer in the final 
tautomerization between the 2H- and 1H-pyrrole is the rate-determinig step of the overall 
process.[77] 
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Scheme 8. Au(I)-catalyzed formation of pyrroles from homopropargylic azides by an acetylenic Schmidt-
reaction. 
The De Kimpe group reported on the AuCl3-catalyzed preparation of fluorinated pyrroles from 
homopropargylic amines 48 (Scheme 9). Initial Au-mediated ring closure to 49 was followed by 
protodeauration and furnished difluorinated 2-pyrrolines 50. After dehydrofluorination the desired 
monofluorinated pyrroles 51 were obtained. Instead of using a Au-catalyst, treatment with AgNO3 or 
bases did not result in pyrroles 51. The sulfonyl group could be removed with the aid of a large 
excess of NaOH in ethanol.[78] Li and co-workers used a similar approach to produce 2,4-disubstituted 
pyrroles.[79] 
 
Scheme 9. AuCl3-catalyzed preparation of fluorinated pyrroles. 
Somewhat later, two groups simultaneously published their pyrrole syntheses starting from 2-
hydroxy homopropargylic amines 52. The Aponick group employed 2 mol% JohnPhosAuCl as a 
catalyst in THF whereas the Akai group applied loadings as low as 0.1 mol% of PPh3AuCl in toluene, 
both in combination with AgOTf in order to generate a cationic Au(I)-catalyst (Table 1). Both 
transformations were very efficient with yields up to 92 and 96%, respectively. Similar to the 
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previous method for fluorinated pyrroles 51, Au-catalyzed 5-endo-dig cyclization is followed by 
dehydration and yields pyrroles 44. Aponick’s method could be performed in an open flask, though 
care had to be taken to avoid water when using very low catalyst loadings.[80-81] 
Table 1. Comparison of Aponick’s and Akai’s results for pyrrole synthesis from homopropargylic amines. 
 
author catalyst conditions R1 R2 R3 R4 
yield 
(%) 
Aponick 
JohnPhosAuCl,  
AgOTf (2 mol%) 
THF, 4Å 
MS, 0 °C, 
10 min -  
1 h 
Ph H H Ts 89 
Octyl H H Ts 91 
Ph H H Bu 91 
Ph H H Bn 92 
Akai 
PPh3AuCl, AgOTf (0.1 mol%) 
toluene, rt, 
1-9 h 
(CH2)2Ph Me H Boc 96 
PPh3AuCl, AgOTf (0.5 mol%) t-Bu H Bn Boc 88 
PPh3AuCl, AgOTf (0.1 mol%) H Me H Ts 92 
In 2011 the Chan group discovered a domino aminocyclization/1,3-sulfonyl migration of N-sulfonyl 
aminobutynols 53, which they further elaborated in 2013 (Scheme 10).[82] Au-assisted cyclization 
toward 54 is followed by dehydration and 1,3-sulfonyl migration, or the other way around. A cross-
over experiment demonstrated that the migration proceeds intramolecularly. This was further 
witnessed by the lack of reaction of a 3-unsubstituted pyrrole (no SO2R
5) with TsCl in the presence of 
the same catalyst.[83] 
 
Scheme 10. Domino aminocyclization/1,3-sulfonyl migration yielding pyrroles. 
Davies and Hou also simultaneously reported their findings on the synthesis of pyrroles 44 from 
alkynylaziridines 56, based on seminal work by Hashmi regarding furan synthesis (Scheme 11).[84] 
Davies found that the outcome of this transformation is largely dependent on the reaction 
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conditions. More precisely, the nature of the counterion of the Au(I) complex as well as the solvent 
exert a large influence. Protic or aromatic solvents give rise to 2,5-disubstituted pyrroles 44b 
exclusively, while for 1,2-dichloroethane (DCE) and dichloromethane the counterion plays a large 
role. The weakly coordinating tosylate promotes 2,5-disubstitution while the non-coordinating 
triflate results in 2,4-disubstitution (44c).[85] Hou, on the other hand, only obtained 2,5-disubstituted 
pyrroles 44b in 59-95% yields under their optimized conditions, i.e. PPh3AuCl/AgOTf in a 5/1 
THF/MeOH mixture.[86] Liu and co-workers obtained similar results, while Liang produced 
spirotetrahydro-β-carbolines from aptly substituted alkynylaziridines.[87-88] 
 
Scheme 11. Formation of 2,5- or 2,4-substituted pyrroles depending on the counterion according to Davies. 
In a following paper, Davies performed an in-depth study using 13C-labeling to elucidate the operative 
mechanism and explain the observed dichotomy (Scheme 12). Initial 4-endo-dig cyclization of 
alkynylaziridine 57 leads to a transition state 58. This product can ring-open in two ways (a or b). 
When a 5-membered ring is formed (59) there are two possibilities: either elimination of a proton 
and protodeauration result in isotopomer 60 (Path A), or a 1,2-aryl shift takes place which ultimately 
leads to isotopomer 63 (Path B). On the other hand formation of a 4-membered ring with a benzylic 
cation 64 will induce a Wagner-Meerwein shift with formation of cation 65, which eventually results 
in isotopomer 67 (Path C).[89] 
Which path operates under which conditions can be predicted to a certain extent. If R1 is an alkyl 
group, products from both Path B and Path C are observed, while if R1 is a phenyl group, Path B is 
favored due to the greater mesomeric stabilization of intermediate 59. There is an electronic effect in 
operation as well with regard to substitution of the phenyl group directly attached to the aziridine. 
Electron-rich phenyl groups will favor formation of benzylic cation 64 and 1,2-migration (Path C and 
B, respectively). Conversely, electron-poor phenyl moieties will favor Path A.[89] 
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Scheme 12. 
13
C-labeling experiment to elucidate the mechanisms behind pyrrole formation. 
Tu and co-workers elegantly adapted Davies’ method for the synthesis of cycloalkane fused pyrroles 
73 (Scheme 13). After 5-endo-dig cyclization, the aziridinium moiety in 69 is opened with 
concomitant protodeauration. Elimination of the OTBS-group, assisted by the Au-catalyst, is followed 
by Wagner-Meerwein rearrangement and aromatization. Electron-rich and electron-poor phenyl 
groups are tolerated for R, as well as thiophenyl, naphthyl, alkyl and cycloalkyl moieties.[90] 
 
Scheme 13. Preparation of fused pyrroles starting from propargylic aziridines. 
1.1.1.2 Pyrrolines 
Gouault obtained substituted pyrrolin-4-ones 75 from alkynones 74 that were derived from amino 
acids (Scheme 14). A catalyst screening indicated that AuCl was the most efficient catalyst for the 
cyclization but engendered complete epimerization of the stereocenter, most likely due to a trace of 
HCl from the catalyst. Upon addition of K2CO3 or 2,6-di-t-butylpyridine the ee augmented but the 
best overall results were obtained with Au2O3 and Au(OH)3.
[91]  
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Scheme 14. Formation of pyrrolinones with retention of stereochemistry. 
Propargylic esters 76 can undergo two types of reactions in the presence of cationic Au(I)-catalysts 
(Scheme 15). Either a direct 5-endo-dig cyclization takes place yielding pyrrolines 77, or a stepwise 
Rautenstrauch rearrangement and cyclization eventually results in dehydropiperidines 79. The 
Rautenstrauch rearrangement consists of 1,2-acyloxy migration with formation of a Au-carbene 
78.[92] This carbene is α,β-unsaturated and operates as a Michael-acceptor, which accounts for 
dehydropiperidine formation. The product ratio 77/79 was found to be strongly dependent on the 
applied ligand, counterion and solvent. A thorough investigation on the factors influencing product 
distribution was performed: the nature of the sulfonamide, the migrating group and propargylic 
substitution were taken into account.[93] 
 
Scheme 15. Formation of 2-pyrrolines and competition between direct and stepwise product formation. 
Ye and co-workers produced a library of enantioenriched dihydropyrroles 81 from chiral 
homopropargyl sulfonamides 80 (Scheme 16). Lack of basic additives resulted in dimerization but 
addition of both 2,6-dibromopyridine and a catalytic amount of Et3N was the most efficacious 
method to prevent this. A ligand screening indicated that BrettPhos was most suited while the similar 
XPhos resulted in partial dimerization. A deuterium labeling experiment proved that the reaction 
proceeds through 5-endo-dig cyclization and not via a vinylidene intermediate. The obtained 2-
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pyrrolines 81 could serve as precursors for (+)-Preussin 82, an antifungal alkaloid.[94] Fustero 
employed similar substrates and obtained dimerization products using PPh3AuCl/AgOTf as catalyst 
system in toluene.[95] The Hammond group developed a tandem hydroamination/cyanation approach 
for homopropargylic anilines. Application of 5 mol% IPrAuCl and AgOTf in dioxane under microwave 
irradiation gave rise to a 2-cyanopyrrolidine in the presence of TMSCN (vide infra, Scheme 64).[96] 
 
Scheme 16. Formation of enantioenriched 2-pyrrolines. 
Finally homopropargylic N-sulfonyl hydroxylamines 83 were used to generate 3-sulfonyl-1-pyrroline 
N-oxides 84 through 5-endo-dig cyclization and 1,3-sulfonyl migration (Scheme 17). The obtained 
nitrones reacted with dipolarophiles in a 1,3-dipolar cycloaddition to yield annulated 
dihydroisoxazoles 85. The sterically demanding sulfonyl group directs the dipolarophile to the 
opposite face, ensuring a diastereoselective reaction. When terminal alkynes were treated with a 
Au(I)-catalyst, 5-exo-dig attack of the OH-group took place and was ensued by fragmentation and 
formation of 3-pyrrolidones.[97] 
 
Scheme 17. Formation of 3-sulfonyl-1-pyrroline N-oxides and subsequent 1,3-dipolar cycloaddition. 
1.1.1.3 Indoles 
After pioneering work in the late 1980’s by Utimoto and co-workers with regard to Pd-catalyzed 
hydroamination,[98] the group of Marinelli was one of the first to revisit the gold-catalyzed 5-endo-dig 
cyclization of 2-alkynylanilines 86 with formation of indoles 87 in 2004.[99-100] They converted a 
number of terminal and internal alkynes into 2-substituted indoles 87 using 4 mol% NaAuCl4·2H2O in 
an EtOH/H2O mixture (Scheme 18). A catalyst screening indicated that Au(III) salts were more 
effective catalysts than Au(I), Pd(II) and Cu(II) salts.[99] This approach was employed by Fukuyama in 
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2010 in the total synthesis of (−)-Mersicarpine 88, an alkaloid isolated from the Kopsia plant 
genus.[101] Perumal reported a one-pot cyclization and consecutive C3-derivatization of indoles.
[102-103] 
 
Scheme 18. Au-catalyzed formation of indoles from 2-alkynylanilines. 
A few years later Marinelli’s group reported on the identical transformation in an ionic liquid solvent 
system, 1-butyl-3-methylimidazolium tetrafluoroborate ([bmim]BF4). Here, application of 1 mol% 
NaAuCl4·2H2O at 50 °C for 24 h resulted in the formation of the desired indoles in 91-94% yield. The 
ionic liquid could be recycled up to five times along with a n-Bu4NAuCl4 catalyst without a significant 
loss of activity.[104] 
Extension of this methodology to trienyne-containing substrates 89 led to the formation of 
polyaromatics such as benzo[a]naphtho[2,1-c]carbazoles 90 via a polycyclization cascade (Scheme 
19). A catalyst screening had indicated that JohnPhosAuCl gave better results than XPhosAuCl and 
that BF4
- was the counteranion of choice. Tetra- and pentacyclization was also possible and 
thiophenes could be used as tether between the alkynes to produce S-containing polyaromatic 
compounds.[105] In a similar fashion, Ohno obtained carbolines.[106] 
 
Scheme 19. Polycyclization of trienyne type anilines through hydroamination and a consecutive 
hydroarylation cascade. 
Sperry and co-workers applied a Au(I)-catalyzed hydroamination step for the total synthesis of (+)-
Terreusinone 94, a photoprotecting dipyrrolobenzoquinone (Scheme 20). Attempted double Larock 
indolization failed, so a tandem Larock indolization/Au(I)-catalyzed hydroamination was employed 
using one of Echavarren’s cationic Au-catalysts 92.[107] A late stage oxidative demethylation furnished 
the desired compound.[108-109] 
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Scheme 20. Au(I)-catalyzed hydroamination in the total synthesis of (+)-Terreusinone. 
A double hydroamination reaction of ortho-alkynylanilines 86 with terminal alkynes 95 furnished N-
alkenylindoles 97, a class of compounds whose synthesis has only scarcely been described in 
literature. Variation of R1 and R2 yielded a number of N-vinyl indoles 97 in mediocre to excellent 
yields (Scheme 21).[110] The mechanism was investigated in order to establish which hydroamination 
reaction occurred first. Upon reaction of the corresponding N-unsubstituted indoles with terminal 
alkynes 95 in the presence of the same catalyst, no formation of N-vinyl indoles was detected. This 
suggests the intermolecular hydroamination takes place first. Imination of a suitable ortho-
alkynylaniline with acetophenone and treatment with the same catalytic system did result in 
formation of the desired N-vinyl indoles 97. This outcome confirmed that the intermolecular 
hydroamination takes place first with formation of imine 96, and only then intramolecular 
hydroamination ensues.[110] 
 
Scheme 21. Double hydroamination with formation of N-vinyl indoles. 
Iwasawa and co-workers transformed N-(o-alkynylphenyl)imines 98 into tricyclic indoles 103. An 
azomethine ylide 100 was in situ generated by AuBr3-mediated 5-endo-dig cyclization and carbene 
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formation. This 1,3-dipole then underwent a [3+2] cylcoaddition with vinyl ethers 101, followed by 
1,2-migration and regeneration of the catalyst (Scheme 22).[111]  
 
Scheme 22. Formation of tricyclic indoles from N-(o-alkynylphenyl)imines. 
Similarly, Fu et al. employed the same substrate 104 but with a tethered nucleophile to trap the in 
situ formed iminium species 105 in a tandem reaction. This strategy gave rise to heterotricyclic 
indoles 106 (Scheme 23). The reaction was initiated either by 5-endo-dig cyclization, as depicted in 
Scheme 23, or by attack of the alcohol at the imine functionality.[112] 
 
Scheme 23. Formation of ring-fused indoles. 
Reddy and co-workers reported on a domino cycloisomerization/Pictet-Spengler approach for the 
production of tetrahydropyrido[4,3-b]indoles 111. These compounds were obtained by treatment of 
ortho-alkynylanilines tethered to tosyl amides 107 with 5 mol% IPrAuCl and 10 mol% AgSbF6 in the 
presence of benzaldehydes 108 (Scheme 24). After intramolecular 5-endo-dig formation of the 
corresponding isotryptamine 109, the Pictet-Spengler reaction takes place and a tetrahydropyridine 
111 is annulated. The authors isolated an intermediate isotryptamine 109 and treated it with AgSbF6 
to assess the role of its excess. The tetrahydropyrido[4,3-b]indole 111 was also obtained, hence 
concluding that the Ag-catalyst facilitates the Pictet-Spengler step.[113] 
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Scheme 24. Domino hydroamination/Pictet-Spengler approach to tetrahydropyrido[4,3-b]indoles. 
In 2009 Liu reported on a Au-catalyzed green protocol for the preparation of indole-1-carboxamides 
113. The reaction was performed in water, an environmentally benign solvent, and microwave 
irradiation was used. This approach led to a library of indole-1-carboxamides 113 in acceptable to 
excellent yields (51-91%). Based on deuterium labeling experiments, a mechanism was proposed 
(Scheme 25). The authors suggested the intermediacy of a gold vinylidene 114, which was then 
attacked intramolecularly. Tautomerization and reductive elimination yield the indole-1-carboxamide 
113 and regenerate the catalyst.[114] Asensio transformed similar substrates but with internal alkynes 
into 2-substituted indoles using a catalytic amount of IPrAuSbF6, while terminal alkynes underwent 6-
exo-dig reaction to the corresponding pyrimidinones. They concluded that the regioselectivity was 
controlled by the substitution pattern of the alkyne.[115] Wu and co-workers used amidines as 
substrates to generate indoles.[116] 
 
Scheme 25. Proposed mechanism for the formation of indole-1-carboxamides. 
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In 2011, Gagosz and Zhang simultaneously published their findings on the cyclization of 2-alkynyl 
arylazides 117. In analogy to Toste’s acetylenic Schmidt reaction (Scheme 8),[75] 5-endo-dig cyclization 
by the proximal N-atom of the azide is followed by Au-assisted expulsion of N2-gas with formation of 
Au-carbene 119 (Scheme 26). Next, a number of mechanistic pathways are feasible for the 
nucleophilic attack. Either direct insertion takes place and 122 is formed from 119, or the nucleophile 
adds to the carbene and several protodeauration mechanisms are possible. Ultimately, indole 123 is 
formed.[117] 
 
Scheme 26. Formation of indoles according to Gagosz. 
When NuH is an allylic alcohol, however, the reaction does not end at 123. A thermal or Au-mediated 
Claisen rearrangement takes place with formation of 3-indolinones 125 (Scheme 27).[117] Zhang’s 
results of this indole umpolung were very similar. Upon treatment of 2-alkynyl arylazides 117 with 5 
mol% IPrAuNTf2 in DCE at 80 °C and 4 equivalents of nucleophile, a number of 3-substituted indoles 
were obtained in 49-91% yields. Use of aromatics as nucleophiles resulted in the formation of 
different regioisomers (e.g. ortho and para substitution). Allylalcohol also resulted in a Claisen 
rearrangement as depicted in Scheme 27. Installation of internal nucleophiles resulted in annulated 
indoles.[118] 
 
Scheme 27. Claisen rearrangement of allyloxyindoles. 
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In 2015 Zhang applied the same methodology to propargyl alcohols 126 instead of allyl alcohols 
(Scheme 28). After formal O-H insertion into the Au-carbene, 127 undergoes a thermal or Au-
catalyzed Saucy-Marbet rearrangement (propargyl-Claisen rearrangement) and allene 128 is formed. 
The present Au-catalyst activates the allene and the indole N-H performs a 5-endo-trig cyclization. 
Protodeauration yields pyrroloindolones 130.[119] 
 
Scheme 28. Propargylation and subsequent Saucy-Marbet rearrangement. 
Azepino[1,2-a]indoles 133 were synthesized from appropriately substituted 2-alkynylanilines 131 
(Scheme 29). Initial 5-endo-dig cyclization was followed by dehydration and furnished vinylgold 
intermediate 132 after insertion. This nucleophilic vinylgold species 132 then added across the 
carbonyl function, which promoted another dehydration, 1,3-proton transfer and 
protodeauration.[120-121] Based on these results Hashmi and co-workers developed a method to 
convert ureas 134 into polycyclic indole scaffolds 135 (Scheme 29).[122] 
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Scheme 29. Synthesis of polycyclic indoles by Bandini and Hashmi. 
The direct preparation of 3-sulfonylindoles 139 from unsubstituted indoles by electrophilic 
substitution is rather challenging as the electrophilicity of a sulfonyl group is much lower than that of 
acyl groups and halogens.[123-124] Reaction of ortho-alkynylanilines 136 with a migrating group on the 
N-atom in the presence of a transition metal catalyst results in the formation of 2,3-disubstituted 
indoles 139.[125-126] In this light ortho-alkynyl-N-sulfonylanilines 136 were treated with AuBr3 in 
toluene (Scheme 30).[124, 127]  
 
Scheme 30. Formation of 3-sulfonylindoles via AuBr3-assisted aminosulfonylation. 
This mechanism was supported by a crossover experiment which indicated that the migration 
proceeds in an intramolecular fashion. Furthermore, mixing indole with tosyl chloride and a catalytic 
amount of AuBr3 did not result in sulfonylated indoles, suggesting that no electrophilic substitution 
took place. It is noteworthy that an unprecedented sulfonyl migration to the benzene ring occurred 
as a side reaction resulting from intramolecular 1,5- or 1,7-migration. Indium(III) bromide also 
catalyzed this transformation.[124]  
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Bertrand and co-workers serendipitously discovered the catalytic hydroammoniumation and 
methylamination of alkynes under Au-catalysis with cyclic (alkyl)(amino) carbene (CAAC) ligands 143. 
Treatment of tertiary 2-alkynylanilines 140 with TfOH and a catalytic amount of Au(I)-catalyst 
resulted in intramolecular hydroammoniumation (Scheme 31). Au(I)-catalyzed ring closure is 
followed by protodeauration in the presence of a strong acid. Treatment with TfOH without a 
catalyst for 3 days at 120 °C did not yield any hydroammoniumation. In addition, reaction of the 
same substrate at 160 °C resulted in aminomethylation of the alkyne (Scheme 31).[128] 
 
Scheme 31. Hydroammoniumation and aminomethylation of o-alkynylanilines. 
1.1.1.4 Indolizines 
Gevorgyan and co-workers synthesized pyrrole-fused heterocycles 147 from 2-propargylpyridines 
144 containing a migrating group G (Scheme 32). Isoquinolines, pyrazines, benzopyrazines and 
thiazoles could be employed as substrates too. In the original paper the authors invoked Au-
vinylidenes as intermediates in the mechanism but DFT calculations disproved this hypothesis. Based 
on these calculations another mechanism was proposed which was in accordance with deuterium 
labeling studies. Initial 5-endo-dig cyclization was followed by an intermolecular H-shift with 
formation of a gold carbene 146. A 1,2-shift of the migrating group then furnished the desired 
indolizines 147. Interestingly, use of a Ag-catalyst instead of AuBr3 also generated pyrrole-fused 
heterocycles but without migration of G.[129-132] 
 
Scheme 32. Formation of indolizines with 1,2-migration. 
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1.1.2 5-exo-dig cyclization 
1.1.2.1 Pyrroles 
After the pioneering work by Arcadi in 2001, Dake discovered a cationic Au(I)-catalyzed pyrrole 
synthesis starting from alkynones 148 and amines 149 (Scheme 33).[133-134] Intermolecular imination 
was followed by hydroamination in a 5-exo-dig fashion, protodeauration and isomerization. The 
authors compared the catalytic activity of AgOTf, AgOTf and PPh3AuCl, and AgOTf with AuCl and 
PPh3. Interestingly, the reaction proceeded with the best yields using separate addition of all three 
species (Scheme 14). On the other hand, AgOTf alone was usually faster, but suffered from 
incomplete conversion.[135] 
 
Scheme 33. Formation of pyrroles via 5-exo-dig cyclization with a cationic Au(I)-catalyst. 
In 2007, Gagosz and co-workers developed a cationic Au(I)-catalyzed aza-Claisen rearrangement with 
formation of trisubstituted pyrroles (Scheme 34). Based on the work of Fürstner, Yamamoto and 
Nakamura on Pt- and Au-catalyzed cycloisomerization reactions,[125-126, 136-137] and more specifically 
Fürstner’s work on the rearrangement of allyl pentynyl ethers,[138-139] the authors envisaged the 
transformation of easily accessible substrates such as 151 into the corresponding pyrroles 158. A 
catalyst screening indicated that the cationic (p-CF3Ph)3PAuNTf2 was the most performant catalyst for 
this transformation, culminating in full conversion in under 30 minutes (2 mol% in CH2Cl2 at rt).
[140] 
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Scheme 34. Formation of homoallylic pyrroles via aza-Claisen rearrangement according to Gagosz. 
With respect to the mechanism, two distinct pathways are feasible. At first, 5-exo-dig cyclization of 
the tosyl amide 152 will result in an ammonium intermediate 153 which can rearrange via two 
pathways. Either intramolecular aza-Claisen rearrangement takes place and 154 is formed (Path A), 
or fragmentation of the allyl ammonium moiety occurs (Path B). In the latter case, an allyl cation is 
formed and recombination engenders homoallylic pyrroles as well. However, in case of substituted 
allyl groups 160/161, the allyl cation can isomerize and ultimately give rise to linear and branched 
homoallylic pyrroles 162/158. If this was the prevailing mechanism, mixtures of branched and linear 
homoallylic groups should have been isolated (158 and 162, respectively). In this transformation, 
only one product was obtained (158). This observation, in combination with crossover experiments, 
proved that allyl migration is a concerted intramolecular process.[140] 
(Z)-enynols 163 react with amines and a cationic Au(I)-catalyst to yield pyrroles 150 in one pot. Liu 
and co-workers developed a Au-mediated preparation of allylic amines from allylic alcohols.[141] 
Based on this methodology they envisioned a one-pot consecutive amination and alkyne 
hydroamination with formation of substituted pyrroles 150 (Scheme 35). It is noteworthy that 
stepwise formation of the corresponding enynamine and cyclization resulted in lower yields. Upon 
addition of three extra equivalents of amine to the stepwise cyclization reaction, the yield was 
restored to its one-pot level.[142] Liang’s group employed a very similar approach to produce 
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annulated pyrroles from 1-en-4-yn-3-ols. Here Au-assisted SN2’ resulted in 2-en-4-yn-1-amides which 
then underwent 5-exo-dig cyclization. HAuCl4·4H2O was applied in CH3CN.
[143] 
 
Scheme 35. One-pot formation of pyrroles from (Z)-enynols and amines 
Zhang developed a pyrrole synthesis from N-(pent-2-en-4-yn-1-yl)-β-lactams 164 (Scheme 36). 
Cationic Au(I)-catalysts performed much better than PtCl2, PtCl4 or AuCl3. After 5-exo-dig cyclization 
the amide bond in 165 was cleaved and a 6-membered ring was annulated. An isomerization step 
then yields dihydroindolizinones.[144] 
 
Scheme 36. Formation of annulated pyrroles according to Zhang. 
Intermolecular hydroamination of 4-yne-nitriles 170 gives rise to amidines 171 which then induce 5-
exo-dig cyclization and formation of 2-aminopyrroles (Scheme 37). The authors suggested that the 
Zn-catalyst was responsible for the hydroamination of the nitrile, while the Au-catalyst activated the 
alkyne for pyrrole formation. Mixtures of 2-amino and 2-alkylaminopyrroles 172/173 were obtained 
in 13-81% yield.[145] 
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Scheme 37. Intermolecular hydroamination of nitriles followed by intramolecular hydroamination for pyrrole 
synthesis. 
Dixon and co-workers reported a one-pot nitro-Mannich/hydroamination cascade (Scheme 38). A 
catalytic amount of base was sufficient to complete the nitro-Mannich reaction after which the Au-
catalyst effectuated the ring closure. The presence of ligands such as PPh3 or JohnPhos did not 
improve the efficiency of the catalyst.[146] 
 
Scheme 38. Nitro-Mannich/hydroamination cascade. 
1.1.2.2 Pyrrolines and pyrrolidines 
In 2008 Che and Liu reported on the tandem synthesis of tetrahydropyrrolo[1,2-a]quinolines 182 in 
water (Scheme 39). At first a 2-methylidenepyrrolidine 180 is formed via 5-exo-dig cyclization or by 
consecutive hydration of the alkyne and imination.[147] Next, alkyne 95 adds across the enamine and 
the activated alkyne is attacked via electrophilic substitution to furnish a tetrahydropyrrolo[1,2-
a]quinoline 182.[148] Fensterbank and co-workers treated N-pent-4-yn-1-yl tosylamides with PPh3AuCl 
and Selectfluor and obtained mixtures of the corresponding 3-fluoro-2-methylenepyrrolidines and 3-
fluoro-2-fluoromethylenepyrrolidines.[149] Lee developed novel Au(III)-oxo catalysts with bipyridine or 
phenanthroline ligands which proved efficacious for intramolecular hydroamination reactions.[150] 
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Scheme 39. Au-mediated aqueous synthesis of tetrahydropyrrolo[1,2-a]quinolines. 
Jørgensen and co-workers developed an enantioselective one-pot Mannich/hydroamination cascade 
for the synthesis of pyrrolines 185 (Scheme 40). Quinidine-derived organocatalyst 186 resulted in the 
best ee’s and further optimization revealed that -60 °C was the optimal temperature for good 
enantiocontrol. A number of transition metals were assessed for the hydroamination reaction (Cu, 
Ag, Pd, Ni, Rh, Fe, Pt, Zn, In) but none were active. Au(I) and Au(III)-salts on the other hand were 
efficacious and the optimal catalyst was Gagosz’s PPh3AuNTf2.
[151-152] 
 
Scheme 40. Enantioselective tandem Mannich/hydroamination reaction. 
The enantioselective desymmetrization of 1,4-diynamides 187 was reported by Czekelius and co-
workers in 2012. Optimization of the reaction conditions revealed that cationic (t-Bu)3PAu
+ with a 
bulky BINOL phosphate counterion 189 resulted in the best yields and ee’s (Scheme 41). The catalyst 
was prepared prior to addition to the reaction, as in situ formation deteriorated the results.[153] 
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Scheme 41. Au-catalyzed desymmetrization of diynamides. 
Similarly, Dixon discovered a Au- and BINOL phosphoric acid (BPA)-catalyzed enantioselective 
hydroamination/N-sulfonyliminium cyclization cascade (Scheme 42). First a 5-exo-dig cyclization 
formed an exocyclic enesulfonamide 191, after which the chiral BPA 193 tethers the indole to the N-
sulfoniminium moiety in an enantioselective fashion.[154] 
 
Scheme 42. Enantioselective tandem hydroamination/cyclization according to Dixon. 
A Au/Pd/Brønsted acid ternary system catalyzed the transformation of amine-tethered 1,8-enynes 
194 to 1-pyrrolines 197 (Scheme 43). After a Au-catalyzed 5-exo-dig cyclization yields an N-allylic 
enamine 195, the nitrogen atom is protonated by the acid and this results in Pd-assisted 
fragmentation of the ammonium species. The cooperative catalysis of a Pd(0)-species and a Brønsted 
acid ensure the regioselective allylation at the sterically least encumbered end of the allyl fragment, 
yielding 1-pyrrolines 197.[155] 
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Scheme 43. Relay and cooperative catalysis with a Au/Pd/Brønsted acid ternary system. 
1.1.2.3 Isoindoles 
Dyker reported a Au-mediated synthesis of isoindoles 200 based on (o-ethynylbenzyl)amines 199. 
They subjected post-Ugi products 199 to treatment with AuCl3 in CH3CN at reflux for 6 hours and 
obtained a mixture of 5-exo-dig and 6-endo-dig product, with more 5-membered ring product 
present (Scheme 44).[156] 
 
Scheme 44. Post-Ugi isoindole formation according to Dyker. 
The Stevens group also published on the Au-catalyzed synthesis of isoindoles 206 (Scheme 45).[72] In 
this case a tertiary allylamine 202 was employed and 5-exo-dig cyclization was succeeded by allyl 
migration through an aza-Claisen rearrangement. This was proven by the fact that no linear isomer 
was present after the allyl migration.[140] Furthermore, upon introduction of steric constraints 
(instead of an allyl group and R1, a 1,2,3,6-tetrahydropyridin-1-yl group was used) no product 
formation was observed, thus precluding a stepwise, fragmentative mechanism. It must be noted 
that the authors did observe a stepwise mechanism under microwave irradiation without the 
presence of any catalyst.[72] 
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Scheme 45. AuCl3-mediated synthesis of cyanoisoindoles. 
Chiral fluorinated isoindolines 208 were accessed from fluorinated (o-ethynylbenzyl)amines 207 
using a SPhosAuNTf2-catalyst. Mixtures of 5-exo and 6-endo products 208 and 209, respectively, were 
obtained, but the ratio was strongly dependent on electronic factors (Scheme 46). Electron-donating 
R-substituents promoted 6-endo-dig cyclization, while the nature of the RF group was a determining 
factor as well: changing RF from C2F5 to CF3 to CHF2 to CH2F to CH3 to H resulted in a regioselectivity 
gradient from 5-exo- to 6-endo-dig products.[157] 
 
Scheme 46. SPhosAuNTf2-mediated cyclization to fluorinated isoindolines and dihydroisoquinolines. 
1.1.2.4 Oxazoles 
In 2006 Hashmi described the conversion of propargylic trichloroacetimidates 210 to the 
corresponding oxazoles 211 (Scheme 47). The cyclization reaction to the oxazoline was very fast but 
the rate-determining step was the subsequent isomerization to the oxazole.[158] Shin and co-workers 
simultaneously reported a similar transformation using 5 mol% P(C6F5)3AuCl and AgSbF6 in DCE. They 
obtained 74-98% yields in 3-9 h at 0 °C.[159] 
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Scheme 47. Formation of oxazoles from propargylic trichloroacetimidates. 
Gagosz and co-workers employed 2-propargyloxypyridines 212 for a 5-exo-dig cyclization and 
subsequent nucleophilic attack (Scheme 48). As an activated 2-fluoropyridinium system is present in 
213, aromatic nucleophilic substitution takes place and results in oxazolopyridine imines 215. Upon 
application of an Ag-catalyst, an isomeric product is formed due to initial 6-endo-dig cyclization and 
rearrangement.[160] 
 
Scheme 48. Au-catalyzed formation of oxazolopyridine imines. 
1.1.2.5 Pyrrolizines 
Based on Toste’s acetylenic Schmidt reaction published in 2005,[75] Zhang envisaged a 
dihydropyrrolizine synthesis originating from a 5-exo-dig cyclization by an azide 216. In order to 
direct the attack to 5-exo, the introduction of an electron-withdrawing C-C double bond at the distal 
end of the alkyne was assessed. In addition, this allowed for a consecutive electrocyclic ring closure 
with formation of a dihydropyrrolizine 220 (Scheme 49).[161] 
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Scheme 49. Formation of dihydropyrrolizines based on Toste’s acetylenic Schmidt reaction. 
1.1.2.6 Imidazoles 
Similar to the approach for pyrrolizine formation (Scheme 49), Zhang designed a method for the 
synthesis of bicyclic imidazoles 225. The reaction took place in nitrile 222 as solvent with alkylazide 
221 at a concentration of 0.05 M. Formation of a Au-carbene via 5-exo-dig ring closure and 
concomitant expulsion of N2-gas was followed by intermolecular trapping with a nitrile. Species 224 
then underwent electrocyclization with formation of a bicyclic imidazole 225 (Scheme 50). The choice 
of the catalyst is crucial to minimize the competing Huisgen cycloaddition with formation of triazole. 
As the obtained products contain basic nitrogen atoms the addition of acid is necessary to prevent 
catalyst deactivation.[162] Propargylic amidines have been applied as substrates for the preparation of 
2-fluoroalkylimidazoles, while propargylureas have not been used to this end.[163-164] 
 
Scheme 50. Formation of bicyclic imidazoles according to Zhang. 
1.1.2.7 Pyrazoles 
Greck and co-workers reported on the formation of pyrazolidines 227 from homopropargylic 
hydrazines 226 (Scheme 51). The transformation proceeded smoothly using in situ generated 
PPh3AuBF4. Either PPh3AuCl or AgBF4 alone did not result in any conversion to 227. Apart from the 
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anticipated 5-exo-dig ring closure, some 6-endo-dig side product was present too, depending on the 
substitution of the phenyl ring. More electron-rich aromatic rings promoted 6-endo-dig reaction.[165] 
 
Scheme 51. Transformation of homopropargylic hydrazines into benzylidenepyrazolidines. 
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1.2 Formation of 6-membered rings 
1.2.1 6-endo-dig cyclization 
1.2.1.1 Pyrazolopyridines 
Wu and co-workers produced pyrazolo[1,5-a]pyridines 230 via a Au(I)-catalyzed cyclization of 
alkynylpyrazoles 228 (Scheme 52). Salts of Pt, Pd, Cu, Ag and Zn were evaluated for the ring closure 
as well but conversion was incomplete or required reflux in CH3CN for prolonged periods of time. A 
combination of PPh3AuCl and AgSbF6 resulted in full conversion after 5 hours at room temperature. 
Iodine-mediated cyclization was possible as well and resulted in iodinated pyrazolo[1,5-a]pyridines 
which are excellent substrates for further derivatization through cross-coupling strategies.[166] It must 
be noted that it is probably the other tautomer of pyrazole 228 which initiates attack on the triple 
bond. Propargylic enamines were converted into pyridines using NaAuCl4·2H2O and PPh3AuOTf by 
Arcadi and Wang, respectively.[167-168] 
 
Scheme 52. Synthesis of pyrazolo[1,5-a]pyridines via Au-mediated 6-endo-dig cyclization. 
1.2.1.2 Dihydropyridines 
Gouault applied a Au-catalyzed hydroamination for the total synthesis of (−)-Epimyrtine 233 (Scheme 
53). One advantage of this cationic Au(I)-mediated ring closure was the use of mild conditions which 
did not engender any racemization. In this manner the desired 6-membered ring was obtained in 
78% yield.[169-170] 
 
Scheme 53. Au-catalyzed 6-endo-dig ring closure in the total synthesis of (−)-Epimyrtine. 
Tricyclic xanthines fused at N7 238 were produced by 6-endo-dig cyclization of alkynylxanthines 234 
(Scheme 54). The authors proposed a mechanism based on deuterium labeling experiments. Initial 
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formation of a Au-vinylidene 235 results in ring closure and generation of a Au-carbene 236. 
Tautomerization and reductive elimination then yield the product and regenerate the catalyst. 
Performing the reaction in D2O instead of H2O resulted in dideuterated product 238-d2. Swift H/D-
exchange at the carbon in α-position to the carbene was assumed to account for the observed result. 
Interestingly, the use of AgAsF6 as catalyst results in N9-fused tricyclic xanthines.
[171] 
 
Scheme 54. Formation of tricyclic xanthines via Au-vinylidenes. 
1.2.1.3 Quinolines 
Liu and co-workers developed a method for the synthesis of tetracyclic isoquinolizinium salts 240 
(Scheme 55). Au-catalyzed 6-endo-dig cyclization preceeded protodeauration and oxidation. The 
reaction only worked for internal alkynes 239 while t-Bu-substituted alkynes were unreactive due to 
steric hindrance.[172]  
 
Scheme 55. Preparation of isoquinolizinium salts via Au(I)-mediated cyclization and oxidation. 
Quinolones 242 could be obtained through hydroamination of alkynones 241 (Scheme 56). Au(I)-
catalysts with phosphane ligands performed much better than with NHC ligands or other catalysts 
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such as PtCl2, KAuCl4, HAuCl4 or Au/C. DFT calculations revealed that amine-gold coordination was 
the preferred binding mode and not alkyne-gold or carbonyl-gold coordination. As such, coordination 
with the alkyne is some 15 kJ/mol more endothermic than with the amine. However, reaction can 
only take place after the catalyst has moved from the amine to the triple bond.[173] Hydroamination 
reactions are known to proceed via an outer sphere mechanism.[174] 
 
Scheme 56. Quinolone formation through intramolecular hydroamination. 
1.2.1.4 Dihydroquinolines and tetrahydroquinolines 
In 2008 Takemoto and co-workers reported on the intramolecular 6-endo-dig hydroamination of 
weakly basic amines 243 in the presence of a cationic Au(I)-catalyst. The reaction rate increased 
dramatically upon the addition of EtOH as a protic additive. The more electron-rich the amine, the 
better the reaction proceeded.[175] In a follow-up publication the same authors expanded the scope 
of the transformation by using different R1 groups. Furthermore they succeeded in a tandem 
cyclization reaction when R1 contained an acetal or Michael acceptor. In this light, a total synthesis of 
Nitidine 245 was achieved, a naturally occurring alkaloid with antimalaria activity (Scheme 57).[176-177] 
Fustero et al. obtained chiral perfluoroalkyl dihydroquinolines along with the corresponding 
isoindoles using SPhosAuNTf2.
[157] 
 
Scheme 57. Formation of dihydroquinolines. 
A related transformation was employed by Ohno and co-workers in the total synthesis of (−)-
Quinocarcin 248 (Scheme 58). Initially, an aminomethyl group was present in the substrate instead of 
an amino-substituted dihydrofuran 246. In the former case the competing 5-exo-dig cyclization 
proved very challenging to avoid. Upon introduction of steric constraints the preference for the 6-
membered ring became larger. Application of a dihydrofuran tether ensured an optimal orientation 
for 6-endo-dig cyclization. In case 5-exo-dig cyclization would take place, this would introduce a 
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significant amount of ring strain into the system, accounting for the preference for 6-endo-dig ring 
closure.[178-179] 
 
Scheme 58. Au-catalyzed hydroamination in the total synthesis of (−)-Quinocarcin. 
The reaction between o-alkynylbenzaldehydes 249 and anilines 250 under Au-catalysis results in 
fused (iso)quinolines 251 (Scheme 59). First, intermolecular imination takes place and then two 
distinct routes are possible, though both with the same outcome: either hydroamination of the 
alkyne takes place first and is followed by electrophilic substitution, or electrophilic substitution 
preceeds the hydroamination step. Monitoring the reaction by 1H-NMR indicated that 
hydroamination is the final step. Anilines tethered to other azaheterocycles were applied as well.[180] 
Saifuddin et al. adopted a similar approach.[181] 
 
Scheme 59. Reaction between o-alkynylbenzaldehydes and anilines under AuCl-catalysis. 
The Gong group disseminated their results on the hydroamination/asymmetric transfer 
hydrogenation of anilines 252 under relay catalysis of an achiral gold complex and chiral Brønsted 
acid 255 (Scheme 60). Application of PPh3AuCH3 in the presence of a Brønsted acid implies that some 
acid will be lost. Upon lowering the ratio of Au-catalyst/acid to 1/1 the reaction slowed down 
significantly, demonstrating that the acid participates by activating the in situ formed imine. 
Furthermore, a control experiment with only Au-phosphorate resulted in inferior yields and ee’s as 
compared to a binary system consisting of cationic Au(I) and a chiral Brønsted acid.[182] 
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Scheme 60. Intramolecular hydroamination and transfer hydrogenation. 
Liu and co-workers constructed 3-functionalized benzazepine skeletons 258 through ring-
opening/cycloamination reactions, catalyzed by cationic Au(I)-complexes (Scheme 61). The reaction 
between (o-alkynylphenyl)aziridines 256 and PPh3AuOTf results in 6-endo-dig ring closure. In this 
manner, aziridinium ion 257 is generated which is prone to ring opening by nucleophiles. An 
electron-poor aniline opens the aziridine regio- and diastereoselectively at C3 which results in a 7-
membered ring with a trans-configuration 258. An electron-withdrawing group as R1 was crucial to 
obtain regioselective ring-opening. Instead of OTf, other counterions such as SbF6 and NTf2 were 
active as well and the reaction proceeded in THF, DCE, dichloromethane, dioxane and acetonitrile. 
Water was also able to open the aziridine ring, resulting in a free alcohol and opening up possibilities 
for further derivatization.[183] 
 
Scheme 61. Synthesis of benzazepines from (o-alkynylphenyl)aziridines. 
1.2.1.5 Oxazines 
The transformation of 2-propargyloxypyridines 259 into α-(N-2-pyridonyl)ketones 262 was described 
by Anderson and her group (Scheme 62). A 6-endo-dig ring closure was followed by rearrangement 
of the intermediate pyridinium 260 to an N-allenyl pyridine 261. Hydrolysis resulted in the 
corresponding ketones 262.[184] 
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Scheme 62. Initial formation of 2H-oxazines and subsequent collapse and hydrolysis. 
1.2.2 6-exo-dig cyclization 
1.2.2.1 Tetrahydropyridines 
After Nozaki in 1987, Müller and co-workers have performed some pioneering work on Au-catalyzed 
6-exo-dig cyclizations with amines around the turn of the millennium but other metal catalysts gave 
superior yields in their hands.[185-187] Dixon extended his enantioselective nitro-
Mannich/hydroamination methodology to the synthesis of tetrahydropyridines 265 (Scheme 63). 
After nitro-Mannich reaction, Echavarren’s cationic Au(I)-catalyst 92 mediated the desired ring 
closure. Prior to addition of the Au-catalyst, the basic N-atom of the organocatalyst was protonated 
using diphenylphosphate (DPP) as to avoid catalyst deactivation.[188]  
 
Scheme 63. Diastereo- and enantioselective nitro-Mannich/hydroamination cascade.  
Hammond’s group developed a tandem hydroamination/cyanation approach for alkynylamines 267 
(Scheme 64). For non-basic amines, IPrAuOTf proved to be the most efficacious catalyst, but basic 
amines were transformed more efficiently with CuBr as a catalyst.[96] Brimble and co-workers 
performed a similar hydroamination reaction in their synthetic studies towards spiroimine marine 
toxins.[189]  
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Scheme 64. Tandem hydroamination/cyanation. 
1.2.2.2 Isoquinolines 
Tetrahydroisoquinolines 271 can easily be accessed from alkynylbenzenes 270 with an amine 
tethered to a carbon linker at a suitable distance. Takemoto adopted this methodology and 
synthesized 1-alkylidene-1,2,3,4-tetrahydroisoquinolines 271 (Scheme 65). The reaction with an in 
situ generated cationic Au(I)-catalyst proceeded in a highly stereoselective manner as the double 
bond geometry was identified as strictly Z. This was remarkable as the stereoselective synthesis of 1-
alkylidene-1,2,3,4-tetrahydroisoquinolines 271 is often cumbersome.[175] 
 
Scheme 65. Stereoselective tetrahydroisoquinoline synthesis using cationic Au(I)-catalysis. 
1.2.2.3 Imidazoles 
Zhang’s bicyclic imidazole synthesis (Scheme 50) was also applicable to 6-membered rings (Scheme 
66). The reaction was performed in nitrile 222 as solvent with alkylazide 272 at a concentration of 
0.05 M. After 6-exo-dig cyclization and attack of the nitrile, the imidazole is generated. No more than 
6% triazole was formed upon application of AuCl3. Again, the addition of acid was required to 
prevent complexation of the imidazole or triazole products with the catalyst.[162] 
 
Scheme 66. Fused imidazole synthesis from alkylazides and nitriles. 
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1.2.2.4 Quinazolinones 
Au-catalyzed intramolecular 6-exo-dig cyclization of (o-ethynylphenyl)ureas 276 resulted in 
methylidenequinazolinones 277 (Scheme 67). Terminal alkynes underwent 5-endo-dig or 6-exo-dig 
ring closure depending on the catalyst system used, resulting from N1- or N3-attack respectively. 
Internal alkynes exclusively underwent 5-endo-dig cyclization. Furthermore, the applied ligand 
exerted a large influence as well: JohnPhos resulted in mixtures of endo- and exo- cyclization while 
IPr selectively gave 6-exo-dig reaction to 277. The closely related but sterically less encumbered IMes 
ligand on the other hand also resulted in mixtures.[115] 
 
Scheme 67. Au(I)-catalyzed formation of quinazolinones from aptly substituted ureas. 
1.2.2.5 Dihydrooxazines 
Subjecting homopropargylic imidates 278 to PPh3AuBF4 in DCE led to formation of dihydrooxazines 
279 (Scheme 68). A large variety of functional groups was tolerated, but for R2 = TMS reaction at 
room temperature and a change of ligand to P(n-Bu)3 were required for the reaction to proceed. A 
catalyst screening revealed there was a considerable counterion effect: catalysts with NTf2, SbF6 and 
OTf were inactive, while BF4 was successful.
[159] 
 
Scheme 68. Au(I)-mediated preparation of dihydrooxazines from homopropargyl trichloroacetimidates.  
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1.3 Formation of 7-membered rings 
1.3.1 7-endo-dig cyclization 
Czekelius and co-workers subjected 1,4-diynamides 280 to cationic Au(I) in order to produce 
tetrahydrooxazepines 281 (Scheme 69). The applied catalyst could not fully convert the substrates, 
probably due to catalyst degradation.[190] 
 
Scheme 69. Au(I)-catalyzed 7-endo-dig cyclization with formation of tetrahydrooxazepines. 
Benzazepinones 283 could be accessed through 7-endo-dig cyclization of amides 282 using a cationic 
Au(I)-catalyst (Scheme 70). It must be noted that use of AgSbF6 alone also resulted in the desired 3-
benzazepinones, but in combination with a Au-catalyst better yields were obtained. Furthermore, 
upon application of 1.2 equiv AuBr3 in acetic acid the corresponding 5-bromo-3-benzazepinones 
were isolated. The authors suggested this was due to a highly unusual and unforeseen reductive 
elimination process rather than protodeauration. Addition of bromine instead of a Au-catalyst or 
combination of AuBr3 with an oxidant did not result in any conversion.
[191] 
 
Scheme 70. Generation of benzazepinones through 7-endo-dig cyclization. 
1.3.2 7-exo-dig cyclization 
Funk and Crawley employed a Au(I)-catalyzed 7-exo-dig ring closure in their attempted synthesis of 
Communesin B 286, a Penicillium metabolite.[192] Application of in situ generated PPh3AuOTf 
smoothly generated the 7-membered ring in 285 (Scheme 71). It must be noted that this 
transformation took place spontaneously as well, albeit very slowly.[193] 
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Scheme 71. 7-exo-dig cyclization in the attempted total synthesis of Communesin B. 
Sawamura and co-workers applied their bulky semihollow-shaped silyl-capped triethynylphosphane 
ligands 289 to the Au(I)-mediated construction of azepines and benzazepines 288 (Scheme 72). A 
regioselective 7-exo-dig cyclization takes place with formation of a tetrahydroazepine ring or 
dihydrobenzazepines 288. The cavity in the ligand forces the amine into the proximity of the alkyne-
Au π-complex, resulting in an entropy-based rate enhancement.[194] The Zhang group has 
demonstrated that AuCl3 can also perform 7-exo-dig cyclizations in their work on bicyclic imidazoles 
(Scheme 50 and Scheme 66).[162] 
 
Scheme 72. Au(I)-mediated 7-exo-dig cyclization by application of semihollow-shaped phosphane ligands. 
  
II. Literature Overview 
48 
 
2. Homogeneous Au-catalyzed intramolecular attack of S-
nucleophiles on alkynes 
S-nucleophiles have been much less investigated than their N-counterparts. Nevertheless, the 
feasibility of combining S-nucleophiles with Au-catalysts as π-acids has been demonstrated. Krause 
and Yamamoto have described reactions between sulfides and allenes, but these transformations are 
outside the scope of this overview.[195-196] 
2.1 Formation of 5-membered rings 
2.1.1 5-endo-dig cyclization 
Nakamura and co-workers were the first to evaluate the Au-catalyzed intramolecular 5-endo-dig 
cycloisomerization of sulfides 290 (Scheme 73). A library of transition-metal catalysts was screened 
and AuCl, AuCl3 and PtCl2 were identified as excellent catalysts. On the contrary AuBr3, PtCl4, AgOTf, 
InCl3 and some Pd- and Cu-salts were inactive in this case. An apolar solvent was required with 
toluene and hexane giving the best results. However, in toluene conversion was faster. Acetonitrile, 
THF or methanol were not suited. A mechanism was proposed: initial 5-endo-dig cyclization is 
followed by [1,3]-migration and elimination of AuCl to yield benzo[b]thiophenes 294. Allyl and PMB-
groups could also undergo [1,3]-migration, while a regular benzyl group could not. A crossover 
experiment indicated that the observed migration is an intramolecular process.[136, 197] Aponick and 
co-workers described a 5-endo-dig cyclization of homopropargyl thiols with formation of 
thiophenes.[80] 
 
Scheme 73. Benzo[b]thiophene formation catalyzed by AuCl. 
Next, the same authors investigated silyl migrating groups in a similar transformation to 297 (Scheme 
74). Ring closure was followed by [1,3]-migration and silyldeauration. Interestingly, a crossover 
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experiment resulted in a 1/1/1/1 distribution of products: two products derived from intramolecular 
migration and two products derived from intermolecular migration of the silyl group. This was in 
contrast with the lack of crossover in the previous case (Scheme 73). The proposed reason behind 
these observations is the low migratory ability of silyl groups as compared to carbon migrating 
groups. This increased the lifetime of sulfonium 296, hence facilitating cross-over.[197] 
 
Scheme 74. Formation of 3-silylbenzo[b]thiophenes. 
Introduction of a chiral migrating group would give more information about the precise nature of the 
[1,3]-migration. Treatment of chiral substrates 301 with AuCl resulted in the desired 
benzo[b]thiophenes with retention of stereochemistry (Scheme 76, vide infra). A deuterium labeling 
experiment had indicated that the migration is indeed a [1,3]-migration and not the consequence of 
two consecutive [1,2]-migrations (Scheme 75). If two consecutive [1,2]-shifts had occurred, 
scrambling of the deuterated and protonated groups would have taken place. However, this was not 
the case, thus corroborating a direct [1,3]-migration.[198] 
 
Scheme 75. Deuterium labeling experiment to investigate the nature of the [1,3]-shift. 
Retention of configuration in Scheme 76 suggests that a contact ion pair 303 is generated which 
smoothly recombines to form a new C-C bond before racemization of the stereocenter is possible. 
This was supported by inferior retention of stereochemistry at higher reaction temperatures due to 
more separation of the ion pair. The presence of an aromatic moiety in the migrating group plays an 
important role in light of π-π-interactions in the contact ion pair 303 (Scheme 76). In case of a 
sigmatropic [1,3]-shift the migration would proceed suprafacially with inversion of stereochemistry. 
This was not the case, so a concerted migration is unlikely.[197] 
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Scheme 76. Generation of a contact ion pair with retention of stereochemistry, and the unobserved 
sigmatropic rearrangement with inversion of stereochemistry. 
2.1.2 5-exo-dig cyclization 
In 2011, the Stevens group published a AuCl3-catalyzed 5-exo-dig ring closure with concomitant 
Claisen rearrangement for the preparation of dihydrothiazoles 308 (Scheme 77). A crossover 
experiment indicated that this is an intramolecular process, while selective formation of branched 
products 308 underlined the concerted nature of this transformation. In addition, performing the 
reaction in nucleophilic solvents such as methanol did not give rise to allylmethyl ethers, supporting 
the conclusions drawn from the crossover experiment. The exocyclic double bond in dihydrothiazoles 
308 was present in the E-configuration according to a NOE experiment.[73] 
 
Scheme 77. Au(III)-catalyzed cycloisomerization with formation of dihydrothiazoles. 
The Bertrand group reported on one example where a S-atom performed a 5-exo-dig cyclization 
(Scheme 78). Using Au(I)Cl with a tetrahydrothiophene (tht) ligand in a stoichiometric amount, 
complex 310 was obtained. However, heating the reaction mixture to reflux temperature resulted in 
the formation of carbene 311. This was the first example of a diarylcarbene Au-complex obtained 
without using a diazo precursor or an oxidative addition.[199] 
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Scheme 78. Au(I)-catalyzed generation of a Au-carbene. 
2.2 Formation of 6-membered rings 
2.2.1 6-endo-dig cyclization 
In the same report Bertrand synthesized another Au-carbene 313 via 6-endo-dig cyclization of a 
thioamide 312 (Scheme 79). This was the first metal complex with a non-N-containing 6-membered 
mesoionic carbene.[199-200] 
 
Scheme 79. Formation of a mesoionic Au-carbene. 
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3. Conclusion 
The Au-catalyzed cyclization reaction of N- and S-nucleophiles with alkynes is a reliable and practical 
manner for the construction of aza- and thiaheterocyclic compounds. The resulting mode of ring 
closure (endo vs. exo) is influenced by a number of factors, which in most cases allow for the 
selective formation of the envisioned heterocycles. 
Five- and six-membered rings are the easiest cyclization products to obtain, resulting from 5-endo-
dig, 5-exo-dig, 6-endo-dig or 6-exo-dig transformations. Firstly, substrate design is obviously the most 
determining factor in steering the regioselectivity. Both 5-endo-dig and 6-exo-dig ring closure usually 
occur with little formation of four- or seven-membered products, respectively, though there are 
exceptions (vide supra).  
Particularly in the case where 5-exo-dig and 6-endo-dig reaction are feasible, competition between 
these two modes of cyclization occurs. There is no categorical recipe to exclude a cyclization mode, 
although some trends can be deduced from this literature overview. Terminal alkynes tend to 
preferentially undergo 5-exo-dig cyclization, whereas internal alkynes are more susceptible to 6-
endo-dig ring closure. Furthermore, the introduction of electron-donating or electron-withdrawing 
substituents on the triple bond can direct the nucleophilic attack: when an electron-donating 
substituent is present on a triple bond, it will push the electron density of the alkyne to the distal 
carbon atom, thus activating the proximal (i.e. the ipso) carbon for nucleophilic attack, and vice versa 
for electron-withdrawing substituents. 
Apart from substrate design, the applied catalyst can have a large impact on the mode of ring 
closure. This often requires a more trial-and-error approach where the oxidation state (soft Au(I) vs. 
hard Au(III)), the ligand (NHC’s, Buchwald ligands, etc.) and the counterion (coordinating ability, 
electron-density, etc.) all play a crucial role in tuning the electronic and steric nature of the catalyst. 
When cationic Au(I)-catalysts are applied, one must keep in mind that their preparation may not be 
as innocent as commonly assumed due to an important “silver effect”.[201-202] 
The choice of solvent can exert an influence on the selectivity as well. Usually, homogeneous Au-
catalysis is performed in apolar solvents such as toluene, dichloromethane and dichloroethane. 
However, reactions in water and other polar solvents are no exceptions. 
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1. Synthetic entry into 3-phosphono-1-
azabicyclo[3.1.0]hexanes 
1.1 Introduction 
Phosphonylated pyrroles are of interest due to their presence in bio-active molecules. Analgetic 
properties have been ascribed to 2-phosphonopyrroles[203] while 2-phosphonoindoles display 
thyromimetic (314),[204] anti-inflammatory (315)[205] and plant growth regulating qualities.[206] 
Furthermore, 3-carboxylpyrroles 316, of which the phosphonates are bioisosteres, have been 
reported as cyclic AMP-specific phosphodiesterase inhibitors (Figure 7).[207] 
 
Figure 7. Examples of biologically active phosphonylated indoles and 3-carboxylpyrroles. 
In continuation of the department’s ongoing research on Heteroatom Transfer Radical Cyclization 
(HATRC) for the design of phosphonylated heterocycles,[41, 53, 59, 70, 208] and the interest in 
phosphonylated azadienes,[41, 66, 69] a retrosynthetic approach toward 3-phosphonopyrroles was 
elaborated (Scheme 80). Commercially available or easily accessible β-ketophosphonates 29 could be 
iminated and α,α-dichlorinated in order to generate a suitable substrate 25 for HATRC. After ring 
closure, a cyclic imine 26 with a leaving group in α-position could be obtained and upon treatment 
with base, this product would undergo a 1,4-dehydrohalogenation with formation of 3H-pyrrole 27. 
This product would then easily equilibrate and yield the envisioned 3-phosphonylated pyrroles 28.  
 
Scheme 80. Retrosynthetic approach to 3-phosphonopyrroles. 
III. Results and discussion 
55 
 
1.2 Attempted synthesis of 3-phosphonopyrroles 
1.2.1 Synthesis of β-ketophosphonates 29 
Most of the required β-ketophosphonates 29 had to be synthesized as only the derivatives with R1 = 
Ph or alkyl are commercially available. In order to study the influence of the electronic properties of 
R1 on the envisioned transformations we decided to use the derivatives with R1 = Me and Ph (29a-b, 
respectively), along with a number of aptly substituted phenyl groups. Subjecting α-halo ketones 317 
to classic Michaelis-Arbuzov conditions with triethyl phosphite would be the most straightforward 
entry in order to generate the desired β-ketophosponates 29 (Scheme 81). However, such α-halo 
ketones are prone to Perkow reaction, i.e. a side reaction arising from phosphite attack across the 
carbonyl function. The Perkow route yields enol phosphate esters via a zwitterionic intermediate.[209] 
 
Scheme 81. Desired Michaelis-Arbuzov reaction and undesired Perkow reaction. 
In order to avoid formation of these enol phosphates 318 during the preparation of β-
ketophosphonates 29, two literature procedures were applied: one relied on the generation of 
intermediate hydrazones (Method A), another employed phosphonoacetic acid (Method B). In a first 
approach (Method A) α-halo acetophenones 317 were converted into the corresponding hydrazones 
320 (Table 2). The use of hydrazones prevented phosphite attack across the carbonyl function and 
favored the envisaged Michaelis-Arbuzov reaction.[209] Consecutive hydrolysis of the hydrazones in a 
1/1 mixture of acetone and 2 M HCl delivered the desired β-ketophosphonates 29c-i in good to 
excellent yields, as depicted in Table 2, and no Perkow-reaction was observed. Electron-poor 
halogen-substituted derivatives were obtained in markedly lower yields than more electron-rich 
derivatives (entries 29c-e vs. 29f-h). 
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Table 2. Generation of β-ketophosphonates 29. Method A is depicted. 
 
product R method yield 29 (%) 
29c 4-F A 50a 
29d 4-Cl A 51a 
29e 4-Br A 52a 
29f 4-OMe A 95a 
29g 4-Me A 90 
29h 4-Ph A 99 
29i 3-OMe A 61a 
29j 4-NO2 B 51
a 
29k 4-CN B 50a 
a 
after column chromatography 
For α-halo acetophenones with strongly electron-withdrawing groups on the phenyl ring (29j-k), 
formation of the hydrazones appeared to be troublesome, leading to severe degradation of the 
reaction products 320. Hence, a different procedure using a MgCl2/Et3N system and diethyl 
phosphonoacetic acid was evaluated (Method B). α-Acylation followed by decarboxylation cleanly 
yielded the desired electron-poor β-ketophosphonates 29j-k (Scheme 82 and Table 2).[210] When the 
purity of the crude reaction product was unsatisfactory, column chromatography was performed 
since even small impurities caused unproportionally large amounts of side products in the following 
steps. Using these two methods, nine β-ketophosphonates 29c-k of various electronic nature were 
obtained. 
 
Scheme 82. Alternative synthesis of β-ketophosphonates 29 (Method B, Table 2). 
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1.2.2 Imination of β-ketophosphonates 29 
Next, β-ketophosphonates 29 were iminated with allylamine and 5 mol% p-TsOH·H2O as a catalyst 
under Dean-Stark conditions for 24 hours (Table 3). This transformation proceeded smoothly and 
resulted in the formation of a mixture of enamines 322 and imines 323. Based on some characteristic 
signals in the 1H-NMR spectrum the ratio of products 322/323 could be determined, as well as their 
conformation: 
 the α-CH2 signal of imines 323 is clearly visible as a doublet with 
2JHP ≈ 22 Hz in the range of 3-
4 ppm 
 the α-CH signal of enamines 322 is clearly visible as a doublet of 2JHP ≈ 13 Hz in case of a Z-
isomer and 2JHP ≈ 10-11 Hz in case of an E-isomer, both in the range of 3.5-4.5 ppm
[211] 
After reaction, a crude mixture was obtained consisting of enamines/imines 322/323 in ratios around 
80/20 in favor of the enamines (Table 3). Only one isomer of enamine 322 prevailed, i.e. the Z-form, 
due to intramolecular stabilization and formation of a 6-membered ring with the phosphonate 
oxygen atom (Figure 8). In contrast, imines 323 were obtained in both their E- and Z-forms, most 
likely with the E-form prevailing, possibly due to the steric hindrance of the phosphonate (for exact 
ratios, see Table 3). However for R = Me, the conformational ratios could not be determined due to 
severe overlap in the 1H-NMR spectrum (entry 1). It is difficult to deduce any trends with regard to 
the E/Z ratio from these results, even taking Hammett substituent constants into account. 
 
Figure 8. Formation of Z-enamines 322 due to intramolecular stabilization. 
These β-enaminophosphonates 322 are versatile building blocks and accordingly, various syntheses 
of these molecules have been reported, e.g. by the addition of amines to phosphonylated alkynes[212-
214] or addition of metalated dialkyl phosphonates to nitriles.[215-218] Furthermore, they can be 
converted into a myriad of acyclic and cyclic compounds, such as 1-aza-1,3-dienes,[219-220] 
pyridines[217] and pyrazoles.[219] 
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Table 3. Yields and conformational ratios of enamines/imines 322/323 and α,α-dichlorinated imines 25. 
 
entry R 
yield 322 + 
323 (%) 
ratio 322/323 
ratio E/Z of 
323 
yield 25 (%) 
1 Me (a) 90 - - 90a 
2 Ph (b) 98 83/17 65/35 95 
3 4-F-C6H4 (c) 89 71/29 53/47 99 
4 4-Cl-C6H4 (d) 80 72/28 51/49 97 
5 4-Br-C6H4 (e) 93 49/51 60/40 82 
6 4-OMe-C6H4 (f) 91 73/27 59/41 92 
7 4-Me-C6H4 (g) 72 74/26 73/27 96 
8 4-Ph-C6H4 (h) 91 82/18 54/46 90 
9 3-OMe-C6H4 (i) 98 84/16 59/41 99 
10 4-NO2-C6H4 (j) 83 50/50 93/7 42
b 
11 4-CN-C6H4 (k) 88 51/49 78/22 44
b 
a 
E/Z ratio 3/1;
 b 
after column chromatography 
In this work, the resulting enamine/imine 322/323 mixtures were α,α-dihalogenated using two 
equivalents of N-chlorosuccinimide (NCS) furnishing the α,α-dichlorinated imines 25a-k in 
satisfactory yields and with high purities.[221] As chlorination proceeded through the enamine 
tautomer this probably ensured the E-form of imine 25 was obtained, though this was not explicitly 
determined. In addition, the steric bulk of the phosphonate and two chlorine atoms is expected to be 
larger than that of the R-groups, also favoring the E-stereomers.[222-223] These imines were present in 
only one isomeric form, except for 25a (R = Me) which was present in a 3/1 E/Z mixture. No 
purification step was required except for the derivatives with strong electron-withdrawing groups on 
the phenyl ring (Table 3, entries 10-11). 
III. Results and discussion 
59 
 
1.2.3 Heteroatom Transfer Radical Cyclization 
With a library of α,α-dichlorinated imines 25a-k in hand, a HATRC was performed in order to acquire 
the envisaged 1-pyrrolines 26a-k (Scheme 83).[59] Usually, copper(I) complexes mediate this free 
radical ring closure and their activity can be tuned by adding ligands that modify their solubility, 
electron density and hence, redox potential.[224] The α,α-dihalogenated imines 25a-k were stirred 
with Cu(I)Cl and N,N,N’,N’,N”-pentamethyldiethylenetriamine (PMDTA) as a tridentate ligand in 
CH2Cl2 at reflux temperature. Application of other ligands such as the bidentate N,N,N’,N’-
tetramethylethylenediamine (TMEDA) gave similar results. The reaction progress was monitored 
using LC-MS.  
Mechanistically, the HATRC starts with the abstraction of a chloride radical by a Cu(I) species which is 
concomitantly oxidized to Cu(II)Cl2 (Scheme 83). The resulting organic radical can then isomerize the 
E-imine into the required Z-form 324 and attacks the double bond of the allyl group in a 5-exo-trig 
fashion, thus forming 1-pyrroline 325.[225] No 6-endo-trig products were detected. Radical 325 then 
reduces the in situ formed Cu(II)Cl2 back to Cu(I)Cl with generation of a chloromethyl substituent on 
the pyrroline 26. After all starting material 25 was consumed (ca. 5 h), the crude reaction mixture 
was subjected to column chromatography. This yielded 1-pyrrolines 26a-k in satisfactory yields 
(Table 4).  
 
Scheme 83. Mechanism of the HATRC. 
Due to the molecular reorganization caused by the radical cyclization process, two stereogenic 
centres were introduced into the molecule (Scheme 83, 26a-k). Interestingly, 31P-NMR analysis of the 
crude mixture revealed the ring closure was highly diastereoselective. Only one major peak was 
present, along with some small signals accounting for the minor diastereomer and some impurities. 
The diastereoisomeric ratios were all in the range of 90/10 and only the major diastereomer was 
obtained in pure form after column chromatography (Table 4).  
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Table 4. Diastereoisomeric ratios of the crude reaction mixtures and yields after purification. 
product R dra yield 26 (%) 
26a Me 84/16 38 
26b Ph 90/10 93b 
26c 4-F-C6H4 92/8 59 
26d 4-Cl-C6H4 90/10 73 
26e 4-Br-C6H4 89/11 43 
26f 4-OMe-C6H4 85/15 45 
26g 4-Me-C6H4 95/5 26 
26h 4-Ph-C6H4 96/4 37 
26i 3-OMe-C6H4 93/7 60 
26j 4-NO2-C6H4 93/7 23
c 
26k 4-CN-C6H4 95/5 14
c 
a 
based on 
31
P-NMR integration;
 b 
no column 
chromatography necessary; 
c
 after first crystallization; 
further crystallization proved difficult so column 
chromatography was used if necessary  
Unfortunately, the first synthesized pyrrolines 26 were not crystalline so their relative 
stereochemistry had to be determined using several NMR techniques. At first, a 2D-NOESY 
experiment demonstrated no interaction between the phosphonate ethoxy groups and Ha, possibly 
indicating a trans-configuration (Figure 9, with the chlorine and chloromethyl group trans). However, 
it is possible that due to steric crowding, the ethoxy groups turn away from the pyrroline and hence 
from Ha, so this experiment was inconclusive.  
To tackle this issue, a heteronuclear 2D-NOESY (HOESY) experiment was performed. This is a similar 
technique that detects Overhauser effect between a heteroatom and protons. Accordingly such an 
experiment was conducted between 31P and 1H. In case the P and stereogenic Ha are in eachother’s 
proximity in space, a correlation should be visible in this 2D-experiment. However, the only clear 
correlation visible was between the P-atom and its ethoxy groups. This experiment thus does not 
contradict the results from the 2D-NOESY, i.e. the stereogenic P and H atoms are in a relative trans-
configuration. 
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Figure 9. Absence of NOE in 26b, both between Ha and the ethoxy groups (2D-NOESY) and between Ha and 
the P-atom (HOESY). 
Unsatisfied, we decided to try and determine the 3JHP coupling constant between P and Ha in 26b in 
order to compare this value to literature reports and draw a conclusion with regard to the relative 
stereochemistry. However, this coupling constant could not straightforwardly be determined from 
the 1H- or 31P-NMR spectra (Figure 10): 
 Ha couples with four adjacent hydrogens (NCHbHc and CHdHeCl) and the P-atom so in theory 
the signal should appear as a ddddd. This signal is visible in the 1H-NMR spectrum as a 
multiplet. 
 a 1H-undecoupled 31P-NMR spectrum would result in splitting of the 31P-signal and possibly 
allow for the determination of the desired 3JHaP. However, coupling of P to other protons has 
to be taken into account. 
In the 1H spectrum of 26b the only signals that couple (visibly) with 31P are Ha and Hf (Figure 10, only 
one ethoxy moiety fully drawn). This means that coupling with 31P is visible over 3 bonds and not 
over 4 bonds with Hb, Hc, Hd, He or Hg as 
4JHP is too small or absent. Consequently, a 
1H-undecoupled 
31P-NMR spectrum would result in a ttd signal which, given the lower resolution of 31P-NMR spectra, 
would not allow for the determination of the desired 3JHaP. The signals for Hf, integrating for 4H, are 
present in the spectra as an overlapping multiplet at ca. 4.0-4.2 ppm, while Ha (integrating for 1H) is 
present as a multiplet at ca. 3.2-3.4 ppm. 
 
Figure 10. 
1
H-
31
P coupling is visible only for Ha and Hf in the 
1
H-NMR spectrum. 
These spectral properties spurred us to record a 1H-undecoupled 31P-NMR spectrum in which the 
region between 4.0-4.2 ppm of the 1H spectrum was selectively irradiated. This would saturate the Hf 
protons and as a consequence they would not couple to P which would only leave coupling with Ha. 
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As such, determination of 3JHaP from the 
31P-NMR spectrum should be possible. However, great care 
had to be taken to avoid saturation of neighbouring signals; if Ha was partially saturated as well due 
to too strong, unselective irradiation this would lead to incorrect results for 3JHaP.  
A number of 1H-undecoupled 31P-NMR spectra were recorded with different intensities of decoupling 
irradiation to find an optimum. The corresponding 1H-NMR spectra with the same intensity of 
irradiation were also recorded in parallel to assess whether the intensity of irradiation was sufficient 
or excessive. This could be quantified by comparing the integration of neighbouring signals with the 
aromatic signals as these were several ppm removed. The results are depicted in Figure 11 and 
Figure 12. 
Four 1H-NMR spectra are shown (Figure 11): the first spectrum (a) is a normal 1H-NMR spectrum 
while the next three were irradiated at different intensities. The intensity of irradiation is expressed 
as a level of attenuation: hence, no irradiation (which results in a normal 1H spectrum) is 
characterized by a very large attenuation of irradiation. The smaller the attenuation becomes (in dB), 
the stronger the irradiation of the Hf protons. This is clearly visible in the region around 4.1 ppm as 
the present signals become smaller until they have nearly disappeared at an attenuation of 30 dB 
(spectrum d). Up until 30 dB the integration of Ha (around 3.3 ppm) is unaffected but stronger 
irradiation at 4.1 ppm resulted in a distorted signal as well as changes in integration. We concluded 
that an attenuation of 35-30 dB was optimal. 
The corresponding 31P-NMR spectra are displayed as well (Figure 12). Without irradiation the signal is 
a very broad multiplet, but upon lowering the attenuation to 45 dB a doublet becomes visible while 
at 35 and 30 dB a clean doublet is visible. At attenuations lower than 30 dB the coupling constant 
3JHaP decreased until only a singlet signal was left, as is the case in a standard 
1H-decoupled 31P-NMR 
spectrum. Based on the parallel 1H-NMR spectra, 3JHaP was calculated as the average between the 
coupling constants at 35 and 30 dB, i.e. 11.91 and 10.42 Hz, resulting in 3JHaP = 11.2 Hz. 
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Figure 11. 
1
H- NMR spectra (300 MHz, CDCl3) of 26k without and with different intensities of irradiation at 4.1 ppm in the 
1
H-NMR spectrum. 
a) no irradiation b) 45 dB attenuation 
c) 35 dB attenuation d) 30 dB attenuation 
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Figure 12. 
31
P-NMR spectra (121 MHz, CDCl3) of 26k without and with different intensities of irradiation at 4.1 ppm in the 
1
H-NMR spectrum.
a) no irradiation b) 45 dB 
c) 35 dB  
d) 30 dB 
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Literature values for 3JHP in five-membered rings have been reported as 
3JHP,trans =
 5.4-6.0 Hz, while 
3JHP,cis = 17.2-18.0
 Hz.[226] Unfortunately the coupling constant observed in 26k lies in the middle of 
these two values, rendering the NMR observations inconclusive. 
Fortunately, after standing on the bench for weeks two derivatives started to crystallize (26j, R = 4-
NO2-C6H4 and 26k, R = 4-CN-C6H4). It must be noted that no other phosphonates synthesized in this 
work were crystalline so this was truly a fortunate coincidence. Crystals suited for single crystal X-ray 
diffraction were analyzed by Prof. Dr. Kristof Van Hecke (XStruct Bio-Inorganic group, Department of 
Inorganic and Physical Chemistry, Ghent University).  
Contrary to the configuration suspected from the preliminary 2D-NOESY and HOESY NMR 
experiments, single crystal X-ray diffraction analyses indicated that the relative stereochemistry is cis 
(the chlorine and chloromethyl group are cis), with a torsion angle of -33.1(3)° between the 
phosphorus atom and Ha
 (Figure 13). The 5-membered ring is almost entirely flat. As compound 26k 
crystallized in the centro-symmetric space group P21/c, both enantiomers were present in the crystal 
structure. Further details with regard to the crystal structures for 26j and 26k can be found in the 
experimental part of this work. 
 
 
Figure 13. Asymmetric unit of the crystal structure of 26k, showing thermal ellipsoids at the 40% probability 
level. Both enantiomers are present in the crystal structure. Disorder of the ethoxy groups is omitted for 
clarity. 
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The origin of this diastereoselectivity most likely lies in steric hindrance caused by the phosphonate’s 
bulky ethoxy substituents, as no other obvious inducing factors are present. Formation of the five-
membered ring proceeds through a radical 5-exo-trig cyclization (Scheme 84). In the transition state 
a five-membered ring 324 is formed, with the bulky phosphonate adopting a pseudo-equatorial 
position. Radical ring closure is followed by recombination with a chloride radical, yielding 26. In this 
manner the energetically most favorable five-membered ring is formed, being the one with the least 
steric repulsion in the transition state.  
 
Scheme 84. Transition state illustrating the origin of diastereoselectivity towards the cis-conformers. 
1.2.4 Attempted pyrrole synthesis 
With five-membered ring 26 in hand, the initial retrosynthetic goal was to perform a 1,4-
dehydrohalogenation reaction in order to ultimately obtain phosphonylated pyrroles 28 (Scheme 
85).[66] As such, several bases were evaluated. Weak bases such as Et3N or K2CO3 did not engender 
the desired elimination. Bases of intermediate strength such as KOt-Bu and NaH also failed to do so. 
The use of LiHMDS yielded a trace of pyrrole 28b so in order to achieve complete conversion n-BuLi 
was employed. However, this resulted in the formation of an unexpected new compound instead of 
the envisaged pyrrole 28b. After purification, careful NMR studies and comparison to literature 
spectral data,[227] the structure of this new compound was assigned as azabicyclic product 326b.  
 
Scheme 85. Attempted synthesis of phosphonylated pyrroles 28b through E2. 
A literature search revealed that bicyclic β-aminophosphonates bearing a phosphonate moiety at the 
bridgehead of a bicyclic structure, such as 326b, have only scarcely been reported.[228-232] Therefore 
we decided to further elaborate this route instead of the envisioned dehydrohalogenation. 
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A mechanism was proposed to account for the formation of azabicycle 326b. The hypothesis was 
that instead of deprotonating 1-pyrroline 26b, the alkyllithium reagent had performed a Li-Cl 
exchange with the tertiary chlorine atom to yield the most stable carbanion 327 (Scheme 86). This 
lithiated anion subsequently performed an intramolecular SN2 affording bicycle 326b. Although 
usually the formation of a tertiary carbanion should be disfavored as compared to primary 
carbanions, conjugation with the imine as well as the electron-withdrawing nature of the 
phosphonate moiety ensured that only the tertiary chlorine was exchanged, and the primary, more 
accessible one was left untouched.  
 
Scheme 86. Mechanistic proposal for the formation of bicyclic phosphonates 326. 
This hypothesis was proven by quenching the reaction with methanol five minutes after the addition 
of n-BuLi, as this yielded the same bicyclic product 326 (Scheme 87). Contrary, quenching the anion 
with acetic acid after the same time interval yielded a mixture of starting material 26, bicycle 326 and 
some monochlorinated compounds, most likely 328. Firstly, upon addition of methanol the lithiated 
product 327 is quenched by the acidic alcohol proton with formation of 328. However, the in situ 
formed LiOMe is basic enough to deprotonate the β-iminophosphonate 328 and mediate the 
intramolecular ring closure. This deprotonation could not be accomplished by the much less basic 
lithium acetate. Secondly, if the primary chlorine atom had been exchanged instead of the tertiary 
one, lithium methoxide would not have been able to deprotonate the resulting aliphatic methyl 
group. Furthermore, this would imply that the primary carbanion was able to displace a tertiary 
leaving group, which is highly unlikely. These experiments prove that the mechanism proposed in 
Scheme 86 is correct: the tertiary chlorine is exchanged after the addition of n-BuLi and a stable aza-
enolate 329 is formed. This aza-enolate then displaces the primary chlorine with formation of the 
annulated cyclopropane 326 moiety.  
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Scheme 87. Quenching of anion 327 to prove the proposed mechanism. 
The other diastereoisomer of 26, in which the tertiary chlorine and the chloromethyl group are in a 
trans-configuration, cannot directly be transformed into bicyclic product 326 as the resulting anion is 
too far from the chloromethyl moiety to attack. The in situ formation of aza-enolate 329 implies that 
the stereocenter at C4 bearing the phosphonate is racemized (Scheme 87, 329). In this case the aza-
enolate 327 simply equilibrates again and the conformation required for ring closure as in 327 is 
attained. 
1.2.5 Cyclopropanation of 26 
All derivatives 26a-k were subjected to treatment with n-BuLi in order to form azabicycles 326. This 
proceeded in acceptable yields for most derivatives (Table 5). 
Table 5. Yields of cyclopropanation. 
product R yield 326 (%) 
326a Me -a 
326b Ph 76 
326c 4-F-C6H4 49 
326d 4-Cl-C6H4 33 
326e 4-Br-C6H4 40
b 
326f 4-OMe-C6H4 51 
326g 4-Me-C6H4 54 
326h 4-Ph-C6H4 30 
326i 3-OMe-C6H4 72 
326j 4-NO2-C6H4 20 
330k 4-pentanoyl-C6H4 36 
a 
complete degradation; 
b
 inseparable mixture 
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Treatment of 326a with n-BuLi resulted in complete degradation, most likely due to α-deprotonation 
of the methyl group and subsequent side reactions. In the 4-Br-C6H4 derivative 26e Li-Br exchange on 
the phenyl ring took place next to the desired Li-Cl exchange. This resulted in inseparable mixtures of 
brominated, chlorinated and dehalogenated products along with some cyclopropanated compound 
326e. Interestingly, Li-Cl exchange in 26d (R = 4-Cl-C6H4) occurs only on the tertiary chlorine atom and 
not on the phenyl ring as no dehalogenated products were detected. For 26k (R = 4-CN-C6H4) the 
simultaneous addition of n-BuLi to the nitrile could not be prevented, resulting in a mixture of 
starting material, cyclopropanated product 326k with the nitrile intact and with a 4-pentanoyl 
substituent 330k (Figure 14). Therefore, all of 26k was converted into 330k by adding an excess (2.2 
equiv) of n-BuLi.  
 
Figure 14. Product after addition of n-BuLi to 26k with loss of the nitrile moiety. 
1.2.6 Reduction of the imine 326 
To our surprise, a reactivity study indicated that further derivatization of the imine in azabicycles 326 
was extremely difficult.[233-235] Hydrolysis in neutral, acidic or alkaline medium as well as addition of 
alkyllithium or Grignard reagents was unsuccessful. N-alkylation using methyl iodide or 
trimethyloxonium tetrafluoroborate (Meerwein’s salt) in order to activate the imine bond was 
ineffective, as was reduction with both NaBH4 and LiAlH4. However, application of equimolar 
amounts of NaCNBH3 and acetic acid proved to be efficacious for the reduction to bicyclic 
pyrrolidines 331 (Table 6).[236] Reaction progress was monitored by HPLC.  
The otherwise lack of reactivity of 326b-k can be explained by steric hindrance at the imine bond 
caused by the bulky ethoxy groups of the phosphonate on one side, and a cyclopropane proton on 
the other side. These groups block the anti-bonding π*-orbitals of the imine, thus impeding attack of 
most species. Only the smallest nucleophiles can add on condition that the imine is suitably 
activated, i.e. by protonation. 
Through this reduction, a third stereogenic centre was introduced into the molecule with high 
diastereoselectivity (dr ≥ 99/1 for all derivatives 331b-k, based on 31P-NMR). This observation may be 
explained by strong steric hindrance at the imine bond caused by the phosphonate. This forces the 
hydride to add from the less hindered side of the five-membered ring, i.e. the side with the 
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cyclopropane moiety. This results in a racemic mixture of diethyl (2-phenyl-3-azabicyclo[3.1.0]hexan-
1-yl)phosphonates 331, with the phenyl ring and the phosphonate moiety in a cis configuration as 
confirmed by 2D-NOESY. No NOE was visible between the ethoxy groups and the stereogenic NCH 
proton, while there was interaction between the ethoxy groups and the phenyl ring. 
Table 6. Reduction of cyclic imine 326 and results from a 2D-NOESY experiment. 
 
Product R time (h) yield 331 (%) 
331b Ph 1 84 
331c 4-F-C6H4 2 74 
331d 4-Cl-C6H4 1 85 
331e 4-Br-C6H4 - -
a 
331f 4-OMe-C6H4 16 92 
331g 4-Me-C6H4 16 63 
331h 4-Ph-C6H4 24 91 
331i 3-OMe-C6H4 24 30
b 
331j 4-NO2-C6H4 4 81
b 
331k 4-pentanoyl-C6H4 24 60
b 
a
 reduction was not performed because of impure starting 
material; 
b
 after column chromatography 
A literature search indicated that in the class of 3-azabicyclo[3.1.0]hexane scaffolds, no bicycles 
phosphonylated at the bridgehead have been reported. The carboxylic acid derivatives on the other 
hand, which are bioisosteres, have been reported in patent literature and exhibit a wide range of 
therapeutic activities.[237] Amino acid 332 is a bicyclic GABA analog,[238] while 333 functions as a NK1 
antagonist, counteracting emesis in cancer patients receiving chemotherapy (Figure 15).[239] Coupling 
of the azabicyclic skeleton to larger molecules furnishes antibacterial agents 334, antihistamines and 
S1P1 agonists.
[240-242]  
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Figure 15. Biologically relevant carboxyl analogs of phosphonylated 3-azabicyclo[3.1.0]hexanes. 
Furthermore, the 3-azabicyclo[3.1.0]hexane skeleton is present in bicifadine 335, an analgesic, in 
boceprevir 336, a protease inhibitor for the treatment of hepatitis C and in (+)-Duocarmycin A 337, 
an antitumor alkaloid (Figure 16).[227, 243-247] The biological properties of compounds 335-337, which 
are analogous to the synthesized azabicycles 331, are a testimony that they are not only interesting 
from a synthetic point of view but they can possess interesting biological activities. 
 
Figure 16. Biologically active 3-azabicyclo[3.1.0]hexanes. 
1.2.7 Attempted ring-opening 
Bicylic imines 326 have proven to be rather unreactive (vide supra) but the successful 
diastereoselective reduction of the imine towards 331 opened up some new possibilities in this 
reactivity study. Firstly, N-alkylation would lead to tertiary amines and secondly, ring-opening via 
intramolecular debenzylation would result in phosphonylated cyclopropanes. The latter was deemed 
more interesting so a number of attempts at debenzylation was made, but none resulted in the 
desired ring-opening to 338 (Table 7). Reactions under H2-atmosphere with Pd/C as a catalyst 
resulted in only trace formation of cyclopropane at best and the addition of formic acid or acetic acid 
to generate the salt of 331 did not lead to improvement (entries 1-4). Application of Pearlman's 
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catalyst also failed, even under very large pressures up to 150 bar H2 (entries 5-8). Finally, reaction 
with ammonium formate as H2-source also failed.
[248-250] 
Table 7. Attempted intramolecular debenzylation of 331b with formation of phosphonylated cyclopropanes. 
 
entry H2-source catalyst additive temp time conversion 
1 1 bar H2   20 wt% Pd/C - rt 18 h - 
2 5 bar H2   20 wt% Pd/C - rt 24 h trace 
3 5 bar H2 10 wt% Pd/C 5% HCOOH rt 16 h - 
4 5 bar H2 20 wt% Pd/C 5 equiv HOAc rt 24 h - 
5 5 bar H2 20 wt% Pd(OH)2/C - rt 24 h trace 
6a 5 bar H2 20 wt% Pd(OH)2/C - rt 24 h trace 
7 50 bar H2 20 wt% Pd(OH)2/C - rt 2 d - 
8 150 bar H2 20 wt% Pd(OH)2/C - rt 3 d - 
9 5 equiv HCOONH4 20% Pd/C - Δ 4 h - 
a
 HCl salt of 331b was used as substrate 
In another attempt, N-methylation of the pyrrolidine 331b using MeI proceeded smoothly and was 
followed by treatment with H2-gas under the same conditions as in entry 2, but this again resulted in 
full recovery of starting material. Debenzylation of this tertiary amine using 1-chloroethyl 
chloroformate in methanol also failed.[248] 
1.3 Conclusion 
In conclusion, a library of novel diethyl (2-phenyl-3-azabicyclo[3.1.0]hexan-1-yl)phosphonates 331 
was synthesized in six steps from commercially available products. The required β-ketophosphonates 
29 were prepared using literature procedures to circumvent the undesired Perkow reaction. This was 
achieved by either formation of intermediate hydrazones 320 or by use of phosphonoacetic acid, 
acylation and subsequent decarboxylation. Imination under Dean-Stark conditions resulted in 
enamines and imines 322/323, which could smoothly be α,α-dichlorinated to 25. Ring closure by 
HATRC to 26 took place in a very diastereoselective manner, due to the steric bulk of the 
phosphonate. Single crystal X-ray diffraction demonstrated that cis-pyrrolines 26 were the major 
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diastereomers. Subsequent treatment with bases did not result in any transformation until n-BuLi 
was evaluated. In this case however, cyclopropanation took place as a result of Li-Cl exchange and 
intramolecular substitution. A reactivity study indicated that these bicyclic pyrrolines 326 were very 
unreactive and only reduction of the imine to 331 was successful. Any further modifications failed. 
At the outset of this work, phosphonylated pyrroles were the aim but an interesting and unexpected 
Li-Cl exchange resulted in cyclopropanation and consequently, this route was further explored. 
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2. Preparation of tetrasubstituted 3-phosphonopyrroles 
through hydroamination: scope and limitations 
2.1 Introduction 
Our envisaged synthesis of phosphonylated pyrroles using HATRC had failed but we had not lost 
interest in these compounds. Therefore, another convenient synthetic methodology was sought 
which would enable us to prepare 3-phosphonopyrroles from β-ketophosphonates 29. 
Next to the classical Knorr, Paal-Knorr and Hantzsch pyrrole syntheses and some less prevailing name 
reactions such as the Barton-Zard or van Leusen transformations, multi-component reactions as well 
as cycloadditions have been intensively utilized for the preparation of a range of polysubstituted 
pyrrole cores. Another frequently applied method is the hydroamination of alkynes in order to 
furnish polysubstituted pyrroles using, among others,[246, 251] gold,[79, 133-134, 252] silver,[253-255] 
titanium[256-257] and platinum catalysts.[258-263] Only in some cases 3-pyrrolylphosphonates were 
obtained.[61-62, 71, 264-265] Beller and co-workers recently published a versatile Ru-catalyzed three-
component reaction involving ketones, amines and vicinal diols, which is applicable to 
phosphonates.[266] Larionov and de Meijere reported on the formal cycloaddition of α-metalated 
isocyanides to acetylenes leading to pyrroles,[267-268] and Demir and Tural transformed α-
cyanomethyl-β-ketophosphonates into pyrrole-3-phosphonates.[63] 
Given the department's experience with transition-metal catalyzed cyclization reactions,[72-73] we 
envisioned a Lewis acid catalyzed cycloisomerization-type pyrrole assembly of α-propargyl imines 
340 (Scheme 88). These substrates could be obtained from the already synthesized β-
ketophosphonates 29 (vide supra, 1.2.1), in two steps by consecutive imination and α-propargylation. 
 
Scheme 88. Retrosynthetic approach to 3-phosphonopyrroles. 
2.2 Synthesis of phosphonylated pyrroles 
2.2.1 Imination of β-ketophosphonates 29 
The imination of β-ketophosphonates 29a-c,f under Dean-Stark conditions proceeded in excellent 
yields.[211, 269] Several amines were used in combination with various substrates to explore the scope 
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of the subsequent reactions (Table 8). Electron-withdrawing (29c) as well as electron-donating (29f) 
aromatic moieties were tolerated as R1, while aliphatic groups could also be used (29a). The 
conversion of the β-ketophosphonates 29 was clean and quantitative. The obtained crude products 
consist of enamines 322b, 341a-f and imines 323b, 342a-f and their ratios could easily be determined 
by analysis of 2JHP in 
1H-NMR (see 1.2.2). The enamines 322b, 341a-f were present in the Z-
conformation due to intramolecular formation of a stable 6-membered ring between the NH and 
P=O moieties (vide supra, Figure 8). Conversely, imines 323b, 342a-f were present in both their E-and 
Z-forms. The majority of the imines was present in the E-configuration due to steric hindrance 
between the R2 substituent and the bulky phosphonate group.  
Table 8. Preparation of phosphonylated enamines and imines. Reaction yields and conformational ratios. 
 
substrate product R1 R2 
yield 322,341 + 
323, 342 (%) 
ratio 322, 341 
/323, 342 
E/Z ratio 323, 
342a 
29b 341a/342a Ph Bn 95 60/40 63/37 
29c 341b/342b 4-F-C6H4 Bn 92 57/43 85/15 
29f 341c/342c 4-OMe-C6H4 Bn 83 70/30 55/45 
29a 341d/342d Me Bn 94 63b/37 63/37 
29b 322b/323b Ph allyl 98 83/17 65/35 
29b 341e/342e Ph n-butyl 87 77/23 76/24 
29b 341f/342f Ph Ph 96 69/31 85/15 
a 
based on 
1
H- and 
31
P-NMR;
 b 
the enamine 341d is present in both the E- and Z-form, in a ratio of 2/1 
respectively 
2.2.2 Propargylation of 322b, 341a-f/323b, 342a-f 
Next, the introduction of an alkyne moiety was achieved by treating the enamine/imine mixture 
322b, 341a-f/323b, 342a-f with LiHMDS at -78 °C, leading to the formation of the corresponding aza-
enolate. This was followed by the addition of propargyl bromide 343 and allowing the reaction 
mixture to warm to room temperature (Table 9).  
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Other strong bases such as n-BuLi, LDA or NaH could be employed as well, but LiHMDS qualified as 
the most suitable base in this case: the reaction proceeded cleaner and with less generation of by-
products. The reaction progress was monitored using 31P-NMR spectroscopy which indicated it was 
difficult to obtain complete conversion. Therefore, additional base and electrophile were 
consecutively added until complete conversion was achieved. However, formation of bis-
propargylated products 345 was inevitable. Unfortunately these compounds have retention factors 
that are similar to those of the desired products 344, accounting for diminished yields after 
purification via column chromatography.  
Table 9. Introduction of the propargylic moiety. 
 
substrate product R1 R2 R3 
yield 344 
(%) 
341a/342a 344a Ph Bn H 41 
341b/342b 344b 4-F-C6H4 Bn H 37 
341c/342c 344c 4-OMe-C6H4 Bn H 43 
341d/342d 344d Me Bn H 94a 
322b/323b 344e Ph allyl H 21 
341e/342e 344f Ph n-butyl H 48 
341f/342f 344g Ph Ph H 31 
341a/342a 344h Ph Bn Me 46 
341a/342a 344i Ph Bn 1-naphthyl 38 
341a/342a 344j Ph Bn SiMe3 45 
a 
crude yield, as 344d is unstable and degrades during column chromatography 
In order to simplify the reaction sequence, we considered first propargylating the β-
ketophosphonates 29 before performing the iminations. Unfortunately, the subsequent imination 
reaction failed, resulting in full recovery of starting material 346 (Scheme 89). This was probably due 
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to increased steric hindrance after introduction of the propargyl moiety, shielding the π*-orbitals at 
the carbonyl carbon from amine attack.  
 
Scheme 89. Attempted imination of α-propargyl β-ketophosphonates 346. 
Having synthesized terminal alkynes 344a-g, it seemed interesting to evaluate our envisioned 
strategy on internal alkynes too. Especially, since they could exert both a steric and electronic effect 
on the future centre of reactivity, i.e. the triple bond.  
Internal alkynes could be produced by Sonogashira coupling using terminal alkynes 344a-g as 
substrates but this would require an extra step in the sequence. An alternative entry was the use of 
non-terminal propargyl bromides 343 with the aza-enolates obtained from 322b, 341a-f and 323b, 
342a-f. As such, the second option employing internal propargyl bromides was adopted and a few 
non-terminal alkynes 344 were produced in this way (R3 = CH3, 1-naphthyl, SiMe3, see Table 9). For R
1 
= Me though (341d/342d), introduction of the propargyl moiety proved a lot more challenging than 
for the other substrates, probably due to deprotonation of the acidic methyl group. Attempted 
purification through column chromatography led to severe degradation, so the next step was 
performed using the crude product.  
The thus obtained α-propargyl phosphonates 344a-j were exclusively present as enamines, mostly in 
the Z-form although some E-isomer was also present. As no more α-protons were present in the 1H-
NMR spectra, the conformational analysis was now based on some characteristic coupling constants 
derived from the 13C-NMR spectra:[270]  
 3JCP,cis ≈ 6 Hz 
 3JCP,trans ≈ 18 Hz 
For both terminal alkynes 344a-g and internal alkynes 344i-j the E/Z ratio was around 1/9 while for 
internal alkyne 344h the ratio was 1/4.  
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2.2.3 Ring closure of 344 
With propargylated enamines 344a-j in hand, we next envisioned a regioselective 5-exo-dig 
hydroamination reaction leading to phosphonylated pyrroles 339. A literature search resulted in a 
copious amount of references regarding hydroamination catalysts, solvents and the substrate scope 
for the synthesis of pyrroles.[271-283]  
Based on our own work regarding transition metal-catalyzed cyclization reactions,[72-73, 284] several Au-
catalysts were evaluated at first with 344a, albeit with mediocre results (Table 10, entries 1-3). 
Formation of the desired pyrrole 339a took place along with hydrolysis of the enamine. According to 
literature, application of gold chlorides under non-anhydrous conditions can lead to in situ 
hydrochloric acid formation which could account for the observed hydrolysis.[285] Indeed, 0.2 
equivalents of aqueous hydrochloric acid only led to hydrolysis of the starting material and 
precipitation, probably due to salt formation (entry 4). Other acids such as TFA also induced 
hydrolysis instead of hydroamination (entry 5). Furthermore, refluxing enamine 344a in toluene with 
a catalytic amount of p-TsOH·H2O yielded the desired pyrrole 339a, but given pyrrole’s tendency to 
decompose, the room temperature catalytic approach was preferred (entry 6). It is noteworthy that 
in no case 6-endo-dig cyclization took place. 
Gratifyingly, application of ZnCl2 yielded the desired pyrrole in quantitative yield after one day while 
AgNO3 required merely one hour (entries 7-8). Both Pd- and Cu-acetates were less suitable (entries 9-
10).  
Next, the catalyst loading was diminished to 5 and 1 mol% for both ZnCl2 and AgNO3 and the reaction 
times were compared (entries 11-14). For ZnCl2 there was no difference in reaction time between a 
catalyst loading of 20 and 5 mol%. Further lowering to 1 mol% resulted in a severe decrease in 
reaction rate, prolonging the reaction to 144 hours. Upon application of 5 mol% AgNO3 the reaction 
time doubled, while use of 1 mol% required 48 hours for the reaction to complete. However, 
prolonged exposure to AgNO3 led to some slight degradation, resulting in lower yields.  
As a result of these observations and as AgNO3 is a factor 30 more expensive than ZnCl2 (ca. 340 
€/mol vs. 11 €/mol, respectively), the latter was chosen at a catalyst loading of 5 mol% for the 
further elaboration of the reaction scope (entry 11), in spite of the discrepancy in reaction rate. In 
literature, Zn-salts have often been applied for the hydroamination of alkynes.[286-297] 
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Table 10. Catalyst screening for pyrrole synthesis through hydroamination. 
 
entry catalyst loading (mol%) 
temperature 
(°C) 
time (h) 
yield 339a 
(%) 
1 AuCl 20 20 4 50a 
2 AuCl3 20 20 5 41
a 
3 HAuCl4 20 20 4 73
a 
4 HClaq 20 20 24 0 
5 TFA 20 20 24 0 
6 p-TsOH·H2O 10 110 48 93 
7 ZnCl2 20 20 24 99 
8 AgNO3 20 20 1 99 
9 Pd(OAc)2 20 20 4 23
a 
10 Cu(OAc)2 20 20 24 32
a 
11 ZnCl2 5 20 24 99 
12 ZnCl2 1 20 144 99 
13 AgNO3 5 20 2 94
a 
14 AgNO3 1 20 48 62
a 
a 
after column chromatography 
Having identified a suitable catalyst, a solvent screening indicated that the transformation also 
proceeded cleanly in more apolar solvents such as CH2Cl2, THF and toluene but at a slower rate (7 d). 
Therefore, CH3CN remained the solvent of choice. Application of these optimized hydroamination 
conditions to the propargylic enamines 344 led to the desired pyrroles in good to excellent yields 
(Table 11). The choice of R1 and/or R2 does not seem to significantly influence the reaction.  
However, non-terminal alkynes 344h-j did not furnish pyrroles 339h-j under these conditions, as only 
starting material was recovered after 24 hours. The reaction was therefore continued at reflux 
temperature (82 °C) and this did deliver the aspired pyrroles 339h-j albeit along with hydrolysis of 
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the starting enamines 344h-j. Consequently, these substrates were transformed using 20 mol% of 
dried ZnCl2
1 in dry CH3CN in order to speed up the pyrrole formation and counteract hydrolysis.  
Table 11. Yields and reaction times for the hydroamination of enamines 344a-j with formation of the 
corresponding pyrroles 339a-i.
a
 
 
product R1 R2 R3 time 
yield 339 
(%) 
339a Ph Bn H 24 h 99 
339b 4-F-C6H4 Bn H 24 h 97 
339c 4-OMe-C6H4 Bn H 24 h 72
b 
339d Me Bn H 45 min 10b,c 
339e Ph allyl H 20 h 89 
339f Ph n-butyl H 20 h 94 
339g Ph Ph H 20 h 91 
339h Ph Bn Me 7 d 46b 
339i Ph Bn 1-naphthyl 24 h 37b 
339j Ph Bn SiMe3 3 d - 
a 
conditions for terminal alkynes 344a-g: 5 mol% ZnCl2, CH3CN, rt, air. Non-terminal 
alkynes 344h-j: 20 mol% dried ZnCl2, dry CH3CN, , N2; 
b 
after column chromatography. 
c 
yield over 2 steps. Crude starting material 344g was used and catalyst was added based on 
this weight, so more than 5 mol% catalyst was added which can account for the shorter 
reaction time 
For R3 = SiMe3 though (344j), no pyrrole formation was detected even after 7 days reaction at reflux 
temperature. This may be attributed to electronic effects, as silicon is more electropositive than sp3- 
and sp2-hybridized carbon atoms and accordingly deactivates the alkyne bond for 5-exo-dig 
hydroamination. However, 6-endo-dig ring closure could take place in this case, but this was 
presumably inhibited by the sterically demanding TMS-group. For the Me and naphthyl group steric 
                                                          
1
 ZnCl2 was dried by heating to 60 °C using an oil bath under a vacuum of ca. 1 mbar for 4 hours. 
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effects were expected to be negligible as attack takes place at the distal alkyne carbon (5-exo-dig 
cyclization). 
2.2.4 Further derivatization of 339 via lithiation 
So far, a general method for the preparation of 1,2,5-substituted-3-phosphonopyrroles 339 was 
developed. In order to add to the versatility of the developed method, it would be interesting to be 
able to introduce a substituent at the 4-position as well. Retrosynthetically, this would require the 
use of branched propargyl halides 343, or the obtained pyrroles 339 had to be derivatized. The first 
option would most likely be troublesome since branched propargyl halides are not commercially 
available and the introduction of the propargyl group is already the most difficult step in the 
synthesis. Therefore, we opted for the development of a general method for the derivatization of the 
obtained pyrroles 339 at the 4-position.  
The most straightforward possibility was deprotonating the pyrrole C-H using a strong base followed 
by subsequent quenching with a suitable electrophile (Table 12, method A). In order to avoid benzylic 
deprotonation, 339f was selected as substrate since it contained an aliphatic R2 moiety on the 
nitrogen atom. While the presence of a methyl group in 339f could also lead to undesired benzylic 
deprotonation, literature examples prove the feasibility of this approach.[298]  
Initial attempts to derivatize the pyrrole 339 using n-BuLi were only partly successful as no complete 
conversion to 349 could be attained after the addition of several electrophiles. Reaction with D2O 
resulted in 60% deuteration to 349a and with the somewhat bulkier iodomethane only 21% 
conversion to 349b was obtained (entries 1-2). Using benzaldehyde as an electrophile did not lead to 
any alkylation at all towards 349c (entry 3). Benzaldehyde is most likely too large to approach the 
lithiated anion which is in the plane of the pyrrole ring and is shielded by the phosphonate group. 
Moreover, lack of full deuteration suggests that n-BuLi did not fully deprotonate the heterocycle 
(entry 1).  
Application of stronger bases such as s-BuLi did lead to full deuteration, proving complete 
deprotonation of 339f (entry 4). Use of iodomethane for alkylation only led to 62% conversion, which 
was blamed on steric hindrance, although formation of lithiated aggregates cannot be excluded 
(entry 5).[299] Interestingly, t-BuLi did not deprotonate pyrrole 339f which again could be attributed to 
the sterically encumbered environment (entry 6). It is noteworthy that under these conditions no 
deprotonation of the methyl group on the 5-position of 339f occurs at all, not even when using t-
BuLi. 
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Table 12. Derivatization at the 4-position of pyrrole 339f. 
 
entry method base 
electrophile  
(equiv) 
additive (equiv) 
product ratio (%) 
339f 349 
1 A n-BuLi D2O (excess) - 40 60 
2 A n-BuLi MeI (1.1) - 79 21 
3 A n-BuLi benzaldehyde (1.1) - 100 0 
4 A s-BuLi D2O (excess) - 0 100 
5 A s-BuLi MeI (1.1) - 38 62 
6 A t-BuLi MeI (1.1) - 100 0 
7 B n-BuLi MeI (1.1) - 40 60 
8 B n-BuLi MeI (10) - 31 69 
9 B n-BuLi MeI (10) AgF (1.2) 36 64 
10 B n-BuLi MeI (10) 12-crown-4 (1.2) 40 60 
11 B n-BuLi TMSCl (1.1) - 98 trace 
12 B n-BuLi benzaldehyde (1.1) - 100 0 
13 B n-BuLi MeI-d3 (1.1) - 26 74 
Another effort to functionalize pyrroles 339f involved bromination and subsequent lithium-bromine 
exchange (Table 12, method B).[300] The introduction of the bromine atom proceeded smoothly but 
attempted methylation proved just as difficult as after direct deprotonation, although method B gave 
cleaner results (entry 7). Even a large excess of iodomethane (entry 8) did not improve conversion, 
nor did the addition of AgF to precipitate AgI, or the addition of 12-crown-4 to scavenge lithium ions 
and counteract aggregation (entries 9-10). Introducing larger electrophiles also failed (entries 11-12). 
These results suggest that steric hindrance caused by the phosphonate is the factor that limits 
conversion. 
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Another possibility was that the newly introduced methyl group at the 4-position of 349e was acidic 
enough to quench the remainder of the starting material 350, thus preventing full methylation. This 
was probed by quenching the lithiate with iodomethane-d3 (Scheme 90). Intermolecular 
deprotonation would ultimately lead to formation of deuterated pyrroles 349a and 349g with a CHD2 
group. However, no deuterated pyrrole 349a was visible in 1H-NMR nor LC-MS analyses. This further 
supports the hypothesis that steric hindrance is the limiting factor in further derivatization at the 4-
position. 
 
Scheme 90. Quench with iodomethane-d3 to verify the hypothesis of intermolecular deprotonation after Li-
Br exchange and addition of iodomethane. 
2.2.5 Further derivatization via cross-coupling 
An alternative to lithiation followed by alkylation is transition metal-catalyzed cross-coupling. 
Admittedly, steric hindrance might equally hamper conversion in this case but the scope would be 
much broader. The 4-bromopyrrole 348 was subjected to standard cross-coupling procedures in 
order to connect the pyrrole core to a sp-, sp2- and sp3-hybridized carbon atom. The results are 
depicted in Table 13.  
Attempted Sonogashira coupling yielded unreacted starting material 348 exclusively, under both 
conventional and microwave heating up to 130 °C (entries 1-4).[301-302] Higher temperatures were 
avoided to prevent thermal degradation.  
As an alternative, Suzuki coupling with 2-phenyl-1-ethynylboronic acid pinacol ester was evaluated at 
130 °C under microwave irradiation.[303-305] After one hour, mainly debrominated product 339f was 
recovered along with some 15% starting material 348. This indicated that oxidative addition of the 
catalyst to the bromopyrrole had taken place, but the transmetalation or reductive elimination steps 
did not proceed (entry 5). No phenylacetylene was detected so transmetalation could not have taken 
III. Results and discussion 
85 
 
place. Prolonging the reaction time to two hours resulted in the formation of some coupled product 
351 and complete consumption of the starting material 348, along with product degradation (entry 
6). However, increasing the amount of boronic ester (entry 7) or further prolonging the reaction time 
(entry 8) did not lead to better results.  
Table 13. Transition metal-catalyzed coupling of pyrrole 348 to sp, sp
2
 and sp
3
 carbon atoms. 
 
entry 
coupling 
reagent (equiv) 
catalyst conditions 
product ratio (%)a 
348 339f 351 
1  
(1.2) 
2 mol% PdCl2(PPh3)2 
1 mol% CuI 
Et3N, N2 
60 h,  
100 0 0 
2  
(1.2) 
2 mol% PdCl2(PPh3)2 
1 mol% CuI 
MW, Et3N 
1 h, 130 °C 
100 0 0 
3  
(1.2) 
2 mol% Pd(PPh3)4 
1 mol% CuI 
MW, Et3N 
1 h, 130 °C 
100 0 0 
4  
(1.2) 
2 mol% PdCl2(PPh3)2 
1 mol% CuI 
1 equiv Et3N 
MW, DME/H2O 3/1 
1 h, 130 °C 
100 0 0 
5 
(1.3) 
5 mol% Pd(PPh3)4 
2 equiv Na2CO3 
MW, DME/H2O 3/1 
1 h, 130 °C 
15 85 0 
6 
(1.3) 
5 mol% Pd(PPh3)4 
2 equiv Na2CO3 
MW, DME/H2O 3/1 
2 h, 130 °C 
0 60 40 
7 
(3.0) 
5 mol% Pd(PPh3)4 
3 equiv Na2CO3 
MW, DME/H2O 3/1 
2 h, 130 °C 
degradation 
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8 
(1.3) 
5 mol% Pd(PPh3)4 
2 equiv Na2CO3 
MW, DME/H2O 3/1 
4 h, 130 °C 
degradation 
9 
(3.0) 
5 mol% Pd(PPh3)4 
MW, DMF 
2 h, 130 °C 
40 0 60 
10 
(3.0) 
5 mol% Pd(PPh3)4 
MW, DMF 
4 h, 130 °C 
25 0 75 
11  
(1.2) 
5 mol% Pd(PPh3)4 
DMF, N2 
60 h, 100 °C 
100 0 0 
12  
(3.0) 
5 mol% Pd(PPh3)4 
MW, DMF 
2 h, 130 °C 
52 0 48 
13  
(1.3) 
5 mol% Pd(PPh3)4 
2 equiv Na2CO3 
MW, DME/H2O 3/1 
1 h, 130 °C 
0 21 
79 
(63)b 
14 
(3.0) 
5 mol% Pd(PPh3)4 
DMF, N2 
60 h, 100 °C 
100 0 0 
15 
(3.0) 
5 mol% Pd(PPh3)4 
MW, DMF 
3 h, 130 °C 
20 10 
70 
(43)b 
a 
based on 
1
H-NMR integration; 
b 
isolated yield 
The results observed in entries 5-6 are peculiar and suggest another mode of action than normal 
cross-coupling. In entry 5, 85% debrominated product 339f was formed and 15% starting material 
348 was left. If the coupling reaction was simply blocked at the transmetalation or reductive 
elimination step, only 5% of debrominated pyrrole 339 would be present in the mixture. In entry 6 
however, 40% of the envisioned product was formed and 60% debrominated compound 339f 
remained.  
These results suggest that initially, oxidative addition of the Pd(0)-species to the bromopyrrole took 
place as the bromine was cleaved off, after which the Pd(II)-intermediate degraded, releases 339f 
and was somehow reduced to Pd(0) again (Scheme 91). This went on until all bromopyrrole had been 
consumed, leaving only debrominated pyrrole 339f and the Pd(0) catalyst. As in entry 6 conversion to 
the desired coupled product 351 took place, debrominated product 339f must have been able to be 
transformed into 351, presumably via a C-H activation process. Oxidative addition must have been 
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faster than C-H activation as in entry 5 no desired product 351 was formed. C-H activation using a 
phosphonate, phosphate or phosphoramidate as directing group is known.[306-311] Next, oxygen that 
was present in the headspace might have oxidized the catalyst to Pd(II). Transmetalation with the 
boronate and reductive elimination then ultimately yielded coupled product 351. However, the 
precise mode of action is unclear up to now and this mechanism remains speculative. 
 
Scheme 91. Speculative mechanism based on C-H activation to account for formal Suzuki-coupling in entry 6. 
Next, Stille coupling with tributyl(phenylethynyl)tin was assessed (Table 13, entries 9-10).[312-313] After 
two hours of microwave irradiation, 60% of coupled product 351 was observed and after four hours 
reaction the conversion to 351 was increased to 75%. Longer reaction times did not lead to full 
conversion of starting material 348, which was chromatographically inseparable from the coupled 
product 351.  
Coupling of the pyrrole core to sp2-carbon atoms was also performed by Stille coupling (entries 11-
12) and Suzuki coupling (entry 13). The Stille coupling was successful only under microwave 
irradiation (entry 12) but the coupled product could not be isolated in analytically pure form. Suzuki 
coupling proceeded cleanly and resulted in the isolation of 63% 351a. Increasing the reaction time 
did not lead to improved conversion to 351a. However, the presence of debrominated product 
suggests that a mechanism similar to that in Scheme 91 was operative.  
An sp3-carbon was coupled to the pyrrole core in 43% isolated yield (351b) using allyltributyltin under 
microwave irradiation (entry 15) whereas conventional heating resulted exclusively in starting 
material (entry 14).  
Overall, the best results were obtained using the Stille cross-coupling methodology. The requirement 
for microwave heating in these cross-coupling reactions might be attributed to the steric bulk of the 
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phosphonate. This hampers oxidative addition of a Pd(0) species which is often complexed to bulky 
phosphane ligands. Only at very high temperatures (ca. 130 °C) oxidative addition takes place and 
the coupling reaction can commence. These high temperatures might account for the degradation of 
certain organopalladium species (Scheme 91). 
2.3 Conclusion 
In conclusion, a library of 9 phosphonylated pyrroles 339 was synthesized in 3 to 4 steps depending 
on the substrate. Imination of β-ketophosphonates 29 was followed by α-alkylation using propargyl 
bromide 343 as electrophile. Full conversion was difficult to obtain and addition of extra base and 
electrophile resulted in mixtures of mono- and dipropargylated products. After purification, 
propargylated enamines 344 were obtained in the Z-form due to intramolecular stabilization. A 
catalyst screening for the hydroamination revealed that ZnCl2 was the catalyst of choice and 
acetonitrile was the best solvent. Both terminal as well as internal alkynes could be cyclized to the 
corresponding pyrroles 339, although in case of TMS-capped alkynes no reaction took place, 
probably due to a combination of electronic and steric factors. In addition, further derivatization of 
the pyrroles 339 was attempted by lithiation but this was not very successful: only deuteration 
resulted in full conversion while reaction with MeI and larger electrophiles was sluggish. Instead, 
cross-coupling strategies were evaluated which allowed coupling to sp-, sp2- and sp3-carbon atoms. 
In particular, Suzuki and Stille cross-coupling proved to be useful for further derivatization. 
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3. Addition of dialkyl trimethylsilyl phosphite and 
triethyl phosphite to α,β,γ,δ-diunsaturated imines 
3.1 Introduction 
In continuation of our work on tandem 1,4-1,2-phosphite addition to α,β-unsaturated imines 355,[54, 
67-70, 314] we wanted to assess the viability of a tandem 1,6-1,4-1,2-addition to suitable α,β,γ,δ-
diunsaturated imines 32 (Scheme 92). Conjugate 1,6-additions (vinylogous Michael reactions) are 
known for C-nucleophiles, both under transition-metal catalyzed conditions as well as in an 
organocatalytic manner, and enantioselective variants have been reported.[315]  
 
Scheme 92. Envisaged transformation of 32 to 33 based on previous work. 
Numerous transition metals have been used to this end, of which Cu(I) has received the most 
attention. Cu-salts are added to transmetalate another organometallic reagent such as 
trialkylaluminium, Grignard reagents, diethyl zinc and organolithiums.[316-319] After initial formation of 
a π-complex the organocuprate undergoes addition to the unsaturated system. 1,3-Migration, or the 
lack of it, dictates the regioselectivity of the conjugate addition and is influenced by electronic and 
steric factors.[317] Pd, Ir and other metals have been reported to mediate 1,6-conjugate additions as 
well,[320-323] and Yamamoto even succeeded in a conjugate 1,8-addition using Pd.[321]  
The approach handled in organocatalytic 1,6-conjugate addition relies on lowering the LUMO of the 
substrate, often by formation of an intermediate iminium ion (‘vinylogous iminium ion catalysis’).[324] 
A pending nucleophile, activated (HOMO-rising) or not, then attacks the conjugated system and is 
directed to the δ-position by both steric and electronic factors.[325] Application of chiral 
organocatalysts, e.g. prolinol and cinchona derivatives, has resulted in excellent remote 
stereocontrol.[325-329] Ooi and coworkers used triaminoiminophosphoranes, a type of phosphazenes, 
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as organocatalysts which resulted in the regio-, stereo- and diastereoselective formation of 1,6- and 
1,8-adducts.[324] 
Selective uncatalyzed conjugate 1,6-addition has not been reported.[330] However, given the strongly 
nucleophilic nature of silylated phosphites and other phosphorus nucleophiles, we wanted to probe 
whether a tandem 1,6-1,4-1,2-addition would be feasible. Triadducts 33 are of potential biological 
interest as their tricarboxylic analogs display micromolar activity as agonists of ionotropic glutamate 
receptors (iGluRs).[331] 
3.2 Attempted triphosphonylation 
3.2.1 Synthesis of diunsaturated aldehydes 360 
The feasibility of a tandem 1,6-1,4-1,2-addition was evaluated using both silylated phosphite 
nucleophiles as well as trialkyl phosphites as they both proved efficacious in previous studies. The 
required α,β,γ,δ-diunsaturated substrates 360 were prepared by Wittig reaction of the 
corresponding α,β-unsaturated aldehydes 357 according to a literature procedure, unless they were 
commercially available (Scheme 93).[332] After the Wittig reaction an E/Z mixture of acetals 359 was 
obtained but after acidic hydrolysis only E,E-isomer 360 remained and was used in the next step. 
Aldehydes 360 were stored under an inert atmosphere at -18 °C in the absence of light, as they were 
not bench-stable. In this manner two different α,β,γ,δ-diunsaturated aldehydes 360a,c were 
prepared while 360b is commercially available (Scheme 93). Aldehyde 360c is derived from (1R)-(−)-
myrtenal, a monoterpenoid naturally occurring in the plant Cyperus articulatus.[333] 
 
Scheme 93. Wittig reaction for the synthesis of α,β,γ,δ-diunsaturated aldehydes. 
3.2.2 Imination of 360 
Imination of these α,β,γ,δ-diunsaturated substrates 360 was evaluated employing i-PrNH2 as a model 
amine of intermediate steric hindrance. After reaction with 1.5 equivalents of i-PrNH2 at room 
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temperature it was clear that during the imination undesired conjugate addition with formation of 
361 took place, accounting for superstoichiometrical yields (Table 14, entry 1). Lowering the amount 
of amine in combination with higher reaction temperature led to some improvement though 
unwanted β-amino imine 361 was still present due to difficult precise dosage of the amine (entry 2). 
Attempted removal of 361 by extraction using a buffer at a pH of 5.8 was successful, yet traces of 
hydrolysis of 32a were present (entry 3). At a higher pH, 361 was still present while at lower pH 
hydrolysis of 32a became significant. Procedures making use of the oxophilic Lewis acids Ti(OEt)4 and 
CuSO4 were evaluated but they gave rise to hydrolysis during work-up and incomplete conversion, 
respectively (entries 4-5). In the end a self-made 2 M stock solution of amine in THF was employed in 
order to avoid undesired double addition of amine (entry 6). This methodology proved efficacious 
and was used for all further imination reactions.  
Table 14. Evaluation of different imination procedures. 
 
entry 
i-PrNH2  
(equiv) 
additive T (°C) t conversion (%) 
crude 
yield (%) 
1 1.5  2 eq. MgSO4 rt 4 h 100 114
a 
2 1  2 eq. MgSO4 Δ 1 h 99 105
a 
3 1  2 eq. MgSO4 Δ 1 h 99 94
b 
4 1  2 eq. Ti(OEt)4 Δ 20 min 100 79
c 
5 1  3 eq. CuSO4 rt 16 h 80 - 
6 1d 2 eq. MgSO4 Δ 1 h 99 96 
a 
yields were calculated based on the formation of 32a;
 b
 acid-base extraction at pH = 5.8; 
c
 partial hydrolysis 
during work-up; 
d
 2 M stock solution 
Utilizing this optimized procedure, a small library of suitable imines 32 was produced using dienals 
360a-c and five different amines (Figure 17). All imines were obtained in quantitative yield, as work-
up only consisted of filtration and concentration of the crude products. As these compounds are 
very sensitiveto hydrolysis, they were not characterized. 
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Figure 17. Synthesis of a small library of α,β,γ,δ-diunsaturated imines 32a-g. 
3.2.3 Phosphite addition to 32 
Subsequently, imines 32a-g were subjected to our previously optimized conditions for a tandem 1,4-
1,2-phosphite addition. In the case of α,β-unsaturated imines 355 both dimethyl trimethylsilyl 
phosphite (silylated phosphite, DMPTMS, Figure 18) and triethyl phosphite (TEP) could successfully 
perform the desired tandem 1,4-1,2-addition. Benzyl imine 32b was used as a model substrate to 
minimize steric hindrance. 
 
Figure 18. DMPTMS and TEP. 
3.2.3.1 Dimethyl trimethylsilyl phosphite as nucleophile 
a) Synthesis 
First, dimethyl trimethylsilyl phosphite was employed as a nucleophile in dry CH2Cl2. The same 
conditions as for the α,β-unsaturated substrates were employed in order to assess which positions 
would favor nucleophilic phosphite addition. After addition of 2 equivalents of DMPTMS to the 
unsaturated substrate 32b, 0.5 equivalents of concentrated H2SO4 were added in a dropwise fashion 
(Table 15). Gratifyingly, the reaction mixture started to boil vigorously upon contact with H2SO4, as 
was the case in our previous experiments, indicating some reaction took place.[314] To our surprise, 
only 1,2-addition had taken place with formation of 362b, and conversion was incomplete at 65%, 
despite an excess of nucleophile (entry 1). Doubling the amount of H2SO4 resulted in exactly the 
same conversion, while 2 equivalents of both H2SO4 and DMPTMS led to full conversion to 
monoadduct 362b (entries 2-3). Addition of extra nucleophile, however, could not drive the reaction 
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to complete conversion (entry 4). When applying stoichiometric amounts of both nucleophile and 
acid, only 52% conversion could be attained (entry 5). 
Extension of these reaction conditions to imines 32a-g resulted exclusively in the formation of 1,2-
addition products, i.e. the products of a Kabachnik-Fields reaction.[334] When more steric bulk was 
present at the imine functionality, more DMPTMS was required to reach complete conversion. In the 
case of t-Bu imine 32d and i-Pr imine 32g even a large excess of nucleophile was insufficient (entries 
8 and 10). The other imines were completely transformed into α-aminophosphonates 362a-g, except 
for 32e (vide infra).  
Table 15. Optimization of the addition of silylated phosphite to α,β,γ,δ-diunsaturated imines 32. 
 
entry substrate 
DMPTMS 
(equiv) 
H2SO4 
(equiv) 
Conversion 
(%) 
yield 362 
(%) 
1 32b 2 0.5 65 nd 
2 32b 2 1 65 nd 
3 32b 2 2 100 61 
4 32b 3 2 87 nd 
5 32b 1 1 52 nd 
6 32a 5 2 100 73 
7 32c 2 2 100 81 
8 32d 10 2 77 68 
9 32f 5 2 100 79 (9/1)a 
10 32g 5 2 89 22 (55/45)b 
nd = not determined;
 a 
E/Z ratio for the distal double bond;
 b
 diastereomeric ratio 
The isolated yields however are somewhat lower than one would expect based on the conversions 
due to the loss of end-product by an acid-base extraction during work-up: 
 First, the crude mixture is acidified using 2 M HCl and extracted with Et2O. Products 362 are 
protonated and accumulate in the aqueous phase while the excess phosphite nucleophile 
remains in the organic phase. The aqueous phase is extracted twice using Et2O. 
31P-NMR 
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analysis of the combined organic layers indicated that some product is lost in the organic 
phase. 
 Next, the aqueous phase is rendered alkaline (pH = 14) by addition of 2 M NaOH and 
extracted using EtOAc. α-Aminophosphonates 362 are neutralized and return to the organic 
phase while the salts are washed out with the aqueous phase. 31P-NMR analysis of the 
aqueous phase demonstrated that some product is lost during this step as well, probably due 
to the highly polar nature of α-aminophosphonates 362. 
Attempted direct neutralization of the crude reaction mixture using 2 M NaOH, followed by column 
chromatography, was unable to remove the excess phosphite from the product, necessitating the 
laborious and rather inefficient acid-base extraction. 
Furthermore, transformation of imine 32e derived from 360a and aniline resulted in complete 
conversion into another product, though very similar to 362. Careful analysis of the spectra identified 
363 as the compound instead of the desired α-aminophosphonate 362, and a mechanism for its 
formation was proposed (Scheme 94). It starts with the desired H2SO4-mediated 1,2-addition of 
DMPTMS to 32e. Then, a catalytic amount of aniline or N-TMS-aniline acts as a carbon nucleophile 
through its para-position and initiates a double SN2’ reaction on 362e” with expulsion of N-TMS- 
aniline and formation of 363. It is possible that a trace of aniline left from the previous imination step 
is responsible for this substitution reaction, as only a catalytic amount is required. This substitution 
was not observed for the other derivatives, perhaps because aniline is a better leaving group than 
aliphatic amines. Alternatively, a SN1’-type mechanism could be operative as well, where 362e” 
fragments into an aniline and a carbenium ion, which then recombines with formation of 363. A third 
option was an intramolecular [5,5]-sigmatropic rearrangement.[335] 
 
Scheme 94. Proposed mechanism for the formation of 363.  
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b) Mechanistic considerations 
The most interesting aspect of the transformation to 362 is the lack of any 1,4- or 1,6-addition even 
though an excess of DMPTMS was used. Whereas α,β-unsaturated imines 355 were cleanly 
converted into diphosphonylated products (Scheme 92), these α,β,γ,δ-diunsaturated imines 32 only 
underwent 1,2-addition. It seems that an expansion of the linear unsaturated system has a dramatic 
effect on the reactivity of these substrates. Scheme 95 shows the elaborate reaction mechanism as it 
was proposed for tandem 1,4-1,2-additions to α,β-unsaturated imines using both DMPTMS and 
trialkyl phosphites (TAPs). It has been extended here to α,β,γ,δ-diunsaturated imines.[314]  
 
Scheme 95. Reaction mechanism for phosphite addition to unsaturated imines. 
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Species A is first activated by protonation to B, otherwise no phosphite addition takes place (Scheme 
95). In the case of α,β-unsaturated imines (i.e. our previous work), double phosphite addition takes 
place with the two nucleophiles, DMPTMS and TEP. Iminium B could first undergo both 1,2- or 1,4-
addition regardless of the nucleophile, DMPTMS or TEP. Careful follow-up of the reaction progress 
demonstrated that 1,2-addition takes place initially with formation of C. This is a very unstable 
species and for DMPTMS, O-N-transfer of the TMS-group occurs (C → D). D is a resting-state and 
when N-O-transfer of the TMS-group takes place (D → C), C immediately undergoes elimination back 
to B or SN’ takes place with formation of F. No E was formed so k9 = 0. If B is regenerated, 1,2-
addition can take place again, or 1,4-addition will now proceed (B → F). F then equilibrates to H and 
1,2-addition follows. For TEP the situation is somewhat different: when 1,2-addition to B takes place 
and C is formed, no transfer of ethyl groups or dealkylation takes place (no formation of D or E). 
Instead, C readily reverts back to B or SN’ takes place with formation of F. If B is regenerated, 1,4-
addition can take place, also furnishing F. Next, dealkylation to K occurs and 1,2-addition takes place. 
In summary, α,β-unsaturated imines undergo double 1,4-1,2-addition with both nucleophiles, 
although 1,2-addition is usually faster but it is reversible. 
In the case of α,β,γ,δ-diunsaturated imines 32 and application of DMPTMS, only 1,2-addition was 
observed in the end-products. This implies that D (which was termed a resting state) or C must be 
the only species present at the end of the reaction. As C, a phosphonium salt, is highly unstable and 
TMS-transfer with formation of D readily takes place, D is probably the only species present. Only in 
the case where C is quickly desilylated in an intermolecular fashion (C to E) could C be the direct 
source of α-aminophosphonates. This is unlikely as intramolecular TMS-shift should be faster (k6 >> 
k9) and no other species capable of desilylation are present in this case as compared to our previous 
work on the α,β-unsaturated imines 355, where no intermolecular desilylation was observed. The 
conclusion is that D must be the only species in the reaction medium. This can only be the case if 
either:[314]  
1. k5 ≈ 0: however, there is no obvious reason why an expansion of the unsaturated 
system would influence this TMS-transfer. In addition, k5 has been shown to be very 
small as compared to k6 as D is a resting state, so it is unlikely that such a small 
difference in k5 (as compared to the previous work) would have a dramatic effect on 
the reaction outcome. 
2. k3 >> k4: here k5 << k6 (and not k5 ≈ 0 as in the previous option) as was the case in the 
mechanism suggested for the α,β-unsaturated imines. From the moment some C is 
present (equilibrium from D) elimination back to B is possible but the equilibrium is 
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strongly shifted towards C (as k3 is much larger than k4, contrary to what is shown in 
Scheme 95) so that no 1,4-addition can occur. 
The second option is more likely as the presence of an extra double bond between R1 and the α,β-
unsaturated imine (Scheme 95) might reduce the tendency of C to revert to B. Hence, the energy 
gained by reconjugation is not as large as for the smaller conjugated system present in α,β-
unsaturated imines. Furthermore, there is no apparent reason why k5 would equal zero instead of 
being very small in this case as compared to the α,β-unsaturated imines. Also, the longer lifetime of C 
could result in irreversible protonation, as an excess of H2SO4 is required, possibly contributing to the 
selectivity of the transformation (not depicted in Scheme 95). It must be said that these explanations 
are mere speculations and molecular modeling is currently underway to try and account for this 
apparent anomaly in reactivity.  
c) Ring closure and further derivatization 
Though they were not envisaged, the obtained α-aminophosphonates 362a-g are interesting 
substrates with potential for further derivatization. In this light, benzyl derivative 362b was smoothly 
acylated using chloroacetyl chloride and pyridine (Scheme 96). Next, amide 364 was treated with a 
slight excess of LiHMDS at room temperature in order to deprotonate the CH of the α-
aminophosphonate moiety. The resulting anion could then mediate an intramolecular SN2 of the 
chloride with formation of a β-lactam 365. Due to the conjugated 4-phenylbutadiene fragment, 
possible delocalization of the anion followed by SN2 of the chloride could give rise to 6- or 8-
membered lactams. The experiment resulted in the formation of the corresponding phosphonylated 
β-lactam exclusively, indicating that conjugation did not play a role in this case.[71]  
 
Scheme 96. Further derivatization of α-aminophosphonate 362b with formation of a phosphonylated β-
lactam. 
This is in agreement with the α,β-unsaturated case: the selectivity for 4-ring formation is associated 
with the intramolecular nature of this reaction. This is caused by hindered rotation around the C-N 
bond of the aminophosphonate moiety in 364. The chloroacetyl group is preferentially oriented away 
from the linear unsaturated system. Hence, the transition state for 6-membered ring-formation is 
energetically disfavored, as much energy is required to attain it. The γ-position is more reactive in the 
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case of intermolecular cation trapping.[49] Phosphonylated β-lactams are of interest as potential 
antibiotics.[71, 336-337] 
Other attempts to derivatize α-aminophosphonates 362 were carried out. In one case 362c was 
treated with aqueous HBr and stirred for half an hour, before adding bromine (Scheme 97). Both the 
addition of 1 and 2 equivalents of bromine resulted in complex mixtures. 
 
Scheme 97. Attempted bromination of α-aminophosphonate 362c. 
3.2.3.2 Triethyl phosphite as nucleophile 
a) Synthesis 
Next, triethyl phosphite (TEP) was applied as a nucleophile in dry EtOH, along with formic acid to 
both activate the imines and dealkylate the intermediate phosphonium ions. Without the presence 
of a dealkylating agent, no Arbuzov-rearrangement can take place so the unstable in situ generated 
phosphonium ions would readily collapse back (for instance C to B or F to B, Scheme 95).[338-339] As 
1,2-addition is predominant at first, k3 must be much larger than k7, but this step is reversible and 
eventually 1,4-addition takes place after which F is then dealkylated to K. 
As in the previous section, benzyl imine 32b was chosen as a model substrate. Here, 3 equivalents of 
TEP along with 3 equivalents of formic acid were added to a solution of 32b in dry ethanol (Table 16, 
entry 1). To our delight, we observed a fast and complete conversion. About 10% conversion to 
monoadduct 362 had taken place, but the major product was a diphosphonylated compound in 85% 
conversion, according to integration of the 31P-NMR spectrum. Two diastereomers were present 
(visible as two doublets and two singlets in 31P-NMR) in a 2/1 ratio but separation using column 
chromatography or preparative TLC proved to be extremely difficult. In the end they were separated 
in minute amounts using preparative HPLC. Careful NMR-analysis confirmed the structure as 369b, 
with the distal double bond intact. The relative configuration of both diastereomers could be 
determined using 1D-NOESY spectroscopy by irradiating the CHP protons (Figure 19): the major 
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diastereomers have a syn configuration and are visible in the 31P-NMR spectrum as two doublets with 
4JPP = 10 Hz. The anti diastereomers are visible as two singlets. These results are in agreement with 
literature information.[340] 
Table 16. Addition of P(OEt)3 to α,β,γ,δ-diunsaturated imines 32. 
 
entry substrate 
P(OEt)3 
(equiv) 
HCOOH 
(equiv) 
conversion (%) 
dra of 369 
362 369 33 
1 32b 3  3 10 85 - 66/34 
2 32b 6 6 - 70 - 65/35 
3 32d 3  3 13 70 trace 43/57 
4 32d 6 6 - 89 trace 44/56 
5 32a 6 6 - 97 trace 60/40 
6 32a 1 1 complex mixture - 
a
 dr = syn/anti, based on 
31
P-NMR 
 
Figure 19. 1D-NOESY experiment to determine the relative configuration of both diastereomers. 
Care must be taken when interpreting these results. Aminophosphonate 369b is not a cyclic 
molecule and therefore its conformation is not locked, as free rotation around the single bonds can 
take place. This might render the conclusions drawn from the 1D-NOESY experiments doubtful. 
However, as 369b contains two bulky phosphonate moieties in a 1,3-relation, its conformation is 
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more rigid than for sterically less-charged substrates. Moreover, it is possible that an intramolecular 
H-bond stabilizes the conformation between the amine and the γ-phosphonate, further impeding 
free rotation.[341] 
The next trial (Table 16, entry 2) with 6 equivalents of nucleophile and formic acid also resulted in the 
formation of diphosphonylated product 369 but no monoadduct 362 was left. However, conversion 
was somewhat less clean. Upon treatment of t-Bu imines 32d with 3 equivalents of nucleophile and 
acid, diphosphonylated compound 369 was again the major compound, along with some 
monoadduct (entry 3). Surprisingly, traces of triphosphonylated product 33 were also present 
according to LC-MS analysis. Doubling the amounts of reagents resulted in 89% conversion to 
diadduct 369 with no monoadduct present. Again some traces of triphosphonylated product 33 were 
detected. It is noteworthy that the dr for this substrate has shifted in favor of the anti isomers. Use of 
i-Pr imine 32a and an excess of nucleophile and acid resulted in nearly quantitative formation of 
diphosphonylated product, again with a trace of triphosphonylation (entry 5). The obtained dr was 
comparable to the one for 32b as substrate. Use of stoichiometric amounts of reagents gave rise to a 
complex mixture (entry 6). 
b) Mechanistic considerations 
The presence of trace amounts of 1,6-1,4-1,2-tandem addition products for the addition of P(OEt)3 to 
32d and 32a (t-Bu and i-Pr imine, respectively) suggests that the steric bulk of the imine is a 
governing factor in the regioselectivity of the addition. When the steric bulk is small, 1,4-addition will 
take place first (probably after reversible 1,2-addition) although 1,2-addition cannot be neglected (k4 
> k8, Scheme 95). Once dealkylation of 1,4-adduct F has taken place to K, the possibility of 1,6-
addition is lost and 1,2-addition will follow. Obviously, when 1,2-addition has taken place and 
dealkylation occurs from C to E, 1,4- or 1,6-addition will not proceed anymore.  
Consequently, in order to selectively obtain 1,6-1,4-1,2-conjugate addition, the 1,6-addition must 
take place first (k10 > k3 and k10 > k7) and k10 > k11, or k4 > k3 and k8 > k7 so there is plenty of B present 
whilst k10 ≥ k11. Once 1,6-addition has taken place, the competition between 1,4- and 1,2-addition 
will recommence as in the case for α,β-unsaturated imines, starting from M (same case as for B). The 
tendency for 1,6-addition could be stimulated by using very bulky imines that disfavor 1,2- and 1,4-
addition. 
Apart from steric factors, computational calculations have indicated that the orbital coefficients of 
the LUMO at the C6-carbon in 370 are considerably smaller than at the C4- and C2-carbons according 
to a literature report by Hayashi et al. (Figure 20). Furthermore, the Mulliken and CHelpG atomic 
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charges demonstrate that the positive charge decreases in the order C2 > C4 > C6. These calculations 
underline the difficulties to be overcome for a tandem 1,6-1,4-1,2-addition.[328] It must be noted that 
it is not sure that ground-state properties as calculated in this example would have a decisive 
influence on the transition state energies, as the transformations under consideration involve 
equilibria or endothermic processes leading to high-energy phosphonium salts. 
 
Figure 20. Model used for the calculation of π-orbital coefficients of the LUMO and the atomic charges. 
3.3 Conclusion 
In conclusion, phosphite addition to α,β,γ,δ-diunsaturated imines 32 has been evaluated using both 
silylated phosphite nucleophiles as well as trialkyl phosphites. The substrates were obtained in two 
steps via Wittig reaction of monounsaturated aldehydes 357 followed by imination. Next, two types 
of phosphorus nucleophiles were added that result in aminophosphonates. Surprisingly, silylated 
phosphite (DMPTMS) attacked in a 1,2-fashion exclusively as opposed to the results obtained with 
α,β-monounsaturated imines 355 in earlier work. An attempt was made to account for this anomaly 
based on the extended general mechanism. Next, the obtained aminophosphonates were acylated 
and deprotonation resulted in intramolecular ring closure to β-lactams 365.  
On the other hand, application of triethyl phoshite mainly resulted in tandem 1,4-1,2-addition 
products 369, parallel to our earlier work, while some monoaddition occurred as well. Only traces of 
1,6-1,4-1,2-triaddition were found upon application of sterically hindered imines as substrates. These 
results were also correlated to the general mechanism in an attempt to account for the observed 
results. 
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4. Gold-superacid catalyzed preparation of 
benzo[c]thiophenes 
4.1 Introduction 
The department’s interest in Au-catalysis was originally sparked with the discovery that 
phosphonoisoindoles could be produced starting from N-(o-ethynylbenzyl)-α-aminophosphonates 
(Scheme 6). This transformation was performed under microwave irradiation at 165 °C but it was 
soon found that similar transformations could be mediated by AuCl3 at ambient temperature.
[55, 72] 
Consequently, cyanoisoindoles and dihydrothiazoles were prepared from similar systems.[72-73] Based 
on this methodology, a three-step approach toward benzo[c]thiophenes 42 was proposed (Scheme 
98).[140, 259-260, 342-344] Starting from ortho-halobenzaldehydes 372, of which plenty of derivatives are 
commercially available, ortho-ethynylbenzaldehydes 371 could be produced via Sonogashira-
coupling. These substrates could then be converted into dithioacetals 41, which were the desired 
reactants to be subjected to Au-catalyzed ring closure. 
 
Scheme 98. Retrosynthetic approach to benzo[c]thiophenes using Au-catalysis. 
Benzo[c]thiophenes or isothianaphthenes 42 are of particular interest to material chemists. Most of 
their applications rely on their presence in oligomers or polymers, bestowing specific photochemical 
and -physical features on these materials.[345] They are used in the generation of organic light-
emitting diodes (OLEDs),[346-350] as colorimetric fluoride anion chemosensors,[351] as chromophores for 
non-linear optics materials,[352] as NIR contrast agents for biomedical applications[353-354] and in 
transistors.[353] However, benzo[c]thiophene oligomers are mostly applied in organic photovoltaic 
cells (OPV) due to their small band gap, as a cheaper alternative to silicon based solar cells.[74, 355-365] 
Hitherto, benzothiophene-based OPVs with efficiencies exceeding 7% have been reported, in 
contrast to Si-based solar cells which display efficiencies of ca. 15%.[366-368]  
Despite the wide applicability of benzo[c]thiophenes in material sciences, the scope of reactions to 
generate them remains relatively limited. Most methods rely on thionating agents such as 
Lawesson’s reagent or P2S5, which display poor atom economy.
[345, 352, 354-355, 369] In other cases, the 
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benzene ring is annulated onto a thiophene or the corresponding dihydroisothianaphthene is 
oxidized to the desired isothianaphthene.[74, 347-350, 357-358, 361-364, 370] 
4.2 Synthesis of benzo[c]thiophenes 
4.2.1 Preparation of o-ethynyl aromatic aldehydes 371 
A number of aptly substituted ortho-ethynyl benzaldehydes 371 was purchased or prepared via 
Sonogashira coupling, according to a literature procedure (Scheme 99).[301-302] The substrate scope 
was further expanded using thiophene-2-carbaldehyde 371i and an internal alkyne 371j instead of 
terminal ones. No halogenated starting material for Sonogashira coupling to 371h was commercially 
available so the corresponding salicylaldehyde was triflated instead.[371] In general these coupling 
reactions and deprotections proceeded smoothly in excellent isolated yields. 
 
Scheme 99. Preparation of ortho-ethynylbenzaldehydes and 3-ethynylthiophene-2-carbaldehyde 371. 
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4.2.2 Dithioacetalization of 371 
4.2.2.1 Precursor synthesis 
Next, these aldehydes had to be converted into the corresponding diallyl thioacetals 376. Allyl 
mercaptan would be used for most derivatives and crotyl mercaptan for one (376k). These reagents 
deserve some special attention: allyl mercaptan is a commercially available liquid but only in ca. 60% 
purity so purification was required. However, allyl mercaptan (bp 69 °C) has a very bad, pungent, 
garlic-like odor which impedes straightforward distillation (odor detection threshold 0.2 ppb; for 
comparison, H2S and triethylamine have odor detection thresholds of 0.5 ppb and 5 ppb, 
respectively).[372] Instead, a vacuum-distillation was performed and it is imperative that the outlet of 
the pump is connected to two washing flasks in order to eliminate any residual allyl mercaptan (one 
with a 5 wt% H2O2 solution, another with aqueous 0.5 M NaOH). More details can be found in the 
experimental part of this work.  
Crotyl mercaptan 375 on the other hand is not commercially available and had to be produced. Like 
its allyl counterpart, crotyl mercaptan has an equally terrible odor which did not facilitate its 
synthesis from a practical point of view. A literature procedure was followed and steam distillation 
resulted in crotyl mercaptan (E/Z 94/6, Scheme 100).[373] 
 
Scheme 100. Synthesis of crotyl mercaptan 375. 
4.2.2.2 Dithioacetalization 
With these mercaptans in hand, aldehydes 371a-j could be converted into the corresponding diallyl 
thioacetals (Scheme 101). Two literature protocols were applied: one using boron trifluoride in acetic 
acid (Method A) and one using copper sulfate in dichloromethane (Method B).[374-375] Electron-rich 
substrates were more efficiently converted using the latter protocol (371f-g), whereas the other 
substrates gave satisfactory results using the boron trifluoride-mediated transformation. Some 30% 
formation of the corresponding benzo[c]thiophene was observed for 371g and 5% for 371i, according 
to 1H-NMR analysis. These mixtures were chromatographically inseparable, so the crude mixture was 
used as such in the following step. 
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Scheme 101. Formation of diallyl thioacetals 376. Values in parentheses refer to the ratio of diallyl 
thioacetal/benzo[c]thiophene. 
4.2.3 Ring closure of 376 
Sulfur-containing compounds have a reputation of being difficult substrates for catalytic reactions as 
they can cause catalyst poisoning. Nevertheless, gold salts have been shown to be compatible with 
thiols or thioethers.[73, 195, 376-379] Based on our previous work on 5-alkylidenedihydrothiazoles, a gold 
catalyzed 5-exo-dig migratory cycloisomerization was envisioned, yet a selection of other catalytic 
systems was evaluated to ensure optimal reaction conditions (Table 17). No 6-endo-dig cyclization 
was encountered for any of the screened catalysts.  
Heating diallyl thioacetal 376a, either conventionally or by microwave irradiation, did not deliver the 
desired benzo[c]thiophene (entries 1-2). The use of iron, copper, ammonium, nickel, palladium and 
silver salts resulted in no conversion after 3 hours of refluxing in dichloromethane (entries 3-8). Also, 
the use of mild and very strong protic acids such as acetic acid, sulfuric acid and tetrafluoroboric acid 
as catalyst proved to be unsuccessful and resulted in full recovery of starting material (entry 9-13). 
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Table 17. Screening of different catalysts. 
 
entry catalyst 
temperature 
(° C) 
time 
(min) 
yield 377 
(%) 
1 - 40 1 d - 
2 -a 165 60 - 
3 Fe(acac)3 40 120 - 
4 CuI 40 120 - 
5 TBAB 40 120 - 
6 Ni(cod)2 40 180 - 
7 PdCl2 40 180 - 
8 AgOTf 40 120 - 
9 p-TsOH 40 180 - 
10 HOAc 20 180 - 
11 H2SO4 20 180 - 
12 HClO4 20 180 - 
13 HBF4 20 180 - 
14 BF3·Et2O 20 180 - 
15 CuSO4 20 180 - 
16 AuCl3 20 15 65 
17 AuBr3 20 15 37 
18 AuCl 20 60 60 
19 AuOTf 20 180 - 
20 PPh3AuCl 20 180 - 
21 HAuCl4 20 60 48 
22 KAuCl4
b 20 180 - 
a
 microwave heating; 
b
 anhydrous conditions 
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Addition of BF3·Et2O or CuSO4 did not yield any benzo[c]thiophene, precluding them as ring closure 
catalysts in the earlier dithioacetalization step (entries 14-15 and Scheme 101, 376g and 376i).  
When moving to the previously optimized conditions for the synthesis of 5-alkylidene-
dihydrothiazoles,[73] using AuCl3 in dichloromethane, full consumption of the starting material was 
observed at room temperature within 15 minutes. AuBr3 and AuCl performed well too, albeit with a 
drop in isolated yield or at a slower rate (entries 16-18). 
However, when other monovalent Au catalysts were used, we were surprised that no conversion 
took place at all (entries 19-20). This led us to believe that small amounts of hydrochloric acid, 
released from the catalyst by moisture, played a key role in the conversion. The acidity of HCl can be 
increased in the presence of AuCl3, by complexation of the chloride and formation of a HAuCl4 
superacid.[285]  
Indeed, when the substrate was treated with HAuCl4, full conversion to the end product could be 
observed (entry 21). However, these conditions were too harsh and the end product showed 
appreciable degradation, resulting in an isolated yield of 48%. Upon addition of 10 mol% 2,6-di-t-
butylpyridine as a sterically hindered base to a mixture of diallyl thioacetal 376c (chosen for stability 
reasons) and 10 mol% AuCl3 the reaction proceeded much slower, indicating that strongly acidic 
conditions are required. This was further supported by the fact that use of KAuCl4 under strictly 
anhydrous conditions did not result in any conversion (entry 22), until moisture was introduced. It is 
known that alkynes can mediate the reduction of trivalent gold to a complex of monovalent gold and 
tetrachloroaurate.[380-382] Yet, this is unlikely to occur here as both AuCl and KAuCl4 did not give better 
results than AuCl3.  
4.2.4 Mechanistic considerations 
Instead of HAuCl4, TfOH was selected as another superacid to verify whether it could perform the 
desired transformation as well.[383-384] Curiously, treatment of 376c with 10 mol% TfOH resulted in 
precisely 10% conversion to the desired benzo[c]thiophene. Repeating the reaction with a 
quantitative amount of TfOH in CDCl3 to allow direct NMR-analysis revealed the formation of an 
intermediate product, which could be converted to the corresponding benzo[c]thiophene by addition 
of Cs2CO3 or by aqueous work-up. Based on the crude 
1H-, 13C-, 19F-, COSY and HSQC NMR data of the 
unknown compound, we postulate having trapped an intermediate as a covalently bound triflate 
(Scheme 102, compound 378). Some characteristic data to support the conclusion: 
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 19F-NMR: -74.32 ppm (s); -78.73 ppm (s, TfOH), -108.46 ppm (multiplet, CarF). The signal at 
 -74.32 ppm corresponds to a covalently bound triflate.[385] 
 1H-NMR: the alkyne proton at 3.31 ppm and the SCH2 signals at 3.09 and 3.30 ppm of 376c 
have disappeared. New signals in the range of 2-3 ppm suggest the presence of a homoallylic 
and S-allyllic group. These factors combined indicate the desired cyclization and 1,3-
migration have taken place. 
 13C-NMR: a CF3-signal is clearly present as a quadruplet around 119 ppm. A singlet at 67 ppm 
corresponds to the CHS2 carbon while signals at 42, 33 and 31 ppm correspond to a SCH2 and 
the CH2 carbons of a homoallylic group, respectively. No alkyne signals are present. These 
observations corroborate that cyclization and 1,3-migration have taken place, but 
aromatization has not as a CHS2 proton is present. 
 
Scheme 102. Treatment of diallyl thioacetals with TfOH and generation of intermediate 378. 
These observations suggest that both the strongly acidic conditions as well as the counterion play a 
key role in the transformation. A sufficiently strong acid is able to execute the migratory 
cycloisomerization but cannot catalytically form the desired benzo[c]thiophene 377, as the 
intermediate is trapped by the counteranion. As such, the use of a catalytic amount of AuCl3 under 
non-anhydrous conditions was selected as the best option. Due to its highly hygroscopic nature, 
simply weighing the catalyst in open air introduced enough moisture to generate HAuCl4 for the 
reaction to proceed swiftly. 
The proposed mechanism for benzo[c]thiophene 377 formation based on these conclusions is 
depicted in Scheme 103. After acidic alkyne activation by in situ formed HAuCl4, a 5-exo-dig 
cyclization takes place, furnishing intermediate 380a which readily undergoes a Claisen 
rearrangement to 381a. Instead of trapping 381a, as was the case for the TfOH-mediated 
transformation in Scheme 102, the AuCl4
- counteranion does not covalently bind to 381a. This allows 
for consecutive aromatization to yield the desired benzo[c]thiophene 377a by elimination of a 
proton, thus regenerating the catalyst.  
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However, combination of AuCl3 and 2,6-di-t-butylpyridine also results in the formation of 
benzo[c]thiophene albeit much slower. This implies that AuCl3 can mediate the transformation as 
well but not as fast as an appropriate superacid.  
 
Scheme 103. Proposed mechanism of the migratory cycloisomerization. 
The concerted nature of this Claisen-type rearrangement was confirmed by selective transformation 
of 376k to branched 377k, ruling out a fragmentative allyl shift as this should yield mixtures of 377k 
and 377k’ (Scheme 104).[138-139] 
 
Scheme 104. Proof of the concerted nature of the Claisen rearrangement. 
4.2.5 Further optimization 
Next, a solvent screening was performed to verify whether CH2Cl2 indeed gave the best results in this 
case. Using strongly apolar solvents (Table 18, entries 1-2) resulted in very long reaction times, as did 
the use of highly polar solvents (entries 7-10). Solvents of intermediate polarity gave more valuable 
results, with yields around 40% and reaction times of 3 hours (entries 3-6). In dichloroethane (entry 
III. Results and discussion 
111 
 
5) the reaction was almost equally fast as in dichloromethane, however, product degradation 
occurred (which was clearly visible upon TLC analysis), resulting in an isolated yield of only 43%.  
These observations established dichloromethane as the solvent of choice. The catalyst loading could 
be lowered to 1 mol%, maintaining an isolated yield of 65%, while lengthening the reaction time to 3 
hours (entry 12). As a compromise, a catalyst loading of 5-10 mol% was applied, depending on how 
fast the transformation proceeded (Scheme 105).  
As product stability was clearly a determining factor in order to obtain good yields, an experiment 
was performed using 2,6-di-t-butyl-4-methylphenol (BHT) as a radical scavenging additive. This 
attempt to further stabilize the end product proved to be unsuccessful and the reaction yield was 
unchanged. For all derivatives 376, except 376j, a conversion of ≥ 98% was achieved based on HPLC, 
though poor product stability led to losses during work-up and purification. 
Table 18. Screening of different solvents for the Au-mediated cycloisomerization. 
 
entry 
loading 
(equiv) 
solvent 
time 
(min) 
yield 377a 
(%) 
1 0.1 Hexane 2 d - 
2 0.1 Toluene 1.5 d 56 
3 0.1 EtOAc 180 40 
4 0.1 DME 180 40 
5 0.1 DCE 30 43 
6 0.1 Acetone 180 45 
7 0.1 DMF 2.5 d 23 
8 0.1 CH3CN 180 35 
9 0.1 1-Pentanol 2.5 d 25 
10 0.1 MeOH 2.5 d 7 
11 0.1 CH2Cl2 15 65 
12 0.01 CH2Cl2 180 65 
13 0.05 CH2Cl2 15 68 
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Oxidative stability seemed to be the most important issue, and simple storage under air for a few 
weeks gave rise to sulfoxide formation. Furthermore, benzo[c]thiophenes 377 are prone to Diels-
Alder reactions as an o-quinodimethane functionality is present.[386-387] 
The influence of electron-withdrawing groups on the migratory cycloisomerization is mainly reflected 
in the improved stability of the formed benzo[c]thiophenes. As for electron-donating groups, there is 
a large discrepancy in reaction time between 376f and 376g for no apparent reason, while the 4-
methoxybenzo[c]thiophene 377h is obtained in excellent yield but only after 24 hours, possibly due 
to steric hindrance. Thieno[3,4-b]thiophene 377i was obtained in 15% yield over 2 steps. Non-
terminal alkyne 376j could not be cyclized, not even after 48 hours of reflux with 5 mol% AuCl3 in 
toluene, and only starting material was recovered. 
 
Scheme 105. Ring closure of diallyl thioacetals 376. Catalyst loading, reaction time and yield are indicated.  
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4.3 Conclusion 
The methodology employed for the synthesis of isoindoles earlier at the research group could be 
extended to benzo[c]thiophenes 377. Sonogashira coupling was followed by generation of 
dithioacetals 376 using allyl and crotyl mercaptan. Two methods were applied using either CuSO4 or 
BF3·Et2O as Lewis acids. With thioacetals 376 in hand, a number of catalysts was evaluated for the 
envisioned ring closure and concomitant migration. In the end, only Au-catalysts were active and 
AuCl3 gave the best results while acids and other metals resulted in full recovery of the starting 
material. However, the lack of transformation upon application of KAuCl4 and the slowing down upon 
addition of base suggested that in situ formed HAuCl4 was the actual catalytic species. This was 
further supported by the ability of TfOH to generate intermediate 378. This observation led to the 
proposed mechanism: alkyne activation by a proton was followed by 5-exo-dig cyclization, then allyl 
migration and finally aromatization occurred. The allyl migration took place in a concerted manner, 
as the use of the crotyl derivative resulted exclusively in branched product, while a fragmentative 
mechanism would furnish both branched and linear compounds. A solvent screening indicated that 
dichloromethane was the solvent of choice. Application of AuCl3 to all derivatives resulted in ring 
closure, except for internal alkynes. 
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Despite the fact that the work on the phosphite additions is the only part of this thesis that was still 
ongoing at the end of the practical work, there are some issues from the other chapters that would 
be interesting to address as well. Some transformations are more relevant from a biological point of 
view while others are of interest for their synthetic endeavours. 
Firstly, the α-alkylation strategy employed for the generation of the 3-phosphonopyrroles permits 
the introduction of a wide variety of alkyl chains. Subsequent ring closure can give rise to a whole 
array of phosphonylated azaheterocycles with a large variation in ring size, saturation and functional 
groups. Ring closure through hydroamination is certainly possible, but other strategies are just as 
viable, e.g. ring-closing metathesis (RCM) or cycloaddition (Scheme 106). Ring-closing metathesis 
would give rise to phosphonylated dihydroazepines 386, a scaffold that has been reported only once 
in literature.[388] In case R2 = allyl and R3 = propargyl, a 1,8-enyne is available. Such substrates are 
known to undergo a cationic Au(I)-mediated formal [2+2]-cycloaddition to 387.[389-390] Moreover, 
reduction of the enamine 385 and subsequent hydroamination would give rise to phosphonylated 
pyrrolidines 388. 
 
Scheme 106. Opportunities for further derivatization of phosphonylated enamine building blocks. 
Furthermore, during the quest for methodologies to derivatize phosphonylated pyrroles 339, we 
stumbled upon a discrepancy during Suzuki coupling reactions. Comparison of the conversions after 1 
hour and 2 hours under microwave irradiation suggested that the mode of action that was operative 
was in fact a C-H activation instead of a coupling reaction. Therefore, it would be most interesting to 
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repeat this protocol with unbrominated pyrrole 339 to see if any transformation takes place (Scheme 
107). If so, it has been proven that a C-H activation protocol is operative and further scrutiny would 
reveal whether this transformation holds any potential. 
 
Scheme 107. Attempted C-H functionalization. 
With regard to the chapter on phosphite addition, plenty of space is left for further research. First of 
all, the results from molecular modeling studies will point out whether it is feasible to further pursue 
1,4- or 1,6-addition on α,β,γ,δ-diunsaturated imines 32 using silylated phosphite nucleophiles. These 
results might help to get a better understanding of the complex mechanism behind this 
transformation.  
Anyway, there remains much work to be done using triethyl phosphite as nucleophile. In concreto, 
instead of R1 = Ph, other substituents must be evaluated, especially unsaturated ones to probe 
whether the size of the conjugated system has any influence on the reaction outcome (Scheme 108). 
Moreover, instead of imines, hydrazones could be evaluated as substrates to verify whether the 
outcome parallels the results of the imines. 
 
Scheme 108. Further elaboration of the addition of P(OEt)3. 
In any case, it would be interesting to evaluate an organocatalytic approach. For instance, the 
Jørgensen group has employed sterically demanding prolinol derivatives in combination with α,β,γ,δ-
diunsaturated aldehydes 360 to promote 1,6-addition (Scheme 109).[391-393] If this approach is helpful 
in directing the nucleophiles to the δ-carbon atom, 1,4- and 1,2-addition may follow. This would lead 
to the incorporation of the organocatalyst, so it would in fact not be a truly catalytic approach. This 
methodology would open up the possibility of enantioselective phosphite addition as well.[394] On the 
other hand, organometallic phosphorus nucleophiles might present a possible solution.[317, 323]  
IV. Perspectives 
118 
 
 
Scheme 109. Application of sterically demanding prolinols as amines. 
The Au-mediated preparation of benzo[c]thiophenes is a useful transformation but the products lack 
stability. Introduction of other substituents instead of the S-allyl moiety might alleviate this issue 
(Scheme 110). This could be accomplished by preparing dithioacetals and then substituting one 
sulfide moiety or the other way around. 
 
Scheme 110. Preparation of more stable benzo[c]thiophenes. 
The literature overview of this work has demonstrated that there are very little precendents of 
combining Au-catalysis with S-nucleophiles so this area might certainly be interesting to further 
elaborate. 
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1. General methods 
Commercially available solvents and products were used as received without any purification unless 
otherwise stated. Reactions were performed in non-flame-dried glassware and open to the air unless 
otherwise noted. Inert atmosphere refers to a N2-atmosphere. 
1.1 Solvents 
Dry diethyl ether (Et2O), tetrahydrofuran (THF) and toluene were freshly distilled from 
sodium/benzophenone ketyl. Dry dichloromethane (CH2Cl2) was freshly distilled over calcium hydride 
(CaH2). Dry acetonitrile (CH3CN) was distilled over CaH2 and stored over 4Å molecular sieves. 
1.2 Pressure reactions 
Reactions performed under more than 1 atmosphere H2-pressure were performed in a thick-walled 
glass bottle, shielded by an iron cage in case of explosion. When more than 5 bar H2 was used, a 
specialized Parr-reactor was employed at the Department of Organic and Macromolecular Chemistry, 
Faculty of Sciences, Ghent University. 
1.3 Column chromatography  
Column chromatography was performed in a glass column with silica gel (particle size 70−200 μm, 
pore diameter 60 Å) using appropriate mixtures of ethyl acetate (EtOAc) and hexanes. Visualisation 
was performed on TLC-plates using UV irradiation and oxidation by a KMnO4 solution or elemental 
iodine.  
1.4 Preparative TLC 
Preparative TLC was executed with 2000 μm 20 × 20 cm TLC plates in an elution chamber using an 
appropriate eluent. 
1.5 Gas chromatography 
GC analyses were performed on an Agilent 6980 Series or an Agilent 1991J-433 gas chromatograph, 
connected to a FID detector, using an Alltech EC-5 capillary column (30 m x 0.25 mm) with a film 
thickness of 0.25 µm and He as the carrier gas. 
1.6 Liquid chromatography 
HPLC and HPLC-MS analyses were performed on an Agilent 1200 Series liquid chromatograph using a 
reversed phase column (Eclipse plus C18 column, 50 x 4.6 mm, particle size 3.5 µm, or a Supelco 
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Ascentis Express C18 column, 30 x 4.6 mm, particle size 2.7 µm) connected to a UV-VIS detector and 
an Agilent 1100 series LC/MSD type SL mass spectrometer (ESI, 70 eV) using a mass selective single 
quadrupole detector. A mixture of 5 mM NH4OAc in H2O and CH3CN was used as eluent. 
1.7 Preparative HPLC 
Preparative HPLC was performed on an Agilent 1100 Series liquid chromatograph using a reversed 
phase column (Zorbax Eclipse XDB-C18 column, 150 x 21.2 mm, particle size 5 µm) that is 
thermostatized at 25 °C. The column is connected to a UV-VIS Variable Wavelength Detector (VWD). 
A mixture of H2O and CH3CN is used as eluent, with TFA or diethylamine as additives if needed. 
1.8 Mass spectrometry 
Low-resolution mass spectra were obtained with an Agilent 1100 series LC/MSD type SL mass 
spectrometer (ESI, 70 eV) using a mass selective single quadrupole detector. High-resolution mass 
spectra were obtained with an Agilent Technologies 6210 Time-Of-Flight (TOF) mass spectrometer 
(ESI or APCI). 
1.9 NMR spectroscopy 
High resolution 1H- (300 or 400 MHz), 13C- (75 or 100 MHz), 19F- (282 or 376 MHz) and 31P- (121 or 
162 MHz) NMR spectra were recorded on a Jeol Eclipse FT 300 or a Bruker Avance III Nanobay 400 
MHz spectrometer at room temperature, unless otherwise noted. Peaks were assigned with the aid 
of DEPT, APT, COSY, HSQC, HMBC, H2BC and NOESY experiments. Samples were dissolved in 
deuterated solvents with TMS as an internal standard. CFCl3 was added as an internal standard for 
19F-NMR analyses. All chemical shifts are expressed as parts per million (ppm). 
1.10 Infrared spectroscopy 
IR-spectra were obtained from a Perkin-Elmer Spectrum One BX FT-IR spectrophotometer with an 
ATR (Attenuated Total Reflectance) accessory. Samples were analyzed in neat form and selected 
peaks are reported. 
1.11 Melting points 
Melting points of crystalline compounds were determined using a Büchi B-540 apparatus or a 
Wagner & Munz WME Heizbank Kofler bench. 
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1.12 Microwave irradiation 
All microwave reactions were performed in a CEM Discover Benchmate with a continuous power 
output from 0 to 300 W and a self-adjusting, single mode microwave cavity. Reactions were 
performed in a 10 mL thick-walled Pyrex reaction vessel, closed with a snap-cap and equipped with a 
small magnetic stirring bar. A ramp time of maximum 5 minutes was used during which the 
temperature was increased from room temperature to the desired temperature. This temperature 
was maintained during the course of the reaction. The temperature control system used an external 
infrared sensor to measure the temperature on the bottom of the vessel and was used in a feedback 
loop with the on-board computer to regulate the temperature from 25 to 250 °C by adjusting the 
power output (1 W increments). The pressure control, Intellivent Pressure Control System, used an 
indirect measurement of the pressure by sensing changes in the external deflection of the septa on 
the top of the sealed pressure vessel. Stirring was performed by a rotating magnetic plate located 
below the bottom of the microwave cavity. After the reaction the vial was cooled down by a stream 
of air which decreased the temperature of the vial from approximately 150 °C to 40 °C in less than 
120 s. 
1.13 X-ray analysis 
X-ray diffraction was performed using a Agilent Supernova Dual Source (Cu at zero) diffractometer 
equipped with an Atlas CCD detector using CuKα radiation (λ = 1.54178 Å) and ω scans. The images 
were interpreted and integrated with the program CrysAlisPro (Agilent Technologies). Using Olex2, 
the structure was solved by direct methods using the ShelXL program package. Non-hydrogen atoms 
were anisotropically refined and the hydrogen atoms in the riding mode and isotropic temperature 
factors fixed at 1.2 times U (eq) of the parent atoms. The amide and amine hydrogen atoms were 
located from a difference electron density map and were unrestrainedly refined.  
All X-ray diffraction analyses were performed in collaboration with Prof. dr. Kristof Van Hecke, 
XStruct, Department of Inorganic and Physical Chemistry, Ghent University, Belgium.  
CCDC 940960-940961 contain the supplementary crystallographic data for this work and can be 
obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge 
Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44-1223-336033; or 
deposit@ccdc.cam.ac.uk). 
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2. Safety 
2.1 General safety aspects 
The practical work in this thesis was performed according to the SynBioC Research Group Internal 
Guidelines and with the aid of the internal safety document “Safety Instructions: How to work with 
chemicals”. Wherever possible, hazardous or toxic reagents were avoided and/or substituted by 
safer or greener alternatives.  
2.2 Specific safety aspects 
A list of the risks associated with each chemical is available in the corresponding material data safety 
sheet (MSDS), which can be found on the website of the supplier. Therein, a classification of the 
hazards was made according to the European Regulation (EC) No 1272/2008 [EU-GHS/CLP], which 
combines the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) and 
Classification, Labelling and Packaging regulations (CLP). A brief overview of the chemicals employed 
in this work classified as category 1, the most severe category, of the respective hazard class will be 
given below, along with the GHS hazards and precautions. 
Alkyllithium reagents: pyrophoric liquids, substances and mixtures which in contact with water emit 
flammable gases, acute toxicity after inhalation, acute and chronic hazards to the aquatic 
environment. Keep away from heat, fire, hot surfaces, sparks and ignition sources. Avoid contact 
with air or water and work under an inert atmosphere. In case of fire use dry sand, dry chemical- or 
alcohol-resistant foam to extinguish. 
Alkyltin reagents: specific target organ toxicity following repeated exposure, acute and chronic 
aquatic toxicity. Wear protective gloves and clothing. Avoid release in the environment. 
Boron trifluoride diethyl etherate (BF3·Et2O): skin corrosion, specific target organ toxicity following 
repeated exposure (inhalation). Avoid inhalation, wear protective gloves and clothing. 
Bromine (Br2): skin corrosion, acute aquatic toxicity. Avoid inhalation, wear protective gloves and 
clothing, avoid release in the environment. 
Chloroacetyl chloride: skin corrosion, specific target organ toxicity following repeated exposure, 
acute aquatic toxicity. Avoid inhalation and release in the environment. Wear protective gloves and 
clothing. 
Chloroform: specific target organ toxicity following repeated exposure. Avoid inhalation. 
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Solvents in general: acute toxicity after inhalation, specific target organ toxicity following single or 
repeated exposure. Keep away from heat, fire, hot surfaces, sparks and ignition sources. Avoid 
inhalation and wear protective gloves and clothing. A useful tool for solvent selection is the “GSK 
solvent selection guide” which lists a wide variety of hazards associated with specific solvent classes 
as well as more benign alternatives for commonly used solvents.[395-397] 
Iodomethane (MeI): respiratory sensitization, skin sensitization. Avoid inhalation and wear 
protective gloves and clothing. 
Propargyl bromide: acute toxicity after inhalation. Avoid inhalation. 
H2-gas: flammable gas, especially when compressed. Keep away from heat, fire, hot surfaces, sparks 
and ignition sources. 
H2O2: serious eye damage. Wear eye protection.  
NaCNBH3: acute toxicity after inhalation, flammable solid, acute and chronic hazards to the aquatic 
environment. Keep away from heat, fire, hot surfaces, sparks and ignition sources. Avoid inhalation 
and release into the environment. Wear protective gloves and clothing. 
Organic acids (acetic acid, formic acid, para-toluenesulfonic acid, trifluoromethanesulfonic acid): 
skin corrosion. Wear protective gloves and clothing. 
Inorganic acids (HCl, HBr, H2SO4, HClO4, HBF4): skin corrosion, corrosive to metals. Wear protective 
gloves and clothing. 
Organic bases (Et3N, KOt-Bu, LDA, LiHMDS): skin corrosion. Keep away from heat, fire, hot surfaces, 
sparks and ignition sources. Avoid inhalation and wear protective gloves and clothing. 
Inorganic bases (NaOH, NaH): skin corrosion, corrosive to metals. Wear protective gloves and 
clothing. 
Transition metal salts: acute and chronic aquatic toxicity. Avoid release in the environment. 
Thiourea: skin sensitization. Wear protective gloves. 
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3. Synthetic procedures and spectral data 
3.1 Synthetic entry into 3-phosphono-1-azabicyclo[3.1.0]hexanes 
3.1.1 Synthesis of diethyl (2-oxo-2-phenylethyl)phosphonates 29 
Synthesis of diethyl (2-oxo-2-phenylethyl)phosphonates 29c-i (Method A): a mixture of substituted 2-
chloroacetophenone or 2-bromoacetophenone (1 equiv) and methyl hydrazinecarboxylate (1.05 
equiv) was dissolved in toluene (0.5 M) in a round-bottom flask equipped with a Dean-Stark 
apparatus and heated to reflux temperature for 5 h. Next, triethyl phosphite was added (1.1 equiv) 
and the reaction mixture was kept at reflux temperature for an additional 2 h. The solvent was 
evaporated in vacuo before redissolving the residue in a mixture of 20 mL acetone and 20 mL 2 M 
HCl. After 3 h of stirring at room temperature, the acetone was evaporated in vacuo and the residue 
was brought to pH 7 with 20 mL 2 M NaOH before extraction with CH2Cl2 (3x 20 mL). The combined 
organic phases were dried over MgSO4 and concentrated in vacuo. If necessary, the product was 
purified using column chromatography. Spectral data were in agreement with literature values. 
Synthesis of diethyl (2-oxo-2-phenylethyl)phosphonates 29j-k (Method B): a mixture of diethyl 
phosphonoacetic acid (1 equiv) was dissolved in CH3CN (0.5 M). MgCl2 (1.2 equiv) and Et3N (2 equiv) 
were added and the reaction mixture was stirred for 2 h at room temperature. Then, the suspension 
was cooled to 0 °C using an ice bath and an appropriate acid chloride (0.5 equiv) was dissolved in 
CH3CN (1 M) and added in a dropwise fashion to the cooled solution. The reaction was allowed to 
slowly warm to room temperature overnight. The solvent was removed in vacuo and the resulting 
solids were redissolved in 20 mL CH2Cl2 and washed with 20 mL 2 M HCl. The aqueous phase was 
extracted with CH2Cl2 (3x 20 mL) and was dried over MgSO4. The solvent was removed in vacuo and 
the product was purified using column chromatography. Spectral data for 29j were in agreement 
with literature values. 
diethyl (2-(4-fluorophenyl)-2-oxoethyl)phosphonate 29c[398] 
1H-NMR (300 MHz, CDCl3) δ 1.29 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.60 (2H, d, 
2JHP = 23.1 Hz, CH2), 4.14 (4H, dq, 
3JHP = 7.2 Hz, J = 7.2 Hz, 2x OCH2CH3), 7.15 
(2H, dd, 3JHF = 8.5 Hz, J = 8.3 Hz, 2x CHar), 8.06 (2H, dd, J = 8.3 Hz, 
4JHF = 5.3 
Hz, 2x CHar).
 19F-NMR (282 MHz, CDCl3) δ -103.88 to -103.97 (m). 
31P-NMR (121 MHz, CDCl3) δ 20.20. 
Chromatography: hexanes/EtOAc 3/7, Rf = 0.26. Yield: 50%, yellow oil. 
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diethyl (2-(4-chlorophenyl)-2-oxoethyl)phosphonate 29d[398] 
1H-NMR (300 MHz, CDCl3) δ 1.29 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.61 (2H, d, 
2JHP = 23.7 Hz, CH2), 4.14 (4H, dq, 
3JHP = 7.2 Hz, J = 7.2 Hz, 2x OCH2CH3), 7.46 
(2H, d, J = 8.3 Hz, 2x CHar), 7.97 (2H, d, J = 8.3 Hz, 2x CHar). 
31P-NMR (121 
MHz, CDCl3) δ 20.05. Chromatography: hexanes/EtOAc 3/7, Rf = 0.25. Yield: 51%, yellow oil. 
diethyl (2-(4-bromophenyl)-2-oxoethyl)phosphonate 29e[398] 
1H-NMR (300 MHz, CDCl3) δ 1.29 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.60 (2H, 
d, 2JHP = 22.6 Hz, CH2), 4.14 (4H, dq, 
3JHP = 7.2 Hz, J = 7.2 Hz, 2x OCH2CH3), 
7.63 (2H, d, J = 8.8 Hz, 2x CHar), 7.89 (2H, d, J = 8.8 Hz, 2x CHar). 
31P-NMR 
(121 MHz, CDCl3) δ 20.00. Chromatography: hexanes/EtOAc 3/7, Rf = 0.20. Yield: 52%, yellow oil. 
diethyl (2-(4-methoxyphenyl)-2-oxoethyl)phosphonate 29f[398] 
1H-NMR (300 MHz, CDCl3) δ 1.29 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.58 (2H, 
d, 2JHP = 22.6 Hz, CH2), 3.88 (3H, s, OCH3), 4.14 (4H, dq, 
3JHP = 7.2 Hz, J = 7.2 
Hz, 2x OCH2CH3), 6.94 (2H, d, J = 8.3 Hz, 2x CHar), 8.01 (2H, d, J = 8.3 Hz, 2x 
CHar). 
31P-NMR (121 MHz, CDCl3) δ 21.01. Chromatography: EtOAc, Rf = 0.20. Yield: 95%, colorless oil. 
diethyl (2-oxo-2-(p-tolyl)ethyl)phosphonate 29g[398] 
1H-NMR (300 MHz, CDCl3) δ 1.28 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 2.42 (3H, 
s, CH3), 3.61 (2H, d, 
2JHP = 22.6 Hz, CH2), 4.13 (4H, dq, 
3JHP = 7.2 Hz, J = 7.2 
Hz, 2x OCH2CH3), 7.27 (2H, d, J = 8.3 Hz, 2x CHar), 7.91 (2H, d, J = 8.3 Hz, 2x 
CHar). 
31P-NMR (121 MHz, CDCl3) δ 20.83. Chromatography: hexanes/EtOAc 1/9, Rf = 0.29. Yield: 
90%, yellow oil. 
diethyl (2-([1,1'-biphenyl]-4-yl)-2-oxoethyl)phosphonate 29h[399] 
1H-NMR (300 MHz, CDCl3) δ 1.30 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.67 
(2H, d, 2JHP = 22.6 Hz, CH2), 4.16 (4H, dq, 
3JHP = 7.2 Hz, J = 7.2 Hz, 2x 
OCH2CH3), 7.41-7.51 (3H, m, 3x CHar), 7.59-7.66 (2H, m, 2x CHar), 7.68-
7.72 (2H, m, 2x CHar) 8.09-8.11 (2H, m, 2x CHar) 
31P-NMR (121 MHz, 
CDCl3) δ 20.60. Yield: 99%, yellow oil. 
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diethyl (2-(3-methoxyphenyl)-2-oxoethyl)phosphonate 29i[400] 
1H-NMR (300 MHz, CDCl3) δ 1.27 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.61 (2H, 
d, 2JHP = 22.6 Hz, CH2), 3.84 (3H, s, OCH3), 4.13 (4H, dq, 
3JHP = 7.2 Hz, J = 7.2 
Hz, 2x OCH2CH3), 7.14 (1H, dd, J = 8.3 Hz, J = 2.8 Hz, CHar), 7.38 (1H, dd, J = 
8.3 Hz, J = 8.3 Hz, CHar), 7.53 (1H, dd, J = 2.8 Hz, J = 2.8 Hz, CHar), 7.60 (1H, dd, J = 8.3 Hz, J = 2.8 Hz, 
CHar). 
31P-NMR (121 MHz, CDCl3) δ 20.54. Chromatography: hexanes/EtOAc 1/4, Rf = 0.17. Yield: 
61%, yellow oil. 
diethyl (2-(4-nitrophenyl)-2-oxoethyl)phosphonate 29j[210, 398] 
1H-NMR (300 MHz, CDCl3) δ 1.30 (6H, t, J = 7.1 Hz, 2x OCH2CH3), 3.68 (2H, 
d, 2JHP = 23.1 Hz, CH2), 4.16 (4H, dq, 
3JHP = 7.4 Hz, J = 7.1 Hz, 2x OCH2CH3), 
8.20 (2H, d, J = 8.5 Hz, 2x CHar), 8.33 (2H, d, J = 8.5 Hz, 2x CHar) 
31P-NMR 
(121 MHz, CDCl3) δ 19.01. Chromatography: hexanes/EtOAc 2/3, Rf = 0.07. Yield: 51%, yellow oil. 
diethyl (2-(4-cyanophenyl)-2-oxoethyl)phosphonate 29k  
1H-NMR (300 MHz, CDCl3) δ 1.30 (6H, t, J = 7.1 Hz, 2x OCH2CH3), 3.64 (2H, 
d, 2JHP = 23.1 Hz, CH2), 4.15 (4H, dq, 
3JHP = 7.4 Hz, J = 7.1 Hz, 2x OCH2CH3), 
7.79 (2H, d, J = 8.0 Hz, 2x CHar), 8.13 (2H, d, J = 8.0 Hz, 2x CHar). 
13C-NMR (75 
MHz, CDCl3) δ 16.1 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 38.7 (d, 
1JCP = 129.2 Hz, CH2P), 62.7 (d, 
2JCP = 5.8 Hz, 
2x OCH2CH3), 116.5 (Cq,arC≡N), 117.8 (C≡N), 129.4 (2x CHar), 132.4 (2x CHar), 139.3 (Cq,arC=O), 190.9 (d, 
2JCP = 5.8 Hz, C=O). 
31P-NMR (121 MHz, CDCl3) δ 19.18. IR (ATR, cm
-1) νmax: 1019 (P-O), 1051 (P-O), 
1248 (P=O), 1685 (C=O), 2232 (C≡N), 2984. MS (ESI, pos): m/z (%) 282.3/283.0 (M+H+, 100/14). 
HRMS: m/z calcd for C13H16NO4P+H
+ 282.0890, found 282.0899. Chromatography: hexanes/EtOAc 
2/3, Rf = 0.11. Yield: 50%, yellow oil. 
3.1.2 Synthesis of diethyl (2-(allylamino)vinyl)phosphonates 322 and diethyl 
(2-(allylimino)ethyl)phosphonates 323 
Diethyl (2-oxoethyl)phosphonates 29a-k were dissolved in toluene (1 M) in a round-bottom flask 
equipped with a Dean-Stark apparatus. Allylamine (1.5 equiv) and p-TsOH monohydrate (0.05 equiv) 
were added and the reaction mixture was heated to reflux temperature and left overnight. The 
reaction progress was monitored using gas chromatography. After all starting material had been 
consumed, the solvent was removed in vacuo and the residue was redissolved in diethyl ether and 
washed with aqueous NaHCO3. The organic phase was extracted with diethyl ether (3x 20 mL), dried 
over MgSO4 and concentrated in vacuo. 
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3.1.3 Synthesis of diethyl (2-(allylimino)-1,1-dichloroethyl)phosphonates 25 
Diethyl (2-(allylamino)vinyl)phosphonates 322a-k and diethyl (2-(allylimino)ethyl)phosphonates 
323a-k were dissolved in CH2Cl2 (1 M) and N-chlorosuccinimide was added (2 equiv). After 4 h, the 
reaction mixture was poured into 2 M NaOH and extracted (3x 20 mL CH2Cl2). The combined organic 
layers were dried over MgSO4 and concentrated in vacuo. If necessary, the residue was purified using 
column chromatography. 
diethyl (2-(allylimino)-1,1-dichloropropyl)phosphonate 25a 
450 mg (1.93 mmol) of enamine/imine 322a/323a was converted into 522 mg 
25a (1.73 mmol, 90% yield, yellow oil). This product was present in a 3/1 E/Z 
mixture. The spectral data for both isomers are reported (M for the major 
isomer, m for the minor isomer). 1H-NMR (300 MHz, CDCl3) δ 1.36 (6H, t, J = 7.2 
Hz, 2x OCH2CH3, M), 1.37 (6H, t, J = 7.2 Hz, 2x OCH2CH3, m), 2.16 (2x 3H, s, CH3, M + m), 4.08 (2x 2H, 
d, J = 5.0 Hz, NCH2, M + m), 4.25-4.42 (2x 4H, m, 2x OCH2CH3, M + m), 5.14 (1H, dd, J = 10.5 Hz, J = 1.7 
Hz, CH=CHEHZ, M), 5.17 (1H, dd, J = 10.5 Hz, J = 1.7 Hz, CH=CHEHZ, m), 5.25 (1H, dd, J = 17.1 Hz, J = 1.7 
Hz, CH=CHEHZ, M), 5.33 (1H, dd, J = 17.1 Hz, J = 1.7 Hz, CH=CHEHZ, m), 5.99 (1H, ddt, J = 17.1 Hz, J = 
10.5 Hz, J = 5.0 Hz, CH=CHEHZ, M), 6.04 (1H, ddt, J = 17.1 Hz, J = 10.5 Hz, J = 5.0 Hz, CH=CHEHZ, m). 
13C-
NMR (75 MHz, CDCl3) δ 13.2 (d, 
3JCP = 3.5 Hz, CH3, M + m), 16.3 (d, 
3JCP = 6.9 Hz, 2x OCH2CH3, M + m), 
53.8 (NCH2, M), 54.4 (NCH2, m) 65.1 (d, 
2JCP = 6.9 Hz, 2x OCH2CH3, M), 65.5 (d, 
2JCP = 6.9 Hz, 2x 
OCH2CH3, m), 81.6 (d, 
1JCP = 177.7 Hz, PCCl2, m), 83.4 (d, 
1JCP = 177.7 Hz, PCCl2, M), 116.0 (CH=CH2, M), 
116.5 (CH=CH2, m), 133.5 (CH=CH2, m), 133.7 (CH=CH2, M), 159.5 (C=N, m) 163.9 (C=N, M). 
31P-NMR 
(121 MHz, CDCl3) δ 10.82 (M), 8.70 (m). IR (ATR, cm
-1) νmax: 1019 (P-O), 1263 (P=O), 1664, 2983. MS 
(ESI, pos): m/z (%) 302.0/304.0/306.0 (M+H+, 100/64/10). 
diethyl (2-(allylimino)-1,1-dichloro-2-phenylethyl)phosphonate 25b 
3.08 g (10.43 mmol) of enamine/imine 322b/323b was converted into 3.61 g 
25b (9.91 mmol, 95 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.37 (6H, t, 
J = 7.2 Hz, 2x OCH2CH3), 3.86 (2H, d, J = 5.3 Hz, NCH2), 4.27-4.48 (4H, m, 2x 
OCH2CH3), 5.10 (1H, dd, J = 10.6 Hz, J = 1.1 Hz, CH=CHEHZ), 5.21 (1H, dd, J = 17.1 
Hz, J = 1.4 Hz, CH=CHEHZ), 5.90 (1H, ddt, J = 17.1 Hz, J = 10.6 Hz, J = 5.3 Hz, CH=CHEHZ), 7.31-7.33 (2H, 
m, 2x CHar), 7.43-7.44 (3H, m, 3x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.5 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 
55.9 (NCH2), 65.4 (d, 
2JCP = 6.9 Hz, 2x OCH2CH3), 82.0 (d, 
1JCP = 176.5 Hz, PCCl2), 116.3 (CH=CH2), 128.1 
(2x CHar), 128.9 (2x CHar), 129.3 (CHar), 131.7 (d, 
3JCP = 5.8 Hz, Cq,ar), 134.3 (CH=CH2), 166.0 (C=N). 
31P-
NMR (121 MHz, CDCl3) δ 10.96. IR (ATR, cm
-1) νmax: 1017 (P-O), 1054 (P-O), 1265 (P=O), 1654, 2982. 
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MS (ESI, pos): m/z (%) 364.0/366.0/368.0 (M+H+, 100/64/10). HRMS: m/z calcd for C15H20Cl2NO3P+H
+ 
364.0631, found 364.0642. 
diethyl (2-(allylimino)-1,1-dichloro-2-(4-fluorophenyl)ethyl)phosphonate 25c  
2.42 g (7.72 mmol) of enamine/imine 322c/323c was converted into 2.92 g 
25c (7.64 mmol, 99 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.38 
(6H, t, J = 7.5 Hz, 2x OCH2CH3), 3.87 (2H, dt, J = 5.3 Hz, J = 1.8 Hz, NCH2), 
4.26-4.48 (4H, m, 2x OCH2CH3), 5.11 (1H, ddd, J = 10.5 Hz, J = 3.4 Hz, J = 1.8 
Hz, CH=CHEHZ), 5.20 (1H, ddd, J = 17.3 Hz, J = 3.4 Hz, J = 1.8 Hz, CH=CHEHZ), 5.90 (1H, ddt, J = 17.3 Hz, J 
= 10.5 Hz, J = 5.3 Hz, CH=CHEHZ), 7.13 (2H, dd, 
3JHF = 8.5 Hz, J = 8.5 Hz, 2x CHar), 7.28-7.35 (2H, m, 2x 
CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.5 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 55.9 (NCH2), 65.5 (d, 
2JCP = 6.9 
Hz, 2x OCH2CH3), 81.9 (d, 
1JCP = 176.5 Hz, PCCl2), 115.3 (d, 
2JCF = 20.8 Hz, 2x CHar), 116.3 (CH=CH2), 
127.6 (Cq,arC=N), 131.0 (d, 
3JCF = 8.1 Hz, 2x CHar), 134.0 (CH=CH2), 163.1 (d, 
1JCF = 249.2 Hz, Cq,arF), 
165.2 (C=N).19F-NMR (282 MHz, CDCl3) δ -110.98 to -110.87 (m). 
31P-NMR (121 MHz, CDCl3) δ 10.76. 
IR (ATR, cm-1) νmax: 1019 (P-O), 1052 (P-O), 1229 (P=O), 1507, 2983. MS (ESI, pos): m/z (%) 
382.0/384.0/386.0 (M+H+, 100/64/10). HRMS: m/z calcd for C15H19Cl2FNO3P+H
+ 382.0536, found 
382.0540. 
diethyl (2-(allylimino)-1,1-dichloro-2-(4-chlorophenyl)ethyl)phosphonate 25d 
0.63 g (1.91 mmol) of enamine/imine 322d/323d was converted into 0.74 g 
25d (1.85 mmol, 97 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.38 
(6H, t, J = 7.5 Hz, 2x OCH2CH3), 3.85-3.88 (2H, m, NCH2), 4.26-4.48 (4H, m, 
2x OCH2CH3), 5.11 (1H, ddd, J = 10.4 Hz, J = 3.4 Hz, 1.7 Hz, CH=CHEHZ), 5.20 
(1H, J = 17.3 Hz, 3.4 Hz, 1.8 Hz, CH=CHEHZ), 5.89 (1H, ddt, J = 17.3 Hz, J = 10.4 Hz, J = 5.2 Hz, 
CH=CHEHZ), 7.26 (2H, d, J = 8.5 Hz, 2x CHar), 7.42 (2H, d, J = 8.5 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) 
δ 16.5 (d, 3JCP = 5.8 Hz, 2x OCH2CH3), 56.0 (NCH2), 65.6 (d, 
2JCP = 6.9 Hz, 2x OCH2CH3), 81.8 (d, 
1JCP = 
177.0 Hz, PCCl2), 116.5 (CH=CH2), 128.5 (2x CHar), 130.1 (d, 
3JCP = 5.8 Hz, Cq,ar), 130.4 (2x CHar), 134.0 
(CH=CH2), 135.7 (Cq,arCl), 165.1 (C=N). 
31P-NMR (121 MHz, CDCl3) δ 10.65. IR (ATR, cm
-1) νmax: 1012 (P-
O), 1054 (P-O), 1264 (P=O), 1487, 2982. MS (ESI, pos): m/z (%) 398.0/400.0/402.0 (M+H+, 
100/97/40). HRMS: m/z calcd for C15H19Cl3NO3P+H
+ 398.0241, found 398.0246. 
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diethyl (2-(allylimino)-1,1-dichloro-2-(4-bromophenyl)ethyl)phosphonate 25e 
0.67 g (1.80 mmol) of enamine/imine 322e/323e was converted into 0.65 g 
25e (1.48 mmol, 82 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.38 
(6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.86-3.87 (2H, m, NCH2), 4.24-4.48 (4H, m, 
2x OCH2CH3), 5.11 (1H, ddd, J = 10.2 Hz, J = 3.3 Hz, J = 1.7 Hz, CH=CHEHZ), 
5.20 (1H, ddd, J = 17.3 Hz, J = 3.3 Hz, J = 1.7 Hz, CH=CHEHZ), 5.90 (1H, ddt, J = 17.3 Hz, J = 10.2 Hz, J = 
5.2 Hz, CH=CHEHZ), 7.20 (2H, d, J = 8.3 Hz, 2x CHar), 7.58 (2H, d, J = 8.3 Hz, 2x CHar). 
13C-NMR (75 MHz, 
CDCl3) δ 16.6 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 56.0 (NCH2), 65.7 (d, 
2JCP = 6.9 Hz, 2x OCH2CH3), 81.7 (d, 
1JCP = 177.7 Hz, PCCl2), 116.5 (CH=CH2), 124.0 (Cq,arBr), 130.5 (Cq,arC=N), 130.7 (2x CHar), 131.5 (2x 
CHar), 134.1 (CH=CH2), 165.1 (C=N). 
31P-NMR (121 MHz, CDCl3) δ 10.64. IR (ATR, cm
-1) νmax: 1010 (P-
O), 1054 (P-O), 1260 (P=O), 1484, 2982. MS (ESI, pos): m/z (%) 442.0/444.0/446.0 (M+H+, 
62/100/45). HRMS: m/z calcd for C15H19BrCl2NO3P+H
+ 441.9736, found 441.9743.  
diethyl (2-(allylimino)-1,1-dichloro-2-(4-methoxyphenyl)ethyl)phosphonate 25f 
1.23 g (3.78 mmol) of enamine/imine 322f/323f was converted into 1.37 
g 25f (3.48 mmol, 92 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.38 
(6H, t, J = 7.4 Hz, OCH2CH3), 3.85 (3H, s, OCH3), 3.89 (2H, dt, J = 5.1 Hz, J = 
1.7 Hz, NCH2), 4.27-4.48 (4H, m, 2x OCH2CH3), 5.10 (1H, ddd, J = 10.5 Hz, J = 3.6 Hz, J = 1.7 Hz, 
CH=CHEHZ), 5.21 (1H, ddd, J = 17.3 Hz, J = 3.6 Hz, J = 1.7 Hz, CH=CHEHZ), 5.91 (1H, ddt, J = 17.3 Hz, J = 
10.5 Hz, J = 5.1 Hz, CH=CHEHZ), 6.95 (2H, d, J = 8.8 Hz, 2x CHar), 7.26 (2H, d, J = 8.8 Hz, 2x CHar). 
13C-
NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 55.0 (OCH3), 55.5 (NCH2), 65.0 (d, 
2JCP = 5.8 
Hz, 2x OCH2CH3), 82.3 (d, 
1JCP = 176.5 Hz, PCCl2), 113.3 (2x CHar), 115.9 (CH=CH2), 123.5 (d, 
3JCP = 5.8 
Hz, Cq,arC=N), 130.1 (2x CHar), 134.2 (CH=CH2), 160.1 (Cq,arOCH3), 165.9 (C=N). 
31P-NMR (121 MHz, 
CDCl3) δ 11.12. IR (ATR, cm
-1) νmax: 1020 (P-O), 1055 (P-O), 1245 (P=O), 1509, 2981. MS (ESI, pos): 
m/z (%) 394.3/396.3/398.3 (M+H+, 100/64/10). HRMS: m/z calcd for C16H22Cl2NO4P+H
+ 394.0736, 
found 394.0744. 
diethyl (2-(allylimino)-1,1-dichloro-2-(4-methylphenyl)ethyl)phosphonate 25g 
1.78 g (5.75 mmol) of enamine/imine 322g/323g was converted into 2.09 g 
25g (5.52 mmol, 96 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.37 
(6H, t, J = 6.9 Hz, 2x OCH2CH3), 2.39 (3H, s, CH3), 3.87 (2H, dt, J = 5.1 Hz, J = 
1.7 Hz, NCH2), 4.27-4.51 (4H, m, 2x OCH2CH3), 5.10 (1H, ddd, J = 10.4 Hz, J = 
3.4 Hz, J = 1.7 Hz, CH=CHEHZ), 5.21 (1H, ddd, J = 17.1 Hz, J = 3.4 Hz, J = 1.7 Hz, CH=CHEHZ), 5.90 (1H, 
ddt, J = 17.1 Hz, J = 10.4 Hz, J = 5.1 Hz, CH=CHEHZ), 7.22 (4H, m, 4x CHar).
13C-NMR (75 MHz, CDCl3) δ 
V. Experimental procedures 
131 
 
16.6 (d, 3JCP = 5.8 Hz, 2x OCH2CH3), 21.5 (CH3), 55.9 (NCH2), 65.5 (d, 
2JCP = 6.9 Hz, 2x OCH2CH3), 82.2 (d, 
1JCP = 176.5 Hz, PCCl2), 116.3 (CH=CH2), 128.8 (2x CHar), 128.9 (2x CHar), 134.5 (CH=CH2), 139.4 
(Cq,arC=N + Cq,arCH3), 166.3 (d, 
2JCP = 2.3 Hz, C=N). 
31P-NMR (121 MHz, CDCl3) δ 11.07. IR (ATR, cm
-1) 
νmax: 1017 (P-O), 1052(P-O), 1262 (P=O), 1654, 2982. MS (ESI, pos): m/z (%) 378.3/380.3/382.3 
(M+H+, 100/64/10). HRMS: m/z calcd for C16H22Cl2NO3P+H
+ 378.0787, found 378.0795. 
diethyl (2-([1,1'-biphenyl]-4-yl)-2-(allylimino)-1,1-dichloroethyl)phosphonate 25h 
1.78 g (5.75 mmol) of enamine/imine 322h/323h was converted into 
2.09 g 25h (5.52 mmol, 90 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) 
δ 1.38 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.92 (2H, dt, J = 5.1 Hz, J = 1.8 Hz, 
NCH2), 4.28-4.50 (4H, m, 2x OCH2CH3), 5.12 (1H, ddd, J = 10.5 Hz, J = 3.4 
Hz, J = 1.8 Hz, CH=CHEHZ), 5.24 (1H, ddd, J = 17.2 Hz, J = 3.4 Hz, J = 1.8 Hz, 
CH=CHEHZ), 5.93 (1H, ddt, J = 17.2 Hz, J = 10.5 Hz, J = 5.1 Hz, CH=CHEHZ), 7.35-7.49 (5H, m, 5x CHar), 
7.57-7.71 (4H, m, 4x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.6 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 56.0 
(NCH2), 65.6 (d, 
2JCP = 6.9 Hz, 2x OCH2CH3), 82.1 (d, 
1JCP = 176.5 Hz, PCCl2), 116.4 (CH=CH2), 126.8 (2x 
CHar), 127.2 (2x CHar), 127.9 (CHar), 129.0 (2x CHar), 129.5 (2x CHar), 130.7 (d, 
3JCP = 5.8 Hz, Cq,arCN), 
134.4 (CH=CH2), 140.2 (Cq,ar), 142.2 (Cq,ar), 166.0 (d, 
2JCP = 2.3 Hz, C=N) .
31P-NMR (121 MHz, CDCl3) δ 
10.93. IR (ATR, cm-1) νmax: 1019 (P-O), 1054 (P-O), 1262 (P=O), 1712, 2982. MS (ESI, pos): m/z (%) 
440.3/442.3/444.3 (M+H+, 100/64/10). HRMS: m/z calcd for C21H24Cl2NO3P+H
+ 440.0944, found 
440.0947. 
diethyl (2-(allylimino)-1,1-dichloro-2-(3-methoxyphenyl)ethyl)phosphonate 25i 
2.01 g (6.18 mmol) of enamine/imine 322i/323i was converted into 2.41 g 
25i (6.12 mmol, 99 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.38 
(6H, t, J = 7.2 Hz, 2x OCH2CH3), 3.82 (3H, OCH3), 3.88 (2H, dt, J = 5.3 Hz, J = 
1.7 Hz, NCH2), 4.27-4.49 (4H, m, 2x OCH2CH3), 5.11 (1H, dd, J = 10.8 Hz, J = 
1.7 Hz, CH=CHEHZ), 5.22 (1H, dd, J = 16.8 Hz, J = 1.7 Hz, CH=CHEHZ), 5.91 (1H, ddt, J = 16.8 Hz, J = 10.8 
Hz, J = 5.3 Hz, CH=CHEHZ), 6.85-6.91 (2H, m, 2x CHar), 6.97 (1H, dd, J = 8.1 Hz, J = 2.2 Hz, CHar), 7.34 
(1H, dd, J = 8.1 Hz, J = 8.1 Hz, CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.4 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 
55.2 (OCH3), 55.8 (NCH2), 65.3 (d, 
2JCP = 6.9 Hz, 2x OCH2CH3), 81.7 (d, 
1JCP = 177.7 Hz, PCCl2), 114.5 
(CHar), 114.8 (CHar), 116.1 (CH=CH2), 121.1 (CHar), 129.2 (CHar), 132.8 (d, 
3JCP = 5.8 Hz, Cq,arC=N), 134.3 
(CH=CH2), 159.1 (Cq,arOCH3), 165.7 (C=N). 
31P-NMR (121 MHz, CDCl3) δ 10.96. IR (ATR, cm
-1) νmax: 
1019 (P-O), 1264 (P=O), 1578, 2982. MS (ESI, pos): m/z (%) 394.3/396.3/398.3 (M+H+, 100/64/10). 
HRMS: m/z calcd for C16H22Cl2NO4P+H
+ 394.0736, found 394.0743.  
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diethyl (2-(allylimino)-1,1-dichloro-2-(4-nitrophenyl)ethyl)phosphonate 25j 
1.78 g (5.23 mmol) of enamine/imine 322i/323i was converted and 
purified by column chromatography into 0.90 g 25j (2.20 mmol, 42 % 
yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.39 (6H, t, J = 7.2 Hz, 2x 
OCH2CH3), 3.86 (2H, d, J = 5.4 Hz, NCH2), 4.27-4.49 (4H, m, 2x OCH2CH3), 
5.15 (1H, d, J = 11.2 Hz, CH=CHEHZ), 5.20 (1H, d, J = 17.8 Hz, CH=CHEHZ), 5.90 (1H, ddt, J = 17.8 Hz, J = 
11.2 Hz, J = 5.4 Hz, CH=CHEHZ), 7.54 (2H, d, J = 8.8 Hz, 2x CHar), 8.31 (2H, d, J = 8.8 Hz, 2x CHar). 
13C-
NMR (75 MHz, CDCl3) δ 16.4 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 56.0 (NCH2), 65.7 (d, 
2JCP = 6.9 Hz, 2x 
OCH2CH3), 81.0 (d, 
1JCP = 175.4 Hz, PCCl2), 116.6 (CH=CH2), 123.2 (2x CHar), 130.2 (2x CHar), 133.5 
(CH=CH2), 138.2 (d, 
3JCP = 5.8 Hz, Cq,arC=N), 148.3 (Cq,arNO2), 163.9 (C=N). 
31P-NMR (121 MHz, CDCl3) δ 
10.12. IR (ATR, cm-1) νmax: 1013 (P-O), 1052 (P-O), 1263 (P=O), 1347 (N-O), 1521 (N-O), 1600, 2980. 
MS (ESI, pos): m/z (%) 409.0/411.0/413.0 (M+H+, 100/64/10). HRMS: m/z calcd for C15H19Cl2N2O5P+H
+ 
409.0481, found 409.0492. Chromatography: hexanes/EtOAc 3/2, Rf = 0.11. 
diethyl (2-(allylimino)-1,1-dichloro-2-(4-cyanophenyl)ethyl)phosphonate 25k 
1.60 g (5.00 mmol) of enamine/imine 322k/323k was converted and 
purified by column chromatography into 0.86 g 25k (2.20 mmol, 44 % 
yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.38 (6H, t, J = 7.2 Hz, 
OCH2CH3), 3.84 (2H, d, J = 5.0 Hz, NCH2), 4.26-4.48 (4H, m, 2x OCH2CH3), 
5.14 (1H, d, J = 11.4 Hz, CH=CHEHZ), 5.19 (1H, d, J = 18.0 Hz, CH=CHEHZ), 5.89 (1H, ddt, J = 18.0 Hz, J = 
11.4 Hz, J = 5.0 Hz, CH=CHEHZ), 7.46 (2H, d, J = 8.3 Hz, 2x CHar), 7.74 (2H, d, J = 8.3 Hz, 2x CHar). 
13C-
NMR (75 MHz, CDCl3) δ 16.4 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 55.8 (NCH2), 65.5 (d, 
2JCP = 6.9 Hz, 2x 
OCH2CH3), 81.0 (d, 
1JCP = 176.5 Hz, PCCl2), 113.3 (Cq,arC≡N), 116.5 (CH=CH2), 117.9 (C≡N), 129.8 (2x 
CHar), 131.8 (2x CHar), 133.6 (CH=CH2), 136.2 (d, 
3JCP = 4.6 Hz, Cq,arC=N), 164.0 (C=N). 
31P-NMR (121 
MHz, CDCl3) δ 9.96. IR (ATR, cm
-1) νmax: 1016 (P-O), 1052 (P-O), 1264 (P=O), 2232 (C≡N), 2984. MS 
(ESI, pos): m/z (%) 389.0/391.0/393.0 (M+H+, 100/64/10). HRMS: m/z calcd for C16H19Cl2N2O3P+H
+ 
389.0583, found 389.0597. Chromatography: hexanes/EtOAc 3/2, Rf = 0.10. 
3.1.4 Synthesis of diethyl (4-chloro-3-(chloromethyl)-3,4-dihydro-2H-pyrrol-4-
yl)phosphonates 26 
In a flame-dried round-bottom flask and under a N2-atmosphere, diethyl (2-(allylimino)-1,1-
dichloroethyl)phosphonates 25a-k were dissolved in dry CH2Cl2 (1 M). Cu(I)Cl (0.4 equiv) and 
N,N,N’,N’,N”-pentamethyldiethylenetriamine (0.8 equiv) were added and the reaction mixture was 
heated to reflux. The reaction progress was monitored using HPLC. After all starting material had 
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been consumed, the reaction mixture was poured into brine and extracted with CH2Cl2 (3x 10 mL). 
The combined organic phases were washed with water until no more Cu salts were present (blue 
color of the aqueous phase disappears). The organic layer was dried over MgSO4 and concentrated in 
vacuo and the residue was purified by crystallization or column chromatography. Only the major 
diastereoisomers could be isolated in pure form.  
diethyl (cis-4-chloro-3-(chloromethyl)-5-methyl-3,4-dihydro-2H-pyrrol-4-yl)phosphonate 26a 
4.04 g (13.4 mmol) of 25a was converted into 26a (dr = 84/16). After column 
chromatography 1.53 g of product was obtained (5.09 mmol, 38 % yield, yellow 
oil). 1H-NMR (300 MHz, CDCl3) δ 1.38 (6H, t, J = 6.9 Hz, 2x OCH2CH3), 2.23 (3H, s, 
CH3), 3.01-3.15 (1H, m, CHCH2Cl), 3.57 (1H, dd, J = 10.7 Hz, J = 10.7 Hz, CHCHaHbCl), 3.72-3.82 (1H, m, 
NCHaHb), 3.94 (1H, dd, J = 10.7 Hz, J = 4.1 Hz, CHCHaHbCl), 4.19-4.36 (5H, m, 2x OCH2CH3 + NCHaHb). 
13C-NMR (75 MHz, CDCl3) δ 16.4 (d, 
3JCP = 4.6 Hz, 2x OCH2CH3), 16.9 (CH3), 43.9 (d, 
3JCP = 3.5 Hz, 
CHCH2Cl), 46.5 (CHCH2Cl), 63.2 (d, 
3JCP = 10.4 Hz, NCH2), 64.2 (d, 
2JCP = 8.1 Hz, OCH2CH3), 64.8 (d, 
2JCP = 
8.1 Hz, OCH2CH3), 72.0 (d, 
1JCP = 168 Hz, PCq) 169.2 (C=N).
 31P-NMR (121 MHz, CDCl3) δ 16.70. IR (ATR, 
cm-1) νmax: 1014 (P-O), 1250 (P=O), 1643, 2983. MS (ESI, pos): m/z (%) 302.0/304.0/306.0 (M+H
+, 
100/64/10). Chromatography: hexanes/EtOAc 1/1, Rf = 0.15. 
diethyl (cis-4-chloro-3-(chloromethyl)-5-phenyl-3,4-dihydro-2H-pyrrol-4-yl)phosphonate 26b 
3.42 g (9.39 mmol) of 25b was converted into 26b (dr = 90/10). After column 
chromatography 3.18 g of product was obtained (8.73 mmol, 93 % yield, brown 
oil). 1H-NMR (300 MHz, CDCl3) δ 1.20 (3H, t, J = 7.2 Hz, OCH2CH3), 1.28 (3H, t, J = 
7.2 Hz, OCH2CH3), 3.22-3.38 (1H, m, CHCH2Cl), 3.67 (1H, dd, J = 10.7 Hz, J = 10.7 
Hz, CHCHaHbCl), 3.96-4.23 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 4.45 (1H, dd, J = 17.1 Hz, J = 
6.6 Hz, NCHaHb), 7.36-7.44 (3H, m, 3x CHar), 8.02 (2H, d, J = 7.2 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) 
δ 16.3 (d, 3JCP = 5.8 Hz, OCH2CH3), 16.4 (d, 
3JCP = 5.8 Hz, OCH2CH3), 44.2 (d, 
3JCP = 2.3 Hz, CHCH2Cl), 48.6 
(CHCH2Cl), 63.2 (d, 
3JCP = 10.4 Hz, NCH2), 64.3 (d, 
2JCP = 6.9 Hz, OCH2CH3), 64.7 (d, 
2JCP = 8.1 Hz, 
OCH2CH3), 71.2 (d, 
1JCP = 166.1 Hz, PCq), 128.0 (2x CHar), 129.3 (2x CHar), 130.7 (CHar), 132.8 (Cq,ar), 
169.1 (d, 2JCP = 2.3 Hz, C=N). 
31P-NMR (121 MHz, CDCl3) δ 17.11. IR (ATR, cm
-1) νmax: 1012 (P-O), 1043 
(P-O), 1263 (P=O), 1606, 2981. MS (ESI, pos): m/z (%) 364.0/366.0/368.0 (M+H+, 100/64/10). HRMS: 
m/z calcd for C15H20Cl2NO3P+H
+ 364.0631, found 364.0636. Chromatography: hexanes/EtOAc 1/1, Rf 
= 0.4.  
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diethyl (cis-4-chloro-3-(chloromethyl)-5-(4-fluorophenyl)-3,4-dihydro-2H-pyrrol-4-yl)phosphonate 
26c 
3.00 g (7.82 mmol) of 25c was converted into 26c (dr = 92/8). After column 
chromatography 1.77 g of product was obtained (4.61 mmol, 59 % yield, brown 
oil). 1H-NMR (300 MHz, CDCl3) δ 1.20 (3H, t, J = 7.2 Hz, OCH2CH3), 1.31 (3H, t, J = 
7.2 Hz, OCH2CH3), 3.23-3.36 (1H, m, CHCH2Cl), 3.66 (1H, dd, J = 10.5 Hz, J = 10.5 
Hz, CHCHaHbCl), 3.96-4.19 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 4.43 (1H, ddd, J = 17.1 Hz, J = 
7.2 Hz, 4JHP = 1.7 Hz, NCHaHb), 7.07 (2H, dd, J = 8.8 Hz, 
3JHF = 8.8 Hz, 2x CHar), 8.10 (2H, dd, J = 8.8 Hz, 
4JFH = 5.5 Hz, 2x CHar).
13C-NMR (75 MHz, CDCl3) δ 16.2 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 44.1 (d, 
3JCP = 2.3 
Hz, CHCH2Cl), 48.4 (CHCH2Cl), 63.1 (d, 
3JCP = 9.2 Hz, NCH2), 64.5 (d, 
2JCP = 12.1 Hz, OCH2CH3), 64.6 (d, 
2JCP = 12.1 Hz, OCH2CH3), 71.1 (d, 
2JCP = 165.0 Hz, PCq), 114.9 (d, 
2JCF = 21.9 Hz, 2x CHar), 128.7 (d, 
4JCF = 
3.5 Hz, Cq,arC=N), 131.6 (d, 
3JCF = 8.1 Hz, 2x CHar), 164.2 (d, 
1JCF = 251.22 Hz, Cq,arF), 167.7 (C=N). 
19F-
NMR (282 MHz, CDCl3) δ -109.43 to -109.32 (m).
31P-NMR (121 MHz, CDCl3) δ 17.08. IR (cm
-1) νmax: 
1012 (P-O), 1039 (P-O), 1263 (P=O), 1509, 2980. MS (ESI, pos): m/z (%) 382.0/384.0/386.0 (M+H+, 
100/64/10). HRMS: m/z calcd for C15H19Cl2FNO3P+H
+ 382.0536, found 382.0543. Chromatography: 
hexanes/EtOAc 4/1, Rf = 0.15. 
diethyl (cis-4-chloro-3-(chloromethyl)-5-(4-chlorophenyl)-3,4-dihydro-2H-pyrrol-4-yl)phosphonate 
26d 
0.70 g (1.76 mmol) of 25d was converted into 26d (dr = 90/10). After column 
chromatography 0.51 g of product was obtained (1.28 mmol, 73 % yield, 
brown oil). 1H-NMR (300 MHz, CDCl3) δ 1.21 (3H, t, J = 7.2 Hz, OCH2CH3), 1.31 
(3H, t, J = 7.2 Hz, OCH2CH3), 3.22-3.36 (1H, m, CHCH2Cl), 3.65 (1H, dd, J = 10.5 
Hz, J = 10.5 Hz, CHCHaHbCl), 3.94-4.23 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 4.43 (1H, ddd, J = 
17.1 Hz, J = 7.2 Hz, 4JHP = 1.7 Hz, NCHaHb), 7.37 (2H, d, J = 8.8 Hz, 2x CHar), 8.02 (2H, d, J = 8.8 Hz, 2x 
CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.4 (d, 
3JCP = 4.6 Hz, OCH2CH3), 
44.1 (d, 3JCP = 3.5 Hz, CHCH2Cl), 48.4 (CHCH2Cl), 63.2 (d, 
3JCP = 9.2 Hz, NCH2), 64.5 (d, 
2JCP = 6.9 Hz, 
OCH2CH3), 64.7 (d, 
2JCP = 6.9 Hz, OCH2CH3), 71.1 (d, 
1JCP = 165.0 Hz, PCq), 128.2 (2x CHar), 130.8 (2x 
CHar), 131.0 (Cq,arC=N), 136.9 (Cq,arCl), 167.8 (C=N).
31P-NMR (121 MHz, CDCl3) δ 17.06. IR (ATR, cm
-1) 
νmax: 1012 (P-O), 1041 (P-O), 1263 (P=O), 1491, 2982. MS (ESI, pos): m/z (%) 398.0/400.0/402.0 
(M+H+, 100/96/40). HRMS: m/z calcd for C15H19Cl3NO3P+H
+ 398.0241, found 398.0249. 
Chromatography: hexanes/EtOAc 7/3, Rf = 0.21. 
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diethyl (cis-4-chloro-3-(chloromethyl)-5-(4-bromophenyl)-3,4-dihydro-2H-pyrrol-4-yl)phosphonate 
26e 
0.65 g (1.47 mmol) of 25e was converted into 26e (dr = 89/11). After column 
chromatography 0.28 g of product was obtained (0.63 mmol, 43 % yield, 
brown oil). 1H-NMR (300 MHz, CDCl3) δ 1.12 (3H, t, J = 7.2 Hz, OCH2CH3), 1.22 
(3H, t, J = 7.2 Hz, OCH2CH3), 3.14-3.27 (1H, m, CHCH2Cl), 3.56 (1H, dd, J = 10.5 
Hz, J = 10.5 Hz, CHCHaHbCl), 3.88-4.13 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 4.33 (1H, ddd, J = 
17.2 Hz, J = 7.0 Hz, 4JHP = 1.7 Hz, NCHaHb), 7.44 (2H, J = 8.8 Hz, 2x CHar), 7.88 (2H, J = 8.8 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.4 (d,
3JCP = 5.8 Hz, OCH2CH3), 44.1 (d, 
3JCP = 3.5 Hz, CHCH2Cl), 48.4 (CHCH2Cl), 63.2 (d, 
3JCP = 9.2 Hz, NCH2), 64.5 (d, 
2JCP = 6.9 Hz, OCH2CH3), 
64.7 (d, 2JCP = 6.9 Hz, OCH2CH3), 71.1 (d, 
1JCP = 165.0 Hz, PCq), 125.4 (Cq,arBr), 131.0 (2x CHar), 131.1 (2x 
CHar), 131.4 (Cq,arC=N), 167.8 (C=N). 
31P-NMR (121 MHz, CDCl3) δ 16.97. IR (ATR, cm
-1) νmax: 1010 (P-
O), 1038 (P-O), 1266 (P=O), 1394, 2978. MS (ESI, pos): m/z (%) 442.0/444.0/446.0(M+H+, 62/100/45). 
HRMS: m/z calcd for C15H19BrCl2NO3P+H
+ 441.9736, found 441.9737. Chromatography: 
hexanes/EtOAc 7/3, Rf = 0.19. 
diethyl (cis-4-chloro-3-(chloromethyl)-5-(4-methoxyphenyl)-3,4-dihydro-2H-pyrrol-4-
yl)phosphonate 26f 
1.11 g (2.82 mmol) of 25f was converted into 26f (dr = 85/15). After column 
chromatography 0.50 g of product was obtained (1.27 mmol, 45 % yield, 
brown oil). 1H-NMR (300 MHz, CDCl3) δ 1.19 (3H, t, J = 7.2 Hz, OCH2CH3), 1.31 
(3H, t, J = 7.2 Hz, OCH2CH3), 3.21-3.35 (1H, m, CHCH2Cl), 3.64 (1H, dd, J = 10.5 
Hz, J = 10.5 Hz, CHCHaHbCl), 3.81 (3H, s, OCH3), 3.91-4.22 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 
4.39 (1H, ddd, J = 17.1 Hz, J = 7.2 Hz, 4JHP = 1.7 Hz, NCHaHb), 6.89 (2H, d, J = 9.4 Hz, 2x CHar), 8.08 (2H, 
d, J = 9.4 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.2 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.4 (d, 
3JCP = 5.8 
Hz, OCH2CH3), 44.3 (d, 
3JCP = 3.5 Hz, CHCH2Cl), 48.4 (CHCH2Cl), 55.2 (OCH3), 62.8 (d, 
3JCP = 9.2 Hz, 
NCH2), 64.3 (d, 
2JCP = 6.9 Hz, OCH2CH3), 64.5 (d, 
2JCP = 6.9 Hz, OCH2CH3), 71.1 (d, 
1JCP = 163.8 Hz, PCq), 
113.2 (2x CHar), 124.8 (Cq,arC=N), 131.0 (2x CHar), 161.5 (Cq,arOCH3), 167.8 (d, 
2JCP = 2.3 Hz, C=N). 
31P-
NMR (121 MHz, CDCl3) δ 17.48. IR (ATR, cm
-1) νmax: 1012 (P-O), 1177 (P-O), 1252 (P=O), 1513, 1606, 
2978. MS (ESI, pos): m/z (%) 394.0/396.0/398.0 (M+H+, 100/64/11). HRMS: m/z calcd for 
C16H22Cl2NO4P+H
+ 394.0736, found 394.0740. Chromatography: hexanes/EtOAc 3/2, Rf = 0.23. 
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diethyl (cis-4-chloro-3-(chloromethyl)-5-(4-methylphenyl)-3,4-dihydro-2H-pyrrol-4-yl)phosphonate 
26g 
1.82 g (4.81 mmol) of 25g was converted into 26g (dr = 95/5). After column 
chromatography 0.47 g of product was obtained (1.25 mmol, 26 % yield, 
brown oil). 1H-NMR (300 MHz, CDCl3) δ 1.20 (3H, t, J = 7.2 Hz, OCH2CH3), 1.30 
(3H, t, J = 7.2 Hz, OCH2CH3), 2.37 (3H, s, CH3), 3.19-3.37 (1H, m, CHCH2Cl), 3.65 
(1H, dd, J = 10.5 Hz, J = 10.5 Hz, CHCHaHbCl), 3.94-4.23 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 
4.42 (1H, ddd, J = 17.1 Hz, J = 7.2 Hz, 4JHP = 1.7 Hz, NCHaHb), 7.19 (2H, d, J = 8.3 Hz, 2x CHar), 7.95 (2H, 
d, J = 8.3 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.5 (d, 
3JCP = 5.8 
Hz, OCH2CH3), 21.6 (CH3), 44.3 (d, 
3JCP = 2.3 Hz, CHCH2Cl), 48.5 (CHCH2Cl), 63.0 (d, 
3JCP = 9.2 Hz, NCH2), 
64.4 (d, 2JCP = 6.9 Hz, OCH2CH3), 64.7 (d, 
2JCP = 6.9 Hz, OCH2CH3), 71.2 (d, 
1JCP = 163.8 Hz, PCq), 128.7 
(2x CHar), 129.3 (2x CHar), 129.7 (Cq,arC=N), 141.0 (Cq,arCH3), 168.8 (C=N). 
31P-NMR (121 MHz, CDCl3) δ 
17.36. IR (ATR, cm-1) νmax: 1014 (P-O), 1096 (P-O), 1264 (P=O), 1606, 2359, 2981. MS (ESI, pos): m/z 
(%) 378.3/380.3/382.3 (M+H+, 100/64/10). HRMS: m/z calcd for C16H22Cl2NO3P+H
+ 378.0787, found 
378.0782. Chromatography: hexanes/EtOAc 1/1, Rf = 0.47. 
diethyl (cis-5-([1,1'-biphenyl]-4-yl)-4-chloro-3-(chloromethyl)-3,4-dihydro-2H-pyrrol-4-
yl)phosphonate 26h 
1.15 g (2.61 mmol) of 25h was converted into 26h (dr = 96/4). After column 
chromatography 0.42 g of product was obtained (0.97 mmol, 37 % yield, 
brown oil). 1H-NMR (300 MHz, CDCl3) δ 1.22 (3H, t, J = 7.0 Hz, OCH2CH3), 
1.31 (3H, t, J = 7.0 Hz, OCH2CH3), 3.25-3.40 (1H, m, CHCH2Cl), 3.68 (1H, dd, J 
= 10.5 Hz, J = 10.5 Hz, CHCHaHbCl), 4.00-4.21 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 4.47 (1H, 
ddd, J = 17.1 Hz, J = 6.9 Hz, 4JHP = 1.9 Hz, NCHaHb), 7.35-7.47 (3H, m, 3x CHar), 7.62-7.65 (4H, m, 4x 
CHar), 8.14-8.18 (2H, m, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.4 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.5 (d, 
3JCP = 5.8 Hz, OCH2CH3), 44.3 (CHCH2Cl), 48.5 (CHCH2Cl), 63.3 (d, 
3JCP = 10.4 Hz, NCH2), 64.5 (d, 
2JCP = 
6.9 Hz, OCH2CH3), 64.7 (d, 
2JCP = 6.9 Hz, OCH2CH3), 71.3 (d, 
1JCP = 165.0 Hz, PCq), 126.6 (2x CHar), 127.2 
(2x CHar), 127.9 (CHar), 129.0 (3x CHar), 129.9 (CHar), 131.5 (Cq,ar), 140.3 (Cq,ar), 143.3 (Cq,ar), 168.5 (d, 
2JCP = 2.3 Hz, C=N).
31P-NMR (121 MHz, CDCl3) δ 17.27.IR (ATR, cm
-1) νmax: 1014 (P-O), 1043 (P-O), 
1263 (P=O), 1602, 2980. MS (ESI, pos): m/z (%) 440.3/442.3/444.3 (M+H+, 100/64/10). HRMS: m/z 
calcd for C21H24Cl2NO3P+H
+ 440.0944, found 440.0949. Chromatography: hexanes/EtOAc 7/3, Rf = 
0.29. 
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diethyl (cis-4-chloro-3-(chloromethyl)-5-(3-methoxyphenyl)-3,4-dihydro-2H-pyrrol-4-
yl)phosphonate 26i 
2.11 g (5.35 mmol) of 25i was converted into 26i (dr = 93/7). After column 
chromatography 1.27 g of product was obtained (3.21 mmol, 60 % yield, brown 
oil). 1H-NMR (300 MHz, CDCl3) δ 1.21 (3H, t, J = 7.2 Hz, OCH2CH3), 1.29 (3H, t, J = 
7.2 Hz, OCH2CH3), 3.24-3.36 (1H, m, CHCH2Cl), 3.66 (1H, dd, J = 10.5 Hz, J = 10.5 
Hz, CHCHaHbCl), 3.84 (3H, s, OCH3), 3.96-4.18 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 4.45 (1H, 
dd, J = 17.1 Hz, J = 7.2 Hz, NCHaHb), 6.99 (1H, d, J = 8.1 Hz, CHar), 7.30 (1H, dd, J = 8.1 Hz, J = 8.1 Hz, 
CHar), 7.63-7.66 (2H, m, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.4 (d, 
3JCP = 5.8 Hz, OCH2CH3), 44.2 (d, 
3JCP = 2.3 Hz, CHCH2Cl), 48.6 (CHCH2Cl), 55.4 (OCH3), 63.1 (d, 
3JCP = 
10.4 Hz, NCH2), 64.3 (d, 
2JCP = 10.4 Hz, OCH2CH3), 64.7 (d, 
2JCP = 10.4 Hz, OCH2CH3), 71.2 (d, 
1JCP = 165.0 
Hz, PCq), 114.1 (CHar), 117.0 (CHar), 121.7 (CHar), 129.0 (CHar), 133.8 (Cq,arC=N), 159.1 (Cq,arOCH3), 168.8 
(C=N). 31P-NMR (121 MHz, CDCl3) δ 17.21. IR (ATR, cm
-1) νmax: 1013 (P-O), 1263 (P=O), 1578, 2981. 
MS (ESI, pos): m/z (%) 394.3/396.3/398.3 (M+H+, 100/64/10). HRMS: m/z calcd for C16H22Cl2NO4P+H
+ 
394.0736, found 394.0732. Chromatography: hexanes/EtOAc 3/2, Rf = 0.29. 
diethyl (cis-4-chloro-3-(chloromethyl)-5-(4-nitrophenyl)-3,4-dihydro-2H-pyrrol-4-yl)phosphonate 
26j 
0.60 g (1.47 mmol) of 25j was converted into 26j (dr = 93/7). After one 
crystallisation 0.14 g of product was obtained (0.34 mmol, 23 % yield, orange 
needles). 1H-NMR (300 MHz, CDCl3) δ 1.22 (3H, t, J = 7.2 Hz, OCH2CH3), 1.32 
(3H, t, J = 7.2 Hz, OCH2CH3), 3.25-3.40 (1H, m, CHCH2Cl), 3.67 (1H, dd, J = 10.5 
Hz, J = 10.5 Hz, CHCHaHbCl), 3.97-4.25 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 4.50 (1H, dd, J = 
17.6 Hz, J = 7.2 Hz, NCHaHb), 8.25 (4H, s, 4x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, 
OCH2CH3), 16.5 (d, 
3JCP = 5.8 Hz, OCH2CH3), 43.9 (d, 
3JCP = 2.3 Hz, CHCH2Cl), 48.4 (CHCH2Cl), 63.6 (d, 
3JCP 
= 9.2 Hz, NCH2), 64.8 (d, 
2JCP = 6.9 Hz, 2x OCH2CH3), 71.1 (d, 
1JCP = 163.8 Hz, PCq), 123.0 (2x CHar), 130.5 
(2x CHar), 138.5 (Cq,arC=N), 149.0 (Cq,arNO2), 167.4 (C=N). 
31P-NMR (121 MHz, CDCl3) δ 16.59. IR (ATR, 
cm-1) νmax: 1011 (P-O), 1041 (P-O), 1266 (P=O), 1342 (N-O), 1518 (N-O), 1594, 2980. MS (ESI, pos): 
m/z (%) 409.0/411.0/413.0 (M+H+, 100/64/10). HRMS: m/z calcd for C15H19Cl2N2O5P+H
+ 409.0481, 
found 409.0483. Melting point range: 108.0-109.0 °C. Crystal data for compound 26j: 
C15H19N2O5PCl2, M = 409.19, monoclinic, space group P21/c (No. 14), a = 9.0945(13) Å, b = 11.1936(9) 
Å, c = 21.398(3) Å, β = 120.027(18)°, V = 1886.0(5) Å3, Z = 4, T = 293.15 K, calc = 1.441 g cm
-3, μ(Cu-Kα) 
= 4.154 mm-1, F(000) = 848, 6793 reflections measured, 3245 unique (Rint = 0.0624) which were used 
V. Experimental procedures 
138 
 
in all calculations. The final R1 was 0.0702 (I >2 (I)) and wR2 was 0.2166 (all data). One of the ethoxy 
groups was found to be disordered and was modeled over two positions.  
diethyl (cis-4-chloro-3-(chloromethyl)-5-(4-cyanophenyl)-3,4-dihydro-2H-pyrrol-4-yl)phosphonate 
26k 
0.85 g (2.18 mmol) of 25k was converted into 26k (dr = 95/5). After one 
crystallisation 0.12 g of product was obtained (0.31 mmol, 14 % yield, 
transparent cubic crystals). 1H-NMR (300 MHz, CDCl3) δ 1.21 (3H, t, J = 7.2 Hz, 
OCH2CH3), 1.32 (3H, t, J = 6.9 Hz, OCH2CH3), 3.24-3.37 (1H, m, NCH2CH), 3.66 
(1H, dd, J = 10.5 Hz, J = 10.5 Hz, CHCHaHbCl), 3.96-4.24 (6H, m, 2x OCH2CH3 + CHCHaHbCl + NCHaHb), 
4.48 (1H, dd, J = 17.6 Hz, J = 7.2 Hz, NCHaHb), 7.69 (2H, d, J = 8.3 Hz, 2x CHar), 8.19 (2H, d, J = 8.3 Hz, 2x 
CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.5 (d, 
3JCP = 4.6 Hz, OCH2CH3), 
44.0 (d, 3JCP = 2.3 Hz, CHCH2Cl), 48.4 (CHCH2Cl), 63.6 (d, 
3JCP = 9.2 Hz, NCH2), 64.8 (d, 
2JCP = 6.9 Hz, 2x 
OCH2CH3), 71.1 (d, 
1JCP = 166.1 Hz, PCq), 114.2 (Cq,ar C≡N), 118.5 (C≡N), 130.1 (2x CHar), 131.7 (2x CHar), 
136.7 (Cq,arC=N), 167.6 (C=N). 
31P-NMR (121 MHz, CDCl3) δ 16.67. IR (ATR, cm
-1) νmax: 1011 (P-O), 
1039 (P-O), 1266 (P=O), 2230 (C≡N), 2984. MS (ESI, pos): m/z (%) 389.0/391.0/393.0 (M+H+, 
100/64/10). HRMS: m/z calcd for C16H19Cl2N2O3P+H
+ 389.0583, found 389.0595. Melting point range: 
111.0-112.5 °C. Crystal data for compound 26k. C16H19N2O3PCl2, M = 389.20, monoclinic, space group 
P21/c (No. 14), a = 9.6158(4) Å, b = 11.3767(5) Å, c = 17.5776(7) Å, β = 98.092(4)°, V = 1903.78(14) Å
3, 
Z = 4, T = 293.15 K, calc = 1.358 g cm
-3, μ(Cu-Kα) = 4.007 mm-1, F(000) = 808, 7893 reflections 
measured, 3369 unique (Rint = 0.0326) which were used in all calculations. The final R1 was 0.0452 (I 
>2 (I)) and wR2 was 0.1342 (all data). Both of the ethoxy groups were found to be disordered and 
were modeled over two positions. 
3.1.5 Synthesis of diethyl (3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonates 326 
and 330 
In a round-bottom flame-dried flask and under a N2-atmosphere, diethyl (cis-4-chloro-3-
(chloromethyl)-3,4-dihydro-2H-pyrrol-4-yl)phosphonates 26a-k were dissolved in dry THF (1 M). The 
solution was cooled to -78 °C and n-BuLi (1.2 equiv, however for 26k 2.2 equiv was used) was added 
in a dropwise fashion. The reaction mixture was kept at -78 °C for 2 h and was then slowly warmed to 
room temperature. Water was added and the solution was extracted with diethyl ether (3x 10 mL). 
After drying the combined organic layers over MgSO4, the solvent was removed in vacuo and the 
residue was purified using column chromatography. 
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diethyl (2-phenyl-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 326b 
2.50 g (6.86 mmol) of 26b was converted into 326b. After column chromatography 
1.53 g of product was obtained (5.21 mmol, 76 % yield, brown oil). 1H-NMR (300 
MHz, CDCl3) δ 0.84-0.90 (1H, ~q, PCqCHaHb), 1.17 (3H, t, J = 7.2 Hz, OCH2CH3), 1.20 
(3H, t, J = 7.2 Hz, OCH2CH3), 1.76 (1H, ddd, 
3JHP = 14.6 Hz, J = 8.5 Hz, J = 4.7 Hz, 
PCqCHaHb), 2.58-2.69 (1H, m, NCH2CH), 3.91-4.03 (4H, m, 2x OCH2CH3), 4.10 (2H, ~t, NCH2), 7.37-7.44 
(3H, m, 3x CHar), 7.91 (2H, d, J = 6.6 Hz, 2x CHar).
 13C-NMR (75 MHz, CDCl3) δ 16.2 (d, 
3JCP = 4.6 Hz, 
OCH2CH3), 16.3 (d, 
3JCP = 5.8 Hz, OCH2CH3), 19.2 (PCqCH2), 28.7 (NCH2CH), 34.0 (d, 
1JCP = 199.6 Hz, PCq), 
61.3 (d, 3JCP = 3.5 Hz, NCH2), 62.2 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.4 (d, 
2JCP = 6.9 Hz, OCH2CH3), 128.0 (2x 
CHar), 128.7 (2x CHar), 130.5 (CHar), 134.1 (Cq,ar), 173.1 (d, 
2JCP = 8.1 Hz, C=N). 
31P-NMR (121 MHz, 
CDCl3) δ 22.91. IR (ATR, cm
-1) νmax: 1022 (P-O), 1049 (P-O), 1247 (P=O), 1596, 2982. MS (ESI, pos): 
m/z (%) 294.3/295.3 (M+H+, 100/16). HRMS: m/z calcd for C15H20NO3P+H
+ 294.1254, found 294.1264. 
Chromatography: EtOAc, Rf = 0.06. 
diethyl (2-(4-fluorophenyl)-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 326c 
0.18 g (0.47 mmol) of 26c was converted into 326c. After column chromatography 
72 mg of product was obtained (0.23 mmol, 49 % yield, brown oil). 1H-NMR (300 
MHz, CDCl3) δ 0.83-0.89 (1H, m, PCCHaHb), 1.18 (3H, t, J = 7.5 Hz, OCH2CH3) 1.21 (3H, 
t, J = 7.5 Hz, OCH2CH3), 1.75 (1H, ddd, 
3JHP = 14.5 Hz, J = 8.4 Hz, J = 4.3 Hz, PCCHaHb), 
2.54-2.69 (1H, m, NCH2CH), 3.93-4.05 (4H, m, 2x OCH2CH3), 4.08 (2H, ~t, NCH2), 7.09 (2H, dd, J = 8.8 
Hz, 3JFH = 8.8 Hz, 2x CHar), 7.94 (2H, dd, J = 8.8 Hz, 
4JHF = 5.5 Hz, 2x CHar).
13C-NMR (75 MHz, CDCl3) δ 
16.3 (d, 3JCP = 5.2 Hz, OCH2CH3), 16.3 (d, 
3JCP = 5.2 Hz, OCH2CH3), 19.2 (PCCH2), 28.9 (NCH2CH), 33.9 (d, 
1JCP = 200.8 Hz, PCq), 61.2 (d, 
3JCP = 3.5 Hz, NCH2), 62.3 (d, 
2JCP = 6 Hz, OCH2CH3), 62.5 (d, 
2JCP = 6 Hz, 
OCH2CH3), 115.1 (d, 
2JCF = 21.9 Hz, 2x CHar), 130.3 (d, 
4JCF = 2.3 Hz, Cq,arC=N), 130.9 (d, 
3JCF = 8.1 Hz, 2x 
CHar), 164.3 (d, 
1JCF = 250.4 Hz, Cq,arF), 172.0 (d, 
2JCP = 8.1 Hz, C=N). 
19F-NMR (282 MHz, CDCl3) δ -
109.92 to -109.82 (m).31P-NMR (121 MHz, CDCl3) δ 22.83. IR (ATR, cm
-1) νmax: 1019 (P-O), 1047 (P-O), 
1229 (P=O), 1510, 2984. MS (ESI, pos): m/z (%) 312.3/313.3 (M+H+, 100/17). HRMS: m/z calcd for 
C15H19FNO3P+H
+ 312.1159, found 312.1165. Chromatography: EtOAc, Rf = 0.09.  
diethyl (2-(4-chlorophenyl)-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 326d 
0.15 g (0.38 mmol) of 26d was converted into 326d. After column chromatography 
41 mg of product was obtained (0.13 mmol, 33 % yield, brown oil). 1H-NMR (300 
MHz, CDCl3) δ 0.81-0.88 (1H, m, PCCHaHb), 1.18 (3H, t, J = 7.2 Hz, OCH2CH3), 1.22 
(3H, t, J = 7.2 Hz, OCH2CH3), 1.75 (1H, ddd, 
3JHP = 14.5 Hz, J = 8.4 Hz, J = 4.4 Hz, 
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PCCHaHb), 2.58-2.69 (1H, m, NCH2CH), 3.93-4.05 (4H, m, 2x OCH2CH3), 4.09 (2H, ~t, NCH2), 7.38 (2H, d, 
J = 8.5 Hz, 2x CHar), 7.87 (2H, d, J = 8.5 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, 
OCH2CH3), 16.4 (d, 
3JCP = 5.8 Hz, OCH2CH3), 19.2 (PCCH2), 28.9 (NCH2CH), 33.9 (d, 
1JCP = 199.6 Hz, PCq), 
61.3 (d, 3JCP = 3.5 Hz, NCH2), 62.4 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.6 (d, 
2JCP = 5.8 Hz, OCH2CH3), 128.3 (2x 
CHar), 130.2 (2x CHar), 132.5 (Cq,arC=N), 136.7 (Cq,arCl), 172.1 (d, 
2JCP = 8.1 Hz, C=N). 
31P-NMR (121 MHz, 
CDCl3) δ 22.74. IR (ATR, cm
-1) νmax: 1020 (P-O), 1048 (P-O), 1247 (P=O), 1596, 2984. MS (ESI, pos): 
m/z (%) 328.3/329.3/330.3 (M+H+, 100/17/32). HRMS: m/z calcd for C15H19ClNO3P+H
+ 328.0864, 
found 328.0868. Chromatography: EtOAc, Rf = 0.09. 
diethyl (2-(4-methoxyphenyl)-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 326f 
1.13 g (2.87 mmol) of 26f was converted into 326f. After column chromatography 
0.47 g of product was obtained (1.46 mmol, 51 % yield, brown oil). 1H-NMR (300 
MHz, CDCl3) δ 0.81-0.87 (1H, m, PCCHaHb), 1.20 (6H, t, J = 7.5 Hz, 2x OCH2CH3), 
1.74 (1H, ddd, 3JHP = 14.6 Hz, J = 8.5 Hz, J = 4.4 Hz, PCCHaHb), 2.56-2.66 (1H, m, 
NCH2CH), 3.84 (3H, s, OCH3), 3.93-4.03 (4H, m, 2x OCH2CH3), 4.06 (2H, m, NCH2), 6.91 (2H, d, J = 8.8 
Hz, 2x CHar), 7.91 (2H, d, J = 8.8 Hz, 2x CHar).
13C-NMR (75 MHz, CDCl3) δ 15.9 (d, 
3JCP = 4.6 Hz, 
OCH2CH3), 16.0 (d, 
3JCP = 4.6 Hz, OCH2CH3), 18.7 (PCCH2), 28.5 (NCH2CH), 33.4 (d, 
1JCP = 199.6 Hz, PCq), 
54.9 (OCH3), 60.5 (d, 
3JCP = 3.5 Hz, NCH2), 61.8 (d, 
2JCP = 6.9 Hz, OCH2CH3), 62.1 (d, 
2JCP = 6.9 Hz, 
OCH2CH3), 113.0 (2x CHar), 126.5 (Cq,arC=N), 130.2 (2x CHar), 161.2 (Cq,arOCH3), 171.8 (d, 
2JCP = 6.9 Hz, 
C=N). 31P-NMR (121 MHz, CDCl3) δ 23.26. IR (ATR, cm
-1) νmax: 1018 (P-O), 1174 (P-O), 1249 (P=O), 
1514, 1607, 2918, 3429. MS (ESI, pos): m/z (%) 324.3/325.3 (M+H+, 100/17). HRMS: m/z calcd for 
C16H22NO4P+H
+ 324.1359, found 324.1359. Chromatography: EtOAc, Rf = 0.08. 
diethyl (2-(4-methylphenyl)-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 326g 
2.70 g (7.14 mmol) of 26g was converted into 326g. After column chromatography 
1.18 g of product was obtained (3.86 mmol, 54 % yield, brown oil). 1H-NMR (300 
MHz, CDCl3) δ 0.83-0.88 (1H, m, PCCHaHb), 1.14-1.26 (6H, m, 2x OCH2CH3), 1.74 
(1H, ddd, 3JHP = 14.3 Hz, J = 8.3 Hz, J = 4.4 Hz , PCCHaHb), 2.38 (3H, s, CH3), 2.61 (1H, 
m, NCH2CH), 3.92-4.04 (4H, m, 2x OCH2CH3), 4.04-4.12 (2H, m, NCH2), 7.20 (2H, d, J = 8.0 Hz, 2x CHar), 
7.82 (2H, d, J = 8.0 Hz, 2x CHar).
13C-NMR (75 MHz, CDCl3) δ 16.2 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.3 (d, 
3JCP = 5.8 Hz, OCH2CH3), 19.2 (PCCH2), 21.5 (CH3), 28.7 (NCH2CH), 33.9 (d, 
1JCP = 201.9 Hz, PCq), 61.1 (d, 
3JCP = 3.5 Hz, NCH2CH), 62.2 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.4 (d, 
2JCP = 5.8 Hz, OCH2CH3), 128.7 (4x 
CHar), 131.3 (Cq,arC=N), 140.7 (Cq,arCH3), 173.0 (d, 
2JCP = 8.1 Hz, C=N).
31P-NMR (121 MHz, CDCl3) δ 
23.18. IR (ATR, cm-1) νmax: 1024 (P-O), 1050 (P-O), 1248 (P=O), 1594, 2922. MS (ESI, pos): m/z (%) 
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308.3/309.3 (M+H+, 100/18). HRMS: m/z calcd for C16H22NO3P+H
+ 308.1410, found 308.1411. 
Chromatography: EtOAc, Rf = 0.09. 
diethyl (2-([1,1'-biphenyl]-4-yl)-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 326h 
1.84 g (4.18 mmol) of 26h was converted into 326h. After column 
chromatography 0.56 g of product was obtained (1.50 mmol, 30 % yield, brown 
oil). 1H-NMR (300 MHz, CDCl3) δ 0.85-0.92 (1H, ~q, PCCHaHb), 1.21 (6H, t, J = 7.6 
Hz, 2x OCH2CH3), 1.78 (1H, ddd, 
3JHP = 14.2 Hz, J = 8.9 Hz, J = 4.8 Hz, PCCHaHb ), 
2.58-2.71 (1H, m, NCH2CH), 3.95-4.07 (4H, m, 2x OCH2CH3), 4.10-4.13 (2H, ~t, NCH2), 7.34-7.38 (1H, 
m, CHar), 7.45 (2H, dd, J = 7.3 Hz, J = 7.3 Hz, 2x CHar), 7.64 (4H, d, J = 8.3 Hz, 4x CHar), 8.01 (2H, d, J = 
7.3 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.4 (d, 
3JCP = 5.8 Hz, 
OCH2CH3), 19.3 (PCCH2), 28.8 (NCH2CH), 33.9 (d, 
1JCP = 199.6 Hz, PCq), 61.3 (d, 
3JCP = 3.5 Hz, NCH2), 
62.3 (d, 2JCP = 5.8 Hz, OCH2CH3), 62.5 (d, 
2JCP = 5.8 Hz, OCH2CH3), 126.7 (2x CHar), 127.2 (2x CHar), 127.8 
(CHar), 128.9 (2x CHar), 129.3 (2x CHar), 133.0 (Cq,ar), 140.5 (Cq,ar), 143.2 (Cq,ar), 172.8 (d, 
2JCP = 8.1 Hz, 
C=N). 31P-NMR (121 MHz, CDCl3) δ 23.02. IR (ATR, cm
-1) νmax: 1021 (P-O), 1045 (P-O), 1246 (P=O), 
1594, 2982. MS (ESI, pos): m/z (%) 370.3/371.3 (M+H+, 100/23). HRMS: m/z calcd for C21H24NO3P+H
+ 
370.1567, found 370.1563. Chromatography: EtOAc, Rf = 0.10. 
diethyl (2-(3-methoxyphenyl)-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 326i 
1.72 g (4.36 mmol) of 26i was converted into 326i. After column chromatography 
1.01 g of product was obtained (3.14 mmol, 72 % yield, brown oil). 1H-NMR (300 
MHz, CDCl3) δ 0.86 (1H, ~q, PCCHaHb), 1.18 (3H, t, J = 7.3 Hz, OCH2CH3), 1.20 (3H, t, J 
= 7.3 Hz, OCH2CH3), 1.75 (1H, ddd, 
3JHP = 14.7 Hz, J = 8.4 Hz, J = 4.3 Hz, PCCHaHb), 
2.57-2.69 (1H, m, NCH2CH), 3.86 (3H, s, OCH3), 3.93-4.04 (4H, m, 2x OCH2CH3), 4.08 
(2H, ~t, NCH2), 6.99 (1H, dd, J = 8.1 Hz, J = 2.8 Hz, CHar), 7.31 (1H, dd, J = 8.1 Hz, J = 8.1 Hz, CHar), 7.48-
7.54 (2H, m, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, 2x OCH2CH3), 19.2 (PCCH2), 
28.9 (NCH2CH), 34.0 (d, 
1JCP = 200.8 Hz, PCq), 55.4 (OCH3), 61.3 (d, 
3JCP = 3.5 Hz, NCH2), 62.2 (d, 
2JCP = 
6.9 Hz, OCH2CH3), 62.5 (d, 
2JCP = 6.9 Hz, OCH2CH3), 113.3 (CHar), 117.1 (CHar), 121.3 (CHar), 129.0 (CHar), 
135.3 (Cq,arC=N), 152.3 (Cq,arOCH3), 173.0 (d, 
2JCP = 6.9 Hz, C=N). 
31P-NMR (121 MHz, CDCl3) δ 22.97. IR 
(ATR, cm-1) νmax: 1018 (P-O), 1238 (P=O), 1327, 1575, 2981. MS (ESI, pos): m/z (%) 324.3/325.3 
(M+H+, 100/16). HRMS: m/z calcd for C16H22NO4P+H
+ 324.1359, found 324.1361. Chromatography: 
EtOAc, Rf = 0.18. 
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diethyl (2-(4-nitrophenyl)-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 326j 
0.38 g (0.94 mmol) of 26j was converted into 326j. After column chromatography 
64 mg of product was obtained (0.19 mmol, 20 % yield, brown oil). 1H-NMR (300 
MHz, CDCl3) δ 0.87-0.93 (1H, m, PCCHaHb), 1.19 (3H, t, J = 6.9 Hz, OCH2CH3), 1.23 
(3H, t, J = 7.2 Hz, OCH2CH3), 1.80 (1H, ddd, 
3JHP = 13.9 Hz, J = 8.1 Hz, J = 4.3 Hz, 
PCCHaHb), 2.69 (1H, m, NCH2CH), 3.95-4.08 (4H, m, 2x OCH2CH3), 4.16 (2H, ~t, NCH2), 8.10 (2H, d, J = 
8.5 Hz, 2x CHar), 8.27 (2H, d, J = 8.5 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 16.3 (d, 
3JCP = 5.8 Hz, 
OCH2CH3), 16.4 (d, 
3JCP = 6.9 Hz, OCH2CH3), 19.3 (PCCH2), 29.0 (NCH2CH), 34.1 (d, 
1JCP = 201.9 Hz, PCq), 
61.9 (NCH2), 62.5 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.7 (d, 
2JCP = 5.8 Hz, OCH2CH3), 123.3 (2x CHar), 129.8 
(2x CHar), 139.9 (Cq,arC=N), 150.0 (Cq,arNO2), 171.5 (d, 
2JCP = 9.2 Hz, C=N). 
31P-NMR (121 MHz, CDCl3) δ 
22.17. IR (ATR, cm-1) νmax: 1018 (P-O), 1047 (P-O), 1248 (P=O), 1325 (N-O), 1519 (N-O), 1586, 2983. 
MS (ESI, pos): m/z (%) 339.3/340.3 (M+H+, 100/16). HRMS: m/z calcd for C15H19N2O5P+H
+ 339.1104, 
found 339.1114. Chromatography: EtOAc, Rf = 0.21. 
diethyl (2-(4-pentanoylphenyl)-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonate 330k 
0.44 g (1.13 mmol) of 26k was converted into 330k. After column 
chromatography 0.15 g of product was obtained (0.41 mmol, 36 % yield, 
brown oil). 1H-NMR (300 MHz, CDCl3) δ 0.86-0.92 (1H, m, PCCHaHb), 0.96 
(3H, t, J = 7.4 Hz, CH3), 1.17 (3H, t, J = 7.3 Hz, OCH2CH3), 1.21 (3H, t, J = 7.3 
Hz, OCH2CH3), 1.41 (2H, sext, J = 7.4 Hz, C(O)CH2CH2CH2CH3), 1.73 (2H, quint, J = 7.4 Hz, 
C(O)CH2CH2CH2CH3), 1.78-1.83 (1H, m, PCCHaHb), 2.61-2.71 (1H, m, NCH2CH), 2.99 (2H, t, J = 7.4 Hz, 
C(O)CH2CH2CH2CH3), 3.92-4.05 (4H, m, 2x OCH2CH3), 4.14 (2H, d, J = 3.9 Hz, NCH2), 7.99 (4H, s, 4x 
CHar). 
13C-NMR (75 MHz, CDCl3) δ 14.0 (CH3), 16.3 (d, 
3JCP = 6.9 Hz, OCH2CH3), 16.4 (d, 
3JCP = 6.9 Hz, 
OCH2CH3), 19.2 (PCCH2), 22.5 (CH2), 26.4 (CH2), 28.9 (NCH2CH), 34.1 (d, 
1JCP = 200.8 Hz, PCq), 38.6 
(CH2), 61.7 (d, 
3JCP = 3.5 Hz, NCH2), 62.4 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.6 (d, 
2JCP = 5.8 Hz, 
OCH2CH3),127.8 (2x CHar), 129.0 (2x CHar), 138.1 (Cq,arC=N), 138.3 (Cq,arNO2), 172.5 (d, 
2JCP = 9.2 Hz, 
C=N), 200.3 (C=O). 31P-NMR (121 MHz, CDCl3) δ 22.56. IR (ATR, cm
-1) νmax: 1024 (P-O), 1249 (P=O), 
1684 (C=O), 2931. MS (ESI, pos): m/z (%) 378.3/379.3 (M+H+, 100/16). HRMS: m/z calcd for 
C20H28NO4P+H
+ 378.1829, found 378.1835. Chromatography: EtOAc, Rf = 0.16. 
3.1.6 Synthesis of diethyl (2-phenyl-3-azabicyclo[3.1.0]hexan- 
1-yl)phosphonates 326 
Diethyl (2-phenyl-3-azabicyclo[3.1.0]hex-2-en-1-yl)phosphonates 326b-d,f-j and 330k were dissolved 
in MeOH (1 M) in a round-bottom flask. Then NaCNBH3 (1.05 equiv) and HOAc (1.05 equiv) were 
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added. The reaction progress was monitored using HPLC. After all starting material had been 
consumed, the reaction mixture was poured into aqueous NaHCO3 and extracted with diethyl ether 
(3x 10 mL). The combined organic layers were dried over MgSO4 and concentrated in vacuo. All 
compounds were obtained in a dr of ≥ 99/1. 
diethyl ((1S*,2S*,5R*)-2-phenyl-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331b 
87 mg (0.32 mmol) of 326b was converted into 331b. 79 mg of product was obtained 
(0.27 mmol, 84 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.00 (3H, t, J = 7.2 
Hz, OCH2CH3), 1.19-1.32 (3H, t, J = 7.2 Hz, OCH2CH3, 2H, m, PCCH2), 1.97-2.06 (1H, m, 
NHCH2CH), 2.09 (1H, br s, NH), 3.16 (2H, s, NHCH2), 3.64-4.05 (4H, m, 2x OCH2CH3), 
4.52 (1H, d, 3JHP = 3.9 Hz, NHCHCP), 7.27-7.34 (3H, m, 3x CHar), 7.48 (2H, d, J = 6.6 Hz, 2x CHar). 
13C-
NMR (75 MHz, CDCl3) δ 8.6 (PCCH2), 16.1 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.5 (d, 
3JCP = 5.8 Hz, OCH2CH3), 
24.8 (NCH2CH), 25.8 (d, 
1JCP = 198.5 Hz, PCq), 47.7 (d, 
3JCP = 3.5 Hz, NHCH2), 61.7 (d, 
2JCP = 5.8 Hz, 
OCH2CH3), 61.9 (d, 
2JCP = 6.9 Hz, OCH2CH3), 63.0 (d, 
2JCP = 10.4 Hz, NHCHCP), 127.9 (CHar), 128.0 (2x 
CHar), 128.2 (2x CHar), 139.6 (Cq,ar). 
31P-NMR (121 MHz, CDCl3) δ 28.51. IR (ATR, cm
-1) νmax: 1019 (P-O), 
1056 (P-O), 1234 (P=O), 1366, 2981, 3310. MS (ESI, pos): m/z (%) 296.3/297.3 (M+H+, 100/16). 
HRMS: m/z calcd for C15H22NO3P+H
+ 296.1410, found 296.1416. 
diethyl ((1S*,2S*,5R*)-2-(4-fluorophenyl)-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331c 
0.48 g (1.53 mmol) of 326c was converted into 331c. 0.36 g of product was obtained 
(1.13 mmol, 74 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.02 (3H, t, J = 7.2 
Hz, OCH2CH3), 1.23-1.30 (3H, t, J = 7.2 Hz, OCH2CH3, 2H, m, PCCH2), 1.89-2.01 (1H, m, 
NHCH2CH), 2.43 (1H, br s, NH), 3.11 (2H, br s, NHCH2), 3.66-4.04 (4H, m, 2x 
OCH2CH3), 4.47 (1H, d, 
3JHP = 4.4 Hz, NCHCP), 6.98 (2H, dd, J = 8.6 Hz,
3JHF = 8.6 Hz, 2x CHar), 7.45 (2H, 
dd, J = 8.6 Hz, 4JHF = 5.5, 2x CHar).
13C-NMR (75 MHz, CDCl3) δ 8.0 (PCCH2), 15.9 (d, 
3JCP = 6.9 Hz, 
OCH2CH3), 16.3 (d, 
3JCP = 6.9 Hz, OCH2CH3), 24.6 (NCH2CH), 25.7 (d, J = 198.5 Hz, PCq), 47.3 (d, 
3JCP = 
3.5 Hz, NHCH2), 61.5 (d, 
2JCP = 6.9 Hz, OCH2CH3), 61.7 (d, 
2JCP = 6.9 Hz, OCH2CH3), 61.9 (d, 
2JCP = 10.4 Hz, 
NHCHCP), 114.6 (d, 2JCF = 21.9 Hz, 2x CHar), 129.4 (d, 
3JCF = 8.1 Hz, 2x CHar), 135.6 (d, 
4JCF = 2.3 Hz, Cq,ar), 
162.2 (d, 1JCF = 245.8 Hz, Cq,arF). 
19F-NMR (282 MHz, CDCl3) δ -115.20 to -115.11 (m). 
31P-NMR (121 
MHz, CDCl3) δ 28.42. IR (ATR, cm
-1) νmax: 1021 (P-O), 1058 (P-O), 1231 (P=O), 1508, 2982. MS (ESI, 
pos): m/z (%) 314.3/315.3 (M+H+, 100/17). HRMS: m/z calcd for C15H21FNO3P+H
+ 314.1316, found 
314.1325 
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diethyl ((1S*,2S*,5R*)-2-(4-chlorophenyl)-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331d 
0.20 g (0.61 mmol) of 326d was converted into 331d. 0.17 g of product was 
obtained (0.52 mmol, 85 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.05 (3H, 
d, J = 7.2 Hz, OCH2CH3), 1.11-1.29 (3H, m, OCH2CH3, 2H, m, PCCH2), 2.00 (1H, m, 
NHCH2CH), 2.53 (1H, br s, NH), 3.15 (2H, br s, NHCH2), 3.72-4.05 (4H, m, 2x 
OCH2CH3), 4.49 (1H, d, 
3JHP = 3.9 Hz, NHCHCP), 7.27-7.31 (2H, m, 2x CHar), 7.41-7.44 (2H, m, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 8.4 (PCCH2), 16.1 (d, 
3JCP = 5.8 Hz, OCH2CH3), 16.5 (d, 
3JCP = 5.8 Hz, 
OCH2CH3), 24.8 (NCH2CH) 25.7 (d, 
1JCP = 198.5 Hz, PCq), 47.5 (NHCH2), 61.8 (d, 
2JCP = 5.8 Hz, OCH2CH3), 
62.0 (d, 2JCP = 5.8 Hz, OCH2CH3), 62.1 (d, 
2JCP = 11.5 Hz, NHCHCP), 128.2 (2x CHar), 129.4 (2x CHar), 
133.4 (Cq,ar), 138.3 (Cq,arCl). 
31P-NMR (121 MHz, CDCl3) δ 28.32. IR (ATR, cm
-1) νmax: 1014 (P-O), 1021 
(P-O), 1232 (P=O), 1491, 2924, 3423. MS (ESI, pos): m/z (%) 330.3/331.3/332.3 (M+H+, 100/17/32). 
HRMS: m/z calcd for C15H21ClNO3P+H
+ 330.1021, found 330.1024. 
diethyl ((1S*,2S*,5R*)-2-(4-methoxyphenyl)-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331f:  
87 mg (0.27 mmol) of 326f was converted into 331f. 81 mg of product was 
obtained (0.25 mmol, 92 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.03 
(3H, t, J = 7.2 Hz, OCH2CH3), 1.19-1.33 (3H, t, J = 7.2 Hz, OCH2CH3, 2H, m, PCCH2), 
1.96-2.04 (1H, m, NHCH2CH), 3.15 (2H, NHCH2), 3.71-4.09 (4H, m, 2x OCH2CH3), 
3.80 (3H, s, OCH3), 4.52 (1H, d, 
3JHP = 4.4 Hz, NHCHCP), 6.86 (2H, d, J = 8.3 Hz, 2x CHar), 7.41 (2H, d, J = 
8.3 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 8.6 (PCCH2), 16.1 (d, 
3JCP = 6.9 Hz, OCH2CH3), 16.5 (d, 
3JCP 
= 6.9 Hz, OCH2CH3), 24.3 (NHCH2CH), 25.5 (d, 
1JCP = 198.5 Hz, PCq), 47.3 (NHCH2), 55.3 (OCH3), 61.8 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.1 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.5 (d, 
2JCP = 11.5 Hz, NHCHCP), 113.6 (2x 
CHar), 129.2 (2x CHar), 130.6 (Cq,ar), 159.4 (Cq,arOCH3). 
31P-NMR (121 MHz, CDCl3) δ 27.95. IR (ATR, cm
-
1) νmax: 1019 (P-O), 1177(P-O), 1249 (P=O), 1514, 1607, 2918, 3429. MS (ESI, pos): m/z (%) 
326.3/327.3 (M+H+, 100/18). HRMS: m/z calcd for C16H24NO4P+H
+ 326.1516, found 326.1521. 
diethyl ((1S*,2S*,5R*)-2-(4-methylphenyl)-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331g 
75 mg (0.24 mmol) of 326g was converted into 331g. 47 mg of product was 
obtained (0.15 mmol, 63 % yield, yellow oil). 1H-NMR (300 MHz, CDCl3) δ 1.03 (3H, 
t, J = 6.9 Hz, OCH2CH3), 1.21-1.30 (3H, t, J = 7.2 Hz, OCH2CH3, 2H, m, PCCH2), 1.91-
2.21 (2H, m, NHCH2CH + NH), 2.33 (3H, s, CH3), 3.15 (2H, br s, NHCH2), 3.67-4.05 
(4H, m, 2x OCH2CH3), 4.50 (1H, d, 
3JHP = 3.9 Hz, NHCHCP), 7.12 (2H, d, J = 8.0 Hz, 2x CHar), 7.36 (2H, d, J 
= 8.0 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 8.5 (PCCH2), 16.1 (d, 
3JCP = 6.9 Hz, OCH2CH3), 16.5 (d, 
3JCP = 6.9 Hz, OCH2CH3), 21.2 (CH3), 24.9 (NHCH2CH), 25.7 (d, 
1JCP = 197.3 Hz, PCq), 47.7 (d, 
3JCP = 3.5 Hz, 
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NHCH2), 61.7 (d, 
2JCP = 6.9 Hz, OCH2CH3), 61.9 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.8 (d, 
2JCP = 10.4 Hz, 
NHCHCP), 127.8 (2x CHar), 128.9 (2x CHar), 136.4 (Cq,arCHN), 137.5 (Cq,arCH3). 
31P-NMR (121 MHz, 
CDCl3) δ 28.62. IR (ATR, cm
-1) νmax: 1020 (P-O), 1177 (P-O), 1236 (P=O), 1443, 2978. MS (ESI, pos): 
m/z (%) 310.3/311.3 (M+H+, 100/18). HRMS: m/z calcd for C16H24NO3P+H
+ 310.1567, found 310.1569. 
diethyl ((1S*,2S*,5R*)-2-([1,1'-biphenyl]-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331h 
0.12 g (0.32 mmol) of 326h was converted into 331h. 0.11 g of product was 
obtained (0.30 mmol, 91 % yield, pale yellow solid). 1H-NMR (300 MHz, CDCl3) 
δ 1.03 (3H, t, J = 7.2 Hz, OCH2CH3), 1.21-1.34 (3H, t, J = 7.2 Hz, OCH2CH3, 2H, m, 
PCCH2), 1.76 (1H, br s, NH), 1.99-2.09 (1H, m, NHCH2CH), 3.19 (2H, d, J = 1.7 Hz, 
NHCH2), 3.73-4.14 (4H, m, 2x OCH2CH3), 4.58 (1H, d, 
3JHP = 4.4 Hz, NHCHCP), 7.21-7.26 (1H, m, CHar), 
7.32-7.37 (1H, m, CHar), 7.42-7.47 (2H, m, 2x CHar), 7.56 (2H, s, 2x CHar), 7.56-7.60 (3H, m, 3x CHar). 
13C-NMR (75 MHz, CDCl3) δ 8.5 (PCCH2), 16.1 (d, 
3JCP = 6.9 Hz, OCH2CH3), 16.5 (d, 
3JCP = 5.8 Hz, 
OCH2CH3), 24.9 (NHCH2CH), 25.9 (d, 
1JCP = 198.5 Hz, PCq), 47.7 (d, 
3JCP = 3.5 Hz, NHCH2), 61.8 (d, 
2JCP = 
5.8 Hz, OCH2CH3), 62.0 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.7 (d, 
2JCP = 10.4 Hz, NCHCP), 126.9 (2x CHar), 
127.1 (2x CHar), 127.4 (CHar), 128.4 (2x CHar), 128.9 (2x CHar), 138.9 (Cq,ar), 140.7 (Cq,ar), 141.0 (Cq,ar). 
31P-NMR (121 MHz, CDCl3) δ 28.59. IR (ATR, cm
-1) νmax: 1017 (P-O), 1052 (P-O), 1233 (P=O), 1484, 
2982. MS (ESI, pos): m/z (%) 372.3/373.3 (M+H+, 100/23). HRMS: m/z calcd for C21H26NO3P+H
+ 
372.1723, found 372.1718. 
diethyl ((1S*,2S*,5R*)-2-(3-methoxyphenyl)-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331i 
88 mg (0.27 mmol) of 326i was converted into 331i. After column chromatography 
26 mg of product was obtained (0.08 mmol, 30 % yield, yellow oil). 1H-NMR (300 
MHz, CDCl3) δ 1.04 (3H, t, J = 7.3 Hz, OCH2CH3), 1.19-1.29 (3H, t, J = 7.3 Hz, OCH2CH3, 
2H, m, PCCH2), 1.96-2.02 (1H, m, NHCH2CH), 2.04 (1H, br s, NH), 3.16 (2H, s, NHCH2), 
3.69-4.16 (4H, m, 2x OCH2CH3), 3.81 (3H, s, OCH3), 4.51 (1H, d, 
3JCP = 4.4 Hz, NHCHCP), 6.82 (1H, dd, J 
= 7.5 Hz, J = 4.5 Hz, CHar), 7.05-7.09 (2H, m, 2x CHar), 7.23 (1H, dd, J = 7.5 Hz, J = 7.3 Hz, CHar). 
13C-
NMR (75 MHz, CDCl3) δ 8.6 (PCCH2), 16.1 (d, 
3JCP = 6.9 Hz, OCH2CH3), 16.5 (d, 
3JCP = 5.8 Hz, OCH2CH3), 
25.0 (NHCH2CH), 25.7 (d, 
1JCP = 197.3 Hz, PCq), 47.7 (d, 
3JCP = 3.5 Hz, NHCH2), 55.3 (OCH3), 61.7 (d, 
2JCP 
= 6.9 Hz, OCH2CH3), 61.9 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.9 (d, 
2JCP = 10.4 Hz, NHCHCP), 113.2 (CHar), 
113.7 (CHar), 120.2 (CHar), 129.1 (CHar), 141.3 (Cq,arCHN), 159.5 (Cq,arCH3). 
31P-NMR (121 MHz, CDCl3) δ 
28.53. IR (ATR, cm-1) νmax: 1020 (P-O), 1232 (P=O), 1438, 1602, 2981, 3308. MS (ESI, pos): m/z (%) 
326.3/327.3 (M+H+, 100/17). HRMS: m/z calcd for C16H24NO4P+H
+ 326.1516, found 326.1512. 
Chromatography: EtOAc, Rf = 0.08. 
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diethyl ((1S*,2S*,5R*)-2-(4-nitrophenyl)-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331j 
70 mg (0.21 mmol) of 326j was converted into 331j. After column 
chromatography 58 mg of product was obtained (0.17 mmol, 81 % yield, yellow 
oil). 1H-NMR (300 MHz, CDCl3) δ 1.06 (3H, t, J = 7.2 Hz, OCH2CH3), 1.13-1.21 (2H, 
m, PCCH2), 1.28 (3H, t, J = 7.2 Hz, OCH2CH3), 1.85 (1H, br s, NH), 2.03-2.11 (1H, m, 
NHCH2CH), 3.22 (2H, s, NHCH2), 3.74-4.09 (4H, m, 2x OCH2CH3), 4.63 (1H, d, 
3JHP = 4.4 Hz, NHCHCP), 
7.69 (2H, d, J = 8.8 Hz, 2x CHar), 8.18 (2H, d, J = 8.8 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 8.5 
(PCCH2), 16.2 (d, 
3JCP = 6.9 Hz, OCH2CH3), 16.5 (d, 
3JCP = 6.9 Hz, OCH2CH3), 25.0 (NHCH2CH), 26.1 (d, 
1JCP 
= 200.8 Hz, PCq), 47.4 (d, 
3JCP = 3.5 Hz, NHCH2), 61.9 (d, 
2JCP = 6.9 Hz, OCH2CH3), 62.0 (NHCHCP), 62.1 
(d, 2JCP = 6.9 Hz, OCH2CH3), 123.3 (2x CHar), 129.0 (2x CHar), 147.6 (Cq,arCHN), 147.9 (Cq,arNO2). 
31P-NMR 
(121 MHz, CDCl3) δ 27.72. IR (ATR, cm
-1) νmax: 1023 (P-O), 1238 (P=O), 1347 (N-O), 1520 (N-O), 2982, 
3303. MS (ESI, pos): m/z (%) 341.3/342.3 (M+H+, 100/17). HRMS: m/z calcd for C15H21N2O5P+H
+ 
341.1261, found 341.1265. Chromatography: EtOAc, Rf = 0.07. 
diethyl ((1S*,2S*,5R*)-2-(4-pentanoylphenyl)-3-azabicyclo[3.1.0]hexan-1-yl)phosphonate 331k 
51 mg (0.14 mmol) of 330k was converted into 331k. After column 
chromatography 32 mg of product was obtained (0.08 mmol, 60 % yield, 
yellow oil). 1H-NMR (300 MHz, CDCl3) δ 0.95 (3H, t, J = 7.5 Hz, CH3), 1.02 
(3H, t, J = 7.0 Hz, OCH2CH3), 1.17-1.29 (3H, t, J = 7.0 Hz, OCH2CH3, 2H, m, 
PCCH2), 1.41 (2H, sext, J = 7.5 Hz, C(O)CH2CH2CH2CH3), 1.71 (2H, quint, J = 7.5 Hz, C(O)CH2CH2CH2CH3), 
1.85 (1H, br s, NH), 1.99-2.09 (1H, NHCH2CH), 2.95 (2H, t, J = 7.5 Hz, C(O)CH2CH2CH2CH3), 3.19 (2H, s, 
NHCH2), 3.69-4.07 (4H, m, 2x OCH2CH3), 4.57 (1H, d, 
3JHP = 4.4 Hz, NHCHCP), 7.58 (2H, d, J = 8.0 Hz, 2x 
CHar), 7.91 (2H, d, J = 8.0 Hz, 2x CHar). 
13C-NMR (75 MHz, CDCl3) δ 8.5 (PCCH2), 14.0 (CH3), 16.1 (d, 
3JCP 
= 5.8 Hz, OCH2CH3), 16.5 (d, 
3JCP = 6.9 Hz, OCH2CH3), 22.6 (CH2), 24.9 (NHCH2CH), 25.9 (d, 
1JCP = 199.6 
Hz, PCq), 26.7 (CH2), 38.5 (CH2), 47.6 (d, 
3JCP = 3.5 Hz, NHCH2), 61.8 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.0 (d, 
2JCP = 5.8 Hz, OCH2CH3), 62.5 (d, 
2JCP = 11.5 Hz, NHCHCP), 128.0 (2x CHar), 128.2 (2x CHar), 136.6 
(Cq,arCHN), 145.2 (Cq,arC=0), 200.5 (C=O). 
31P-NMR (121 MHz, CDCl3) δ 28.14. IR (ATR, cm
-1) νmax: 1025 
(P-O), 1238 (P=O), 1681 (C=O), 2931, 3308. MS (ESI, pos): m/z (%) 380.3/381.3 (M+H+, 100/17). 
HRMS: m/z calcd for C20H30NO4P+H
+ 380.1985, found 380.1978. Chromatography: EtOAc, Rf = 0.06. 
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3.2 Preparation of tetrasubstituted 3-phosphonopyrroles 
through hydroamination: scope and limitations  
3.2.1 Synthesis of diethyl (Z)-(2-aminovinyl)phosphonates 322b,341a-f and 
diethyl (2-iminoethyl)phosphonates 323b,342a-f 
Diethyl (2-oxoethyl)phosphonates 29a-c,f were dissolved in toluene (1 M) in a round-bottom flask 
equipped with a Dean-Stark apparatus. An appropriate primary amine (1.2 equiv) and p-TsOH 
monohydrate (0.05 equiv) were added and the reaction mixture was heated to reflux temperature 
and left overnight. The reaction progress was monitored using gas chromatography. After all starting 
material had been consumed, the solvent was removed in vacuo and the residue was redissolved in 
diethyl ether and washed with aqueous NaHCO3. The organic phase was extracted with diethyl ether 
(3x 20 mL), dried over MgSO4 and concentrated in vacuo. 
3.2.2 Synthesis of diethyl (Z)-(1-aminopent-1-en-4-yn-2-yl)phosphonates 344 
In a flame-dried round-bottom flask, enaminophosphonates 322b,341a-f and 
iminoethylphosphonates 323b,342a-f were dissolved in dry THF (0.5 M) and placed under an inert 
N2-atmosphere. The solution was cooled to -78 °C before adding LiHMDS (1.2 equiv) and was kept 
stirring at -78 °C for one hour. Next, a propargyl bromide solution in toluene (1.2 equiv) was added in 
a dropwise fashion and the reaction mixture was allowed to warm to 20 °C. Reaction progress was 
monitored using HPLC. If no further conversion was observed, additional LiHMDS and propargyl 
bromide were added until no more starting material was present. Water was added and the solution 
was extracted using diethyl ether (3x 20 mL). After drying the combined organic layers over MgSO4, 
the solvent was removed in vacuo and the residue was purified using column chromatography. E/Z 
mixtures were obtained but only the peaks of the major isomers (Z-form) were assigned. 
diethyl (Z)-(1-(benzylamino)-1-phenylpent-1-en-4-yn-2-yl)phosphonate 344a 
317 mg (0.92 mmol) of 341a/342a was converted into 344a. After column 
chromatography, 144 mg of 344a was obtained in a E/Z ratio of 1/9 (0.38 
mmol, 41% yield, brown oil). 1H-NMR (300 MHz, CDCl3)  1.36 (6H, t, J = 7.2 Hz, 
2x OCH2CH3), 1.84 (1H, t, J = 2.2 Hz, C≡CH), 2.62 (2H, dd, 
3JHP = 16.5 Hz, J = 2.2 
Hz, PCqCH2), 3.91 (2H, d, J = 6.5 Hz, NHCH2), 4.11 (4H, dd, 
3JHP = 8.3 Hz, J = 7.2 
Hz, 2x OCH2CH3), 7.08-7.10 (2H, m, 2x CHar), 7.19-7.26 (4H, m, 4x CHar), 7.36-7.43 (4H, m, 4x CHar), 
8.30 (1H, t, J = 6.5 Hz, NH). 13C-NMR (75 MHz, CDCl3)  16.4 (d, 
3JCP = 6.9 Hz, 2x OCH2CH3), 18.6 (d, 
2JCP 
= 10.4 Hz, PCqCH2), 48.6 (NCH2), 61.3 (d, 
2JCP = 4.6 Hz, 2x OCH2CH3), 67.0 (C≡CH), 81.8 (d, 
1JCP = 184.6 
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Hz, PCq), 84.8 (C≡CH), 126.9 (CHar), 127.1 (2x CHar), 128.4 (2x CHar), 128.5 (4x CHar), 128.9 (CHar), 134.8 
(d, 3JCP = 17.3 Hz, Cq,ar), 140.1 (Cq,ar), 165.0 (d, 
2JCP = 13.9 Hz, CqN). 
31P-NMR (121 MHz, CDCl3)  27.31. 
IR (ATR, cm-1) νmax: 1021 (P-O), 1050 (P-O), 1205 (P=O), 1589, 1606, 2113, 2980, 3288. MS (ESI, pos): 
m/z (%) 384.2/385.2 (M+H+, 100/25). HRMS: m/z calcd for C22H26NO3P+H
+ 384.1723, found 384.1734. 
Chromatography: hexanes/EtOAc 7/3, Rf = 0.26. 
diethyl (Z)-(1-(benzylamino)-1-(4-fluorophenyl)pent-1-en-4-yn-2-yl)phosphonate 344b 
1.12 g (3.08 mmol) of 341b/342b was converted into 344b. After column 
chromatography, 0.46 g of 344b was obtained in a E/Z ratio of 1/9 (1.14 
mmol, 37% yield, yellow oil). 1H-NMR (400 MHz, CDCl3)  1.36 (6H, td, J = 7.1 
Hz, 4JHP = 0.4 Hz, 2x OCH2CH3), 1.85 (1H, t, J = 2.6 Hz, C≡CH), 2.61 (2H, dd, 
3JHP 
= 16.4 Hz, J = 2.6 Hz, PCqCH2), 3.91 (2H, d, J = 6.6 Hz, NHCH2), 4.06-4.15 (4H, 
m, 2x OCH2CH3), 7.04-7.09 (4H, m, 4x CHar), 7.19-7.26 (5H, m, 5x CHar), 8.32 (1H, t, J = 6.6 Hz, NH). 
13C-
NMR (100 MHz, CDCl3)  16.3 (d, 
3JCP = 7.0 Hz, 2x OCH2CH3), 18.4 (d, 
2JCP = 9.5 Hz, PCqCH2), 48.4 
(NHCH2), 61.3 (d, 
2JCP = 4.4 Hz, 2x OCH2CH3), 67.2 (C≡CH), 82.7 (d, 
1JCP = 186.2 Hz, PCq), 84.5 (d, 
3JCP = 
1.5 Hz, C≡CH), 115.5 (d, 2JCF = 21.7 Hz, 2x CHar), 126.89 (CHar), 126.94 (2x CHar), 128.4 (2x CHar), 130.4 
(d, 3JCF = 8.1 Hz, 2x CHar), 130.6 (dd, 
3JCP = 18.1 Hz, 
4JCF = 3.2 Hz, Cq,ar), 139.9 (Cq,ar), 162.8 (d, 
1JCF = 248.3 
Hz, Cq,arF), 163.9 (d, 
2JCP = 12.9 Hz, CqN). 
19F-NMR (376 MHz, CDCl3)  -112.06 to -111,99 (multiplet). 
31P-NMR (162 MHz, CDCl3)  26.23. IR (ATR, cm
-1) νmax: 1022 (P-O), 1050 (P-O), 1205 (P=O), 1589, 
1607, 2113, 2981, 3283. MS (ESI, pos): m/z (%) 402.1/403.1 (M+H+, 100/23). HRMS: m/z calcd for 
C22H25FNO3P+H
+ 402.1629, found 402.1628. Chromatography: hexanes/EtOAc 7/3, Rf = 0.29. 
diethyl (Z)-(1-(benzylamino)-1-(4-methoxyphenyl)pent-1-en-4-yn-2-yl)phosphonate 344c 
1.0 g (2.67 mmol) of 341c/342c was converted into 344c. After column 
chromatography, 0.47 g of 344c was obtained in a E/Z ratio of 1/9 (1.14 
mmol, 43% yield, yellow oil). 1H-NMR (400 MHz, CDCl3)  1.35 (6H, td, J = 
7.2 Hz, 4JHP = 0.4 Hz, 2x OCH2CH3), 1.86 (1H, t, J = 2.6 Hz, C≡CH), 2.66 (2H, 
dd, 3JHP = 16.5 Hz, J = 2.6 Hz, PCqCH2), 3.84 (3H, s, OCH3), 3.93 (2H, d, J = 
6.5 Hz, NHCH2), 4.10 (4H, dq, 
3JHP = 9.4 Hz, J = 7.2 Hz, 2x OCH2CH3), 6.83-6.92 (2H, m, 2x CHar), 7.09-
7.25 (7H, m, 7x CHar), 8.26 (1H, t, J = 6.5 Hz, NH). 
13C-NMR (100 MHz, CDCl3)  16.3 (d, 
3JCP = 7.1 Hz, 2x 
OCH2CH3), 18.6 (d, 
2JCP = 9.2 Hz, PCqCH2), 48.5 (NHCH2), 55.1 (OCH3), 61.1 (d, 
2JCP = 4.3 Hz, 2x 
OCH2CH3), 67.1 (C≡CH), 82.1 (d, 
1JCP = 185.6 Hz, PCq), 84.9 (d, 
3JCP = 1.2 Hz, C≡CH), 113.8 (2x CHar), 
126.8 (CHar), 126.8 (d, 
3JCP = 17.7 Hz, Cq,ar), 127.0 (2x CHar), 128.3 (2x CHar), 129.8 (2x CHar), 140.1 
(Cq,ar), 159.9 (Cq,arOCH3), 164.9 (d, 
2JCP = 12.8 Hz, CqN). 
31P-NMR (162 MHz, CDCl3)  26.82. IR (ATR, 
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cm-1) νmax: 1022 (P-O), 1050 (P-O), 1248 (P=O), 1592, 1610, 1712, 2116, 2980, 3287. MS (ESI, pos): 
m/z (%) 414.2/415.2 (M+H+, 100/23). HRMS: m/z calcd for C23H28NO4P+H
+ 414.1829, found 414.1842. 
Chromatography: hexanes/EtOAc 7/3, Rf = 0.21. 
diethyl (Z)-(1-(allylamino)-1-phenylpent-1-en-4-yn-2-yl)phosphonate 344e 
300 mg (1.02 mmol) of 322b/323b was converted into 344e. After column 
chromatography, 71 mg of 344e was obtained in a E/Z ratio of 1/9 (0.21 mmol, 
21% yield, brown oil). 1H-NMR (300 MHz, CDCl3)  1.37 (6H, t, J = 7.2 Hz, 2x 
OCH2CH3), 1.86 (1H, t, J = 2.3 Hz, C≡CH), 2.61 (2H, dd, 
3JHP = 16.5 Hz, J = 2.3 Hz, 
PCqCH2), 3.32 (2H, dd, J = 6.1 Hz, J = 5.0 Hz, NHCH2), 4.14 (4H, dq, 
3JHP = 7.2 Hz, J 
= 7.2 Hz, 2x OCH2CH3), 5.03 (1H, dd, J = 9.9 Hz, J = 1.1 Hz, CH=CHEHZ), 5.13 (1H, dd, J = 17.1 Hz, J = 1.4 
Hz, CH=CHEHZ), 5.68 (1H, ddt, J = 17.1 Hz, J = 9.9 Hz, J = 5.0 Hz, CH=CHEHZ), 7.29-7.33 (2H, m, 2x CHar), 
7.40-7.41 (3H, m, 3x CHar), 7.96 (1H, t, J = 6.1 Hz, NH). 
13C-NMR (75 MHz, CDCl3)  16.3 (d, 
3JCP = 6.9 
Hz, 2x OCH2CH3), 18.5 (d, 
2JCP = 10.4 Hz, PCqCH2), 46.9 (NCH2), 61.3 (d, 
2JCP = 4.6 Hz, 2x OCH2CH3), 66.9 
(C≡CH), 80.6 (d, 1JCP = 188.0 Hz, PCq), 84.9 (C≡CH), 115.3 (CH=CH2), 128.3 (2x CHar), 128.5 (2x CHar), 
128.8 (CHar), 134.8 (d, 
3JCP = 17.3 Hz, Cq,ar), 136.1 (CH=CH2), 165.0 (d, 
2JCP = 12.7 Hz, CqN). 
31P-NMR 
(121 MHz, CDCl3) , 27.47. IR (ATR, cm
-1) νmax: 1021 (P-O), 1050 (P-O), 1204 (P=O), 1587, 1607, 2114, 
2981, 3288. MS (ESI, pos): m/z (%) 334.3/335.3 (M+H+, 100/25). HRMS: m/z calcd for C18H24NO3P+H
+ 
334.1567, found 334.1574. Chromatography: hexanes/EtOAc 7/3, Rf = 0.20. 
diethyl (Z)-(1-(butylamino)-1-phenylpent-1-en-4-yn-2-yl)phosphonate 344f 
418 mg (1.34 mmol) of 341e/342e was converted into 344f. After column 
chromatography, 224 mg of 344f was obtained in a E/Z ratio of 1/9 (0.64 mmol, 
48% yield, brown oil). 1H-NMR (300 MHz, CDCl3)  0.71 (3H, t, J = 7.2 Hz, CH3), 
1.12-1.22 (2H, m, CH2), 1.25-1.30 (8H, m, 2x OCH2CH3 + CH2), 1.78 (1H, t, J = 2.8 
Hz, C≡CH), 2.51 (2H, dd, 3JHP = 16.5 Hz, J = 2.8 Hz, PCqCH2), 2.60 (2H, td, J = 6.6 
Hz, J = 6.1 Hz, NHCH2), 4.04 (4H, dq, 
3JHP = 8.6 Hz, J = 7.2 Hz, 2x OCH2CH3), 7.21-7.25 (2H, m, 2x CHar), 
7.29-7.36 (3H, m, 3x CHar), 7.38 (1H, t, J = 6.1 Hz, NH). 
13C-NMR (75 MHz, CDCl3)  13.7 (CH3), 16.3 (d, 
3JCP = 6.9 Hz, 2x OCH2CH3), 18.3 (d, 
2JCP = 10.4 Hz, PCqCH2), 19.8 (CH2), 33.0 (CH2), 44.4 (NCH2), 61.1 (d, 
2JCP = 4.6 Hz, 2x OCH2CH3), 66.8 (C≡CH), 79.2 (d, 
1JCP = 188.1 Hz, PCq), 85.0 (C≡CH), 128.2 (2x CHar), 
128.4 (2x CHar), 128.6 (CHar), 135.2 (d, 
3JCP = 17.3 Hz, Cq,ar), 165.3 (d, 
2JCP = 12.7 Hz, CqN). 
31P-NMR (121 
MHz, CDCl3)  27.88. IR (ATR, cm
-1) νmax: 1022 (P-O), 1052 (P-O), 1203 (P=O), 1588, 1607, 2176, 2932, 
3283. MS (ESI, pos): m/z (%) 350.3/351.3 (M+H+, 100/25). HRMS: m/z calcd for C19H28NO3P+H
+ 
350.1880, found 350.1878. Chromatography: hexanes/EtOAc 8/2, Rf = 0.16. 
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diethyl (Z)-(1-phenyl-1-(phenylamino)pent-1-en-4-yn-2-yl)phosphonate 344g 
495 mg (1.50 mmol) of 341f/342f was converted into 344g. After column 
chromatography, 172 mg of 344g was obtained in a E/Z ratio of 1/9 (0.47 
mmol, 31% yield, yellow oil). 1H-NMR (300 MHz, CDCl3)  1.37 (6H, td, J = 7.2 
Hz, 4JHP = 1.1 Hz, 2x OCH2CH3), 2.01 (1H, t, J = 2.8 Hz, C≡CH), 2.85 (2H, dd, 
3JHP = 
16.5 Hz, J = 2.8 Hz, PCqCH2), 4.18 (4H, dq, 
3JHP = 8.3 Hz, J = 7.2 Hz, 2x OCH2CH3), 
6.51 (2H, d, J = 8.5 Hz, 2x CHar), 6.64 (1H, d, J = 8.5 Hz, CHar), 6.73-6.79 (1H, m, CHar), 6.96 (2H, dd, J = 
7.2 Hz, 2x CHar), 7.30-7.33 (2H, m, 2x CHar), 7.42-7.45 (2H, m, 2x CHar), 9.82 (1H, br s, NH). 
13C-NMR 
(75 MHz, CDCl3)  16.4 (d, 
3JCP = 6.9 Hz, 2x OCH2CH3), 18.8 (d, 
2JCP = 8.1 Hz, PCqCH2), 61.8 (d, 
2JCP = 4.6 
Hz, 2x OCH2CH3), 68.1 (C≡CH), 84.5 (C≡CH), 88.7 (d, 
1JCP = 182.3 Hz, PCq), 121.2 (2x CHar), 121.9 (CHar), 
128.9 (4x CHar), 129.2 (CHar), 129.5 (2x CHar), 134.9 (d, 
3JCP = 17.3 Hz, Cq,ar), 141.5 (Cq,ar), 159.0 (d, 
2JCP = 
10.4 Hz, CqN). 
31P-NMR (121 MHz, CDCl3)  25.65. IR (ATR, cm
-1) νmax: 1020 (P-O), 1049 (P-O), 1242 
(P=O), 1496, 1576, 1595, 2116, 2980, 3283. MS (ESI, pos): m/z (%) 370.3/371.3 (M+H+, 100/23). 
HRMS: m/z calcd for C21H24NO3P+H
+ 370.1567, found 370.1566. Chromatography: hexanes/EtOAc 
8/2, Rf = 0.22. 
diethyl (Z)-(1-(benzylamino)-1-phenylhex-1-en-4-yn-2-yl)phosphonate 344h 
0.70 g (2.03 mmol) of 341a/342a was converted into 344h. After column 
chromatography, 0.37 g of 344h was obtained in a E/Z ratio of 1/4 (0.93 mmol, 
46% yield, yellow oil). 1H-NMR (400 MHz, CDCl3)  1.36 (6H, td, J = 7.1 Hz, 
4JHP = 
0.4 Hz, 2x OCH2CH3), 1.70 (3H, t, J = 2.5 Hz, CH3), 2.56 (2H, dq, 
3JHP = 16.8 Hz, J = 
2.5 Hz, PCqCH2), 3.90 (2H, d, J = 6.5 Hz, NHCH2), 4.10 (4H, dq, 
3JHP = 10.2 Hz, J = 
7.1 Hz, 2x OCH2CH3), 7.08-7.11 (2H, m, 2x CHar), 7.19-7.25 (4H, m, 4x CHar), 7.34-7.38 (4H, m, 4x CHar), 
8.25 (1H, t, J = 6.5 Hz, NH). 13C-NMR (100 MHz, CDCl3)  3.6 (CH3), 16.3 (d, 
3JCP = 7.1 Hz, 2x OCH2CH3), 
18.6 (d, 2JCP = 9.5 Hz, PCqCH2), 48.5 (NHCH2), 61.2 (d, 
2JCP = 4.3 Hz, 2x OCH2CH3), 73.9 (C≡CCH3), 79.4 
(d, 3JCP = 1.9 Hz, C≡CCH3), 82.9 (d, 
1JCP = 184.3 Hz, PCq), 126.8 (CHar), 127.0 (2x CHar), 128.3 (4x CHar), 
128.5 (2x CHar), 128.7 (CHar), 134.9 (d, 
3JCP = 17.9 Hz, Cq,ar), 140.1 (Cq,ar), 164.6 (d, 
2JCP = 12.9 Hz, CqN). 
31P-NMR (162 MHz, CDCl3)  27.17. IR (ATR, cm
-1) νmax: 1022 (P-O), 1051 (P-O), 1204 (P=O), 1590, 
1606, 2238, 2918, 3266. MS (ESI, pos): m/z (%) 398.2/399.2 (M+H+, 100/23). HRMS: m/z calcd for 
C23H28NO3P+H
+ 398.1880, found 398.1887. Chromatography: hexanes/EtOAc 8/2, Rf = 0.29. 
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diethyl (Z)-(1-(benzylamino)-5-(naphthalen-1-yl)-1-phenylpent-1-en-4-yn-2-yl)phosphonate 344i 
0.70 g (2.03 mmol) of 341a/342a was converted into 344i. After column 
chromatography, 0.39 g of 344i was obtained in a E/Z ratio of 1/9 (0.77 
mmol, 38% yield, pale yellow oil). 1H-NMR (400 MHz, CDCl3)  1.34 (6H, t, J 
= 7.1 Hz, 2x OCH2CH3), 3.00 (2H, d, 
3JHP = 16.4 Hz, PCqCH2), 3.95 (2H, d, J = 
6.4 Hz, NHCH2), 4.16 (4H, dq, 
3JHP = 7.2 Hz, J = 7.1 Hz, 2x OCH2CH3), 7.10-7.12 
(2H, m, 2x CHar), 7.17-7.20 (1H, m, CHar), 7.23-7.25 (1H, m, CHar), 7.32-7.37 
(3H, m, 3x CHar), 7.38-7.42 (4H, m, 4x CHar), 7.49-7.53 (3H, m, 3x CHar), 7.76 (1H, d, J = 8.3 Hz, CHar), 
7.82-7.84 (1H, m, CHar), 8.21-8.24 (1H, m, CHar), 8.36 (1H, t, J = 6.4 Hz, NH). 
13C-NMR (100 MHz, 
CDCl3)  16.5 (d, 
3JCP = 7.0 Hz, 2x OCH2CH3), 19.8 (d, 
2JCP = 9.7 Hz, PCqCH2), 48.6 (NHCH2), 61.5 (d, 
2JCP = 
4.4 Hz, 2x OCH2CH3), 77.4 (C≡CAr), 82.2 (d, 
1JCP = 186.1 Hz, PCq), 95.8 (d, 
3JCP = 1.6 Hz, C≡CAr), 122.1 
(Cq,ar), 125.4 (CHar), 126.35 (CHar), 126.43 (CHar), 126.5 (CHar), 127.0 (CHar), 127.1 (2x CHar), 127.9 
(CHar), 128.3 (CHar), 128.5 (4x CHar), 128.61 (CHar), 128.62 (CHar), 129.0 (CHar), 129.8 (CHar), 133.3 
(Cq,ar),  133.7 (Cq,ar), 134.9 (d, 
3JCP = 17.8 Hz, Cq,ar), 140.2 (Cq,ar), 165.2 (d, 
2JCP = 12.7 Hz, CqN). 
31P-NMR 
(162 MHz, CDCl3)  26.96. IR (ATR, cm
-1) νmax: 1022 (P-O), 1049 (P-O), 1205 (P=O), 1588, 1606, 2231, 
2924, 3273. MS (ESI, pos): m/z (%) 510.2/511.2 (M+H+, 100/30). HRMS: m/z calcd for C32H32NO3P+H
+ 
510.2193, found 510.2182. Chromatography: hexanes/EtOAc 8/2, Rf = 0.16. 
diethyl (Z)-(1-(benzylamino)-1-phenyl-5-(trimethylsilyl)pent-1-en-4-yn-2-yl)phosphonate 344j 
0.70 g (2.03 mmol) of 341a/342a was converted into 344j. After column 
chromatography, 0.42 g of 344j was obtained in a E/Z ratio of 1/9 (0.91 mmol, 
45% yield, yellow oil). However, 344j and its bis-propargylated product 345 
constitute a chromatographically inseparable mixture. As a consequence, 20% 
of bis-propargylated product is present (31P-NMR (162 MHz, CDCl3)  25.61 
ppm). Spectral data are reported for 339j only. 1H-NMR (400 MHz, CDCl3)  
0.10 (9H, s, SiMe3), 1.36 (6H, td, J = 7.1 Hz, 
4JHP = 0.3 Hz, 2x OCH2CH3), 2.63 (2H, d, J = 16.3 Hz, 
PCqCH2), 3.91 (2H, d, J = 6.5 Hz, NHCH2), 4.11 (4H, dq, 
3JHP = 7.4 Hz, J = 7.1 Hz, 2x OCH2CH3), 7.09-7.11 
(2H, m, 2x CHar), 7.19-7.30 (4H, m, 4x CHar), 7.33-7.38 (4H, m, 4x CHar), 8.28 (1H, t, J = 6.5 Hz, NH). 
13C-
NMR (100 MHz, CDCl3)  0.1 (SiMe3), 16.4 (d, 
3JCP = 7.2 Hz, 2x OCH2CH3), 19.7 (d, 
2JCP = 9.7 Hz, 
PCqCH2), 48.5 (NHCH2), 61.2 (d, 
2JCP = 4.2 Hz, 2x OCH2CH3), 82.0 (d, 
1JCP = 185.7 Hz, PCq), 82.7 
(C≡CSiMe3), 87.1 (d, 
3JCP = 1.3 Hz, C≡CSiMe3), 126.8 (CHar), 127.0 (2x CHar), 127.6 (CHar), 128.1 (CHar), 
128.29 (CHar), 128.32 (2x CHar), 128.6 (CHar), 128.8 (CHar), 134.7 (d, 
3JCP = 17.7 Hz, Cq,ar), 140.1 (Cq,ar), 
165.1 (d, 2JCP = 12.7 Hz, CqN). 
31P-NMR (162 MHz, CDCl3)  26.83. IR (ATR, cm
-1) νmax: 1024 (P-O), 1051 
(P-O), 1248 (P=O), 1590, 1607, 2172, 2959, 3267. MS (ESI, pos): m/z (%) 456.2/457.2 (M+H+, 100/30). 
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HRMS: m/z calcd for C25H34NO3PSi+H
+ 456.2118, found 456.2121. Chromatography: hexanes/EtOAc 
7/3, Rf = 0.19. 
3.2.3 Synthesis of pyrroles 339 
Synthesis of pyrroles 339a-g. Propargylic enaminophosphonates 344a-g were dissolved in CH3CN (0.5 
M) in a round-bottom flask and 5 mol% of ZnCl2 was added. The reaction progress was monitored 
using HPLC. When all starting material had been consumed, the reaction mixture was filtered over a 
plug of silica (ca. 5 cm) to remove the catalyst. If necessary, column chromatography was performed.  
Synthesis of pyrroles 339h-i. Propargylic enaminophosphonates 344h-i were dissolved in dry CH3CN 
(0.5 M) in a round-bottom flask and 20 mol% of dried ZnCl2 (4 hours at 60 °C under a 1 mbar vacuum) 
was added. The mixture was then heated to reflux temperature. The reaction progress was 
monitored using HPLC. When all starting material had been consumed, the reaction mixture was 
filtered over a plug of silica (ca. 5 cm) to remove the catalyst. If necessary, column chromatography 
was performed. 
diethyl (1-benzyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)phosphonate 339a 
51 mg (0.13 mmol) of 344a was converted into 50 mg of 339a (0.13 mmol, 99% 
yield, yellow oil). 1H-NMR (300 MHz, CDCl3)  1.12 (6H, t, J = 6.9 Hz, 2x OCH2CH3), 
2.11 (3H, s, CH3), 3.81-4.03 (4H, m, 2x OCH2CH3), 4.96 (2H, s, NCH2), 6.40 (1H, d, 
3JHP = 4.4 Hz, CHar), 7.19-7.37 (10H, m, 10x CHar). 
13C-NMR (75 MHz, CDCl3)  12.5 
(CH3), 16.2 (d, 
3JCP = 6.9 Hz, 2x OCH2CH3), 47.9 (NCH2), 61.4 (d, 
2JCP = 5.8 Hz, 2x 
OCH2CH3), 106.5 (d, 
1JCP = 218.1 Hz, PCq), 111.7 (d, 
2JCP = 11.5 Hz, CHar), 125.7 (2x CHar), 127.3 (CHar), 
128.0 (2x CHar), 128.4 (CHar), 128.8 (2x CHar), 130.0 (d, 
3JCP = 15.0 Hz, Cq,arCH3), 130.8 (2x CHar), 131.9 
(Cq,ar), 137.9 (Cq,ar), 139.3 (d, 
2JCP = 23.1 Hz, Cq,arN). 
31P-NMR (121 MHz, CDCl3)  18.89. IR (ATR, cm
-1) 
νmax: 1024 (P-O), 1053 (P-O), 1227 (P=O), 1400, 1454, 2979. MS (ESI, pos): m/z (%) 384.3/385.3 
(M+H+, 100/15). HRMS: m/z calcd for C22H26NO3P+H
+ 384.1723, found 384.1719.  
diethyl (1-benzyl-2-(4-fluorophenyl)-5-methyl-1H-pyrrol-3-yl)phosphonate 339b 
100 mg (0.25 mmol) of 344b was converted into 97 mg of 339b (0.24 mmol, 
97% yield, yellow oil). 1H-NMR (400 MHz, CDCl3)  1.15 (6H, t, J = 7.1 Hz, 2x 
OCH2CH3), 2.12 (3H, s, CH3), 3.87-3.98 (4H, m, 2x OCH2CH3), 4.92 (2H, s, NCH2), 
6.39 (1H, d, 3JHP = 3.7 Hz, CHar), 6.81-6.83 (2H, m, 2x CHar), 6.79-7.02 (2H, m, 2x 
CHar), 7.21-7.30 (5H, m, 5x CHar). 
13C-NMR (100 MHz, CDCl3)  12.4 (CH3), 16.2 
(d, 3JCP = 6.9 Hz, 2x OCH2CH3), 47.8 (NCH2), 61.4 (d, 
2JCP = 5.8 Hz, 2x OCH2CH3), 106.7 (d, 
1JCP = 209.0 
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Hz, PCq), 111.5 (d, 
2JCP = 12.0 Hz, CHar), 114.9 (d, 
2JCF = 21.5 Hz, 2x CHar), 125.5 (2x CHar), 127.3 (CHar), 
127.7 (d, 4JCF = 3.44 Hz, Cq,ar), 128.8 (2x CHar), 130.1 (d, 
3JCP = 15.5 Hz, Cq,arCH3), 132.6 (d, 
3JCF = 8.5 Hz, 
2x CHar), 137.6 (Cq,ar), 138.1 (d, 
2JCP = 23.4 Hz, Cq,arN), 162.8 (d, 
1JCF = 248.1 Hz, Cq,arF).
 19F-NMR (376 
MHz, CDCl3)  -113.01. 
31P-NMR (162 MHz, CDCl3)  17.92. IR (ATR, cm
-1) νmax: 1025 (P-O), 1053 (P-
O), 1223 (P=O), 1392, 1480, 1529, 2981. MS (ESI, pos): m/z (%) 402.2/403.2 (M+H+, 100/25). HRMS: 
m/z calcd for C22H25FNO3P+H
+ 402.1629, found 402.1635. 
diethyl (1-benzyl-2-(4-methoxyphenyl)-5-methyl-1H-pyrrol-3-yl)phosphonate 339c 
98 mg (0.24 mmol) of 344c was converted into 339c. After preparative TLC, 
71 mg of 339c was obtained (0.17 mmol, 72% yield, yellow oil). 1H-NMR (400 
MHz, CDCl3)  1.15 (6H, td, J = 7.1 Hz, 
4JHP = 0.4 Hz, 2x OCH2CH3), 2.10 (3H, s, 
CH3), 3.79 (3H, s, OCH3), 3.83-4.02 (4H, m, 2x OCH2CH3), 4.94 (2H, s, NCH2), 
6.37 (1H, dq, 3JHP = 4.5 Hz, J = 0.9 Hz, CHar), 6.82-6.85 (4H, m, 4x CHar), 7.21-
7.28 (5H, m, 5x CHar).
 13C-NMR (100 MHz, CDCl3)  12.4 (CH3), 16.2 (d, 
3JCP = 7.2 Hz, 2x OCH2CH3), 47.7 
(NCH2), 55.2 (OCH3), 61.3 (d, 
2JCP = 5.3 Hz, 2x OCH2CH3), 106.1 (d, 
1JCP = 218.0 Hz, PCq), 111.4 (d, 
2JCP = 
11.9 Hz, CHar), 113.3 (2x CHar), 123.9 (Cq,ar), 125.6 (2x CHar), 127.2 (CHar), 128.7 (2x CHar), 129.7 (d, 
3JCP 
= 15.5 Hz, Cq,arCH3), 131.9 (2x CHar), 137.9 (Cq,ar), 139.2 (d, 
2JCP = 23.5 Hz, Cq,ar), 159.6 (Cq,arOCH3).
 31P-
NMR (162 MHz, CDCl3)  18.45. IR (ATR, cm
-1) νmax: 1025 (P-O), 1053 (P-O), 1245 (P=O), 1395, 1481, 
1531, 2979. MS (ESI, pos): m/z (%) 414.2/415.2 (M+H+, 100/25). HRMS: m/z calcd for C23H28NO4P+H
+ 
414.1829, found 414.1838. Chromatography: EtOAc, Rf = 0.50. 
diethyl (1-benzyl-2,5-dimethyl-1H-pyrrol-3-yl)phosphonate 339d 
100 mg of crude 344d was converted into 339d. After preparative TLC, 10 mg of 
339d was obtained (0.03 mmol, 10% yield over 2 steps, yellow oil). 1H-NMR (400 
MHz, CDCl3)  1.32 (6H, td, J = 7.1 Hz, 
4JHP = 0.4 Hz, 2x OCH2CH3), 2.11 (3H, br s, 
CH3), 2.37 (3H, d, 
4JHP = 1.8 Hz, CH3), 3.99-4.16 (4H, m, 2x OCH2CH3), 5.03 (2H, s, 
NCH2), 6.14 (1H, dq, 
3JHP = 4.2 Hz, J = 1.0 Hz, CHar), 6.86-6.88 (2H, m, 2x CHar), 
7.25-7.33 (3H, m, 3x CHar). 
13C-NMR (100 MHz, CDCl3)  11.6 (CH3), 12.2 (d, 
3JCP = 1.0 Hz, CH3), 16.4 (d, 
3JCP = 6.8 Hz, 2x OCH2CH3), 47.0 (d, 
4JCP = 1.5 Hz, NCH2), 61.3 (d, 
2JCP = 5.0 Hz, 2x OCH2CH3), 103.6 (d, 
1JCP = 216.9 Hz, PCq), 109.6 (d, 
2JCP = 11.9 Hz, CHar), 125.6 (2x CHar), 127.4 (CHar), 128.9 (2x CHar), 129.1 
(d, 3JCP = 15.3 Hz, Cq,arCH3), 136.3 (d, 
2JCP = 24.2 Hz, Cq,arCH3), 137.0 (Cq,ar).
 31P-NMR (162 MHz, CDCl3)  
19.77. IR (ATR, cm-1) νmax: 1025 (P-O), 1076 (P-O), 1230 (P=O), 1410, 1519, 2980. MS (ESI, pos): m/z 
(%) 322.1/323.1 (M+H+, 100/15). HRMS: m/z calcd for C17H24NO3P+H
+ 322.1567, found 322.1575. 
Chromatography: EtOAc, Rf = 0.47.  
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diethyl (1-allyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)phosphonate 339e 
80 mg (0.24 mmol) of 344e was converted into 71 mg of 339e (0.21 mmol, 89% 
yield, yellow oil). 1H-NMR (300 MHz, CDCl3)  1.10 (6H, t, J = 7.2 Hz, 2x OCH2CH3), 
2.23 (3H, s, CH3), 3.79-4.01 (4H, m, 2x OCH2CH3), 4.29 (2H, m, NCH2), 4.76 (1H, d, 
J = 16.8 Hz, CH=CHEHZ), 5.15 (1H, d, J = 10.6 Hz, CH=CHEHZ), 5.80 (1H, ddt, J = 16.8 
Hz, J = 10.6 Hz, J = 4.5 Hz, CH=CHEHZ), 6.36 (1H, d, 
3JHP = 4.4 Hz, CHar), 7.38 (5H, s, 5x CHar). 
13C-NMR 
(75 MHz, CDCl3)  12.2 (CH3), 16.2 (d, 
3JCP = 6.9 Hz, 2x OCH2CH3), 46.7 (NCH2), 61.5 (d, 
2JCP = 5.8 Hz, 2x 
OCH2CH3), 105.8 (d, 
1JCP = 219.2 Hz, PCq), 111.3 (d, 
2JCP = 11.5 Hz, CHar), 116.3 (CH=CH2), 127.9 (2x 
CHar), 128.5 (CHar), 129.9 (d, 
3JCP = 16.1 Hz, Cq,arCH3), 130.7 (2x CHar), 131.9 (Cq,ar), 133.9 (CH=CH2), 
138.9 (d, 2JCP = 24.2 Hz, Cq,ar). 
31P-NMR (121 MHz, CDCl3)  18.99. IR (ATR, cm
-1) νmax: 1024 (P-O), 1054 
(P-O), 1235 (P=O), 1399, 1475, 2979. MS (ESI, pos): m/z (%) 334.3/335.3 (M+H+, 100/17). HRMS: m/z 
calcd for C18H24NO3P+H
+ 334.1567, found 334.1566. 
diethyl (1-butyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)phosphonate 339f 
100 mg (0.29 mmol) of 344f was converted into 95 mg of 339f (0.27 mmol, 94 % 
yield, yellow oil). 1H-NMR (300 MHz, CDCl3)  0.74 (3H, t, J = 7.6 Hz, CH3), 1.07-
1.16 (8H, m, 2x OCH2CH3 + CH2), 1.45 (2H, quint, J = 7.6 Hz, CH2), 2.27 (3H, s, CH3), 
3.69 (2H, t, J = 7.6 Hz, NCH2), 3.78-4.01 (4H, m, 2x OCH2CH3), 6.32 (1H, d, 
3JHP = 
3.9 Hz, CHar), 7.38 (5H, s, 5x CHar). 
13C-NMR (75 MHz, CDCl3)  12.5 (CH3), 13.5 
(CH2CH3), 16.1 (d, 
3JCP = 6.9 Hz, 2x OCH2CH3), 19.8 (CH2), 32.9 (CH2), 44.2 (NCH2), 61.5 (d, 
2JCP = 4.6 Hz, 
2x OCH2CH3), 105.4 (d, 
1JCP = 218.1 Hz, PCq), 111.3 (d, 
2JCP = 12.7 Hz, CHar), 128.0 (2x CHar), 128.3 
(CHar), 129.3 (d, 
3JCP = 16.2 Hz, Cq,arCH3), 130.9 (2x CHar), 132.3 (Cq,ar), 138.7 (d, 
2JCP = 24.2 Hz, Cq,ar). 
31P-
NMR (121 MHz, CDCl3)  19.21. IR (ATR, cm
-1) νmax: 1024 (P-O), 1054 (P-O), 1227 (P=O), 1400, 1475, 
2931, 2959. MS (ESI, pos): m/z (%) 350.3/351.3 (M+H+, 100/13). HRMS: m/z calcd for C19H28NO3P+H
+ 
350.1880, found 350.1885. 
diethyl (5-methyl-1,2-diphenyl-1H-pyrrol-3-yl)phosphonate 339g 
75 mg (0.20 mmol) of 344g was converted into 68 mg of 339g (0.18 mmol, 91% 
yield, yellow oil). 1H-NMR (300 MHz, CDCl3)  1.12 (6H, t, J = 6.9 Hz, 2x OCH2CH3), 
2.10 (3H, s, CH3), 3.84-4.06 (4H, m, 4x OCH2CH3), 6.44 (1H, d, 
3JHP = 4.4 Hz, CHar), 
7.03-7.06 (2H, m, 2x CHar), 7.14-7.23 (5H, m, 5x CHar), 7.27-7.31 (3H, m, 3x CHar). 
13C-NMR (75 MHz, CDCl3)  13.1 (CH3), 16.2 (d, 
3JCP = 6.9 Hz, 2x OCH2CH3), 61.5 (d, 
2JCP = 5.8 Hz, 2x OCH2CH3), 106.9 (d, 
1JCP = 218.1 Hz, PCq), 111.7 (d, 
2JCP = 11.5 Hz, CHar), 127.48 (2x 
CHar), 127.54 (CHar), 128.0 (CHar), 128.5 (2x CHar), 129.0 (2x CHar), 130.9 (2x CHar), 131.2 (Cq,ar), 131.8 
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(Cq,ar), 138.1 (Cq,ar), 139.0 (d, 
2JCP = 24.2 Hz, Cq,ar).
 31P-NMR (121 MHz, CDCl3)  18.81. IR (ATR, cm
-1) 
νmax: 1023 (P-O), 1053 (P-O), 1238 (P=O), 1391, 1496, 2979. MS (ESI, pos): m/z (%) 370.1/371.2 
(M+H+, 100/18). HRMS: m/z calcd for C21H24NO3P+H
+ 370.1567, found 370.1570. 
diethyl (1-benzyl-5-ethyl-2-phenyl-1H-pyrrol-3-yl)phosphonate 339h 
140 mg (0.35 mmol) of 344h was converted into 339h. After preparative TLC, 
63 mg of 339h was obtained (0.16 mmol, 46% yield, yellow oil). 1H-NMR (400 
MHz, CDCl3)  1.11 (6H, td, J = 7.1 Hz, 
4JHP = 0.4 Hz, 2x OCH2CH3), 1.22 (3H, t, J = 
7.5 Hz, CH2CH3), 2.40 (2H, q, J = 7.5 Hz, CH2CH3), 3.82-4.01 (4H, m, 2x OCH2CH3), 
4.96 (2H, s, NCH2), 6.44 (1H, dt, 
3JHP = 4.7 Hz, J = 1.0 Hz, CHar), 6.83 (2H, d, J = 
8.0 Hz, 2x CHar), 7.22-7.27 (4H, m, 4x CHar), 7.29-7.33 (4H, m, 4x CHar). 
13C-NMR (100 MHz, CDCl3)  
12.0 (CH3), 16.1 (d, 
3JCP = 7.1 Hz, 2x OCH2CH3), 19.7 (CH2), 47.7 (NCH2), 61.3 (d, 
2JCP = 5.3 Hz, 2x 
OCH2CH3), 106.3 (d, 
1JCP = 218.1 Hz, PCq), 109.7 (d, 
2JCP = 12.3 Hz, CHar), 125.6 (2x CHar), 127.2 (CHar), 
127.9 (2x CHar), 128.4 (CHar), 128.7 (2x CHar), 130.8 (2x CHar), 131.7 (Cq,ar), 136.1 (d, 
3JCP = 15.0 Hz, 
Cq,arCH2), 137.9 (Cq,ar), 139.1 (d, 
2JCP = 23.2 Hz, Cq,ar). 
31P-NMR (162 MHz, CDCl3)  18.53. IR (ATR, cm
-1) 
νmax: 1023 (P-O), 1053 (P-O), 1229 (P=O), 1390, 2976. MS (ESI, pos): m/z (%) 398.2/399.2 (M+H
+, 
100/25). HRMS: m/z calcd for C23H28NO3P+H
+ 398.1880, found 398.1884. Chromatography: EtOAc, Rf 
= 0.55.  
diethyl (1-benzyl-5-(naphthalen-1-ylmethyl)-2-phenyl-1H-pyrrol-3-yl)phosphonate 339i 
0.30 g (0.59 mmol) of 344i was converted into 339i. After column 
chromatography, 0.11 g of 339i was obtained (0.22 mmol, 37% yield, 
yellow oil). 1H-NMR (400 MHz, CDCl3)  1.06 (6H, t, J = 6.8 Hz, 2x 
OCH2CH3), 3.78-3.96 (4H, m, 2x OCH2CH3), 4.16 (2H, s, CH2), 4.98 (2H, s, 
NCH2), 6.17 (1H, d, 
3JHP = 4.5 Hz, CHar), 6.87 (2H, d, J = 7.4 Hz, 2x CHar), 
7.17 (1H, d, J = 7.0 Hz, CHar), 7.25-7.47 (11H, m, 11x CHar), 7.69 (1H, d, J = 8.4 Hz, CHar), 7.75 (1H, d, J = 
8.2 Hz, CHar), 7.84 (1H, d, J = 8.1 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  16.1 (d, 
3JCP = 7.0 Hz, 2x 
OCH2CH3), 30.3 (CH2), 48.1 (NCH2), 61.3 (d, 
2JCP = 5.4 Hz, 2x OCH2CH3), 106.9 (d, 
1JCP = 218.2 Hz, PCq), 
113.3 (d, 2JCP = 12.3 Hz, CHar), 123.8 (CHar), 125.56 (CHar), 125.63 (CHar), 125.8 (2x CHar), 126.0 (CHar), 
126.7 (CHar), 127.5 (2x CHar), 128.0 (2x CHar), 128.5 (CHar), 128.7 (CHar), 128.9 (2x CHar), 130.8 (2x 
CHar), 131.6 (Cq,ar), 132.0 (Cq,ar), 132.3 (d, 
3JCP = 15.4 Hz, Cq,arCH2), 133.9 (Cq,ar), 134.1 (Cq,ar), 137.8 
(Cq,ar), 139.9 (d, 
2JCP = 23.4 Hz, Cq,ar). 
31P-NMR (162 MHz, CDCl3)  18.06. IR (ATR, cm
-1) νmax: 1027 (P-
O), 1055 (P-O), 1236 (P=O), 1453, 2928. MS (ESI, pos): m/z (%) 510.2/511.3 (M+H+, 100/35). HRMS: 
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m/z calcd for C32H32NO3P+H
+ 510.2193, found 510.2215. Chromatography: hexanes/EtOAc 1/1, Rf = 
0.41. 
3.2.4 Synthesis of bromopyrrole 348 
In a round-bottom flask pyrrole 339f was dissolved in a 2/1 1,4-dioxane/acetic acid mixture (0.5 M), 
N-Bromosuccinimide (NBS, 1.05 equiv) was added and the reaction mixture was stirred for 30 
minutes at 20 °C. The reaction mixture was poured into a 2 M NaOH solution (10 mL) and extracted 
with diethyl ether (3x 10 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo. 
diethyl (4-bromo-1-butyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)phosphonate 348  
100 mg (0.29 mmol) of 339f was converted into 99 mg of 348 (0.27 mmol, 92% 
yield, yellow oil). 1H-NMR (400 MHz, CDCl3)  0.74 (3H, t, J = 7.3 Hz, CH3), 1.06-
1.15 (8H, m, 2x OCH2CH3 + CH2), 1.39-1.46 (2H, m, CH2), 2.28 (3H, d, 
5JHP = 0.4 Hz, 
CH3), 3.60-3.64 (2H, m, NCH2), 3.78-3.87 (2H, m, OCH2CH3), 3.92-4.01 (2H, m, 
OCH2CH3), 7.30-7.33 (2H, m, 2x CHar), 7.38-7.41 (3H, m, 3x CHar). 
13C-NMR (100 
MHz, CDCl3)  11.1 (CH3), 13.4 (CH3), 16.1 (d, 
3JCP = 7.0 Hz, 2x OCH2CH3), 19.7 (CH2), 32.7 (CH2), 45.0 
(NCH2), 61.4 (d, 
2JCP = 5.6 Hz, 2x OCH2CH3), 97.9 (d, 
2JCP = 8.4 Hz, Cq,arBr), 106.3 (d, 
1JCP = 223.1 Hz, PCq), 
127.9 (2x CHar), 128.2 (d, 
3JCP = 12.6 Hz, Cq,ar), 128.6 (CHar), 131.1 (2x CHar), 131.9 (Cq,ar), 139.7 (d, 
2JCP = 
21.0 Hz, Cq,ar). 
31P-NMR (162 MHz, CDCl3)  14.12. IR (ATR, cm
-1) νmax: 1024 (P-O), 1057 (P-O), 1243 
(P=O), 1391, 1469, 2960. MS (ESI, pos): m/z (%) 428.1/430.1 (M+H+, 98/100). HRMS: m/z calcd for 
C19H27BrNO3P+H
+ 428.0985, found 428.0991. 
3.2.5 Synthesis of deuterated pyrrole 349a 
In a round-bottom flask pyrrole 339f was dissolved in dry THF (0.5 M) under a N2-atmosphere and 
cooled to -78 °C. A solution of s-BuLi (1.2 equiv) was added in a dropwise fashion and the reaction 
mixture was kept at -78 °C for one hour. Next, an excess of D2O was added and the mixture was 
allowed to warm to room temperature, after which it was extracted with diethyl ether (3x 10 mL). 
The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. The crude 
residue was purified using preparative TLC. 
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diethyl (1-butyl-5-methyl-2-phenyl-1H-pyrrol-3-yl-4-d)phosphonate 349a 
127 mg (0.36 mmol) of 339f was converted into 349a. After preparative TLC, 72 
mg of 349a was obtained (0.21 mmol, 57% yield, yellow oil). 1H-NMR (400 MHz, 
CDCl3)  0.75 (3H, t, J = 7.4 Hz, CH3), 1.07-1.16 (8H, m, 2x OCH2CH3 + CH2), 1.41-
1.49 (2H, m, CH2), 2.27 (3H, s, CH3), 3.68 (2H, t, J = 7.8 Hz, NCH2), 3.78-3.97 (4H, 
m, 2x OCH2CH3), 7.36-7.40 (5H, m, 5x CHar). 
13C-NMR (100 MHz, CDCl3)  12.4 (d, 
4JCP = 1.1 Hz, CH3), 13.5 (CH3), 16.0 (d, 
3JCP = 7.2 Hz, 2x OCH2CH3), 19.7 (CH2), 32.8 (CH2), 44.1 (NCH2), 
61.2 (d, 2JCP = 5.5 Hz, 2x OCH2CH3), 105.6 (d, 
1JCP = 218.6 Hz, PCq), 110.9 (td, 
1JDC = 25.2 Hz, 
2JCP = 13.3 
Hz, CDar), 127.9 (2x CHar), 128.2 (CHar), 129.1 (d, 
3JCP = 15.7 Hz, Cq,ar), 130.9 (2x CHar), 132.3 (Cq,ar), 
138.5 (d, 2JCP = 23.3 Hz, Cq,ar). 
31P-NMR (162 MHz, CDCl3)  18.45. IR (ATR, cm
-1) νmax: 1026 (P-O), 1055 
(P-O), 1229 (P=O), 1392, 1474, 2960. MS (ESI, pos): m/z (%) 351.3/352.3 (M+H+, 100/15). HRMS: m/z 
calcd for C19H27DNO3P+H
+ 351.1942, found 351.1946. Chromatography: EtOAc, Rf = 0.41. 
3.2.6 Synthesis of methylpyrrole 349b 
In a round-bottom flask pyrrole 339f was dissolved in dry THF (1 M) under an inert N2-atmosphere 
and cooled to -78 °C. A solution of s-BuLi (1.2 equiv) was added in a dropwise fashion and the 
reaction mixture was kept at -78 °C for one hour. Next, iodomethane (1.1 equiv) was added and the 
mixture was allowed to warm to room temperature after which it was extracted with diethyl ether 
(3x 10 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. 
The residue was purified using column chromatography. 
diethyl (1-butyl-4,5-dimethyl-2-phenyl-1H-pyrrol-3-yl)phosphonate 349b  
0.86 g (2.45 mmol) of 339f was converted into 349b. After column 
chromatography, 0.23 g of 349b was obtained (0.64 mmol, 26% yield, yellow oil). 
1H-NMR (400 MHz, CDCl3)  0.74 (3H, t, J = 7.3 Hz, CH3), 1.07-1.13 (8H, m, 2x 
OCH2CH3 + CH2), 1.38-1.46 (2H, m, CH2), 2.18 (3H, s, CH3), 2.22 (3H, s, CH3), 3.58 
(2H, t, J = 7.9 Hz, NCH2), 3.72-3.82 (2H, m, OCH2CH3), 3.86-3.95 (2H, m, OCH2CH3), 
7.31-7.38 (5H, m, 5x CHar). 
13C-NMR (100 MHz, CDCl3)  9.9 (d, 
3JCP = 1.4 Hz, CH3), 10.8 (CH3), 13.0 
(CH3), 16.0 (d, 
3JCP = 7.1 Hz, 2x OCH2CH3), 19.7 (CH2), 32.9 (CH2), 44.0 (NCH2), 60.7 (d, 
2JCP = 5.3 Hz, 2x 
OCH2CH3), 105.1 (d, 
1JCP = 215.2 Hz, PCq), 117.9 (d, 
2JCP = 13.0 Hz, Cq,ar), 126.0 (d, 
3JCP = 16.1 Hz, Cq,ar), 
127.6 (2x CHar), 128.0 (CHar), 131.1 (2x CHar), 132.8 (Cq,ar), 138.4 (d, 
2JCP = 23.6 Hz, Cq,ar). 
31P-NMR (162 
MHz, CDCl3)  18.56. IR (ATR, cm
-1) νmax: 1026 (P-O), 1056 (P-O), 1230 (P=O), 1246, 1393, 2930. MS 
(ESI, pos): m/z (%) 364.2/365.2 (M+H+, 100/22). HRMS: m/z calcd for C20H30NO3P+H
+ 364.2036, found 
364.2047. Chromatography: EtOAc/hexanes 3/2, Rf = 0.15. 
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3.2.7 Synthesis of pyrroles 351 
3.2.7.1 Synthesis of pyrrole 351a.  
In a 10 mL Pyrex microwave vial equipped with a ‘snap-cap’ and magnetic stirrer, pyrrole 348 was 
dissolved in a 3/1 DME/H2O mixture. PhB(OH)2 (1.3 equiv) was added, along with Na2CO3 (2 equiv) 
and Pd(PPh3)4 (5 mol%). The vial was inserted into the microwave and the reaction was carried out at 
130 °C for one hour. Afterwards, the reaction mixture was poured into water (10 mL) and extracted 
with diethyl ether (3x 10 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo. The crude product was purified using preparative TLC.  
diethyl (1-butyl-5-methyl-2,4-diphenyl-1H-pyrrol-3-yl)phosphonate 351a  
96 mg (0.22 mmol) of 348 was converted into 351a. After preparative TLC, 52 
mg of 351a was obtained (0.12 mmol, 63% yield, yellow oil). 1H-NMR (400 MHz, 
CDCl3)  0.75-0.80 (9H, m, 2x OCH2CH3 + CH3), 1.15 (2H, sext, J = 7.4 Hz, CH2), 
1.46-1.54 (2H, m, CH2), 2.20 (3H, s, CH3), 3.41-3.51 (2H, m, NCH2), 3.59-3.70 (4H, 
m, 2x OCH2CH3), 7.23-7.28 (1H, m, CHar), 7.34-7.48 (9H, m, 9x CHar). 
13C-NMR 
(100 MHz, CDCl3)  10.7 (d, 
4JCP = 1.2 Hz, CH3), 13.5 (CH3), 15.7 (d, 
3JCP = 7.3 Hz, 2x OCH2CH3), 19.9 
(CH2), 32.9 (CH2), 44.4 (NCH2), 60.8 (d, 
2JCP = 6.0 Hz, 2x OCH2CH3), 106.0 (d, 
1JCP = 217.6 Hz, PCq), 124.6 
(d, 2JCP = 12.0 Hz, Cq,ar), 126.2 (CHar), 126.9 (d, 
3JCP = 15.0 Hz, Cq,ar), 127.6 (2x CHar), 127.8 (2x CHar), 
128.2 (CHar), 130.8 (2x CHar), 131.2 (2x CHar), 132.9 (Cq,ar), 136.1 (Cq,ar), 139.0 (d, 
2JCP = 22.9 Hz, Cq,ar). 
31P-NMR (162 MHz, CDCl3)  17.30. IR (ATR, cm
-1) νmax: 1029 (P-O), 1057 (P-O), 1228 (P=O), 1248, 
1392, 2960. MS (ESI, pos): m/z (%) 426.2/427.2 (M+H+, 100/22). HRMS: m/z calcd for C25H32NO3P+H
+ 
426.2193, found 426.2195. Chromatography: EtOAc, Rf = 0.59. 
3.2.7.2 Synthesis of pyrrole 351b  
In a 10 mL Pyrex microwave vial equipped with a ‘snap-cap’ and magnetic stirrer, pyrrole 348 was 
dissolved in DMF. Allyl tributyltin (3.0 equiv) was added, along with Pd(PPh3)4 (5 mol%). The vial was 
inserted into the microwave and the reaction was carried out at 130 °C for three hours. Afterwards, 
the reaction mixture was poured into brine (10 mL) and extracted with diethyl ether (3x 10 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. The crude 
product was purified using column chromatography.  
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diethyl (4-allyl-1-butyl-5-methyl-2-phenyl-1H-pyrrol-3-yl)phosphonate 351b 
80 mg (0.19 mmol) of 348 was converted into 351b. After column 
chromatography, 32 mg of 351b was obtained (0.08 mmol, 43% yield, yellow 
oil). 1H-NMR (400 MHz, CDCl3)  0.74 (3H, t, J = 7.4 Hz, CH3), 1.06-1.13 (8H, m, 2x 
OCH2CH3 + CH2), 1.39-1.43 (2H, m, CH2), 2.17 (3H, s, CH3), 3.48 (2H, d, J = 6.2 Hz, 
CH2), 3.57-3.61 (2H, m, NCH2), 3.72-3.79 (2H, m, OCH2CH3), 3.86-3.92 (2H, m, 
OCH2CH3), 4.95 (1H, ddd, J = 10.1 Hz, J = 3.5 Hz, J = 1.6 Hz, CH=CHEHZ), 5.00 (1H, ddd, J = 17.0 Hz, J = 
3.8 Hz, J = 1.6 Hz, CH=CHEHZ), 5.99 (1H, ddt, J = 17.0 Hz, J = 10.1 Hz, J = 6.2 Hz, CH=CHEHZ), 7.31-7.34 
(2H, m), 7.36-7.39 (3H, m). 13C-NMR (100 MHz, CDCl3)  10.1 (d, 
4JCP = 1.5 Hz, CH3), 13.5 (CH3), 16.1 
(d, 3JCP = 7.2 Hz, 2x OCH2CH3), 19.8 (CH2), 29.9 (CH2), 32.9 (CH2), 44.1 (NCH2), 60.8 (d, 
2JCP = 5.4 Hz, 2x 
OCH2CH3), 104.7 (d, 
1JCP = 215.9 Hz, PCq), 113.5 (CH=CH2), 120.3 (d, 
2JCP = 13.5 Hz, Cq,ar), 126.9 (d, 
3JCP = 
16.1 Hz, Cq,ar), 127.6 (2x CHar), 128.1 (CHar), 131.2 (2x CHar), 132.9 (Cq,ar), 138.36 (CH=CH2), 138.41 (d, 
2JCP = 23.0 Hz, Cq,ar). 
31P-NMR (162 MHz, CDCl3)  18.23. IR (ATR, cm
-1) νmax: 1028 (P-O), 1056 (P-O), 
1225 (P=O), 1246, 1395, 1466, 2929. MS (ESI, pos): m/z (%) 390.2/391.2 (M+H+, 100/22). HRMS: m/z 
calcd for C22H32NO3P+H
+ 390.2193, found 390.2205. Chromatography: hexanes/EtOAc 7/3, Rf = 0.11. 
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3.3 Addition of dialkyl trimethylsilyl phosphite and triethyl 
phosphite to α,β,γ,δ-diunsaturated imines  
3.3.1 Synthesis of α,β,γ,δ-diunsaturated aldehydes 360 
In a flame-dried round-bottom flask equipped with a stirring bar a suitable α,β-unsaturated aldehyde 
357 was dissolved in dry THF under an inert atmosphere. Next, (1,3-dioxolan-2-
ylmethyl)triphenylphosphonium bromide 358 (1.5 equiv) and LiOMe (2.2 equiv) were added and the 
reaction mixture was heated to reflux temperature for 16 h. A solution of 2 M HCl with a volume 
equal to the reaction solvent was then added to the reaction mixture at room temperature and was 
left to stir for 1 hour. Afterwards the THF was evaporated in vacuo until only the aqueous phase 
remained. Ethyl acetate was added and the mixture was extracted thrice using ethyl acetate. The 
combined organic layers were washed using NaHCO3 once, dried over MgSO4, filtered and 
concentrated in vacuo.[332] The crude product was then triturated using a 9/1 mixture of 
hexanes/EtOAc and filtered: the desired α,β,γ,δ,-diunsaturated aldehyde 360 was present in the 
filtrate while the residue consisted of triphenylphosphine oxide. The filtrate was concentrated in 
vacuo and purified using column chromatography. Spectral data for 360a were in agreement with 
literature values. 
(2E,4E)-5-phenylpenta-2,4-dienal 360a[332] 
Cinnamaldehyde (0.29 mL, 2.32 mmol) was transformed into (2E,4E)-5-
phenylpenta-2,4-dienal 360a. After column chromatography, 257 mg was 
obtained (1.62 mmol, 70% yield, yellow oil). Spectral data are in accordance 
with reported values.[332] 1H-NMR (400 MHz, CDCl3)  6.28 (1H, dd, J = 15.1 Hz, J = 7.9 Hz, CHCHO), 
7.00-7.03 (2H, m, 2x CH), 7.24-7.31 (1H, m, CH), 7.33-7.41 (3H, m, 3x CH), 7.49-7.53 (2H, m, 2x CH), 
9.63 (1H, d, J = 7.9 Hz, CHO). Chromatography: hexanes/EtOAc 95/5, Rf = 0.25. 
(E)-3-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)acrylaldehyde 360c 
(1R)-(−)-Myrtenal (1.18 g, 7.73 mmol) was transformed into (E)-3-((1R,5S)-6,6-
dimethylbicyclo[3.1.1]hept-2-en-2-yl)acrylaldehyde 360c. After column 
chromatography, 636 mg was obtained as an E/Z mixture in a 93/7 ratio (3.61 
mmol, 47% yield, yellow oil). Spectral data are given for the major isomer. 1H-
NMR (400 MHz, CDCl3)  0.78 (3H, s, CH3), 1.16 (1H, d, J = 9.0 Hz, CHd,1), 1.35 (3H, s, CH3), 2.15-2.20 
(1H, m, CHg), 2.46-2.53 (3H, m, CH2,f + CHd,2), 2.57 (1H, m, CHe), 6.06 (1H, dd, J = 15.6 Hz, J = 7.8 Hz, 
CHa), 6.17-6.20 (1H, m, CHc), 7.10 (1H, d, J = 15.6 Hz, CHb), 9.58 (1H, d, J = 7.8 Hz). 
13C-NMR (100 MHz, 
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CDCl3)  20.8 (CH3), 26.0 (CH3), 31.1 (CHd), 32.9 (CH2,f), 37.8 (Cq), 40.5 (CHg), 41.4 (CHe), 125.5 (CHa), 
136.9 (CHc), 146.2 (Cq), 153.2 (CHb), 194.2 (CHO). IR (ATR, cm
-1) νmax: 1121, 1609 (C=C), 1678 (C=O), 
2921. MS (ESI, pos): m/z (%) 177.1/178.1 (M+H+, 100/12). Chromatography: hexanes/EtOAc 95/5, Rf 
= 0.34. 
3.3.2 Synthesis of α-aminophosphonates 362 and 363 
3.3.2.1 Synthesis of dimethyl trimethylsilyl phosphite (DMPTMS) 
In a flame-dried round-bottom flask equipped with a magnetic stirring bar dimethyl phosphite (DMP) 
was dissolved in dry dichloromethane under a N2-atmosphere. Next the flask was cooled to 0 °C using 
an ice bath before Et3N (1.2 equiv) was added. Then TMSCl (1.1 equiv) was added in a dropwise 
fashion and the reaction mixture was kept at 0 °C for 30 minutes. Afterwards the resulting 
suspension was filtered using an oven-dried filter and flame-dried glassware (which was allowed to 
cool first in a dessicator). The residue was washed using dry diethyl ether and the filtrate was 
concentrated in vacuo. The resulting suspension was again filtered using an oven-dried filter and 
flame-dried glassware and was washed using dry diethyl ether. The filtrate was concentrated in 
vacuo. This filtration/concentration procedure was repeated until no more salt was visibly present 
and a clear colorless solution was obtained. The resulting DMPTMS was stored in a flame-dried flask 
under a N2-atmosphere in the freezer at -18 °C and could be kept as such without significant 
hydrolysis for several months. Prior to use, the exact concentration was determined using 1H- and 
31P-NMR spectroscopy (relevant signals: DMPTMS: 1H-NMR (400 MHz, CDCl3)  3.40 (6H, d, 
3JHP = 
10.4 Hz, 2x OCH3) and 
31P-NMR (162 MHz, CDCl3)  128.1. DMP: 
1H-NMR (400 MHz, CDCl3)  3.72 
(6H, d, 3JHP = 11.9 Hz, 2x OCH3) and 
31P-NMR (162 MHz, CDCl3)  10.4). 
3.3.2.2 Synthesis of α,β,γ,δ-diunsaturated imines 32 
In a round-bottom flask equipped with a magnetic stirring bar, a diunsaturated aldehyde was 
dissolved in THF (0.3 M). Then 2 equivalents of MgSO4 and 1 equivalent of a suitable amine (2 M 
stock solution in THF to ensure precise dosage) were added to the flask. The mixture was heated to 
reflux temperature and the reaction progress was monitored using 1H-NMR spectroscopy. After 
consumption of all starting material, the MgSO4 was filtered off and washed three times using dry 
THF. The filtrate was concentrated in vacuo and the resulting crude was used as such in the next step 
if no hydrolysis had taken place during work-up according to 1H-NMR spectroscopy. 
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3.3.2.3 Synthesis of α-aminophosphonates 362 and 363 
In a flame-dried round-bottom flask equipped with a magnetic stirring bar α,β,γ,δ-diunsaturated 
imines  were dissolved in dry dichloromethane under a N2-atmosphere. Next, an appropriate amount 
of DMPTMS was added using a syringe. H2SO4 was then added via a syringe in a dropwise fashion 
after which the reaction mixture started to boil vigorously. The reaction progress was monitored 
using LC-MS and after complete consumption of the starting material, the reaction mixture was 
poured into 10 mL of a 2 M HCl-solution. Diethyl ether was added and the mixture was extracted 
thrice using diethyl ether. The resulting aqueous layer was then rendered alkaline to a pH of 14 using 
a 2 M NaOH solution. Next, the alkaline aqueous phase was extracted thrice using ethyl acetate (3x 
10 mL). The combined ethyl acetate fractions were dried over MgSO4, filtered and concentrated in 
vacuo, yielding the crude desired α-aminophosphonates 362. The obtained products were purified 
using column chromatography or preparative TLC. 
dimethyl ((2E,4E)-1-(isopropylamino)-5-phenylpenta-2,4-dien-1-yl)phosphonate 362a 
190 mg (0.95 mmol) of (1E,2E,4E)-N-isopropyl-5-phenylpenta-2,4-dien-
1-imine 32a was converted into 362a using 5 equiv of DMPTMS and 2 
equiv of H2SO4. After column chromatography, 213 mg was obtained 
(0.69 mmol, 73% yield, yellow oil). 1H-NMR (400 MHz, CDCl3) 1.01 
(3H, d, J = 6.2 Hz, CH3), 1.09 (3H, d, J = 6.2 Hz, CH3), 2.92 (1H, sept, J = 6.2 Hz), 3.74 (1H, d, 
2JHP = 21.6 
Hz, J = 8.5 Hz, NCHP), 3.79 (3H, d, 3JHP = 10.5 Hz, OCH3), 3.83 (3H, d, 
3JHP = 10.4 Hz, OCH3), 5.71 (1H, 
ddd, J = 15.2 Hz, J = 8.5 Hz, 3JHP = 6.3 Hz, CHa), 6.43 (1H, ddd, J = 15.2 Hz, J = 10.5 Hz, 
4JHP = 4.6 Hz, 
CHb), 6.56 (1H, dd, J = 15.7 Hz, J = 2.1 Hz, CHd), 6.80 (1H, dd, 15.7 Hz, J = 10.5 Hz, CHc), 7.21-7.40 (5H, 
m , 5x CHar). 
13C-NMR (100 MHz, CDCl3)  21.5 (CH3), 23.8 (CH3), 46.0 (d, 
3JCP = 15.4 Hz, NCH), 53.3 (d, 
2JCP = 7.1 Hz, OCH3), 53.80 (d, 
2JCP = 7.2 Hz, OCH3), 55.9 (d, 
1JCP = 157.2 Hz, NCHP), 126.4 (2x CHar), 
127.7 (CHar), 127.8 (d, 
4JCP = 4.3 Hz, CHc), 128.58 (2x CHar), 128.61 (d, 
2JCP = 5.0 Hz, CHa), 133.0 (d, 
5JCP = 
4.3 Hz, CHd), 134.2 (d, 
3JCP = 14.2 Hz, CHb), 136.9 (d, 
6JCP = 1.5 Hz, Cq,ar). 
31P-NMR (162 MHz, CDCl3)  
26.27. IR (ATR, cm-1) νmax: 1024 (P-O), 1244 (P=O), 1448, 2956. MS (ESI, pos): m/z (%) 200.0/201.0 
(M-[P(O)(OMe)2]
-, 100, 15) 310.0 (M+H+, 8). HRMS: m/z calcd for C16H24NO3P+H
+ 310.1567, found 
310.1561. Chromatography: EtOAc, Rf = 0.17. 
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dimethyl ((2E,4E)-1-(benzylamino)-5-phenylpenta-2,4-dien-1-yl)phosphonate 362b 
210 mg (0.85 mmol) of (1E,2E,4E)-N-benzyl-5-phenylpenta-2,4-dien-1-
imine 32b was converted into 362b using 2 equiv DMPTMS and 2 equiv 
H2SO4. After column chromatography, 186 mg was obtained (0.52 
mmol, 61% yield, yellow oil). 1H-NMR (400 MHz, CDCl3) 3.66 (1H, dd, 
2JHP = 19.9 Hz, J = 8.5 Hz, NCHP), 3.73 (1H, d, J = 13.4 Hz, NCHaHb), 3.79 
(3H, d, 3JHP = 10.5 Hz, OCH3), 3.82 (3H, d, 
3JHP = 10.5 Hz, OCH3), 3.96 (1H, d, J = 13.4 Hz, NCHaHb), 5.77 
(1H, ddd, J = 15.2 Hz, J = 8.5 Hz, 3JHP = 6.4 Hz, Hc), 6.47 (1H, ddd, J = 15.2 Hz, J = 10.6 Hz, 
4JHP = 4.6 Hz, 
Hd), 6.60 (1H, dd, J = 15.7 Hz, J = 1.8 Hz, Hf), 6.85 (1H, dd, J = 15.7 Hz, J = 10.6 Hz, He), 7.23-7.43 (10H, 
m, 10x CHar). 
13C-NMR (100 MHz, CDCl3)  50.9 (d, 
3JCP = 16.3 Hz, NCH2), 53.1 (d, 
2JCP = 6.8 Hz, OCH3), 
53.3 (d, 2JCP = 7.1 Hz, OCH3), 56.8 (d, 
1JCP = 156.3 Hz, NCHP), 126.1 (2x CHar), 126.8 (CHar), 127.3 (d, 
2JCP 
= 7.7 Hz, CHc), 127.4 (CHar), 127.5 (d, 
4JCP = 5.2 Hz, CHe), 127.9 (2x CHar), 128.1 (2x CHar), 128.3 (2x 
CHar), 132.9 (d, 
5JCP = 4.2 Hz, CHf), 134.7 (d, 
3JCP = 14.0 Hz, CHd), 136.6 (d, 
6JCP = 1.5 Hz, Cq,ar), 138.9 
(Cq,ar). 
31P-NMR (162 MHz, CDCl3)  25.91. IR (ATR, cm
-1) νmax: 1025 (P-O), 1241 (P=O), 1450, 2952. 
MS (ESI, pos): m/z (%) 358.2/359.2 (M+H+, 100/22). HRMS: m/z calcd for C20H24NO3P+H
+ 358.1567, 
found 358.1560. Chromatography: EtOAc, Rf = 0.37. 
dimethyl ((2E,4E)-5-phenyl-1-(propylamino)penta-2,4-dien-1-yl)phosphonate 362c 
295 mg (1.48 mmol) of (1E,2E,4E)-N-propyl-5-phenylpenta-2,4-dien-1-
imine 32c was converted into 362c using 2 equiv of DMPTMS and 2 
equiv of H2SO4. After work-up, 370 mg was obtained (1.20 mmol, 81% 
yield, yellow oil). 1H-NMR (400 MHz, CDCl3) 0.92 (3H, t, J = 7.4 Hz, 
CH3), 1.44-1.55 (2H, m, CH2), 2.51 (1H, dt, J = 11.3 Hz, J = 7.0 Hz, NCHaHb), 2.69 (1H, dt, J = 11.3 Hz, J = 
7.4 Hz, NCHaHb), 3.63 (1H, dd, 
2JHP = 19.6 Hz, J = 8.6 Hz, NCHP), 3.79 (3H, d, 
3JHP = 7.8 Hz, OCH3), 3.82 
(3H, d, 3JHP = 7.8 Hz, OCH3), 5.72 (1H, ddd, J = 15.2 Hz, J = 8.6 Hz, 
3JHP = 6.4 Hz, CHc), 6.45 (1H, ddd, J = 
15.2 Hz, J = 10.6 Hz, 4JHP = 4.6 Hz, CHd), 6.57 (1H, dd, J = 15.7 Hz, J = 1.9 Hz, CHf), 6.81 (1H, dd, J = 15.7 
Hz, J = 10.6 Hz, CHe), 7.23 (1H, dd, J = 7.3 Hz, J = 7.3 Hz, CHar), 7.32 (2H, dd, J = 7.3 Hz, J = 7.3 Hz, 2x 
CHar), 7.40 (2H, d, J = 7.3 Hz, 2x CHar). 
13C-NMR (100 MHz, CDCl3)  11.6 (CH3), 23.0 (CH2), 50.0 (d, 
3JCP 
= 15.5 Hz, NCH2), 53.3 (d, 
2JCP = 7.2 Hz, OCH3), 53.5 (d, 
2JCP = 7.2 Hz, OCH3), 58.6 (d, 
1JCP = 155.6 Hz, 
NCHP), 126.4 (2x CHar), 127.7 (CHar), 127.8 (d, 
4JCP = 4.3 Hz, CHe), 128.3 (d, 
2JCP = 7.9 Hz, CHc), 128.6 (2x 
CHar), 133.0 (d, 
5JCP = 4.3 Hz, CHf), 134.4 (d, 
3JCP = 14.0 Hz, CHd), 136.9 (d, 
6JCP = 1.9 Hz, Cq,ar). 
31P-NMR 
(162 MHz, CDCl3)  26.00. IR (ATR, cm
-1) νmax: 1025 (P-O), 1242 (P=O), 1448, 2955. MS (ESI, pos): m/z 
(%) 200.1/201.0 (M-[P(O)(OMe)2]
-, 100/15) 310.0/311.0 (M+H+, 25/5). HRMS: m/z calcd for 
C16H24NO3P+H
+ 310.1567, found 310.1562. 
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dimethyl ((2E,4E)-1-(t-butylamino)-5-phenylpenta-2,4-dien-1-yl)phosphonate 362d 
798 mg (3.74 mmol) of (1E,2E,4E)-N-t-butyl-5-phenylpenta-2,4-dien-1-
imine 32d was converted into 362d using 10 equiv of DMPTMS and 2 
equiv H2SO4. After column chromatography, 834 mg was obtained (2.58 
mmol, 68% yield, yellow oil). 1H-NMR (400 MHz, CDCl3) 1.11 (9H, s, 
(CH3)3), 3.76 (3H, d, 
3JHP = 10.4 Hz, OCH3), 3.80 (1H, dd, 
2JHP = 24.8 Hz, J = 8.4 Hz, NCHP), 3.84 (3H, d, 
3JHP = 10.3 Hz, OCH3), 5.81 (1H, ddd, J = 15.1 Hz, J = 7.5 Hz, 
3JHP = 7.5 Hz, CHa), 6.44 (1H, ddd, J = 15.3 
Hz, J = 10.5 Hz, 4JHP = 5.0 Hz, CHb), 6.54 (1H, dd, J = 15.6 Hz, J = 2.5 Hz, CHd), 6.79 (1H, dd, J = 15.6 Hz, J 
= 10.5 Hz, CHc), 7.22 (1H, dd, J = 7.3 Hz, J = 7.3 Hz, CHar), 7.31 (2H, dd, J = 7.3 Hz, J = 7.3 Hz, 2x CHar), 
7.39 (2H, d, J = 7.3 Hz, 2x CHar). 
13C-NMR (100 MHz, CDCl3)  29.9 ((CH3)3), 52.1 (d, 
3JCP = 14.5 Hz, NCq), 
53.2 (d, 2JCP = 7.4 Hz, OCH3), 53.5 (d, 
1JCP = 158.5, NCHP), 54.4 (d, 
2JCP = 7.3 Hz, OCH3), 126.3 (2x CHar), 
127.6 (CHar), 128.1 (d, 
4JCP = 5.0 Hz, CHc), 128.6 (2x CHar), 131.9 (d, 
2JCP = 6.2 Hz, CHa), 132.6 (d, 
5JCP = 
4.9 Hz, CHd), 132.7 (d, 
3JCP = 13.7 Hz, CHb), 137.0 (d, 
6JCP = 2.1 Hz, Cq,ar). 
31P-NMR (162 MHz, CDCl3)  
26.24. IR (ATR, cm-1) νmax: 1022 (P-O), 1053 (P-O), 1240 (P=O), 1447, 2953. MS (ESI, pos): m/z (%) 
214.1/215.1 (M-[P(O)(OMe)2]
-, 100/18) 324.0/325.0 (M+H+, 35/5). HRMS: m/z calcd for 
C17H26NO3P+H
+ 324.1723, found 324.1725. Chromatography: EtOAc/hexanes 4/1, Rf = 0.14. 
dimethyl ((2E,4E)-1-(isopropylamino)hexa-2,4-dien-1-yl)phosphonate 362f 
235 mg (1.72 mmol) of (1E,2E,4E)-N-isopropylhexa-2,4-dien-1-imine 32f 
was converted into 362f using 5 equiv of DMPTMS and 2 equiv of H2SO4. 
After work-up, 336 mg was obtained as an E/Z mixture in a 9/1 ratio (1.36 
mmol, 79% yield, pale yellow oil). Spectral data are reported only for the 
major isomer. 1H-NMR (400 MHz, CDCl3) 0.98 (3H, d, J = 6.2 Hz, CH3), 1.06 (3H, d, J = 6.2 Hz, CH3), 
1.76 (3H, dd, J = 7.0 Hz, J = 1.7 Hz, CH3), 2.88 (1H, sept, J = 6.2 Hz, CH), 3.64 (1H, dd, 
2JHP = 21.2 Hz, J = 
8.6 Hz, NCHP), 3.76 (3H, d, 3JHP = 10.5 Hz, OCH3), 3.80 (3H, d, 
3JHP = 10.4 Hz, OCH3), 5.43 (1H, ddd, J = 
15.0 Hz, J = 8.6 Hz, 3JHP = 6.2 Hz, CHa), 5.72 (1H, dqd, J = 13.4 Hz, J = 7.0 Hz, J = 2.3 Hz, CHd), 6.08 (1H, 
m, CHc), 6.21 (1H, ddd, J = 15.0 Hz, J = 10.5 Hz, 
4JHP = 4.5 Hz, CHb). 
13C-NMR (100 MHz, CDCl3)  18.1 
(CH3), 21.4 (NCHCH3), 23.8 (NCHCH3), 45.8 (d, 
3JCP = 15.6 Hz, NCH), 53.3 (d, 
2JCP = 7.2 Hz, OCH3), 53.7 
(d, 2JCP = 7.2 Hz, OCH3), 55.8 (d, 
1JCP = 157.7 Hz, NCHP), 125.1 (d, 
2JCP = 6.6 Hz, CHa), 130.4 (d, 
5JCP = 4.1 
Hz, CHd), 130.6 (d, 
4JCP = 3.8 Hz, CHc), 134.4 (d, 
3JCP = 14.3 Hz, CHb).
 31P-NMR (162 MHz, CDCl3)  26.67. 
IR (ATR, cm-1) νmax: 1024 (P-O), 1233 (P=O), 1448, 2958. MS (ESI, pos): m/z (%) 138.1/139.1 (M-
[P(O)(OMe)2]
-, 100/10). HRMS: m/z calcd for C11H22NO3P+H
+ 248.1401, found 248.1407. 
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dimethyl ((E)-3-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-1-
(isopropylamino)allyl)phosphonate 362g 
185 mg (0.85 mmol) of (1E,2E)-3-((1R,5S)-6,6-
dimethylbicyclo[3.1.1]hept-2-en-2-yl)-N-isopropylprop-2-en-1-imine 
32g was converted into 362g using 5 equiv DMPTMS and 2 equiv 
H2SO4. After preparative TLC, 65 mg of 362g was obtained of a mixture 
of diastereomers in a 55/45 ratio (0.20 mmol, 22% yield, yellow oil). 
Signals were assigned to the major (M) or minor (m) diastereomer. 1H-NMR (400 MHz, CDCl3) 0.76 
(3H, s, CH3,k, m), 0.77 (3H, s, CH3,k, M), 0.98 (3H, d, J = 6.1 Hz, NCHCH3,a, m), 0.99 (3H, d, J = 6.1 Hz, 
NCHCH3,a, M), 1.05 (3H, s, NCHCH3,a, m), 1.06 (3H, s, NCHCH3,a, M), 1.12-1.16 (2x 1H, m, CHi,1, M+m), 
1.32 (2x 3H, s, 2x CH3,k, M+m), 2.09-2.15 (2x 1H, m, 2x CHh, M+m), 2.27-2.39 (2x 2H, m, 2x CHg, M+m), 
2.40-2.46 (2x 1H, m, 2x CHi,2, M+m), 2.53-2.57 (2x 1H, m, 2x CHj, M+m), 2.82-2.94 (2x 1H, m, 2x 
NCHb(CH3)2, M+m), 3.61-3.71 (2x 1H, m, 2x NCHcP, M+m), 3.73 (3H, d, 
3JHP = 10.1 Hz, OCH3, M or m), 
3.75 (3H, d, 3JHP = 10.2 Hz, OCH3, M or m), 3.80 (2x 3H, d, 
3JHP = 10.4 Hz, 2x OCH3, M+m), 5.39 (2x 1H, 
ddd, J = 15.4 Hz, J = 8.7 Hz, 3JHP = 6.5 Hz, 2x Hd, M+m), 5.57 (2x 1H, br s, 2x Hf, M+m), 6.24 (2x 1H, dd, J 
= 15.7 Hz, 4JHP = 4.2 Hz, 2x He, M+m). 
13C-NMR (100 MHz, CDCl3)  20.67, 20.70 (2x CH3,k, M+m), 21.5, 
21.6 (2x CH3,a, M+m), 23.80, 23.82 (2x CH3,a, M+m), 26.22 (2x CH3,k, M+m), 31.2 (2x CH2,i, M+m), 31.9 
(2x CH2,g, M+m), 37.7 (2x CqMe2, M+m), 40.9 (2x CHh, M+m), 41.1, 41.2 (2x CHj, M+m), 45.7, 45.8 (2x 
NCHb, M+m), 53.4, 53.6 (2x d, 
2JCP = 7.2 Hz, 2x OCH3, M+m), 53.7 (2x d, 
2JCP = 7.2 Hz, 2x OCH3, M+m), 
56.1 (d, 1JCP = 157.1 Hz, NCHP, m), 56.2 (d, 
1JCP = 157.3 Hz, NCHP, M), 120.0, 120.2 (2x d, 
2JCP = 6.0 Hz, 
CHd, M+m), 125.0, 125.1 (2x d, 
5JCP = 4.3 Hz, CHf, M+m), 135.3, 135.4 (2x d, 
3JCP = 14.3 Hz, CHe, M+m), 
145.6 (d, 4JCP = 3.6 Hz, 2x Cq).
 31P-NMR (162 MHz, CDCl3)  26.88 (M), 26.74 (m). IR (ATR, cm
-1) νmax: 
1026 (P-O), 1242 (P=O), 1466, 2952. MS (ESI, pos): m/z (%) 218.1/219.1 (M-[P(O)(OMe)2]
-, 100/18) 
328.0/329.0 (M+H+, 40/8). HRMS: m/z calcd for C17H30NO3P+H
+ 328.2036, found 328.2036. 
Chromatography: EtOAc, Rf = 0.38. 
dimethyl ((1E,3E)-5-(4-aminophenyl)-5-phenylpenta-1,3-dien-1-yl)phosphonate 363 
294 mg (1.26 mmol) of (1E,2E,4E)-N-phenyl-5-phenylpenta-2,4-dien-1-
imine 32e was converted into 363 using 2 equiv of DMPTMS and 2 
equiv H2SO4. After column chromatography, 255 mg was obtained (0.74 
mmol, 59% yield, yellow oil). 1H-NMR (400 MHz, CDCl3) 3.63 (2H, br s, 
NH2), 3.71 (6H, d, 
3JHP = 11.1 Hz, 2x OCH3), 4.73 (1H, d, J = 7.2 Hz, CHe), 
5.55 (1H, dd, 2JHP = 19.5 Hz, J = 16.9 Hz, CHa), 6.04 (1H, dd, J = 15.1 Hz, J = 10.7 Hz, CHc), 6.51 (1H, dd, J 
= 15.1 Hz, J = 7.2 Hz, CHd), 6.63 (2H, d, J = 8.2 Hz, 2x CHar), 6.93 (2H, d, J = 8.2 Hz, 2x CHar), 7.21-7.24 
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(4H, m, 3x CHar + CHb), 7.27-7.32 (2H, m, 2x CHar). 
13C-NMR (100 MHz, CDCl3)  52.3 (d, 
2JCP = 5.6 Hz, 
2x OCH3), 53.3 (CHe), 114.4 (d, 
1JCP = 191.4 Hz, CHa), 115.2 (2x CHar), 126.6 (CHar), 128.52 (2x CHar), 
128.54 (2x CHar), 129.4 (2x CHar), 130.1 (d, 
3JCP = 27.0 Hz, CHc), 131.9 (Cq,ar), 142.9 (Cq,ar), 145.3 (Cq,ar), 
145.8 (CHd), 149.6 (d, 
2JCP = 6.0 Hz). 
31P-NMR (162 MHz, CDCl3)  22.20. IR (ATR, cm
-1) νmax: 1021 (P-
O), 1235 (P=O), 1514, 1636, 2950, 3343. MS (ESI, pos): m/z (%) 343.9/344.9 (M+H+, 100/20). HRMS: 
m/z calcd for C19H22NO3P+H
+ 344.1410, found 344.1408. Chromatography: EtOAc, Rf = 0.12. 
3.3.3 Synthesis of α-N-(2-chloroacetamido)phosphonate 364 
In a flame dried round-bottom flask equipped with a magnetic stirring bar dimethyl ((2E,4E)-1-
(benzylamino)-5-phenylpenta-2,4-dien-1-yl)phosphonate 362b was dissolved in dry THF under a N2-
atmosphere. Chloroacetyl chloride (1.5 equiv) was added along with 2 equiv pyridine and the 
reaction mixture was stirred at room temperature for 1 h. Then the reaction mixture was poured into 
a saturated NaHCO3-solution and extracted thrice with diethyl ether. The combined organic layers 
were washed with 2 M HCl, after which the resulting aqueous layer was extracted with diethyl ether 
again twice. The resulting combined organic layers were dried over MgSO4, filtered and concentrated 
in vacuo. 
dimethyl ((2E,4E)-1-(N-benzyl-2-chloroacetamido)-5-phenylpenta-2,4-dien-1-yl)phosphonate 364 
180 mg (0.50 mmol) of dimethyl ((2E,4E)-1-(benzylamino)-5-phenylpenta-
2,4-dien-1-yl)phosphonate 362b was converted into 364. After work-up, 
214 mg was obtained (0.495 mmol, 99% yield, yellow oil). 1H-NMR (400 
MHz, CDCl3) 3.77 (3H, d, 
3JHP = 10.8 Hz, OCH3), 3.81 (3H, d, 
3JHP = 10.8 Hz, 
OCH3), 3.89 (1H, d, J = 12.7 Hz, ClCHaHb), 3.97 (1H, d, J = 12.7 Hz, ClCHaHb), 
4.82 (1H, d, J = 18.3 Hz, NCHcHd), 4.98 (1H, d, J = 18.3 Hz, NCHcHd), 5.58 (1H, dd, 
2JHP = 20.9 Hz, J = 9.4 
Hz, NCHP), 5.80 (1H, ddd, J = 16.2 Hz, J = 8.1 Hz, 3JHP = 8.1 Hz, CHe), 6.52-6.67 (3H, m, Hf, Hg, Hh), 7.20-
7.23 (3H, m, 3x CHar), 7.27-7.38 (7H, m, 7x CHar). 
13C-NMR (100 MHz, CDCl3)  41.5 (CH2Cl), 49.8 
(NCH2), 53.2 (d, 
2JCP = 7.1 Hz, OCH3), 54.0 (d, 
2JCP = 6.6 Hz, OCH3), 54.7 (d, 
1JCP = 157.3 Hz, NCHP), 122.2 
(CHe), 126.0 (2x CHar), 126.6 (2x CHar), 127.2 (CHg), 127.8 (CHar), 128.1 (CHar), 128.7 (2x CHar), 129.0 (2x 
CHar), 135.0 (d, 
5JCP = 1.8 Hz, CHh), 136.56 (Cq,ar), 136.63 (Cq,ar), 137.9 (d, 
3JCP = 13.6 Hz, CHf), 167.4 (d, 
3JCP = 2.9 Hz, C=O). 
31P-NMR (162 MHz, CDCl3)  22.96. IR (ATR, cm
-1) νmax: 1026 (P-O), 1051 (P-O), 
1251 (P=O), 1448, 1660 (C=O), 2954. MS (ESI, pos): m/z (%) 433.8/435.8 (M+H+, 15/5). HRMS: m/z 
calcd for C22H25ClNO4P+H
+ 434.1283, found 434.1267. 
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3.3.4 Synthesis of phosphonylated β-lactams 365 
In a flame dried round-bottom flask equipped with a magnetic stirring bar 2-chloroacetamide 364 
was dissolved in dry THF under a N2-atmosphere. LiHMDS (1.1 equiv, 1 M solution) was added in a 
dropwise fashion and the reaction mixture was kept at room temperature for 1 hour. Then the 
reaction mixture was poured into water and extracted thrice using ethyl acetate. The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. The crude product was 
purified using preparative TLC. 
dimethyl (1-benzyl-4-oxo-2-((1E,3E)-4-phenylbuta-1,3-dien-1-yl)azetidin-2-yl)phosphonate 365 
160 mg dimethyl ((2E,4E)-1-(N-benzyl-2-chloroacetamido)-5-
phenylpenta-2,4-dien-1-yl)phosphonate 364 was converted into 365. 
After preparative TLC, 54 mg was obtained (0.136 mmol, 37% yield, 
yellow oil). 1H-NMR (400 MHz, CDCl3) 3.02 (1H, dd, J = 14.6 Hz, 
3JHP = 
5.8 Hz, C=OCHaHb), 3.43 (1H, dd, J = 14.6 Hz, 
3JHP = 8.1 Hz, C=OCHaHb), 
3.72 (3H, d, 3JHP = 10.6 Hz, OCH3), 3.75 (3H, d, 
3JHP = 10.6 Hz, OCH3), 4.41 (1H, d, J = 15.4 Hz, NCHcHd), 
4.63 (1H, d, J = 15.4 Hz, NCHcHd), 5.81 (1H, dd, J = 15.5 Hz, 
3JHP = 9.5 Hz, CHe), 6.36 (1H, ddd, J = 15.5 
Hz, J = 10.4 Hz, 4JHP = 3.3 Hz, CHf), 6.42 (1H, d, J = 15.6 Hz, CHh), 6.60 (1H, dd, J = 15.6 Hz, J = 10.4 Hz, 
CHg), 7.22-7.42 (10H, m, 10x CHar). 
13C-NMR (100 MHz, CDCl3)  45.9 (NCH2), 48.0 (C=OCH2), 53.6 (d, 
2JCP = 7.5 Hz, OCH3), 53.9 (d, 
2JCP = 7.2 Hz, OCH3), 59.1 (d, 
1JCP = 167.6 Hz, NCqP), 126.1 (d, 
2JCP = 6.6 Hz, 
CHe), 126.6 (2x CHar), 127.1 (d, 
4JCP =2.3 Hz, CHg), 127.7 (CHar), 128.1 (CHar), 128.6 (2x CHar), 128.7 (2x 
CHar), 128.9 (2x CHar), 134.8 (d, 
3JCP = 9.5 Hz, CHf), 135.0 (d, 
5JCP = 2.6 Hz, CHh), 136.56 (Cq,ar), 136.59 
(Cq,ar), 166.2 (d, 
3JCP = 8.0 Hz, C=O).
 31P-NMR (162 MHz, CDCl3)  23.31. IR (ATR, cm
-1) νmax: 1026 (P-O), 
1252 (P=O), 1751 (C=O), 2954. MS (ESI, pos): m/z (%) 397.9/398.9 (M+H+, 100/20). HRMS: m/z calcd 
for C22H24NO4P+H
+ 398.1516, found 398.1513. Chromatography: EtOAc, Rf = 0.47. 
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3.4 Gold-superacid catalyzed preparation of benzo[c]thiophenes 
3.4.1 Synthesis of 2-formyl-6-methoxyphenyl trifluoromethanesulfonate 372h 
2-Hydroxy-3-methoxybenzaldehyde was triflated according to an adapted literature procedure.[371] In 
a round-bottom flame-dried flask, a suitable phenol (1 equiv) was dissolved in dry toluene under a 
N2-atmosphere and cooled to 0 °C. Next, pyridine (2 equiv) and triflic anhydride (1.2 equiv) were 
added in a dropwise fashion. The mixture was then stirred at room temperature for 1 h. Then, the 
crude mixture was concentrated in vacuo. Diethyl ether was added to the residue and the mixture 
was neutralized using NaHCO3. After extraction (3x 10 mL diethyl ether) the product was dried over 
MgSO4 and concentrated in vacuo. Spectral data are in accordance with reported values.
[401] 
1H-NMR (400 MHz, CDCl3) 3.96 (3H, s, OCH3), 7.31 (1H, dd, J = 8.0 Hz, J = 1.6 Hz, CHar), 
7.47 (1H, dd, J = 8.0 Hz, J = 8.0 Hz, CHar), 7.53 (1H, dd, J = 8.0 Hz, J = 1.6 Hz, CHar), 10.25 
(1H, s, CHO). Yield: 90%, colorless oil. 
 
3.4.2 Synthesis of ortho-ethynyl aromatic aldehydes 371 
A number of 2-bromobenzaldehydes and 2-formyl-6-methoxyphenyl trifluoromethanesulfonate 372h 
were subjected to a Sonogashira coupling and subsequent deprotection. 2-Ethynylbenzaldehyde is 
commercially available. Representative procedure: 5.32 g 2-bromo-4,5-dimethoxybenzaldehyde 
(21.2 mmol, 1 equiv), 0.30 g PdCl2(PPh3)2 (0.43 mmol, 2 mol%) and 83 mg CuI (0.43 mmol, 2 mol%) 
were dissolved in 20 mL Et3N in a 50 mL round-bottom flask under N2-athmosphere. 3.70 mL TMS-
acetylene was added in a dropwise fashion (26.0 mmol, 1.2 equiv) after which the reaction mixture 
was heated to reflux temperature. After completion of the reaction according to HPLC analysis, the 
solvent was removed in vacuo and the crude was then redissolved in ethyl acetate and filtered 
through a thick layer (ca. 5 cm) of Celite®. The filtrate was concentrated in vacuo, redissolved in 
methanol and 0.99 g of K2CO3 (7.2 mmol, 0.33 equiv) was added. As such, the reaction mixture was 
stirred for 15 minutes at room temperature. The solvent was removed in vacuo and the crude 
reaction mixture was dissolved in a saturated NaHCO3 solution with ethyl acetate and extracted 3 
times with ethyl acetate (3x 20 mL). The combined organic fractions were dried over MgSO4 and 
concentrated in vacuo. 3.83 g (20.1 mmol, 95%) of 371f was obtained. The spectral data, if available, 
were in accordance with reported values. If necessary, column chromatography or recrystallization 
was performed. 
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2-ethynyl-4,5-dimethxoybenzaldehyde 371f[402] 
1H-NMR (400 MHz, CDCl3) 3.39 (1H, s, C≡CH), 3.95 (3H, s, OCH3), 3.97 (3H, s, 
OCH3), 7.03 (1H, s, CHar), 7.41 (1H, s, CHar), 10.39 (1H, s, CHO). Yield: 95%, pale 
brown solid. 
2-ethynyl-4-fluorobenzaldehyde 371b[403] 
1H-NMR (400 MHz, CDCl3) 3.51 (1H, s, C≡CH), 7.19 (1H, ddd, J = 8.7 Hz, 
3JHF = 8.4 Hz, 
J = 2.5 Hz, CHar), 7.30 (1H, dd, 
3JHF = 8.7 Hz, J = 2.5 Hz, CHar), 7.97 (1H, dd, J = 8.7 Hz, 
4JHF 
= 5.8 Hz, CHar), 10.46 (1H, s, CHO). Yield: 92%, pale yellow solid. 
2-ethynyl-5-fluorobenzaldehyde 371c[403]  
1H-NMR (400 MHz, CDCl3) 3.44 (1H, s, C≡CH), 7.29 (1H, dd, 
3JHF = 8.4 Hz, J = 2.8 Hz, 
CHar), 7.58-7.64 (2H, m, 2x CHar), 10.49 (1H, d, 
5JHF = 3.2 Hz, CHO). Yield: 92%, grey 
solid. 
5-chloro-2-ethynylbenzaldehyde 371d[403]  
1H-NMR (400 MHz, CDCl3) 3.50 (1H, s, C≡CH), 7.53 (1H, dd, J = 8.3 Hz, J = 2.1 Hz, 
CHar), 7.56 (1H, dd, J = 8.3 Hz, J = 0.6 Hz, CHar), 7.90 (1H, dd, J = 2.1 Hz, J = 0.6 Hz, 
CHar), 10.48 (1H, s, CHO). Yield: 94%, white solid. 
2-ethynyl-5-methylbenzaldehyde 371e 
1H-NMR (300 MHz, CDCl3) 2.38 (3H, s, CH3), 3.41 (1H, s, C≡CH), 7.26 (1H, d, J = 8.3 
Hz, CHar), 7.40 (1H, s, CHar), 7.81 (1H, d, J = 8.3 Hz, CHar), 10.45 (1H, s, CHO). Yield: 
72%. 
6-ethynylbenzo[d][1,3]dioxole-5-carbaldehyde 371g[404] 
1H-NMR (400 MHz, CDCl3) 3.37 (1H, s, C≡CH), 6.08 (2H, s, CH2), 6.99 (1H, s, CHar), 
7.35 (1H, s, CHar), 10.38 (1H, s, CHO). Yield: 60%, grey solid. 
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2-ethynyl-3-methoxybenzaldehyde 371h 
1H-NMR (400 MHz, CDCl3) 3.70 (1H, s, C≡CH), 3.96 (3H, s, OCH3), 7.14 (1H, dd, J = 8.1 
Hz, J = 0.9 Hz, CHar), 7.44 (1H, dd, J = 8.1 Hz, J = 7.9 Hz, CHar), 7.54 (1H, dd, J = 7.9 Hz, J = 
0.9 Hz, CHar), 10.55 (1H, s, CHO). Yield: 76%, grey solid. 
 
3-ethynylthiophene-2-carbaldehyde 371i[403]  
1H-NMR (400 MHz, CDCl3) 3.46 (1H, s, C≡CH), 7.22 (1H, d, J = 5.0 Hz, CHar), 7.68 (1H, dd, 
J = 5.0 Hz, J = 1.3 Hz, CHar), 10.15 (1H, d, J = 1.3 Hz, CHO). Yield: 87%, yellow solid. 
 
2-(phenylethynyl)benzaldehyde 371j[405]  
Instead of TMS-acetylene, phenylacetylene was used for the Sonogashira coupling. 
Evidently, no K2CO3-treatment was performed. 
1H-NMR (400 MHz, CDCl3) 7.38-
7.41 (3H, m, 3x CHar), 7.44-7.48 (1H, m, CHar), 7.55-7.67 (4H, m, 4x CHar), 7.96 (1H, 
d, J = 8.2 Hz, CHar), 10.66 (1H, d, J = 0.8 Hz, CHO). Yield: 72%, yellow oil. 
3.4.3 Synthesis of diallyl thioacetals 376 
3.4.3.1 Distillation of allyl mercaptan  
Commercially available allyl mercaptan is only ca. 60% pure so a purification step before use was 
essential. The setup as depicted in the figure below was used, due to the very pungent, unpleasant 
odor of the product: a round-bottom flask filled with allyl mercaptan was equipped with a vigreux 
column, a thermometer and a standard distillation piece. To this distillation piece, a water cooler was 
connected and the distillate was collected in a flame-dried round-bottom flask filled with 4Å 
molecular sieves that was cooled to -78 °C. A pump was attached to the setup and all connections 
were sealed with vacuum grease. The outlet of the pump was connected to two washing flasks, the 
first one containing a 5 wt% H2O2 solution and the other one containing a 0.5 M NaOH solution, in 
order to oxidize or deprotonate any residual allyl mercaptan and avoid spreading of the odor. 
Evidently, the distillation was performed in a working fume hood. After the distillation, all glassware 
was cleaned using a H2O2 solution. Allyl mercaptan was obtained as a colorless, clear liquid (bp 33-35 
°C, 380 mbar) and was stored at -18 °C under an inert atmosphere. 
V. Experimental procedures 
171 
 
 
3.4.3.2 Synthesis of crotyl mercaptan 375 
Crotyl mercaptan 375 (but-2-ene-1-thiol) was prepared according to a literature procedure.[373] A 
mixture of crotyl alcohol (10 g, 0.139 mol), thiourea (1 equiv, 12.5 g, 0.139 mol) and 20 mL 48% HBr 
were heated to reflux for 30 minutes. Then, the reaction mixture was treated with 250 mL 6 M NaOH 
for 1.5 h at room temperature. Next, the resulting mixture was subjected to steam distillation The 
same precautions as with the distillation of allyl mercaptan were taken due to the very pungent odor 
of the product. After distillation and separation in a separatory funnel, 6 mL of crude crotyl 
mercaptan was obtained in an E/Z ratio of 94/6 (5.07 g, 58 mmol, 41% yield). Crotyl mercaptan was 
stored at -18 °C under an inert atmosphere. Crotyl mercaptan was assumed to have the same density 
as crotyl alcohol (0.845 g/mL). 
Spectral data are reported for the E-isomer only. 1H-NMR (400 MHz, CDCl3) 1.43 (1H, 
br s, SH), 1.66-1.68 (3H, m, CH3), 3.11-3.13 (2H, m, SHCH2), 5.56-5.59 (2H, m, CH=CH). 
13C-NMR (75 MHz, CDCl3)  17.5 (CH3), 26.8 (SCH2), 126.7 (CH=CHCH3), 130.2 (CH=CHCH3). Yield: 41%, 
colorless liquid. 
3.4.3.3 Synthetic procedures 
Method A: representative example: in a 25 mL round-bottom flask 0.4 g (3.1 mmol, 1 equiv) 2-
ethynylbenzaldehyde 371a and 0.5 g (6.8 mmol, 2.2 equiv) freshly distilled allyl mercaptan (380 
mbar, 33-35 °C – CAUTION: very pungent smell, take precautions during distillation, vide supra) were 
dissolved in 4 mL toluene and 2 mL acetic acid. The flask was cooled to 0 °C and 0.44 g (3.1 mmol, 1 
equiv) BF3·OEt2 was added in a dropwise fashion. The reaction mixture was stirred at room 
temperature and the progress was monitored using HPLC. After completion, it was diluted with 8 mL 
dichloromethane and washed three times with water (8 mL). After drying over MgSO4 and removal of 
V. Experimental procedures 
172 
 
the volatiles, the crude product was purified by means of column chromatography. 0.67 g (2.57 
mmol, 83%) of 376a was obtained. 
Method B: representative example: in a 25 mL round-bottom flask 0.2 g (1.1 mmol, 1 equiv) 2-
ethynyl-4,5-dimethoxybenzaldehyde 371f and 34 mg (0.21 mmol, 0.2 equiv) anhydrous Cu(II)SO4 
were dissolved in 10 mL dry dichloromethane under N2-atmosphere. 0.19 mL (2.31 mmol, 2.2 equiv) 
freshly distilled allyl mercaptan (380 mbar, 33-35 °C – CAUTION: very pungent smell, take 
precautions during distillation, vide supra) was added to this flask in a dropwise fashion and the 
reaction mixture was heated to reflux temperature. The reaction progress was monitored using 
HPLC. After completion, the mixture was poured into water and extracted thrice using 
dichloromethane (3x 10 mL). After drying over MgSO4 and removal of the volatiles, the crude was 
purified by means of column chromatography. 0.12 g (0.37 mmol, 34%) of 376f was obtained. 
((2-ethynylphenyl)methylene)bis(allylsulfane) 376a, prepared by method A 
1H-NMR (300 MHz, CDCl3) 3.09 (2H, dd, J = 13.9Hz, J = 7.2Hz, 2x SCHaHb), 3.29 
(2H, dd, J = 13.9 Hz, J = 7.2 Hz, 2x SCHaHb), 3.33 (1H, s, C≡CH), 5.08 (2H, dd, J = 9.9 
Hz, J = 1.1 Hz, 2x CH=CHEHZ), 5.14 (2H, dd, J = 16.9 Hz, J = 1.1 Hz, 2x CH=CHEHZ), 
5.47 (1H, s, CHS2), 5.81 (2H, ddt, J = 16.9Hz, J = 9.9Hz, J = 7.2 Hz, 2x CH=CHEHZ), 
7.21 (1H, dd, J = 7.7 Hz, CHar), 7.37 (1H, dd, J = 7.7 Hz, CHar), 7.46 (1H, d, J = 7.7 Hz, CHar), 7.76 (1H, d, J 
= 7.7 Hz, CHar). 
13C-NMR (75 MHz, CDCl3)  35.6 (2x SCH2), 48.3 (CHS2), 81.3 (C≡CH), 82.9 (C≡CH), 
117.8 (2x CH=CH2), 121.0 (Cq,arC≡CH), 127.6 (CHar), 128.5 (CHar), 129.5 (CHar), 132.8 (CHar), 133.7 (2x 
CH=CH2), 142.8 (Cq,ar). IR (ATR, cm
-1) νmax: 1634 (CH=CH2), 3288 (C≡CH). MS (ESI, pos): m/z (%) 187.1 
(M-[SCH2CH=CH2]
-, 75). HRMS: m/z calcd for C15H16S2+H
+ 261.0771, found 261.0765. 
Chromatography: hexanes/EtOAc 98/2. Rf = 0.21. Yield: 83%, yellow oil. 
((2-ethynyl-4-fluorophenyl)methylene)bis(allylsulfane) 376b, prepared by method A 
1H-NMR (400 MHz, CDCl3) 3.08 (2H, dddd, J = 13.7 Hz, J = 7.0 Hz, J = 1.2 Hz, J = 
0.9 Hz, 2x SCHaHb), 3.29 (2H, dddd, J = 13.7 Hz, J = 7.3 Hz, J = 1.2 Hz, J = 0.9 Hz, 
2x SCHaHb), 3.36 (1H, s, C≡CH), 5.08 (2H, dddd, J = 9.9 Hz, J = 1.4 Hz, J = 0.9Hz, J 
= 0.9 Hz, 2x CH=CHEHZ), 5.13 (2H, ddt, J = 17.0Hz, J = 1.4 Hz, J = 1.2 Hz, 2x 
CH=CHEHZ), 5.40 (1H, s, CHS2), 5.79 (2H, dddd, J = 17.0 Hz, J = 9.9 Hz, J = 7.3 Hz, J = 7.0 Hz, 2x 
CH=CHEHZ), 7.09 (1H, ddd, J = 8.6 Hz, 
3JHF = 8.4Hz, J = 2.7 Hz, CHar), 7.14 (1H, dd, 
3JHF = 8.9 Hz, J = 2.7 
Hz, CHar), 7.75 (1H, dd, J = 8.6 Hz, 
4JHF = 5.7 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  35.5 (2x SCH2), 47.4 
(CHS2), 80.1 (C≡CH), 83.7 (C≡CH), 117.0 (d, 
2JCF = 21.5Hz, CHar), 117.8 (2x CH=CH2), 119.0 (d, 
2JCF = 
23.4 Hz, CHar), 122.6 (d, 
3JCF = 9.6 Hz, Cq,ar), 130.4 (d, 
3JCF = 8.9 Hz, CHar), 133.6 (2x CH=CH2), 138.4 (d, 
V. Experimental procedures 
173 
 
4JCF = 3.3 Hz, Cq,arCHS2), 161.3 (d, 
1JCF = 247.7 Hz, Cq,arF). 
19F-NMR (376 MHz, CDCl3) -114.52 to -
114.59 (m). IR (ATR, cm-1) νmax: 1265, 1487, 1578, 1635 (CH=CH2), 2912, 3081, 3296. MS (ESI, pos): 
m/z (%) 205.0 (M-[SCH2CH=CH2]
-, 100). HRMS: m/z calcd for C12H10FS
+ (M-[SCH2CH=CH2]
-) 205.0482, 
found 205.0478. Chromatography: hexanes/EtOAc 99/1. Rf = 0.21. Yield: 75%, yellow oil. 
((2-ethynyl-5-fluorophenyl)methylene)bis(allylsulfane) 376c, prepared by method A 
1H-NMR (300 MHz, CDCl3) 3.09 (2H, dd, J = 13.7 Hz, J = 7.2 Hz, 2x SCHaHb), 3.30 
(2H, dd, J = 13.7 Hz, J = 7.2 Hz, 2x SCHaHb), 3.31 (1H, s, C≡CH), 5.08 (2H, dd, J = 
9.9 Hz, J = 1.6 Hz, 2x CH=CHEHZ), 5.13 (2H, dd, J = 17.1 Hz, J = 1.1 Hz, 2x 
CH=CHEHZ), 5.40 (1H, d, 
5JHF = 1.7 Hz, CHS2), 5.80 (2H, ddt, J = 17.1 Hz, J = 9.9 Hz, 
J = 7.2 Hz, 2x CH=CHEHZ), 6.93 (1H, ddd, 
3JHF = 8.3 Hz, J = 8.3 Hz, J = 2.7 Hz, CHar), 7.44 (1H, dd, J = 8.3 
Hz, 4JHF = 5.5 Hz, CHar), 7.50 (1H, dd, 
3JHF = 9.6 Hz, J = 2.7 Hz, Cq,arCHarCF). 
13C-NMR (75 MHz, CDCl3)  
35.6 (2x SCH2), 47.9 (CHS2), 80.4 (C≡CH), 82.6 (C≡CH), 115.3 (d, 
2JCF = 23.1 Hz, CHar), 115.7 (d, 
2JCF = 
24.2 Hz, CHar), 117.1 (d, 
4JCF = 2.3 Hz, Cq,arC≡CH), 118.0 (2x CH=CH2), 133.5 (2x CH=CH2), 134.6 (d, 
3JCF 
= 9.2 Hz, CHar), 145.4 (d, 
3JCF = 6.9 Hz, Cq,arCHS2), 163.1 (d, 
1JCF = 250.4 Hz, Cq,arF). 
19F-NMR (282 MHz, 
CDCl3): -108.48 to -108.55 (m). IR (ATR, cm
-1) νmax: 1633 (CH=CH2), 3301 (C≡CH). MS (ESI, pos): m/z 
(%): 205.0 (M-[SCH2CH=CH2]
-, 100). HRMS: m/z calcd for C15H15FS2+H
+ 279.0677, found 279.0672. 
Chromatography: hexanes/EtOAc 98/2. Rf = 0.23. Yield: 86%, pale yellow oil. 
((5-chloro-2-ethynylphenyl)methylene)bis(allylsulfane) 376d, prepared by method A 
1H-NMR (400 MHz, CDCl3) 3.09 (2H, dddd, J = 13.7 Hz, J = 7.1 Hz, J = 1.2 Hz, J 
= 0.8 Hz, 2x SCHaHb), 3.30 (2H, dddd, J = 13.7 Hz, J = 7.4 Hz, J = 1.2 Hz, J = 0.8 Hz, 
2x SCHaHb), 3.35 (1H, s, C≡CH), 5.08 (2H, dddd, J = 9.9 Hz, J = 1.5 Hz, J = 1.2 Hz, 
J = 0.8 Hz, 2x CH=CHEHZ), 5.14 (2H, dddd, J = 17.0 Hz, J = 1.5 Hz, J = 1.2 Hz, J = 
0.8 Hz, 2x CH=CHEHZ), 5.37 (1H, s, CHS2), 5.80 (2H, dddd, J = 17.0 Hz, J = 9.9 Hz, J = 7.4 Hz, J = 7.1 Hz, 
2x CH=CHEHZ), 7.20 (1H, dd, J = 8.3 Hz, J = 2.2 Hz, CHar), 7.38 (1H, d, J = 8.3 Hz, CHar), 7.76 (1H, d, J = 
2.2 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  35.6 (2x SCH2), 47.7 (CHS2), 80.2 (C≡CH), 83.7 (C≡CH), 
118.0 (2x CH=CH2), 119.4 (Cq,ar), 128.0 (CHar), 128.7 (CHar), 133.4 (2x CH=CH2), 133.8 (CHar), 135.5 
(Cq,ar), 144.3 (Cq,ar). IR (ATR, cm
-1) νmax: 1475, 1588, 1634 (CH=CH2), 2914, 3081, 3293. MS (ESI, pos): 
m/z (%): 221.0 (M-[SCH2CH=CH2]
-, 100). HRMS: m/z calcd for C12H10ClS
+ (M-[SCH2CH=CH2]
-) 221.0186, 
found 221.0185. Chromatography: hexanes/EtOAc 99/1. Rf = 0.09. Yield: 70%, yellow oil. 
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 ((2-ethynyl-5-methylphenyl)methylene)bis(allylsulfane) 376e, prepared by method A 
1H-NMR (300 MHz, CDCl3) 2.31 (3H, s, CH3), 3.08 (2H, dd, J = 13.5 Hz, J = 7.2 
Hz, 2x SCHaHb), 3.28 (2H, dd, J = 13.5 Hz, J = 7.2 Hz, 2x SCHaHb), 3.29 (1H, s, 
C≡CH), 5.07 (2H, dd, J = 9.9 Hz, J = 1.6 Hz, 2x CH=CHEHZ), 5.13 (2H, dd, J = 16.9 
Hz, J = 1.6 Hz, 2x CH=CHEHZ), 5.42 (1H, s, CHS2), 5.80 (2H, ddt, J = 16.9 Hz, J = 
9.9 Hz, J = 7.2 Hz, 2x CH=CHEHZ), 7.19 (1H, d, J = 8.3 Hz, CHar), 7.27 (1H, s, CHar), 7.64 (1H, d, J = 8.3 Hz, 
CHar). 
13C-NMR (75 MHz, CDCl3) 21.0 (CH3), 35.5 (2x SCH2), 48.0 (CHS2), 81.4 (C≡CH), 82.4 (C≡CH), 
117.8 (2x CH=CH2), 120.8 (Cq,arC≡CH), 128.4 (CHar), 130.5 (CHar), 133.2 (CHar), 133.8 (2x CH=CH2), 
137.5 (Cq,arCH3), 139.4 (Cq,arCHS2). MS (ESI, pos): m/z (%): 201 (M-[SCH2CH=CH2]
-, 100). HRMS: m/z 
calcd for C16H18S2+H
+ 275.0928, found 275.0921. IR (ATR, cm-1) νmax: 1634 (CH=CH2), 3305 (C≡CH). 
Chromatography: hexanes/EtOAc 98/2. Rf = 0.19. Yield: 67%, yellow oil. 
((2-ethynyl-4,5-dimethoxyphenyl)methylene)bis(allylsulfane) 376f, prepared by method B 
1H-NMR (400 MHz, CDCl3) 3.10 (2H, dddd, J = 13.6 Hz, J = 7.0 Hz, J = 1.2 Hz, 
J = 1.0 Hz, 2x SCHaHb), 3.25 (1H, s, C≡CH), 3.27 (2H, dddd, J = 13.6 Hz, J = 7.3 
Hz, J = 1.2 Hz, J = 1.0 Hz, 2x SCHaHb), 3.87 (3H, s, OCH3), 3.87 (3H, s, OCH3), 
5.08 (2H, dddd, J = 9.9 Hz, J = 1.5 Hz, J = 1.0 Hz, J = 1.0 Hz, 2x CH=CHEHZ), 5.15 
(2H, dddd, J = 17.0 Hz, J = 1.5 Hz, J = 1.2 Hz, J = 1.2 Hz, 2x CH=CHEHZ), 5.42 (1H, s, CHS2), 5.82 (2H, 
dddd, J = 17.0 Hz, J = 9.9 Hz, J = 7.3 Hz, J = 7.0 Hz, 2x CH=CHEHZ), 6.90 (1H, s, CHar), 7.26 (1H, s, CHar). 
13C-NMR (100 MHz, CDCl3)  35.6 (2x SCH2), 48.0 (CHS2), 56.0 (2x CqOCH3), 81.3 (C≡CH), 81.3 (C≡CH), 
110.8 (CHar), 112.8 (Cq,ar), 114.2 (CHar), 117.7 (2x CH=CH2), 133.6 (2x CH=CH2), 135.8 (Cq,ar), 148.1 
(Cq,ar), 150.3 (Cq,ar). MS (ESI, pos): m/z (%): 247.1 (M-[SCH2CH=CH2]
-, 75), 321.1 (M+H+, 25). HRMS: 
m/z calcd for C17H20O2S2+H
+ 321.0978, found 321.0976. IR (ATR, cm-1) νmax: 1505, 1601, 1634 
(CH=CH2), 2912, 3280. Chromatography: hexanes/EtOAc 9/1. Rf = 0.20. Yield: 34%, brown oil. 
((2-ethynyl-3-methoxyphenyl)methylene)bis(allylsulfane) 376h, prepared by method A 
1H-NMR (400 MHz, CDCl3) 3.10 (2H, dddd, J = 13.5 Hz, J = 7.0 Hz, J = 1.2 Hz, J = 
0.9 Hz, 2x SCHaHb), 3.29 (2H, dddd, J = 13.5 Hz, J = 7.3 Hz, J = 1.2 Hz, J = 0.9 Hz, 2x 
SCHaHb), 3.58 (1H, s, C≡CH), 3.90 (3H, s, OCH3), 5.07 (2H, dddd, J = 10.0 Hz, J = 1.5 
Hz, J = 0.9 Hz, J = 0.9 Hz, 2x CH=CHEHZ), 5.15 (2H, dddd, J = 17.0 Hz, J = 1.5 Hz, J = 
1.2 Hz, J = 1.2 Hz, 2x CH=CHEHZ), 5.47 (1H, s, CHS2), 5.81 (2H, dddd, J = 17.0 Hz, J = 10.0 Hz, J = 7.3 Hz, 
J = 7.0 Hz, 2x CH=CHEHZ), 6.81 (1H, dd, J = 7.9 Hz, J = 1.3 Hz, CHar), 7.33 (1H, dd, J = 7.9 Hz, J = 7.9 Hz, 
CHar), 7.37 (1H, dd, J = 7.9 Hz, J = 1.3 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  35.5 (2x SCH2), 48.1 
(CHS2), 56.1 (OCH3), 77.4 (C≡CH), 87.2 (C≡CH), 109.5 (CHar), 110.1 (Cq,ar), 117.8 (2x CH=CH2), 120.6 
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(CHar), 130.1 (CHar), 133.7 (2x CH=CH2), 144.4 (Cq,ar), 160.6 (Cq,ar). IR (ATR, cm
-1) νmax: 1270, 1468, 
1573, 1633 (CH=CH2), 2913, 3265. MS (ESI, pos): m/z (%): 217.1 (M-[SCH2CH=CH2]
-, 90), 291.1 (M+H+, 
10). HRMS: m/z calcd for C13H13OS
+ (M-[SCH2CH=CH2]
-) 217.0682, found 217.0683. Chromatography: 
hexanes/EtOAc 96/4. Rf = 0.23. Yield: 45%, yellow oil. 
((2-(phenylethynyl)phenyl)methylene)bis(allylsulfane) 376j, prepared by method A 
1H-NMR (400 MHz, CDCl3) 3.10 (2H, dddd, J = 13.7 Hz, J = 7.1 Hz, J = 1.3 Hz, J = 
1.0 Hz, 2x SCHaHb), 3.32 (2H, dddd, J = 13.7 Hz, J = 7.3 Hz, J = 1.2 Hz, J = 0.9 Hz, 2x 
SCHaHb), 5.02 (2H, dddd, J = 10.0 Hz, J = 1.5 Hz, J = 1.0 Hz, J = 0.9 Hz, 2x CH=CHEHZ), 
5.15 (2H, dddd, J = 17.0 Hz, J = 1.5 Hz, J = 1.3 Hz, J = 1.2 Hz, 2x CH=CHEHZ), 5.54 (1H, 
s, CHS2), 5.81 (2H, dddd, J = 17.0 Hz, J = 10.0 Hz, J = 7.3 Hz, J = 7.1 Hz, 2x 
CH=CHEHZ), 7.23-7.27 (1H, m, CHar), 7.34-7.40 (4H, m, 4 x CHar), 7.49-7.55 (3H, m, 3 x CHar), 7.77 (1H, 
dd, J = 7.9 Hz, J = 1.1 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  35.5 (2x SCH2), 48.2 (CHS2), 87.1 (C≡C), 
94.8 (C≡C), 117.8 (2x CH=CH2), 122.1 (Cq,ar), 123.2 (Cq,ar), 127.7 (CHar), 128.5 (3 x CHar), 128.6 (CHar), 
129.0 (CHar), 131.5 (2x CHar), 132.2 (CHar), 133.8 (2x CH=CH2), 141.7 (Cq,ar). IR (ATR, cm
-1) νmax: 1422, 
1442, 1491, 1636 (CH=CH2), 2978. MS (ESI, pos): m/z (%): 263.1 (M-[SCH2CH=CH2]
-, 80). HRMS: m/z 
calcd for C18H15S
+ (M-[SCH2CH=CH2]
-) 263.0889, found 263.0886. Chromatography: hexanes/EtOAc 
98/2. Rf = 0.26. Yield: 69%, yellow oil. 
((2-ethynylphenyl)methylene)bis(but-2-en-1-ylsulfane) 376k, prepared by method A 
This compound was obtained as a mixture of E/Z stereoisomers in a 9/1 E,E/E,Z 
ratio, according to 1H-NMR integration. Spectral data are reported for the E,E 
isomer. 1H-NMR (400 MHz, CDCl3) 1.68 (6H, dd, J = 6.1 Hz, J = 1.1 Hz, 2x CH3), 
3.02 (2H, ddd, J = 13.5 Hz, J = 6.8 Hz, J = 1.0 Hz, 2x SCHaHb), 3.23 (2H, ddd, J = 
13.5 Hz, J = 7.3 Hz, J = 0.9 Hz, 2x SCHaHb), 3.31 (1H, s, C≡CH), 5.39-5.56 (5H, m, 4 x CH= + CHS2), 7.21 
(1H, ddd, J = 7.7 Hz, J = 7.7 Hz, J = 1.3 Hz, CHar), 7.37 (1H, ddd, J = 7.7 Hz, J =7.7 Hz, J = 1.3 Hz, CHar), 
7.45 (1H, dd, J = 7.7 Hz, J = 1.0 Hz, CHar), 7.77 (1H, d, J = 7.7 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  
17.8 (2x CH3), 34.7 (2x SCH2), 47.6 (CHS2), 81.4 (C≡CH), 82.1 (C≡CH), 120.9 (Cq,arC≡CH), 126.5 (2x 
CH=), 127.4 (CHar), 128.4 (CHar), 128.8 (2x CH=), 129.4 (CHar), 132.7 (CHar), 142.6 (Cq,ar). IR (ATR, cm
-1) 
νmax: 1220, 1444, 1475, 1665 (CH=CH), 2915. MS (ESI, pos): m/z (%): 201.0 (M-[SCH2CH=CHCH3]
-, 95). 
HRMS: m/z calcd for C13H13S
+ (M-[SCH2CH=CHCH3]
-) 201.0733, found 201.0733. Chromatography: 
hexanes/EtOAc 99/1. Rf = 0.19. Yield: 87%, yellow oil. 
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3.4.4 Synthesis of benzo[c]thiophenes 377 
Representative example: 400 mg ((2-ethynylphenyl)methylene)bis(allylsulfane) 376a (1.54 mmol, 1 
equiv) was dissolved in 3 mL dichloromethane in a round-bottom flask and 5 mol% AuCl3 was added. 
The reaction progress was monitored using TLC and HPLC. In case of a very slow reaction, another 5 
mol% AuCl3 was added to the reaction mixture, bringing the total to 10 mol% catalyst. After all 
starting material had been consumed, the crude reaction mixture was filtered over a small plug of 
silica gel using ethyl acetate. The filtrate was concentrated in vacuo and the resulting oil was purified 
by means of column chromatography. 0.27 g (1.05 mmol, 68%) of 377a was obtained. 
1-(allylthio)-3-(but-3-en-1-yl)benzo[c]thiophene 377a 
1H-NMR (400 MHz, CDCl3) 2.53 (2H, tddd, J = 7.6 Hz, J = 6.6 Hz, J = 1.4 Hz, J = 1.2 
Hz, CqCH2CH2), 3.25 (2H, t, J = 7.6 Hz, CqCH2), 3.36 (2H, ddd, J = 7.4 Hz, J = 1.2 Hz, J = 
0.8 Hz, SCH2), 4.82 (1H, ddt, J = 17.0 Hz, J = 1.5 Hz, J = 1.2 Hz, SCH2CH=CHEHZ), 4.93 
(1H, ddt, J = 9.9 Hz, J = 1.5 Hz, J = 0.8 Hz, SCH2CH=CHEHZ), 5.02 (1H, ddt, J = 10.3 Hz, J 
= 1.7 Hz, J = 1.2 Hz, CH=CHECHZ), 5.08 (1H, ddt, J = 17.0 Hz, J = 1.7 Hz, J = 1.4 Hz, CH=CHEHZ), 5.85 (1H, 
ddt, J = 17.0 Hz, J = 9.9 Hz, J = 7.4 Hz, SCH2CH), 5.86 (1H, ddt, J = 17.0 Hz, J = 10.3 Hz, J = 6.6 Hz, 
CqCH2CH2CH), 7.03 (1H, ddd, J = 8.7 Hz, J = 6.3 Hz, J = 1.0 Hz, CHar), 7.11 (1H, ddd, J = 8.7 Hz, J = 6.3 Hz, 
J = 1.0 Hz, CHar), 7.52 (1H, dd, J = 8.7 Hz, J = 1.0 Hz, CHar), 7.74 (1H, dd, J = 8.7 Hz, J = 1.0 Hz, CHar). 
13C-
NMR (100 MHz, CDCl3)  27.5 (CqCH2), 35.7 (CqCH2CH2), 42.5 (SCH2), 116.0 (CH=CH2), 117.8 
(SCH2CH=CH2), 118.2 (Cq,ar), 120.2 (CHar), 121.0 (CHar), 122.6 (CHar), 124.3 (CHar), 133.8 (SCH2CH), 
135.6 (Cq,ar), 137.1 (CH=CH2), 139.8 (Cq,ar), 142.4 (Cq,ar). IR (ATR, cm
-1) νmax: 1638 (CH=CH2), 1691 
(CH=CH2). MS (ESI, pos): m/z (%): 277.1 (C15H16OS2+H
+ (S=O), 100). HRMS: m/z calcd for C15H16OS2+H
+ 
(S=O) 277.0715, found 277.0712. Chromatography: hexanes. Rf = 0.31. Yield: 68%, orange oil. 
1-(allylthio)-3-(but-3-en-1-yl)-5-fluorobenzo[c]thiophene 377b 
1H-NMR (400 MHz, CDCl3) 2.51 (2H, tddd, J = 7.6 Hz, J = 6.7 Hz, J = 1.4 Hz, J = 
1.3 Hz, CqCH2CH2), 3.16 (2H, t, J = 7.6 Hz, CqCH2), 3.35 (2H, ddd, J = 7.4 Hz, J = 1.1 
Hz, J = 0.8Hz, SCH2), 4.81 (1H, ddt, J = 17.1 Hz, J = 1.4 Hz, J = 1.1 Hz, 
SCH2CH=CHEHZ), 4.92 (1H, ddt, J = 9.8 Hz, J = 1.4 Hz, J = 0.8 Hz, SCH2CH=CHEHZ), 
5.03 (1H, ddt, J = 10.3 Hz, J = 1.6 Hz, J = 1.3 Hz, CH=CHECHZ), 5.08 (1H, ddt, J = 17.0 Hz, J = 1.6 Hz, J = 
1.4 Hz, CH=CHEHZ), 5.84 (1H, ddt, J = 17.1 Hz, J = 9.8 Hz, J = 7.4 Hz, SCH2CH), 5.86 (1H, ddt, J = 17.0 Hz, 
J = 10.3 Hz, J = 6.7 Hz, CqCH2CH2CH), 6.94 (1H, ddd, J = 9.4 Hz, 
3JHF = 8.3 Hz, J = 2.3 Hz, CHar), 7.07 (1H, 
ddd, 3JHF = 10.3 Hz, J = 2.3 Hz, J = 0.6 Hz, CHar), 7.70 (1H, ddd, J = 9.4 Hz, 
4JHF = 5.5 Hz, J = 0.6 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  27.5 (Cq,arCH2), 35.5 (Cq,arCH2CH2), 42.6 (SCH2), 102.2 (d, 
2JCF = 22.5 Hz, 
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CHar), 116.1 (CH=CH2), 116.5 (d, 
2JCF = 29.5 Hz, CHar), 118.0 (SCH2CH=CH2), 119.9 (Cq,ar), 122.9 (d, 
3JCF = 
10.0 Hz, CHar), 133.6 (SCH2CH), 134.7 (d, 
3JCF = 9.0 Hz, Cq,ar), 136.9 (CH=CH2), 137.8 (d, 
4JCF = 9.4 Hz, 
Cq,ar), 139.9 (Cq,ar), 159.7 (d, 
1JCF = 244.9 Hz, Cq,arF). 
19F-NMR (282 MHz, CDCl3) -119.75 to -119.81 
(m). IR (ATR, cm-1) νmax: 1175, 1222, 1508, 1626 (CH=CH2), 1693 (CH=CH2), 2918. MS (ESI, pos): m/z 
(%): 279.1 (M+H+, 100). HRMS: m/z calcd for C15H15FOS2+H
+ (S=O) 295.0621, found 295.0621. Yield: 
74%, pale yellow oil. 
3-(allylthio)-1-(but-3-en-1-yl)-5-fluorobenzo[c]thiophene 377c 
1H-NMR (300 MHz, CDCl3) 2.52 (2H, m, CqCH2CH2), 3.23 (2H, t, J = 7.6 Hz, 
CqCH2), 3.33 (2H, d, J = 7.7 Hz, SCH2), 4.80 (1H, d, J = 16.7 Hz, SCH2CH=CHEHZ), 4.92 
(1H, d, J = 9.9 Hz, SCH2CH=CHEHZ), 5.03 (1H, d, J = 9.9 Hz, CH=CHECHZ), 5.08 (1H, d, 
J = 17.1 Hz, CH=CHEHZ), 5.77-5.93 (2H, m, SCH2CH + CH2CH2CH) 6.86 (1H, ddd, J = 
9.5 Hz, 3JHF = 8.3Hz, J = 2.2Hz, CHar), 7.31 (1H, dd, 
3JHF = 9.9 Hz, J = 2.2 Hz, CHar), 7.49 (1H, dd, J = 9.5 Hz, 
4JHF = 5.2 Hz, CHar). 
13C-NMR (75 MHz, CDCl3)  27.8 (Cq,arCH2), 35.7 (Cq,arCH2CH2), 42.5 (SCH2), 103.2 (d, 
2JCF = 23.1 Hz, CHar), 115.1 (d, 
2JCF = 28.8 Hz, CHar), 116.3 (CH=CH2), 116.9 (d, JCF = 9.2 Hz, Cq,ar), 118.0 
(SCH2CH=CH2), 122.1 (d, 
3JCF = 9.2 Hz, CHar), 133.2 (Cq,ar), 133.8 (SCH2CH), 136.9 (CH=CH2), 141.4 (Cq,ar), 
142.5 (d, 4JCF = 9.2 Hz, Cq,ar), 161.2 (d, 
1JCF = 246.9 Hz, Cq,arF). 
19F-NMR (282 MHz, CDCl3) -117.3. IR 
(ATR, cm-1) νmax: 1625 (CH=CH2), 1696 (CH=CH2). MS (ESI, pos): m/z (%): 279.1 (M+H
+, 100). HRMS: 
m/z calcd for C15H15FS2+H
+ 279.0672, found 279.0666. Chromatography: hexanes. Rf = 0.25. Yield: 
63%, pale yellow oil. 
3-(allylthio)-1-(but-3-en-1-yl)-5-chlorobenzo[c]thiophene 377d 
1H-NMR (400 MHz, CDCl3) 2.50 (2H, tddd, J = 7.6 Hz, J = 6.6 Hz, J = 1.4 Hz, J = 
1.2 Hz, CqCH2CH2), 3.22 (2H, t, J = 7.6 Hz, CqCH2), 3.34 (2H, ddd, J = 7.4 Hz, J = 1.2 
Hz, J = 0.8 Hz, SCH2), 4.81 (1H, ddt, J = 17.0 Hz, J = 1.5 Hz, J = 1.2 Hz, 
SCH2CH=CHEHZ), 4.94 (1H, ddt, J = 10.0 Hz, J = 1.5 Hz, J = 0.8 Hz, SCH2CH=CHEHZ), 
5.02 (1H, ddt, J = 10.3 Hz, J = 1.7 Hz, J = 1.2 Hz, CH=CHECHZ), 5.07 (1H, ddt, J = 17.0 Hz, J = 1.7 Hz, J = 
1.4 Hz, SCH2CH=CHEHZ), 5.84 (1H, ddt, J = 17.0 Hz, J = 10.0 Hz, J = 7.4 Hz, SCH2CH), 5.84 (1H, ddt, J = 
17.0 Hz, J = 10.3 Hz, J = 6.6 Hz, CqCH2CH2CH), 6.96 (1H, dd, J = 9.2 Hz, J = 1.9 Hz, CHar), 7.44 (1H, dd, J = 
9.2 Hz, J = 0.8 Hz, CHar), 7.72 (1H, dd, J = 1.9 Hz, J = 0.8 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  27.6 
(Cq,arCH2), 35.6 (Cq,arCH2CH2), 42.5 (SCH2), 116.2 (CH=CH2), 117.9 (Cq,ar), 118.0 (SCH2CH=CH2), 119.5 
(CHar) , 121.3 (CHar) , 124.1 (CHar), 131.4 (Cq,ar), 133.6 (SCH2CH), 133.7 (Cq,ar), 136.8 (CH=CH2), 141.1 
(Cq,ar), 142.3 (Cq,ar). IR (ATR, cm
-1) νmax: 1219, 1273, 1425, 1604, 1638 (C=CH2), 1698 (C=CH2), 2918, 
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3078. MS (ESI, pos): m/z (%): 295.0 (M+H+, 100). HRMS: m/z calcd for C15H15ClS2+H
+ = 295.0377, 
found = 295.0370. Yield: 91%, orange oil. 
3-(allylthio)-1-(but-3-en-1-yl)-5-methylbenzo[c]thiophene 377e 
1H-NMR (300 MHz, CDCl3) 2.37 (3H, s, CH3), 2.51 (2H, m, CqCH2CH2), 3.20 (2H, 
t, J = 7.4 Hz, CqCH2), 3.34 (2H, d, J = 7.2 Hz, SCH2), 4.81 (1H, d, J = 17.1 Hz, 
SCH2CH=CHEHZ), 4.91 (1H, d, J = 9.1 Hz, SCH2CH=CHEHZ), 5.02 (1H, d, J = 11.0 Hz, 
CH=CHEHZ), 5.08(1H, d, J = 17.1 Hz, CH=CHEHZ), 5.76-5.95 (2H, m, SCH2CH + 
CqCH2CH2CH), 6.95 (1H, d, J = 8.9Hz, CHar), 7.24 (1H, s, CHar), 7.63 (1H, d, J = 8.9 Hz, CHar). 
13C-NMR (75 
MHz, CDCl3)  21.8 (CH3), 27.5 (Cq,arCH2), 35.7 (Cq,arCH2CH2), 42.6 (SCH2), 115.9 (CH2CH2CH=CH2), 117.8 
(SCH2CH=CH2), 118.1 (Cq,ar), 118.3 (Cq,arCHar), 120.6 (Cq,arCHar), 127.6 (CHar), 132.1 (Cq,ar), 133.9 
(SCH2CH), 136.0 (Cq,ar), 137.3 (CH=CH2), 138.0 (Cq,ar), 141.4 (Cq,ar). IR (ATR, cm
-1) νmax: 1638 (CH=CH2). 
MS (ESI, pos): m/z (%): 291 (C16H18OS2+H
+ (S=O), 100). Chromatography: hexanes. Rf = 0.30. Yield: 
41%, yellow oil. 
1-(allylthio)-3-(but-3-en-1-yl)-5,6-dimethoxybenzo[c]thiophene 377f 
1H-NMR (400 MHz, CDCl3) 2.51 (2H, tddd, J = 7.7 Hz, J = 6.6 Hz, J = 1.8 Hz, J = 
1.5 Hz, CqCH2CH2), 3.14 (2H, t, J = 7.7 Hz, CqCH2), 3.34 (2H, ddd, J = 7.4 Hz, J = 
1.5 Hz, J = 1.2 Hz, SCH2), 3.92 (3H, s, OCH3), 3.97 (3H, s, OCH3), 4.87 (1H, ddt, J 
= 17.0 Hz, J = 1.5 Hz, J = 1.2 Hz, SCH2CH=CHEHZ), 4.94 (1H, ddt, J = 9.9 Hz, J = 1.5 
Hz, J = 1.2 Hz, SCH2CH=CHEHZ), 5.03 (1H, ddt, J = 10.3 Hz, J = 1.8 Hz, J = 1.5 Hz, CH=CHEHZ), 5.10 (1H, 
ddt, J = 17.1 Hz, J = 1.8 Hz, J = 1.5 Hz, CH=CHEHZ), 5.87 (1H, ddt, J = 17.0 Hz, J = 9.9 Hz, J = 7.4 Hz, 
SCH2CH), 5.89 (1H, ddt, J = 17.1 Hz, J = 10.3 Hz, J = 6.6 Hz, CqCH2CH2CH), 6.65 (1H, s, CHar), 6.96 (1H, s, 
CHar). 
13C-NMR (100 MHz, CDCl3)  27.6 (Cq,arCH2), 35.3 (Cq,arCH2CH2), 42.4 (SCH2), 55.8 (OCH3), 55.9 
(OCH3), 97.0 (CHar), 98.0 (CHar), 114.7 (Cq,ar), 115.8 (CH=CH2), 117.7 (SCH2CH=CH2), 131.1 (Cq,ar), 134.0 
(SCH2CH), 136.2 (Cq,ar), 137.3 (CH=CH2), 139.0 (Cq,ar), 149.2 (Cq,ar), 150.6 (Cq,ar). IR (ATR, cm
-1) νmax: 
1230, 1352, 1490, 1638 (CH=CH2), 1682 (CH=CH2), 2932. MS (ESI, pos): m/z (%): 337.1 (C17H20O3S2+H
+ 
(S=O), 66), 321.1 (M+H+, 33). HRMS: m/z calcd for C17H20O3S2+H
+ (S=O) 337.0927, found 337.0928. 
Yield: 87%, brown oil. 
5-(allylthio)-7-(but-3-en-1-yl)thieno[3',4':4,5]benzo[1,2-d][1,3]dioxole 377g 
1H-NMR (400 MHz, CDCl3) 2.47 (2H, tddd, J = 7.7 Hz, J = 6.7 Hz, J = 1.5 Hz, J = 
1.2 Hz, CqCH2CH2), 3.08 (2H, t, J = 7.7 Hz, CqCH2), 3.32 (2H, ddd, J = 7.4 Hz, J = 1.1 
Hz, J = 0.8 Hz, SCH2), 4.85 (1H, ddt, J = 16.9 Hz, J = 1.4 Hz, J = 1.1 Hz, 
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SCH2CH=CHEHZ), 4.93 (1H, ddt, J = 9.9 Hz, J = 1.4 Hz, J = 0.8 Hz, SCH2CH=CHEHZ), 5.01 (1H, ddt, J = 10.3 
Hz, J = 1.7 Hz, J = 1.2 Hz, CH=CHEHZ), 5.07 (1H, ddt, J = 17.1 Hz, J = 1.7 Hz, J = 1.5 Hz, CH=CHEHZ), 5.84 
(1H, ddt, J = 16.9 Hz, J = 9.9 Hz, J = 7.4 Hz, SCH2CH), 5.85 (1H, ddt, J = 17.1 Hz, J = 10.3 Hz, J = 6.7 Hz, 
CqCH2CH2CH), 5.95 (2H, s, OCH2O), 6.72 (1H, s, CHar), 6.99 (1H, s, CHar). 
13C-NMR (100 MHz, CDCl3)  
27.7 (Cq,arCH2), 35.4 (Cq,arCH2CH2), 42.3 (SCH2), 94.8 (CHar), 96.0 (CHar), 101.2 (OCH2O), 115.5 (Cq,ar), 
115.9 (CH=CH2), 117.7 (SCH2CH=CH2), 132.3 (Cq,ar), 133.8 (SCH2CH=CH2), 136.6 (Cq,ar), 137.1 (CH=CH2), 
140.4 (Cq,ar), 147.4 (Cq,ar), 148.8 (Cq,ar). IR (ATR, cm
-1) νmax: 1213, 1336, 1594, 1638 (C=CH2), 1684 
(C=CH2), 2360, 2901. MS (ESI, pos): m/z (%): 305.0 (M+H
+, 100). HRMS: calcd for C16H16O2S2+H
+ 
305.0665, found 305.0665. Chromatography: hexanes/EtOAc 99/1. Rf = 0.16. Yield: 53% (2 steps), 
yellow oil. 
1-(allylthio)-3-(but-3-en-1-yl)-4-methoxybenzo[c]thiophene 377h 
1H-NMR (400 MHz, CDCl3) 2.51 (2H, tddd, J = 7.7 Hz, J = 6.7 Hz, J = 1.3 Hz, J = 1.3 
Hz, CqCH2CH2), 3.34 (2H, ddd, J = 7.3 Hz, J = 1.0 Hz, J = 1.0 Hz, SCH2), 3.42 (2H, t, J = 
7.7 Hz, CqCH2), 3.90 (3H, s, OCH3),  4.82 (1H, ddt, J = 17.1 Hz, J = 1.4 Hz, J = 1.0 Hz, 
SCH2CH=CHEHZ), 4.93 (1H, ddt, J = 9.9 Hz, J = 1.4 Hz, J = 1.0 Hz, SCH2CH=CHEHZ), 5.00 
(1H, ddt, J = 10.3 Hz, J = 1.9 Hz, J = 1.3 Hz, CH=CHEHZ), 5.06 (1H, ddt, J = 17.1 Hz, J = 1.9 Hz, J = 1.3 Hz, 
CH=CHEHZ), 5.84 (1H, ddt, J = 17.1 Hz, J = 9.9 Hz, J = 7.3 Hz, SCH2CH), 5.89 (1H, ddt, J = 17.1 Hz, J = 
10.3 Hz, J = 6.7 Hz, CqCH2CH2CH), 6.22 (1H, d, J = 7.2 Hz, CHar), 6.99 (1H, dd, J = 8.7 Hz, J = 7.2 Hz, 
CHar), 7.31 (1H, d, J = 8.7 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  30.1 (Cq,arCH2), 36.6 (Cq,arCH2CH2), 
42.2 (SCH2), 55.0 (OCH3), 98.84 (CHar), 113.5 (CHar), 115.4 (CH=CH2), 116.6 (Cq,ar), 117.8 (SCH2CH=CH2), 
124.9 (CHar), 128.3 (Cq,ar), 133.9 (SCH2CH), 137.8 (CH=CH2), 141.8 (Cq,ar), 144.9 (Cq,ar), 155.1 (Cq,arOMe). 
IR (ATR, cm-1) νmax: 1428, 1528, 1614, 1638 (CH=CH2), 1695 (CH=CH2), 2911. MS (ESI, pos): m/z (%): 
217.1 (M-[SCH2CH=CH2]
-, 60). HRMS: calcd for C16H18O2S2+H
+ (S=O) 307.0821, found 307.0827. Yield: 
92%, brown oil. 
6-(allylthio)-4-(but-3-en-1-yl)thieno[3,4-b]thiophene 377i 
1H-NMR (400 MHz, CDCl3) 2.46 (2H, tddd, J = 7.6 Hz, J = 6.6 Hz, J = 1.5 Hz, J = 1.3 
Hz, CqCH2CH2), 3.04 (2H, t, J = 7.6 Hz, CqCH2), 3.41 (2H, ddd, J = 7.3 Hz, J = 1.2 Hz, J = 
1.1 Hz, SCH2), 4.95 (1H, ddt, J = 16.8 Hz, J = 1.5 Hz, J = 1.2 Hz, SCH2CH=CHEHZ), 4.99 
(1H, ddt, J = 10.2 Hz, J = 1.5 Hz, J = 1.1 Hz, SCH2CH=CHEHZ), 5.02 (1H, ddt, J = 10.3 Hz, 
J = 1.7 Hz, J = 1.3 Hz, CH=CHECHZ), 5.07 (1H, ddt, J = 17.1 Hz, J = 1.7 Hz, J = 1.5 Hz, CH=CHECHZ), 5.84 
(1H, ddt, J = 17.1 Hz, J = 10.3 Hz, J = 6.6Hz, CqCH2CH2CH), 5.88 (1H, ddt, J = 16.8 Hz, J = 10.2 Hz, J = 7.3 
Hz, SCH2CH), 6.82 (1H, d, J = 5.6 Hz, CHar), 7.21 (1H, d, J = 5.6 Hz, SCHar). 
13C-NMR (100 MHz, CDCl3)  
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28.9 (Cq,arCH2), 35.5 (Cq,arCH2CH2), 41.0 (SCH2), 113.6 (Cq,ar), 116.0 (CH=CH2), 116.7 (CHar), 118.0 
(SCH2CH=CH2), 130.9 (CHar), 133.7 (SCH2CH), 136.1 (Cq,ar), 137.0 (CH=CH2), 144.4 (Cq,ar), 146.4 (Cq,ar). IR 
(ATR, cm-1) νmax: 1220, 1425, 1639 (C=CH2), 1841, 2913, 3077. MS (ESI, pos): m/z (%): 267.1 (M+H
+, 
25), 283.1 (C13H14OS3+H
+ (S=O), 100). HRMS: calcd for C13H14OS3+H
+ (S=O) 283.0280, found 283.0276. 
Chromatography: hexanes/EtOAc 98/2. Rf = 0.24. Yield: 15% (2 steps), orange oil. 
1-(but-2-en-1-ylthio)-3-(2-methylbut-3-en-1-yl)benzo[c]thiophene 377k 
This compound was obtained as a mixture of E/Z stereoisomers in a 9/1 E/Z ratio, 
according to 1H-NMR integration. Spectral data are reported for the E-isomer only. 
1H-NMR (400 MHz, CDCl3) 1.06 (3H, d, J = 7.0 Hz, CH3CH), 1.51 (3H, ddt, J = 6.5 
Hz, J = 1.5 Hz, J = 0.8 Hz, CH=CHCH3), 2.61 (1H, sept, J = 7.0 Hz, CH3CH), 3.09 (1H, 
dd, J = 14.8 Hz, J = 7.0 Hz, CHaHb), 3.20 (1H, dd, J = 14.8 Hz, J = 7.0 Hz, CHaHb), 3.29 (2H, d, J = 7.5 Hz, 
SCH2), 4.95 (1H, dm, J = 10.6 Hz, CH=CHEHZ), 4.99 (1H, ddd, J = 17.1 Hz, J = 1.4 Hz, J = 1.4 Hz, 
CH=CHEHZ), 5.10 (1H, dqt, J = 15.0 Hz, J = 6.5 Hz, 1.0 Hz, CH=CHCH3), 5.48 (1H, dtq, J = 15.0 Hz, J = 7.5 
Hz, J = 1.5 Hz, CH=CHCH3), 5.82 (1H, ddd, J = 17.1 Hz, J = 10.6 Hz, J = 7.0 Hz, CH=CHEHZ), 7.01 (1H, ddd, 
J = 8.7 Hz, J = 6.4 Hz, J = 1.0 Hz, CHar), 7.10 Hz (1H, ddd, J = 8.7 Hz, J = 6.4 Hz, J = 1.0 Hz, CHar), 7.50 
(1H, d, J = 8.7 Hz, CHar), 7.71 (1H, d, J = 8.7 Hz, CHar). 
13C-NMR (100 MHz, CDCl3)  17.7 (CH3), 19.6 
(CH3), 35.0 (CH2), 40.1 (CH), 41.9 (SCH2), 113.7 (CH=CH2), 118.9 (Cq,ar), 120.3 (CHar), 121.0 (CHar), 122.5 
(CHar), 124.0 (CHar), 126.4 (CH=CHCH3), 129.2 (CH=CHCH3), 136.1 (Cq,ar), 138.3 (Cq,ar), 142.3 (Cq,ar), 
143.0 (CH=CH2). IR (ATR, cm
-1) νmax: 1220, 1444, 1665 (C=CH2), 2915, 3288. MS (ESI, pos): m/z (%): 
289.0 (M+H+, 100). HRMS: calcd for C17H20S2+H
+ 289.1079, found 289.1083. Chromatography: 
hexanes. Rf = 0.23. Yield: 80%, yellow oil. 
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Due to the experience in the SynBioC research group with the heteroatom transfer radical cyclization 
(HATRC) methodology and due to the interesting biological properties of aminophosphonates, a 
synthetic route toward 3-phosphonopyrroles was designed with a HATRC key step. The required β-
ketophosphonates iv were synthesized by a Michaelis-Arbuzov reaction on α-haloketones i. In order 
to prevent Perkow reaction, i.e. a side reaction leading to enol phosphates, the α-haloketones were 
transformed into the corresponding hydrazones iii (Scheme 111). For very electron-poor substrates 
another method was adopted to prevent Perkow reaction, based on acylation of phosphonoacetic 
acid and subsequent decarboxylation. 
 
Scheme 111. Formation of β-ketophosphonates. 
After Michaelis-Arbuzov reaction and hydrolysis, the obtained β-ketophosphonates iv were subjected 
to imination under Dean-Stark conditions (Scheme 112). This smoothly resulted in a mixture of the 
desired enamines vi and imines vii, in a ratio of 1/1 to 4/1. The enamines were solely present in the 
Z-form due to intramolecular H-bond formation. The imines occurred in both their E- and Z- forms in 
a ratio of 1/1 to 9/1. Next, the crude mixtures were subjected to treatment with NCS which cleanly 
resulted in α,α-dichlorination to viii.  
 
Scheme 112. Imination and α,α-dichlorination. 
With N-allyl α,α-dichloroimines viii in hand, the HATRC was evaluated and resulted in the generation 
of the desired 1-pyrrolines xi (Scheme 113). Interestingly, this transformation proceeded with a large 
diastereoselectivity (9:1). After purification, only the major diastereomer was left and quite some 
effort was devoted to the determination of the relative stereochemistry. A 2D-NOESY experiment 
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showed no NOE between the phosphonate ethoxy groups and the CH of the pyrroline, while a 
heteronuclear NOESY (HOESY) did not render further information either. In an effort to determine 
the 3JHP coupling constant, a number of 
1H-undecoupled 31P-NMR spectra were recorded in which the 
interfering protons were saturated. This indicated that 3JHP was 11.2 Hz. Unfortunately, this result did 
not provide unambiguous information about the relative configuration of the products. Luckily 
however, the two last synthesized derivatives were crystalline and with the aid of single crystal X-ray 
diffraction, the relative configuration was assigned as cis. The reason for this was most likely the 
bulky phosphonate adopting a pseudo-equatorial position in the transition state ix, minimizing steric 
repulsion with the other substituents.  
 
Scheme 113. HATRC with formation of cis-diastereomers xi. 
Next, treatment with base would result in 1,4-dehydrohalogenation and formation of the envisioned 
3-phosphonopyrroles. However, only starting material was recovered after treatment with a number 
of bases. Upon application of n-BuLi though, a new product was formed and surprisingly, it was not 
the anticipated pyrrole. Instead, the structure was elucidated as bicycle xiii and a possible 
mechanism for its formation was proposed (Scheme 114). Instead of performing the desired 1,4-
dehydrohalogenation, a Li-Cl exchange had occurred (xii) after which intramolecular elimination 
resulted in cyclopropanation. As this conversion was innovative, it was further pursued in spite of the 
originally envisoned pyrrole synthesis. 
 
Scheme 114. Unforeseen cyclopropanation through Li-Cl exchange. 
The imine bond was reduced with NaCNBH3 and HOAc which resulted in azabicyclo[3.1.0]hexanes xiv 
(Scheme 115). A 2D-NOESY experiment indicated that this reduction also proceeded in a very 
diastereoselective manner. This was most likely due to the bulky phosphonate group. After 
reduction, intramolecular debenzylation was attempted in order to generate phosphonylated 
aminomethyl cyclopropanes. However, all attempts in this direction failed. 
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Scheme 115. Reduction of the imine and 2D-NOESY. 
As the envisioned 3-phosphonopyrrole synthesis had failed, another synthetic route was devised 
starting from the same β-iminophosphonates, based on π-acid catalysis. As was the case in the first 
attempt, imination proceeded smoothly and again a mixture of enamines xv and imines xvi was 
obtained. Next, introduction of a propargyl group was attempted by generation of the corresponding 
aza-enolate using LiHMDS and quenching with propargyl bromide xvii (Scheme 116). This method 
proved fruitful, but it was difficult to obtain full conversion. Addition of extra base and electrophile 
resulted in mixtures of mono- and dipropargylated products xviii and xix. Compounds xviii were 
present as enamines in the Z-form due to intramolecular H-bond formation. 
 
Scheme 116. Introduction of a propargyl group. 
After purification, a number of π-acids were evaluated for the envisioned hydroamination of xviii. 
Both 20 mol% ZnCl2 and AgNO3 were efficacious catalysts but AgNO3 was much faster. However, 
upon decreasing the catalyst loading the reaction time augmented and some degradation occurred in 
the case of AgNO3. This observation, in combination with the much higher price of Ag than Zn, 
resulted in the choice for 5 mol% ZnCl2 as π-acidic catalyst. This worked smoothly for terminal 
alkynes, but internal alkynes were much more reluctant towards hydroamination. A higher catalyst 
loading of 20 mol% was required as well as reflux temperature to effectuate ring closure. Using this 
hydroamination approach, a library of phosphonylated pyrroles xxi was synthesized (Scheme 117). 
 
Scheme 117. Hydroamination catalyzed by ZnCl2. 
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In order to further derivatize pyrroles xxi, lithiation of the aromatic ring followed by quenching with 
electrophiles was evaluated. This was done either directly using organolithium bases to deprotonate 
the pyrrole xxi or via bromination (xxii) and subsequent Li-Br exchange (methods A and B, Scheme 
118). The latter approach was somewhat cleaner but in all cases it was very difficult to alkylate the 
pyrrole ring. Full deuteration to xxiiia was accomplished but reaction with other electrophiles than 
D2O did not lead to full conversion. This was most likely due to steric hindrance caused by the vicinal 
bulky phosphonate group. 
 
Scheme 118. Derivatization by lithiation. 
Finally, brominated pyrroles xxii were subjected to a number of cross-coupling reactions under 
microwave irradiation. Sonogashira coupling failed, but Suzuki and Stille coupling reactions were 
more effective and resulted in coupling to sp-, sp2- and sp3-carbons. Nevertheless complete 
conversion was difficult to attain and chromatography was necessary to separate the products from 
residual starting material. In case of Suzuki coupling, there are indications that the actual mechanism 
was in fact a C-H activation instead of cross-coupling. 
In a third part of this work the diphosphonylation of α,β-unsaturated aliphatic and aromatic imines 
was further extended to α,β,γ,δ-diunsaturated imines. In order to do so, the corresponding aldehyde 
precursors xxvii were required. These compounds were prepared by Wittig reaction from 
commercially available short-chain aldehydes xxiv like cinnamaldehyde (Scheme 119). The 
intermediate acetals existed as mixtures of E- and Z-isomers xxvi but after hydrolysis of the acetal, 
the desired E,E-product xxvii was obtained. 
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Scheme 119. Wittig reaction for the generation of diunsaturated aldehydes xxvii. 
Subsequently these diunsaturated aldehydes xxvii were iminated. Employing standard conditions 
with MgSO4 and an excess of amine resulted in imination but a considerable amount of 1,6- or 1,4-
addition had taken place as well. Other imination procedures using CuSO4 or Ti(OEt)4 did not result in 
improvement. MgSO4-mediated imination with 1 equivalent of amine was selected as the most 
suitable method. 
With α,β,γ,δ-diunsaturated imines xxviii in hand, the triaddition of two types of phosphorus 
nucleophiles was evaluated. First, dimethyl trimethylsilyl phosphite (DMPTMS) was applied as 
nucleophile in the presence of H2SO4 (Scheme 120). Surprisingly, this resulted in the clean conversion 
of diunsaturated imines into diunsaturated aminophosphonates xxix. No 1,6- or 1,4-addition had 
taken place, regardless of the steric bulk or electronic nature of R2. Also, for the three types of 
substrates xxviiia-c, the R1 group had no effect whatsoever on 1,6- or 1,4-addition with DMPTMS. In 
case R2 = Ph though, 1,2-addition was followed by intermolecular substitution or a [5,5]-sigmatropic 
rearrangement and an isomeric compound was obtained. These results stand in sharp contrast to the 
previous work conducted at the department on phosphite addition to α,β-unsaturated imines.  
 
Scheme 120. 1,2-addition of DMPTMS. 
Based on the proposed mechanism for the tandem 1,4-1,2-addition, an explanation was sought to 
account for the lack of any 1,4- or 1,6-addition in this case. However, at this stage this is rather 
speculative and molecular modeling studies are underway to support the hypothesis. 
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The obtained aminophosphonates xxix were further acylated using chloroacetyl chloride (Scheme 
121). Subsequent deprotonation and intramolecular substitution resulted in the formation of a 
phosphonylated β-lactam xxxi in good yield. Other attempts at derivatization of xxix failed. 
 
Scheme 121. Acylation of xxixb and formation of a β-lactam. 
Upon application of another phosphorus nucleophile, i.e. triethyl phospite, instead of DMPTMS the 
result was rather different. In this case tandem 1,4-1,2-addition occurred, yielding xxxii as the major 
product (Scheme 122). Some monoadduct xxix was also present and in case of a sterically demanding 
R1-group, traces of a triaddition product, possibly xxxiii, were formed. However, in all cases 
diphosphonylation to xxxii was the major pathway. This stands in sharp contrast to the addition of 
DMPTMS, where only monoaddition arose.  
 
Scheme 122. Addition of triethyl phosphite to α,β,γ,δ-diunsaturated imines xxviii. 
As a result of the diphosphonylation, two pairs of diastereomers were present in a 2/1 ratio for 
xxxiib. They were separated using preparative HPLC and the major diastereomer was assigned a syn-
configuration based on a NOE experiment. 
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Scheme 123. Identification of syn- and anti-isomers. 
The final part of this work aimed at preparing benzo[c]thiophenes using Au as a π-acid for a 
cycloisomerization. A number of halogen- or triflate-substituted benzaldehydes were subjected to 
Sonogashira coupling using TMS-acetylene or phenylacetylene. In case of TMS-protected substrates, 
the silyl group was cleaved off in order to produce terminal alkynes. 
Next, these aromatic aldehydes xxxiv were converted into their corresponding diallyl thioacetals 
xxxv (Scheme 124). This was achieved using allyl or crotyl mercaptan in combination with a Lewis 
acid. 
 
Scheme 124. Generation of dithioacetals. 
With these compounds xxxv in hand, the envisioned Au-mediated cyclization toward 
benzo[c]thiophenes xxxx could be evaluated. A large number of catalysts was assessed and revealed 
that 5 mol% AuCl3 was the most suited catalyst for this transformation. AuCl, AuBr3 and HAuCl4 also 
catalyzed the reaction but other monovalent Au-catalysts did not. Addition of 2,6-di-t-butylpyridine 
considerably slowed down the reaction while the use of KAuCl4 under anhydrous conditions did not 
result in any conversion. These observations suggested that a trace of HAuCl4 was formed in situ 
from AuCl3 and moisture, as is known from literature.  
In this case other superacids might also be able to catalyze this transformation, so the reaction was 
evaluated with TfOH. Surprisingly, this led to the formation of an intermediate that could be 
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converted into the desired benzo[c]thiophene upon work-up (Figure 21). Based on a number of 
spectral data, the intermediate was identified as xxxvi. 
 
Figure 21. Isolated intermediate after treatment of xxxvc with TfOH. 
These observations suggested that a sufficiently strong acid could mediate the ring closure as well as 
the allyl migration, but a stoichiometric amount of acid was required as aromatization did not occur 
spontaneously. A solvent screening revealed that dichloromethane resulted in the best yields. 
Based on this scrutiny, a mechanism was proposed for the transformation of diallyl thioacetals xxxv 
into benzo[c]thiophenes xxxx (Scheme 125). In situ generation of HAuCl4 results in activation of the 
alkyne. Ring closure takes place in a 5-exo-dig fashion and is followed by a Claisen rearrangement. 
The concerted nature of this rearrangement was proven by using the crotyl derivative instead of the 
allyl group. This resulted solely in a branched product instead of a mixture of branched and linear 
products, which means no fragmentation took place. After allyl migration, aromatization takes place 
and the catalyst is regenerated. 
 
Scheme 125. Mechanism of benzo[c]thiophene formation. 
This transformation succeeded for all terminal alkynes (Scheme 126). Subjecting internal alkyne xxxvj 
to these optimized conditions however resulted in full recovery of starting material. 
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Scheme 126. Preparation of a library of benzo[c]thiophenes. 
In summary, this work has resulted in the synthesis of 93 novel compounds and the development of 
innovative entries to aza- and thiaheterocyclic compounds. The retrosynthetically envisioned 
synthesis of phosphonylated pyrroles based on the chemistry of phosphono-azadienes failed but 
resulted in the discovery of an unexpected lithium-halogen exchange on an sp3-carbon. In addition, 
this led to an intramolecular cyclopropanation with formation of an azabicyclic framework, which is 
difficult to straightforwardly access. Therefore, this methodology was explored and subsequently, 
another approach to phosphonylated pyrroles was developed based on a transition-metal catalyzed 
intramolecular hydroamination of phosphonylated alkynamines. This time the outlined strategy 
proved fruitful and tetrasubstituted pyrroles were obtained. Further derivatization of the pyrrole ring 
proved feasible employing Pd-based cross-coupling reactions.  
Apart from these classes of unsaturated N-heterocycles, phosphonylated β-lactams could be 
accessed too. The results of the extension of earlier developed tandem phosphite addition reactions 
to α,β,γ,δ-diunsaturated imines surprisingly depended on the type of nucleophile. The obtained α-
aminophosphonates could smoothly be converted into β-lactams. Finally, one class of 
thiaheterocycles was prepared using a Au-mediated cycloisomerization strategy from commercially 
available benzaldehydes. Scrutiny of the catalyst system and isolation of an intermediate revealed 
that a Au-assisted proton-driven mechanism was operative.  
In retrospect, four classes of transformations were studied and in every chapter a number of 
valuable results were obtained, either from a synthetic or mechanistic viewpoint. Many of these 
results have engendered new opportunities or raised other questions, which ensure plenty of room 
for the further elaboration of certain parts of this work. 
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Gezien de ervaring in de SynBioC onderzoeksgroep omtrent de heteroatoom transfer radicalaire 
cyclisatie (HATRC) methodologie en gezien de interessante biologische eigenschappen van 
aminofosfonaten, werd een synthetische route tot 3-fosfonopyrrolen ontworpen met als 
belangrijkste stap een HATRC. De bereiding van het startmateriaal voor de HATRC werd uitgevoerd in 
drie stappen (Schema 1). De benodigde β-ketofosfonaten iv werden gesynthetiseerd uit α-
haloketonen i gebruik makend van een Michaelis-Arbuzov reactie. Om de ongewenste Perkow 
reactie tegen te gaan, i.e. een nevenreactie die leidt tot enolfosfaten, werden de α-haloketonen i 
getransformeerd tot de overeenkomstige hydrazonen iii. Voor erg elektronarme substraten werd een 
andere methode aangewend om Perkow reactie te voorkomen, gebaseerd op de acylering van 
fosfonoazijnzuur en de daaropvolgende decarboxylering. 
 
Schema 1. Vorming van β-ketofosfonaten. 
Na Michaelis-Arbuzov reactie en hydrolyse werden de bekomen β-ketofosfonaten iv onderworpen 
aan iminering onder Dean-Stark condities (Schema 2). Dit resulteerde vlot in een mengsel van de 
gewenste enamines vi en imines vii, in een verhouding van 1/1 tot 4/1. De enamines vi waren enkel 
aanwezig in de Z-vorm omwille van intramoleculaire H-brugvorming. De imines vii werden gevormd 
in zowel de E- als Z-vorm in een verhouding van 1/1 tot 9/1. Vervolgens werden de ruwe mengsels 
behandeld met NCS, wat resulteerde in α,α-dichlorering tot imines viii. 
 
Schema 2. Iminering en α,α-dichlorering. 
Met deze N-allyl α,α-dichloorimines viii ter beschikking werd de HATRC geëvalueerd, hetgeen 
resulteerde in de vorming van de gewenste 1-pyrrolines xi (Schema 3). Opmerkelijk was het feit dat 
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deze transformatie doorging met een grote diastereoselectiviteit (9/1 verhouding). Na opzuivering 
bleef enkel het major diastereomeer over en werd geprobeerd de relatieve stereochemie te 
achterhalen. Een 2D-NOESY experiment toonde geen NOE aan tussen de ethoxygroepen van het 
fosfonaat en de CH van het pyrroline, terwijl een heteronucleaire NOESY (HOESY) ook geen extra 
infomatie verschafte. In een poging om 3JHP te bepalen werd een aantal 
1H-onontkoppelde 31P-NMR 
spectra opgenomen waarin de overlappende protonen verzadigd werden. Hieruit werd 
geconcludeerd dat 3JHP 11.2 Hz was. Jammer genoeg kon dit resultaat geen uitsluitsel geven over de 
relatieve configuratie van de producten. Gelukkig, echter, waren de twee laatst gesynthetiseerde 
derivaten kristallijn en wees X-straaldiffractie uit dat de relatieve configuratie van xi cis was. Dit was 
hoogstwaarschijnlijk te wijten aan de pseudo-equatoriale positie van het bulky fosfonaat in de 
transitietoestand ix, om de sterische repulsie met de andere substituenten te minimaliseren. 
 
Schema 3. HATRC met vorming van cis-diastereomeren. 
Vervolgens zou behandeling van xi met base moeten resulteren in een 1,4-dehydrohalogenering en 
vorming van de beoogde 3-fosfonopyrrolen. Echter, na behandeling met een aantal basen werd 
enkel startmateriaal gerecupereerd. Na gebruik van n-BuLi echter werd een nieuw product gevormd, 
maar niet het verhoopte pyrrool (Schema 4). In de plaats werd de structuur bepaald als bicyclisch 
product xiii en een mogelijk mechanisme voor de vorming hiervan werd voorgesteld. Niet de 
gewenste 1,4-dehydrohalogenering maar een Li-Cl uitwisseling tot xii had plaatsgevonden waarna 
intramoleculaire substitutie resulteerde in cyclopropanering. Gezien deze conversie innovatief was, 
werd ze verder uitgewerkt ten koste van de oorspronkelijk beoogde pyrroolsynthese. 
 
Schema 4. Onvoorziene cyclopropanering door middel van Li-Cl uitwisseling. 
Vervolgens werd de iminebinding gereduceerd met NaCNBH3 en HOAc, hetgeen resulteerde in 
azabicyclo[3.1.0]hexanen xiv (Schema 5). Een 2D-NOESY experiment toonde aan dat deze reductie 
evenzeer doorging op een erg diastereoselectieve manier. Dit was hoogstwaarschijnlijk opnieuw te 
wijten aan de grote fosfonaatgroep. Na reductie werd gepoogd een intramoleculaire debenzylering 
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te bewerkstelligen om zo gefosfonyleerde aminomethylcyclopropanen te bekomen. Echter, alle 
pogingen in deze richting faalden. 
 
Schema 5. Reductie van het imine en 2D-NOESY. 
Aangezien de beoogde synthese van 3-fosfonopyrrolen had gefaald, werd een andere syntheseroute 
ontworpen gebaseerd op π-zuur katalyse. Net zoals in de voorgaande poging verliep de iminering 
vlot en werd opnieuw een mengsel van enamines xv en imines xvi bekomen. Vervolgens werd 
gepoogd een propargylgroep te introduceren door het overeenkomstige aza-enolaat te genereren 
met behulp van LiHMDS en te quenchen met propargyl bromide xvii (Schema 6). Deze methode was 
succesvol maar het was moeilijk om volledige conversie te bekomen. Additie van extra base en 
elektrofiel resulteerde in mengsels van mono- en digepropargyleerde producten xviii en xix. Deze 
verbindingen xviii waren aanwezig als enamines in de Z-vorm ten gevolge van intramoleculaire H-
brugvorming. 
 
Schema 6. Introductie van een propargylgroep. 
Na opzuivering werd een aantal π-zuren geëvalueerd voor de beoogde hydroaminering van xviii. 
Zowel 20 mol% ZnCl2 als AgNO3 waren effectief als katalysator maar AgNO3 was veel sneller. Echter, 
bij het verminderen van de hoeveelheid katalysator nam de reactietijd toe en trad enige degradatie 
op in het geval van AgNO3. Deze observatie, in combinatie met de veel hogere kostprijs van Ag dan 
Zn, resulteerde in de keuze voor 5 mol% ZnCl2 als π-zure katalysator. Deze methode werkte vlot voor 
terminale alkynen maar interne alkynen waren minder reactief. Een grotere hoeveelheid katalysator 
alsook refluxtemperatuur waren nodig om de ringsluiting te bewerkstelligen. Gebruik makend van 
deze hydroaminering werd een bibliotheek gefosfonyleerde pyrrolen gesynthetiseerd (Schema 7). 
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Schema 7. Hydroaminering gekatalyseerd door ZnCl2. 
Om de pyrrolen xxi verder te derivatiseren werd de aromatische ring achtereenvolgens gelithieerd 
en gequencht met elektrofielen (Schema 8). Dit werd ofwel direct uitgevoerd door deprotonering 
met behulp van organolithiumbasen, ofwel via bromeren tot xxii en daaropvolgende Li-Br 
uitwisseling (methodes A en B). De laatste aanpak bleek iets zuiverder maar in alle gevallen was het 
erg moeilijk om de pyrroolring te alkyleren. Volledige deuterering werd bekomen maar reactie met 
andere elektrofielen dan D2O leidde niet tot volledige conversie. Dit had waarschijnlijk te maken met 
de sterische hinder die veroorzaakt werd door de grote vicinale fosfonaatgroep. 
 
Schema 8. Derivatisering door lithiëring. 
Uiteindelijk werden de gebromeerde pyrrolen xxii onderworpen aan een aantal koppelingsreacties 
onder microgolfbestraling. Sonogashirakoppeling faalde, maar Suzuki- en Stillekoppeling waren 
efficiënter en resulteerden in koppeling met sp-, sp2- en sp3-koolstofatomen. Desondanks was het 
moeilijk om volledige conversie te bekomen en was chromatografie vereist om de producten te 
scheiden van het residuele startmateriaal. In geval van de Suzukikoppeling zijn er aanwijzingen dat 
het eigenlijke werkingsmechanisme veeleer een C-H activatie was dan een koppelingsreactie. 
In een derde gedeelte van dit werk werd de difosfonylering van α,β-onverzadigde alifatische en 
aromatische imines verder uitgebreid naar α,β,γ,δ-dionverzadigde imines. Daartoe waren de 
overeenkomstige aldehydeprecursoren xxvii nodig. Deze verbindingen werden gesynthetiseerd aan 
de hand van een Wittig reactie uitgaande van commercieel beschikbare kortketen aldehyden xxiv 
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zoals cinnamaldehyde (Schema 9). De intermediaire acetalen bestonden als mengsels van E- en Z- 
isomeren xxvi maar na acetaalhydrolyse werd uitsluitend het gewenste E,E-isomeer xxvii bekomen. 
 
Schema 9. Wittig reactie voor de vorming van dionverzadigde aldehyden. 
Vervolgens konden deze dubbel onverzadigde aldehyden xxvii geïmineerd worden. Gebruik makend 
van standaardcondities met MgSO4 en een overmaat amine werden imines bekomen naast een 
aanzienlijke hoeveelheid 1,6- of 1,4-adduct. Andere imineringsprocedures gebruik makend van CuSO4 
of Ti(OEt)4 resulteerden niet in een verbetering. De methode gebruik makend van MgSO4 in 
combinatie met 1 equivalent amine werd geselecteerd als de meest geschikte methode. 
Met deze α,β,γ,δ-dionverzadigde imines xxviii ter beschikking werd de drievoudige additie van twee 
types fosfornucleofielen geëvalueerd. Eerst werd dimethyl trimethylsilyl fosfiet (DMPTMS) gebruikt 
als nucleofiel in de aanwezigheid van H2SO4. Verrassend genoeg resulteerde dit in een vlotte 
conversie van dionverzadigde imines in dionverzadigde aminofosfonaten xxix (Schema 10). Geen 1,6- 
of 1,4-additie had plaatsgevonden, ongeacht de sterische bulk of de elektronsiche aard van R2. 
Bovendien had de R1 groep voor geen enkele van de drie types substraten een invloed op 1,6- of 1,4-
additie met DMPTMS. Echter, voor R2 = Ph werd 1,2-additie gevolgd door intermoleculaire substitutie 
of [5,5]-sigmatrope omlegging en werd een isomere verbinding bekomen. Deze resultaten staan in 
schril contrast tot het vorige werk over fosfietaddities aan α,β-onverzadigde imines dat werd 
uitgevoerd aan de onderzoeksgroep. 
 
Schema 10. 1,2-additie van DMPTMS. 
Gebaseerd op het voorgestelde mechanisme voor de tandem 1,4-1,2-additie werd een verklaring 
gezocht voor het gebrek aan 1,4- of 1,6-additie in dit geval. Hoewel, momenteel is dit speculatief en 
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moleculaire modellering studies worden op dit ogenblik uitgevoerd om de hypothese te 
ondersteunen. 
De bekomen aminofosfonaten xxix werden verder geacyleerd met behulp van chlooracetyl chloride 
(Schema 11). Daaropvolgende deprotonering en intramoleculaire substitutie resulteerden in de 
vorming van een gefosfonyleerd β-lactam xxxi in een goed rendement. Andere pogingen om xxix 
verder te derivatiseren, faalden. 
 
Schema 11. Acylering van xxixb en vorming van een β-lactam xxxi. 
Bij gebruik van een ander fosfornucleofiel, zijnde triëthyl fosfiet in plaats van DMPTMS, was het 
resultaat enigszins anders (Schema 12). In dit geval trad tandem 1,4-1,2-additie op en xxxii was het 
majorproduct. Er was eveneens wat monoadduct xxix aanwezig en bij sterisch gehinderde R-groepen 
werd een spoor triadduct, mogelijks xxxiii, waargenomen. Echter, in alle gevallen was difosfonylering 
tot xxxii de voornaamste reactieweg. Dit stond in schril contrast met de additie van DMPTMS, waar 
alleen monoadditie tot xxix optrad. 
 
Schema 12. Additie van triëthyl fosfiet aan onverzadigde imines xxviii. 
Als gevolg van de difosfonylering waren twee paren diastereomeren aanwezig in een 2/1 verhouding 
voor xxxiib. Ze werden gescheiden met behulp van preparatieve HPLC en het major diastereomeer 
werd de syn-configuratie toegewezen gebaseerd op een NOE experiment (Schema 13). 
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Schema 13. Identificatie van syn- en anti-isomeren. 
Het laatste deel van dit werk beoogde de bereiding van benzo[c]thiofenen met behulp van Au als π-
zuur voor een cycloisomerisatie. Een aantal benzaldehydes gesubstitueerd met een halogeen of een 
triflaat in ortho-positie werd onderworpen aan Sonogashirakoppeling gebruik makend van TMS-
acetyleen of fenylacetyleen. In het geval van TMS-beschermde substraten werd de silylgroep 
verwijderd om terminale alkynen te bekomen. 
Vervolgens werden deze aromatische aldehyden xxxiv omgezet in hun overeenkomstige diallyl 
thioacetalen (Schema 14). Dit werd bereikt gebruikmakend van allyl- of crotylmercaptaan in 
combinatie met een Lewiszuur. 
 
Schema 14. Vorming van dithioacetalen. 
Met deze verbindingen xxxv ter beschikking kon de beoogde Au-gekatalyseerde cyclisatie tot 
benzo[c]thiofenen xxxx geëvalueerd worden. Een groot aantal aan katalysatoren werd getest en dit 
toonde aan dat 5 mol% AuCl3 de meest geschikte katalysator was voor deze transformatie. AuCl, 
AuBr3 en HAuCl4 katalyseerden de reactie ook, maar andere monovalente Au-species deden dit niet. 
Additie van 2,6-di-t-butylpyridine vertraagde de reactie aanzienlijk terwijl het gebruik van KAuCl4 
onder droge omstandigheden niet resulteerde in enige omzetting. Deze observaties suggereerden 
dat een spoor HAuCl4 in situ gevormd was uitgaande van AuCl3 en vocht, zoals beschreven in de 
literatuur. 
VII. Samenvatting 
199 
 
In dit geval konden andere superzuren deze omzetting mogelijks ook katalyseren, dus werd de 
reactie met TfOH geëvalueerd. Verrassend genoeg leidde dit tot de vorming van een intermediair dat 
kon omgezet worden tot het beoogde benzo[c]thiofeen bij opwerking. Gebaseerd op een aantal 
spectrale data werd het intermediair geïdentificeerd als xxxvi (Figuur 1). 
 
Figuur 1. Geïsoleerd intermediair na behandeling van xxxvc met TfOH. 
Deze observaties suggereerden dat een voldoende sterk zuur de ringsluiting en allylmigratie kon 
bewerkstelligen, maar dat een stoichiometrische hoeveelheid zuur nodig was aangezien 
aromatisering niet spontaan optrad. Een solventscreening toonde aan dat dichloormethaan het 
meest geschikte solvent was. 
Gebaseerd op deze analyse werd een mechanisme voorgesteld voor de omzetting van diallyl 
thioacetalen xxxv naar benzo[c]thiofenen xxxx (Schema 15). In situ vorming van HAuCl4 resulteert in 
activering van het alkyn. Ringsluiting treedt op via 5-exo-dig cyclisatie en wordt gevolgd door een 
Claisen omlegging. De geconcerteerde aard van deze omlegging werd bewezen door het 
crotylderivaat te gebruiken in plaats van een allylderivaat. Dit resulteerde selectief in een vertakt 
product in plaats van een mengsel van vertakt en lineair product, hetgeen aantoont dat geen 
fragmentatie plaatsgreep. Na allylmigratie treedt aromatisering op en wordt de katalysator 
geregenereerd. 
 
Schema 15. Mechanisme van benzo[c]thiofeenvorming. 
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Deze transformatie slaagde voor alle terminale alkynen (Schema 16). Intern alkyn xxxvj blootstellen 
aan deze geoptimaliseerde contities, echter, resulteerde alleen in recuperatie van startmateriaal. 
 
Schema 16. Bereiding van een bibliotheek aan benzo[c]thiofenen. 
Samengevat heeft dit werk geresulteerd in de synthese van 93 nieuwe verbindingen en de 
ontwikkeling van innovatieve toetredingen tot aza- en thiaheterocyclische verbindingen. De 
retrosynthetisch beoogde synthese van gefosfonyleerde pyrrolen gebaseerd op de chemie van de 
fosfonoazadiënen faalde, maar heeft geresulteerd in de ontdekking van een onverwachte lithium-
halogeen uitwisseling op een sp3-koolstof. Bovendien heeft dit geleid tot een intramoleculaire 
cyclopropanering met vorming van een azabicyclisch skelet dat anders moeilijk te bekomen is. 
Bijgevolg werd een andere toenadering tot gefosfonyleerde pyrrolen ontwikkeld gebaseerd op een 
transitie-metaal gekatalyseerde intramoleculaire hydroaminering van gefosfonyleerde alkynamines. 
Dit keer was de beoogde strategie succesvol en tetragesubstitueerde pyrrolen werden bekomen. 
Verdere derivatisatie van de pyrroolring was mogelijk gebruik makend van Pd-gebaseerde 
koppelingsreacties.  
Naast deze klassen onverzadigde N-heterocyclische verbindingen konden gefosfonyleerde β-
lactamen ook gemaakt worden. De resultaten van de uitbreiding van eerder ontwikkelde tandem 
fosfietadditiereacties aan α,β,γ,δ,-dionverzadigde imines hingen verrassend genoeg af van het type 
nucleofiel. De bekomen α-aminofosfonaten konden vlot worden omgezet naar β-lactamen. Tot slot 
werd een klasse thiaheterocyclische verbindingen gesynthetiseerd gebruik makend van Au-
gekatalyseerde cycloisomerisatie uitgaande van commercieel beschikbare benzaldehydes. 
Nauwkeurige analyse van het katalytisch systeem en isolering van een intermediair toonde aan dat 
een Au-geassisteerd proton-gedreven mechanisme werkzaam was. 
Terugblikkend op dit werk werden vier klassen aan transformaties bestudeerd en in elk hoofstuk 
werd een aantal waardevolle resultaten behaald, vanuit een synthetisch of mechanistisch standpunt. 
Veel van deze resultaten hebben nieuwe opportuniteiten voortgebracht of andere vragen 
opgeroepen, die meer dan genoeg ruimte laten voor de verdere uitwerking van bepaalde delen van 
dit werk. 
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Yes, in 1917, when Albert Einstein established the theoretic foundation for the laser in his paper “Zur 
Quantentheorie der Strahlung,” his fondest hope was that the resulting device be “bitchin’.” 
- Sheldon Cooper 
